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Abbreviations 
3-NBA 3-nitro-benzyl alcohol (matrix for FAB-
MS) 
J coupling constant 
Å Ångström (10-10 m) m multiplet (NMR) 
ACPKR asymmetric catalytic Pauson-Khand 
reaction 
m.p. melting point 
Ar aryl MS Mass spectroscopy 
BArF tetrakis[3,5-
bis(trifluoromethyl)phenyl]borate 
nd not determined 
BICP 2,2’-bis-(diphenylphosphino)-1,1’-di-
cyclopentane 
NHC N-heterocyclic carbene 
BINAP 2,2’-bis-(diphenylphosphino)-1,1’-bi-
naphthalene 
NHS N-heterocyclic silylene 
BOX bisoxazoline NMR nuclear magnetic resonance 
br broad (NMR, IR) NOE Nuclear Overhauser effect 
c concentration Ph Phenyl 
CAMP (2-methoxyphenyl)methylphenyl-
phosphine 
PHOX phosphinooxazoline 
cat. catalyst ppm parts per million 
CCDC Cambridge Crystallographic Data Centre pst pseudo-triplet (NMR) 
cod 1,5-cyclooctadiene q quartett (NMR) 
conv. conversion rac. racemic 
COSY correlation spectroscopy (NMR) Rf retention factor 
Cy cyclohexyl RT room temperature 
 chemical shift s singlet (NMR), strong (IR) 
d doublet (NMR) sat. saturated 
DIOCP 2,3-O-isopropylidene-2,3-dihydroxy-1-
(dicyclohexyl-phosphino)-4-(diphenyl-
phosphino)butane 
sh shoulder (IR) 
DIOP 2,3-O-isopropylidene-2,3-dihydroxy-1,4-
bis(diphenyl-phosphino)butane 
t triplet (NMR) 
DIPAMP bis[(2-methoxyphenyl)phenylphos-
phino]ethane 
tert tertiary 
DMAP dimethylaminopyridine THF tetrahydrofurane 
DMF N,N-dimethyformamide TLC thin-layer chromatography 
DMSO dimethylsulfoxide TOF turnover frequency 
ebthi ethylene-1,2-bis(5-4,5,6,7-tetrahydro-1-
indenyl) 
TON turnover number 
EDC ethyl-N,N’-dimethylamino-propyl-
carbodiimide hydrochloride 
tR retention time 
ee enantiomeric excess w weak (IR) 
EI elelctron impact ionization (MS) ν~  wave number (IR) 
eq. equivalent   
ESI electrospray ionization   
FAB fast atom bombardment   
FTIR Fourier transform infra-red   
GC gas chromatography   
HMBC heteronuclear multiple-bond correlation 
(NMR) 
  
HMQC heteronuclear multiple quantum 
coherrence 
  
HOBt 1-hydroxybenzotriazole   
HPLC high performance liquid chromatography   
Hz Hertz   
i iso   
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1 Introduction 
1.1 Ligands - Coordination Chemistry - Catalysis 
The term ligand [latin, ligare = bind] has its origin in coordination chemistry. It denotes a 
molecule that is able to bind to a metal center in most cases via one or several free electron 
pairs.[1] Ligands can be described by the number of electron-pair donor atoms as monodentate, 
bidentate, tridentate etc. ligands. The latter are also called chelating ligands [greek, chele = 
(crab’s) claw]. A typical classification of ligands is according to their electronic properties. 
They serve either as a σ-donating, σ-donating/π-accepting, or σ,π-donating/π-accepting 
ligands.[2] A more practical, often encountered approach is the classification of ligands 
according to their donor atoms, especially when larger molecules and molecules containing 
heteroatoms are regarded (compare 1.2). 
Coordination chemistry was already established in the 19th century. In 1893 Alfred Werner 
suggested an octahedral arrangement of ligands coordinated to a central metal ion for many 
compounds. This explained, for example, the appearance and reactivity of four different 
cobalt(III) complexes (Figure 1.1), when CoCl2 is dissolved in aqueous ammonia and then 
oxidized by air to the +3 oxidation state. The formulas of these complexes can be written as 
depicted in Figure 1.1. Werner’s work was rewarded with the Nobel prize in 1913.[3] 
Co
H3N
H3N NH3
NH3
NH3
NH3
3+
3 Cl- Co
H3N
H3N NH3
NH3
Cl
NH3
2+
2 Cl- Co
H3N
H3N NH3
NH3
Cl
Cl
+
Cl- Co
H3N
H3N NH3
NH3
OH2
NH3
3+
3 Cl-
[Co(NH3)6]Cl3 [Co(NH3)5Cl]Cl2 [Co(NH3)4Cl2]Cl [Co(NH3)5(H2O)]Cl3  
Figure 1.1: “Werner-complexes” 
Coordination chemistry is mainly chemistry of transition metal compounds. Here, ns-, np- and 
nd-orbitals are valence orbitals, while the participation of nd-orbitals in main group metal 
chemistry is the exception. Figure 1.2 shows the different orbital interactions: σ-donating 
interaction takes place between s, pz and dz2-orbitals of the transition metal and s and pz orbital 
of the ligand. π-donating and π-accepting (retrodative) interaction occurs between px, py, dxz, 
and dxy atomic orbitals of the transition metal and px, py, dxz, and dxy of the ligand. 
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M C O
πx*, πy*
π-retrodative bond
( back-bonding)
M C O
πx, πy
π-dative bond
σs*
M C O
σ-dative bond
 
Figure 1.2: Orbital interactions in transition metal complexes 
Transition metal complexes play an important role in homogeneous catalysis. Coordination at 
the metal center brings the reactants in close proximity and thus accelerates the reaction. 
Sometimes reaction can only take place when one or both reactants are activated through 
coordination. For example, coordination of a substrate to the metal can facilitate nucleophilic 
attack at the substrate. If the catalyst is chiral, e.g. through coordination of a chiral ligand, it 
can allow enantioselective syntheses through asymmetric induction. Normally, the metal 
component activates the reactants, while the chiral ligand is responsible for enantiocontrol. 
1.2 Important Ligand-Classes 
For a long time, the dominating ligands in asymmetric catalysis were C2-symmetric.[4] C2-
symmetric ligands lead to fewer isomeric metal complexes in comparison to non-symmetric 
ligands, and thus to fewer transition states in catalysis. That renders them favourable objects 
for the determination of reaction mechanisms and the elucidation the origin of the observed 
asymmetric induction.  
However, more recently nonsymmetrical ligands have found increasing attention. In fact, 
efficient nonsymmetrical ligands were in some reactions superior to C2-symmetric ligands. 
This was well illustrated for rhodium-catalyzed asymmetric hydrogenation, where the 
intermediates in the catalytic cycle are nonsymmetrical (Scheme 1.1, left).[5]  
Rh
Pcis
Ptrans S
X
R
X = C, O, N
S = O, N, Cl, solvent
O
O
O
O
HO
O
*
50 atm H2, Rh-cat.
THF, 50°C, 45 h O
O
PR'2
PR2
H
H
37% (R)
72% (R)
R2 =R'2 = Ph (R,R)-DIOP 
R2 = Cy, R'2 = Ph (R,R)-DIOCP 
Scheme 1.1: Desymmetrized diphosphine in rhodium-catalyzed hydrogenation 
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In consequence the two phosphine groups interact with the substrate in a different manner. 
Since electronic effects are delivered preferentially to the trans-coordinated ligand, Ptrans 
executes mainly an electronic effect. Pcis, in contrast, exerts mainly steric interactions with the 
substrate. Indeed, DIOCP ligand was more effective than DIOP in the asymmetric 
hydrogenation of ketopantolactone (Scheme 1.1, right). 
1.2.1 P,P-Ligands: Diphosphines 
Following several decades of developments, the use of asymmetric catalysis allows nowadays 
the enantioselective synthesis of numerous biologically active molecules or natural 
products.[6,7] The first breakthroughs in asymmetric catalysis have been carried out in the field 
of rhodium-catalyzed homogeneous hydrogenation. The use of C2-symmetric phosphines as 
chiral inducers led to the formation of products with significant enantiomeric excesses. 
Kagan's work using the tartrate-derived diphosphine DIOP, and Knowles’, using the P-chiral 
diphoshine DIPAMP, are the most salient pioneering examples of such catalytic systems 
(compare 2.1).[8,9]  
The most prominent ligand among the diphosphines is probably BINAP 1, an axially chiral 
ligand that was developed by Noyori et al. in 1980.[10] Being a so-called “privileged” ligand 
(Figure 1.3),[11] BINAP is used in numerous asymmetric catalytic reactions, such as 
hydrogenation, Diels-Alder reaction, Mukaiyama aldol reaction, etc., where excellent results 
are obtained.[12,13,14]  
PPh2
PPh2 N
O
N
O
t-Bu t-Bu
OH
OHO
O
Ph Ph
Ph Ph
BINAP 1 BOX 2 TADDOL 3  
Figure 1.3: Some “priviledged” ligands 
1.2.2 N,N-Ligands: Semicorrins and Bisoxazolines 
Chiral C2-symmetric semicorrins were introduced as ligands in asymmetric catalysis by Pfaltz 
et al..[15] These ligands were inspired by corrinoid and porphinoid metal complexes, which are 
known as biocatalysts. The flexibility of the semicorrin ligand framework is restricted by the 
inherent π-system and the two five-membered rings. The substituents at the two stereogenic 
centers shield the metal center from two opposite directions. They are expected to strongly 
influence the reaction taking place in the coordination sphere. Semicorrins were found to give 
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excellent results in copper-catalyzed cyclopropanation of olefins and cobalt-catalyzed 
conjugate reduction of α,β-unsaturated carboxylic acid derivatives.[16] 
A related structural motive is found in bisoxazoline (BOX) ligands 2, which were reported 
independently by several research groups.[17] BOX ligands are especially attractive, because 
they are easily accessible from amino alcohols which are derived from natural amino acids in 
enantiomerically pure form. This allows facile structural modification for different 
applications. More recently, related ligands (borabox, azabox) were developed, which are 
bearing heteroatoms in the bridge that connects the two oxazoline rings.[18,19] 
1.2.3 P,N-Ligands: Phosphinooxazolines 
Pfaltz, Helmchen[20] and Williams[21] developed independently a new class of ligands, the 
phosphinooxazoline (PHOX) ligands 4. The combination of a P-ligand part and a chiral N-
ligand part is another way to build up non-C2-symmetric, chelating ligands, wherein the two 
ligand parts are more fundamentally distinguished, compared to the modified diphosphine 
ligands mentioned in 1.2. Here, the “soft” P-ligand exhibits π-acceptor properties, while the 
“hard” N-ligand is dominantly acting as a σ-donor. The beneficial effect of the combination 
of two ligands with different electronic properties is well illustrated in the palladium-
catalyzed allylic alkylation (Figure 1.4, left). Crystal structure and NMR data confirmed that 
palladium-allyl-PHOX complexes exhibit a strong electronic differentiation of the allylic 
termini, and it was observed that these complexes are predisposed to be attacked at the allylic 
carbon atom trans to the phosphino group.[20,22] Electronic differentiation of this type has also 
been calculated by Ward[23] and demonstrated by Moberg et al. using pseudo-C2-symmetric 
ligands (e.g. 5), i.e. with sterical symmetry and electronic asymmetry (e.g. Figure 1.4, 
right).[24] 
P NN
O
PPh2
Pfaltz
Helmchen
Williams MobergR R
NP
Pd
Nu- 4 5  
Figure 1.4: Regioselectivity in palladium-catalyzed allylic alkylation (left), different P,N-ligands 4 and 5.[15,24] 
PHOX ligands are modularly constructed and can be synthesized in few steps. This enables a 
relatively easy variation and allows to tailor the ligand according to its application. Apart 
from allylic alkylation, PHOX ligands were also applied in other metal-catalyzed processes, 
including Heck reactions,[25] silver-catalyzed 1,3 dipolar cycloaddition,[26] and iridium-
Introduction 
 19
catalyzed hydrogenation.[27] The latter reaction was tested with numerous PHOX analogues, 
which are able to hydrogenate unfunctionalized aryl- and alkyl-substituted unfunctionalized 
and functionalized olefins, with high enantioselectivities and at low catalyst loadings. 
1.2.4 C-Donor Ligands: N-Heterocyclic Carbenes 
N-Heterocyclic carbenes (NHCs) were developed independently by Wanzlick[28] and Öfele in 
1968.[29] However, it took about twenty years until an adamantyl-substituted carbene was 
isolated by Arduengo,[30] and only in the mid 1990s NHCs were finally introduced in 
asymmetric catalysis by Enders[31] and Herrmann.[32] Since then, the scope of catalytic 
reactions has largely expanded, and NHCs are now applied in a variety of metal-catalyzed 
asymmetric reactions, such as olefin-metathesis, allylic alkylation, transfer hydrogenation, 
1,4-addition and others.[33,34,35,36]  
O N
N
N
R1 R2
N
O
N
N
R2
R1
N
N
Ar
PPh2
6 7 8  
Figure 1.5: Oxazoline-NHC ligand 6 and paracyclophane based NHC chelating ligands 7 and 8[37,38] 
More recently, NHCs were incorporated in chelating P,C- and N,C-ligands, such as 6-8 
(Figure 1.5), and tested in iridium-catalyzed hydrogenation. Burgess et al. reported high 
enantioselectivities for a range of olefins using a bidentate oxazoline-NHC ligand 6.[38] 
1.3 Objectives of this Work 
Although many studies are carried out in order to design new catalysts on a rational basis, 
finding new selective ligands is also a matter of luck and intuition. Laborious screening is still 
the major way in obtaining taylor-made catalyst systems for a specific substrate.  
Iridium-complexes derived from P,N-ligands represent a highly active class of catalysts for 
asymmetric hydrogenation. We were interested to extend our library of P,N-ligands (Figure 
1.6), and to investigate the influence of a smaller ring-chelate 10, since most previously tested 
ligands form six-ring-chelates. Another objective was to examine the effect of a strong π-
accepting and planar phosphorus-moiety, as is found in λ3-phosphinines 11. 
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P N
O
R2
Ir
R1
R1
Ir
P N
O
R1N
O
Ph2P
Ir X
- X- X-
9 10 11  
Figure 1.6: Cationic iridium-PHOX complexes 
In addition, we were interested in the scope of iridium-PHOX complexes in other catalytic 
reactions. Initial studies towards the application of this system in asymmetric catalytic 
Pauson-Khand reaction have shown promising results (Scheme 1.2). The studies were to be 
completed regarding pressure influence, reproducability and the influence of the counteranion 
on the enantioselectivity of the reaction. 
O
R1
O O
R1
CO
*
N
O
Ph2P
Ir X
-
 
Scheme 1.2: Iridium-catalyzed asymmetric intramolecular Pauson-Khand reaction 
The popularity of NHCs raised the question why their group 14 heavier analogues have not 
experienced the same attention in catalysis to date.[39] Although Fürstner et al. have published 
the application of a silylene-palladium complex 12 in Suzuki cross-coupling,[40] the actual 
catalytically active species remains unknown. No further attemps of using silylenes (Figure 
1.7) in catalysis have been reported. 
N
Si
N
N
Si
N
Pd PdPh3P PPh3
12  
Figure 1.7: Dinuclear palladium-silylene complex 12[40] 
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Inspired by the recent success of NHCs in the iridium catalyzed hydrogenation, we envisioned 
the synthesis of silylene containing iridium- and rhodium-complexes, suitable for 
hydrogenation studies.  
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2 New PHOX Ligands for Enantioselective Hydrogenation 
2.1 Hydrogenation of Functionalized Alkenes 
Asymmetric hydrogenation of alkenes has the longest history in enantioselective catalysis and 
is the best studied reaction with the largest number of industrial applications today.[41,42] 
Homogeneous hydrogenation catalysts were first introduced in 1961 by Halpern. [43] For the 
first time simple alkenes, such as maleic, fumaric, and acrylic acids, could be reduced under 
homogeneous conditions using a chlororuthenate(II) complex. Other significant advances 
were made by Wilkinson and co-workers, who developed a number of effective rhodium and 
ruthenium catalysts.[44] RhCl(PPh)3 (Wilkinson's complex), was shown to effect hydrogenation 
reactions with site- and diastereoselectivity under mild conditions.[45] Terminal double-bonds 
could be efficiently reduced in the presence of hindered double-bonds and functional groups. 
O
O
PPh2
PPh2
H
H
PP
O
O
P
O
13 14 15  
Figure 2.1: Early developments of chiral phosphines: CAMP 13,[46,47] DIOP 14,[8] DIPAMP 15[9] 
Knowles[46] and Horner[47] extended this method by introducing chiral phosphorus ligands. A 
major advance was made by the development of chiral chelating diphosphines such as 
Kagan’s DIOP 14, a tartric acid derived diphosphine (Figure 2.1).[8] The respective 
rhodium(I) catalyst was found to reduce β-substituted α-acetamidoacrylic acids with optical 
yields in the range of 70 to 80% ee. It was again Knowles who developed the first industrially 
used rhodium-catalyst.[9] The rhodium-DIPAMP catalytic system which possesses two 
stereogenic phosphorus atoms, and can be regarded as a second generation of the chiral 
monophosphine CAMP 13 (Figure 2.1). This development allowed Monsanto company the 
industrial scale production of an L-DOPA precursor in the 1970s using enantioselective 
reduction (Scheme 2.1).[48]  
AcO
COOH
NHAc
AcO
COOH
NHAc
HH
HRh(I)/DIPAMP
10 bar H2, 25°C
MeO
MeO
96% ee  
Scheme 2.1: Rhodium catalyzed enantioselective hydrogenation of an L-DOPA precursor 
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Numerous chelating diphosphines have been synthesized, a few of which are commercially 
available today (Figure 2.2). In the 1980s focus has changed towards chiral ruthenium 
catalysts,[49,50] which were applicable to a wider range of substrates, including allyl alcohols, 
with respectable results. However, both rhodium and ruthenium catalysts can only be applied 
in the reduction of functionalized olefins that bear a coordinating group next to the carbon-
carbon double bond (with the excemption of 1,1-disubstituted alkenes). 
FeR2P
H
PR'2
CH3 P P
Ph2P PPh2
H
H
Josiphos
(Solvias)
Duphos
(Dow Chirotech)
BICP
(DSM)  
Figure 2.2: Some commercially available chelating diphosphines 
2.2 Hydrogenation of Unfunctionalized Alkenes 
In contrast to the enantioselective hydrogenation of functionalized alkene substrates, where 
the additional coordinating sites are crucial for achieving high enantioselectivity, the 
hydrogenation of prochiral unfunctionalized alkenes was much less delveloped. While 
Rhodium diphosphine catalyst systems showed only moderate selectivity,[51] very good results 
were achived with chiral group four metallocene complexes. A reduced form of Brintzinger’s 
bis(tetrahydroindenyl)titanium binaphtholate catalyzed the hydrogenation of a number of 
trisubstituted arylalkenes with selectivities above 90% ee.[52] More recently a related cationic 
zirconocene 16 was found to reduce tetrasubstituted alkenes with up to 99% ee.[53] However, 
relatively long reaction times, high pressure and relatively high catalyst loadings are required 
due to the rather low catalyst activity (Scheme 2.2). 
Zr
F
8 mol% catalyst
1700 psi (117 bar) H2
13-21 hours
[PhMe2NH]+B(C6F5)4-
77% yield
96% ee
F
16
 
Scheme 2.2: Enantioselective hydrogenation of tetrasubstituted alkene with cationic zirconocene 
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In 1976 Crabtree developed a cationic iridium catalyst 17 which was found to reduce tri- and 
tetrasubstituted alkenes with high activity (Figure 2.3).[54] Subsequently, Pfaltz has reported a 
new class of chiral iridium catalysts which is structurally related to Crabtree’s catalyst.[55] 
These chiral iridium complexes with phosphinooxazoline (PHOX) ligands catalyzed the 
hydrogenation of various aryl-substituted alkenes with high activity and 
enantioselectivity.[56,20,27]  
Cy3P N
Ir
PF6- N
O
o-Tol2P
Ir
S/C < 1000 S/C< 4000
97% ee
17 18
 
Figure 2.3: Crabtree’s catalyst (left) and one of Pfaltz’ catalyst (right) 
Encouraged by those results, numerous related chelating ligands have been developed by 
Pfaltz et al.[57], Burgess et al.[58] and others.[59] Besides phosphines, more electron-poor 
phosphinites, phosphites and phosphoramidite ligands were employed as P-donors. Chelating 
N-heterocyclic carbenes and pyridine-based N-donors were also investigated. By tuning the 
steric and electronic properties through varying the substitution pattern, the ligands can be 
optimized for various substrates. 
2.3 Objectives of this Chapter 
Among others[60], Smidt et al.[61] and Zhang et al.[62] have prepared phosphinooxazolines 
ligands containing a stereogenic phosphorus atom. Zhang published the use of phospholane-
oxazoline ligands for iridium-catalyzed asymmetric hydrogenation. These ligands, bearing a 
chiral phosphacycle next to the amino alcohol derived chiral oxazoline moiety, showed good 
results in the hydrogenation of methylstilbene derivatives. Furthermore, very good results 
were achieved in the hydrogenation of β-methylcinnamic esters. 
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Ir
COOEt COOEt
*
BArF-
CH2Cl2, 50 bar H2, 3h, r.t.
P N
OH
t-Bu
R
19
 
catalyst a b c d e f 
R = iPr tBu Ph Bn iBu iPr 
conf. ligand S S S S S R 
ee [%] 94 91 98 92 95 93 
conf. product R R R R R S 
Scheme 2.3: Hydrogenation of (E)-ethyl-3-phenyl-but-2-enoate 
Catalysts a and f (Scheme 2.3) are diastereoisomers and differ only at the phosphorus 
stereocenter. For the hydrogenation of (E)-ethyl-3-phenyl-but-2-enoate, essentially the same 
enantioselectivity is observed: 94% ee (R) versus 93% ee (S). Although the situation is 
somewhat different for unfunctionalized (E)-1,2-diphenyl-1-propene (91% ee (R) versus 77% 
ee (S)), it can be assumed that the influence of the chiral phospholane moiety is relatively 
small since only weak matched-mismatched behaviour is observed. It can be assumed that the 
absolute configuration of the phospholane is not responsible for enhanced enantioselectivity. 
We therefore decided to synthesize related phosphinoxazolines, containing a non-chiral 
phosphorus centre. 
Diphenylphosphinomethyloxazolines of the same ligand-type have been previously published, 
and tested in palladium-catalyzed allylic alkylation and ruthenium catalyzed transfer 
hydrogenation.[63] These ligands were prepared according to the method depicted in Scheme 
2.4. Methyloxazolines were lithiated and then transmetallated with TMS-chloride. According 
to Braunstein et al., reaction with chlorodiphenylphosphine afforded the ligands 20 a-c in up 
to 75% yield.  
O
N
R2
R1
O
N
R2
R1Et2O
n-BuLi
O
N
R2
R1
TMSCl O
N
R2
R1
Ph2PCl
TMS Ph2P
Li
a: R1 = R2 = H
b: R1 = R2 = Me
c: R1 = H, R2 = iPr
20  
Scheme 2.4: Synthesis of diphenylphosphineoxazolines[63] 
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Due to the strong basic conditions of the synthesis (an excess of n-BuLi is used), the use of 
phenyl substituted oxazolines would probably lead to racemization at the stereogenic centre. 
A more general route to ligands of this type was therefore investigated. 
During the course of this work Imamoto et al. published the synthesis of P-stereogenic 
ligands of the same type as 20, and their application in palladium-catalyzed allylic 
alkylation.[64] His approach is related to route A (see below). 
2.4 Ligand and Complex Synthesis 
Two new routes to chiral phosphinomethyloxazolines were developed based on the 
retrosynthetic analysis depicted in Scheme 2.5. The ligand can be prepared by ring-closure of 
the respective amide, which in turn is derived from the amide coupling of a chiral amino 
alcohol with a phosphinoacetic acid (Scheme 2.5, route A). The latter can be obtained from 
the corresponding methylphosphine. In a more convergent route a secondary phosphine can 
be coupled with a 2-chloromethyl-2-oxaline. The latter ligand can be synthesised from 
chloroacetyl chloride and a chiral amino alcohol via amide coupling and ring-closure. 
P R1
R1
P
R1
R1
COOH
P
R1
R1
N
H
O
OH
R2
P
R1
R1
N
O
R2 Cl N
O
R2PH
R1
R1
N
H
O
OH
R2
Cl
Cl
O
Cl
+
H2N OH
R2
H2N OH
R2
CO2 +
+
+
route A route B
P R1
Cl
R1  
Scheme 2.5: Retrosynthesis of phosphinomethyl-oxazolines 
Since phosphine compounds are rather air-sensitive we chose to borane-protect the phosphino 
group to prevent oxidation. This facilitates the purification of the intermediates since 
phosphine borane-adducts are relatively air-stable and usually give crystalline compounds. 
The protective group was removed prior to complex synthesis. Three ligands were prepared 
according to route A (R1 = R2 = tBu; R1 = tBu, R2 = Ph; R1 = Cy, R2 = Ph). However, it was 
observed that ring-closure conditions also cleaved the protective group resulting in only 
moderate yields. Particularly in the case of R1 = Ph deprotection was comparatively fast, so 
that the phosphine was almost completely oxidized. For this reason we chose route B 
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(Scheme 2.5) in this case. Since it was observed that the convergent route was generally 
higher yielding, it was also employed for the remaining dialkylphosphinomethyl-oxazolines. 
2.4.1 Phosphinoacetic Acid-Borane Adducts 
Similar to Zhang et al.[62] the linear approach was initially chosen (route A). It starts with the 
preparation of phosphinoacetic acids, which are later coupled with the amino alcohol to the 
corresponding amides. The latter can then be cyclized to the respective oxazolines. 
The phosphinoacetic acids were prepared according to two different procedures. Di-tert-
butylchlorophospine and chlorodicyclohexylphosphine were transformed to the corresponding 
methylphosphines, by use of methyl lithium, and borane-protected in one pot. In a second 
step, the methylphosphines were lithiated with sec-BuLi at low temperature. Treatment with 
CO2 and acidic workup afforded the dialkylphosphinoacetic acid-borane adducts 24 and 28 in 
good yields.[65] (Scheme 2.6) 
P
BH3
tBu2PCl + MeLi
pentane
-78°C, 12 h
borane-THF
0°C      rt, 15 h
PH3B COOH-78°C, 2 h
tBu2PMe
+ sec-BuLi
THF
H+/H2O
CO2
P
BH3
PCy
BH3
Cy
Cy2PCl + MeLi
pentane
-78°C, 12 h
borane-THF
0°C      rt, 15 h
PCy
BH3
Cy
COOH
-78°C, 2 h
+ sec-BuLi
THF
H+/H2O
CO2
PCy
BH3
Cy
Cy2PMe
84%
94%
82%
66%
23
24
27
28
2221
25 26
23
27  
Scheme 2.6: Preparation of dialkylphosphinoacetic acid-borane adducts 24 and 28 
Chlorodiphenylphosphine was also transformed to the methylphosphine-borane adduct using 
methyl Grignard. However, the subsequent lithiation was found to be unselective. A 
procedure from Ebran et al.[66] was therefore used in which borane-protected diphenyl-
phosphine was treated with chloroacetic acid ethylester in presence of NaH. Saponification of 
the ester 32 afforded the desired diphenylphosphinoacetic acid-borane-adduct 33 (Scheme 
2.7). 
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borane-THF
THF, 17 h
PPh
BH3
Ph
COOEt
PPh
BH3
Ph
H0°C      rt, 15 h
PPh
BH3
Ph
H
Ph2PCl
NaH
Cl COOEt+
PPh
BH3
Ph
COOEt
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PPh
BH3
Ph
COOH
KOH, H2O
30
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86%
99%
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29
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Scheme 2.7: Preparation of diphenylphosphino acetic acid-borane adduct 33 
2.4.2 Phosphanyl-methyl-4,5-dihydro-oxazoline-Borane Adducts by Cyclization 
The phosphinoacetic acid-borane adduct was condensed with chiral amino alcohols using 
ethyl-N,N’-dimethylamino-propyl-carbodiimide hydrochloride (EDC) (which gives a water 
soluble urea by-product thus facilitating work up) and 1-hydroxybenzotriazole (HOBt) as an 
activating agent for the acid compound.[67] The amides obtained were used without further 
purification (Scheme 2.8). Ring-closure was performed with (methoxycarbonyl-sulfamoyl) 
triethylammonium hydroxide, inner salt (Burgess’ reagent)[68] to give the phosphanyl-methyl-
4,5-dihydro-oxazoline-borane adducts 45-47. Burgess’ reagent provides a reactive alcohol 
derivative and acts as an intramolecular base to facilitate the cyclization process. In contrast to 
dehydration to olefins (which is observed for secondary and tertiary alcohols) primary 
alcohols prefer to undergo substitution. In this case ring-closure is achieved by intramolecular 
SN2 reaction of the intermediate sulfonate. (Scheme 2.9) 
P
R1R1
H3B NH
O
OH
R2 MeO2CNSO2NEt3
N
O
R2P BH3
R1
R1
THF, 70°C, 4h
34-44 45-47
P
R1R1
H3B OH
O EDC, HOBt
CH2Cl2
aminoalcohol
 
R1 tBu tBu tBu tBu Cy Cy Cy Cy Ph Ph Ph 
R2 tBu Np Ph iPr tBu Np Ph iPr tBu Ph iPr 
amide 34 35 36 37 38 39 40 41 42 43 44 
oxazoline 45 - 46 - - - 47 - - - - 
yieldoxazoline 56% - 43% - - - 94% - - - - 
Scheme 2.8: Phosphanyl-methyl-4,5-dihydro-oxazoline-borane adducts 45-47 via amides 34, 36, 40 
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The use of Burgess’ reagent proved to be problematic for diphenylphosphino acetamide-
borane-adducts since the liberated triethylamine deprotected the less basic 
diphenylphosphine-derivatives. Di-tert-butyl- and dicyclohexyl-derivatives reacted with 
moderate to good yields to afford the corresponding oxazolines 45 to 47, since deprotection of 
the more electron-rich phosphino groups is hampered.[69] 
P
R1R1
H3B NH
O
OH
R2
P
R1R1
H3B NH
O
O
R2
MeO2CNSO2NEt3
S
NMeO2C
O O
N
O
R2P BH3
R1
R1
NEt3H
 
Scheme 2.9: Activation of phosphino acetamide-borane-adduct with Burgess’ reagent 
Confronted with the unwanted inherent deprotection, an alternative route was chosen (route 
B). This route consists of the coupling of secondary phosphine-borane adducts and a 2-
chloromethyl-2-oxazoline. The borane adducts were synthesized by addition of a borane 
source to the secondary phosphines. 2-Chloromethyl-2-oxazolines were obtained by reaction 
of chloroacetyl chloride with the respective amino alcohol in the presence of triethylamine. 
The amide was then cyclized as described above, using Burgess’ reagent. 
2.4.3 Secondary Phosphine-Borane Adducts 
According to route B (Scheme 2.5) the phosphinomethyl-oxazoline was synthesized from a 
secondary phosphine and 2-chloromethyl-2-oxazoline. Again we chose to borane-protect the 
phosphino group to prevent oxidation during work-up. 
The most common approaches towards the synthesis of phosphine–boranes employ the 
reaction of the parent phosphine with borane sources such as borane–tetrahydrofuran and 
borane–dimethylsulfide.[70] The use of sodium borohydride as a borane source, in conjunction 
with a hydride acceptor such as acetic acid, also yields phosphine-borane adducts. The latter 
method was extended to the one-pot reduction-protection procedure of phosphine oxides or 
chlorophosphines without isolation of the intermediate phosphines, in the presence of lithium 
aluminium hydride and cerium trichloride.[71]  
In the present case, di-tert-butylphosphine and diphenylphosphine were reacted with borane-
THF-adduct, whereas dicyclohexylphosphine was reacted according to McNulty et al. with 
sodium borohydride in THF-acetic acid (Scheme 2.10). The respective secondary phosphine-
borane adducts 30, 48 and 49 were obtained in good to very good yields.[72] 
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HH3BBH3-THF, THF
0°C      rt, 2-15 h
H
P
CyCy
P
CyCy
HH3BNaBH4, AcOH, THF
0°C      rt, 18 h
30 R1 = Ph
48 R1 = tBu
81%
99%
86%49
 
Scheme 2.10: Synthesis of secondary phosphine-borane adducts[72] 
2.4.4 Chloromethyloxazolines 
2-Chloromethyl-2-oxazolines detailed in Scheme 2.11 were derived from 2-chloro-N-(1-
hydroxymethyl)-acetamides and subsequent intramolecular SN2 reaction. The amides were 
prepared from chloroacetyl chloride and an amino alcohol in dichloromethane in the presence 
of triethylamine. The amide coupling reaction proceeded smoothly to give the 2-chloro-N-(1-
hydroxymethyl)-acetamides 50 to 53 in 73-95% yield. Ring-closure was performed as 
described above (see section 2.4.2) with Burgess’ reagent in THF to afford the oxazolines 54 
to 57 in 61-89% yield. 
MeO2CNSO2NEt3
N
O
R2ClTHF, 70°C, 4h
50-53
Cl
Cl
O NEt3, aminoalcohol
CH2Cl2, rt, 15 h
Cl
H
N
O
OH
R2
54-57  
 50 51 52 53 54 55 56 57 
R2 tBu Np Ph iPr tBu Np Ph iPr 
yield 73% 74% 92% 95% 65% 89% 77% 61% 
Scheme 2.11: Synthesis of chloromethyloxazolines 54-57 
To date, one of the best P,N-ligands for the hydrogenation of tetrasubstituted olefins is a 
neopentyl-substituted PHOX-ligand (compare 2.5.3, Figure 2.5). In order to test the influence 
of the neopentyl group in phosphinomethyl-oxazolines, the amino alcohol, derived from the 
non-natural amino acid (S)-neopentylglycine, was also synthesized (Scheme 2.12). (S)-
Neopentylglycinol 32 was obtained by reduction of the corresponding amino acid with 
LiAlH4 in 82% yield.[73] 
H2N OH
H2N OH
THF, rt, 4h
O
LiAlH4
58  
Scheme 2.12: Reduction of (S)-neopentylglycinol (left); neopentyl-substituted PHOX (right) 
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2.4.5 Phosphanyl-methyl-4,5-dihydro-oxazoline-Borane Adducts by Coupling 
Route B (Scheme 2.5) towards phosphanyl-methyl-4,5-dihydro-oxazoline-borane adducts 
proceeds via direct coupling of a borane-protected secondary phosphine and a 
chloromethyloxazoline. In comparison to the linear synthesis A (2.4.2) this convergent route 
is more versatile. For example, it can be extended to more electron-poor phosphines which 
cannot tolerate the presence of a concurrent Lewis-base without suffering from deprotection 
and thus oxidation. In contrast to the synthesis of Sprinz et al.,[63] it also permits the synthesis 
of a broader range of oxazolines, such as phenylglycinol-derived oxazoline, without 
racemization of the stereogenic center. 
The coupling was achieved by two slightly different variants of the same procedure (I and II in 
Scheme 2.13). Either borane-protected phosphine, 2-chloromethyl-2-oxazoline and NaH are 
reacted in one pot to give the product, or the phosphine is deprotonated at low temperature 
with n-BuLi and subsequent addition of the 2-chloromethyl-2-oxazoline gives the product in 
moderate to good yields. When phenylglycinol-derived oxazolines were used, a small excess 
of phosphine was applied to prevent racemization in the acidic benzylic position. 
Diphenylphosphine borane-adduct was usually deprotonated with NaH, while the protected 
dicyclohexylphosphine only reacted under more basic conditions. Phosphanyl-methyl-4,5-
dihydro-oxazoline-borane adducts 59 to 67 were synthesized in moderate to very good yields. 
(Scheme 2.13) 
NaH, THF
0°C      rt, 4-15 hN
O
R2Cl
+
-78°C rt, 4-15 h
N
O
R2Cln-BuLi, THF
-78°C, 2 h
I:
II: 59-67
P N
O
R2
R1
R1
BH3
P
H
R1
R1 BH3
P
H
R1
R1 BH3  
 59 60 61 62 63 64 65 66 67 
R1 tBu tBu Cy Cy Cy Ph Ph Ph Ph 
R2 Np iPr tBu Np iPr tBu Np Ph iPr 
method: I II II II II I II I I 
yield: 57% 86% 89% 83% 82% 67% 35% 44% 91% 
Scheme 2.13: Synthesis of phosphanyl-methyl-4,5-dihydro-oxazoline-borane adducts 33 to 41 
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2.4.6 Deprotection and Complex Synthesis 
Deprotection was accomplished in excess diethylamine at elevated temperature.[74] The 
reaction took one to five days, depending on the phosphorus substituents. Diphenylphosphine-
derivatives usually reacted faster, which is in accordance to the enhanced reactivity (i.e. lower 
lewis-basicity) as discussed above (2.4.5).  
N
O
R2PR
1
R1
NEt2H
60-70°C
68-79
P N
O
R2
R1
R1
BH3
 
Scheme 2.14: Deprotection of the phosphanyl-methyl-4,5-dihydro-oxazoline-borane adducts 
The conversion was followed by 1H and 31P NMR. As expected, the deprotection was 
accompanied by a significant upfield shift of the phosphorus and the adjacent CH2-group in 
31P NMR and the 1H NMR spectrum, respectively. The phosphorus signal, which in the 
borane-protected compounds is broadened by a borane-coupling, was shifted about 20 to 35 
ppm (Table 2.1). The methylene protons α to the phosphorus are upfield-shifted by 0.2 to 0.4 
ppm, demonstrating the considerable electron-withdrawing nature of the Lewis-acid. 
Table 2.1:31P{1H} NMR resonances for all protected and free ligands in CD2Cl2, (For spectra that were 
measured on the 400 MHz NMR spectrometer, the shifts were corrected (+ 3.6 ppm)) 
R1 tBu tBu tBu tBu Cy Cy Cy Cy Ph Ph Ph Ph 
R2 tBu Np Ph iPr tBu Np Ph iPr tBu Np Ph iPr 
+BH3 45 59 46 60 61 62 47 63 64 65 66 67 
δ [ppm] 48.3 48.3 49.0 48.4 28.3 28.1 28.9 28.1 17.6 17.6 17.8 17.8 
-BH3 68 69 70 71 72 73 74 75 76 77 78 79 
δ [ppm] 27.3 27.3 28.8 27.2 -2.7 -3.1 -1.9 -2.9 -17.3 -17.3 -17.1 -19.3 
If freshly distilled diethylamine was used, the ligands were formed quantitatively and cleanly. 
After the reaction excess diethylamine was evaporated under high-vacuum, and the amine-
borane adduct at 80°C under high-vacuum. The ligands were used without further 
purification, since initial trials to improve the ligand purity with column-chromatography 
under argon, showed no great effect. 
The complexes 80 to 91 were synthesized using standard procedures.[56] The ligands 68 to 79 
were treated with bis[chloro-(1,5-cyclooctadiene) iridium(I)] in dichloromethane. The 
complexation was followed by anion exchange with a slight excess of sodium tetrakis-[3,5-
bis(trifluoromethyl)phenyl]borate. The crude iridium-BArF salts were purified by column 
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chromatography on silica. Some complexes were recrystallized from dichloromethane and 
hexane at low temperature. The yields were between 29% and 96%. 
P N
O
R2
Ir BArF
R1
R1
1. CH2Cl2, 48°C, 2h
2. NaBArF, rt, 15 hN
O
R2PR
1
R1
80-91
[Ir(cod)Cl]2+
 
R1 tBu tBu tBu tBu Cy Cy Cy Cy Ph Ph Ph Ph 
R2 tBu Np Ph iPr tBu Np Ph iPr tBu Np Ph iPr 
 80 81 82 83 84 85 86 87 88 89 90 91 
yield 80% 83% 79% 96% 78% 67% 80% 78% 77% 65% 29% 65% 
δ [ppm] 42.7 46.1 41.1 41.7 21.7 25.1 25.8 22.9 24.9 23.7 19.2 21.6 
Scheme 2.15: Complex Synthesis with subsequent anion-exchange 
Eleven new phosphinomethyloxazoline ligands 68 to 78 were prepared via two different 
routes (Figure 2.4). In total twelve cationic iridium complexes 80 to 91 of these chelating 
ligands were synthesized.  
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Figure 2.4: Twelve synthesized phosphinomethyloxazolines 
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2.5 Catalytic Hydrogenation Reactions 
A number of unfunctionalized and functionalized highly-substituted substrates were tested in 
iridium-catalyzed enantioselective hydrogenation. The results of the hydrogenation of 
unfunctionalized and some functionalized alkenes are presented in the following section. 
2.5.1 (E)-1,2-Diphenyl-1-propene 
The hydrogenation of (E)-1,2-diphenyl-1-propene was performed with full conversion for all 
catalysts and gave selectivities from 37 to 99% ee. The best result was obtained for (S)-2-[(di-
tert-butyl-phosphanyl)-methyl]-4-tert-butyl)-4,5-dihydrooxazoline 68. Generally, the di-tert-
butylphosphinooxazolines gave the best results with ees of >88%. The selectivity with respect 
to the phosphorus substituents decreased in the order tert-butyl > cyclohexyl > phenyl. For the 
substituent at the oxazoline-ring, no trend was observed. The enantioselective results for this 
trisubstituted alkene, with the exception of 80, are lower than with the best PHOX ligands, 
where selectivities bigger 99% were obtained.[57d,75] 
P N
O
R2
Ir
BArF-
R1
R1
CH2Cl2, 50 bar H2, 3h, rt
*
 
Table 2.2: Hydrogenation of (E)-1,2-diphenyl-1-propene 
catalyst 80b 81a 82b 83b 84b 85a 86b 87a 88b 89a 90a 91a 
R1 = tBu tBu tBu tBu Cy Cy Cy Cy Ph Ph Ph Ph 
R2 = tBu Np Ph iPr tBu Np Ph iPr tBu Np Ph iPr 
conf. ligand S S R S S S R S S S S S 
conv. [%] >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 
ee [%] 99 88 97 97 68 67 80 79 37 52 69 53 
conf. product R R S R R R S R R R R R 
a 1 mol% catalyst, in dichloromethane (0.5 mL); b 1 mol% catalyst, in dichloromethane (1 mL) 
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2.5.2 (E)-2-(4’-Methoxyphenyl)-2-butene and (Z) -2-(4’-methoxyphenyl)-2-butene 
Full conversion was obtained for the hydrogenation of (E)-2-(4’-methoxyphenyl)-2-butene 
and (Z)-2-(4’-methoxyphenyl)-2-butene with any catalyst. 
*
MeO MeO
CH2Cl2, 50 bar H2, 3h, rt
P N
O
R2
Ir
BArF-
R1
R1
 
Table 2.3: Hydrogenation of (E)-2-(4’-methoxyphenyl)-2-butene 
catalyst 80b 81a 82b 83a 84b 85a 86b 87a 88a 89a 90a 91a 
R1 = tBu tBu tBu tBu Cy Cy Cy Cy Ph Ph Ph Ph 
R2 = tBu Np Ph iPr tBu Np Ph iPr tBu Np Ph iPr 
conf. ligand S S R S S S R S S S S S 
conv. [%] >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 
ee [%] 96 60 94 84 89 71 78 58 73 34 62 14 
conf. product R R S R R R S R R R R R 
a 1 mol% catalyst, in dichloromethane (0.5 mL); b 1 mol% catalyst, in dichloromethane (1 mL) 
The selectivities for the E-substrate were much higher with 14 to 96% ee compared to the Z-
substrate with only up to 16% ee. Furthermore, the absolute configuration for the 
hydrogenation-product of (Z)-2-(4’-methoxyphenyl)-2-butene could not always be predicted. 
Catalysts 81 and 85 gave the product with only 8% ee but with the R-configuration. These 
results suggest that the catalytic cycle involves isomerization of the double bond. 
*
MeO MeO
CH2Cl2, 50 bar H2, 3h, rt
P N
O
R2
Ir
BArF-
R1
R1
 
Table 2.4: Hydrogenation of (Z)-2-(4’-methoxyphenyl)-2-butene 
catalyst 80a 81a 82a 83a 84b 85a 86a 87a 88a 89a 90a 91a 
R1 = tBu tBu tBu tBu Cy Cy Cy Cy Ph Ph Ph Ph 
R2 = tBu Np Ph iPr tBu Np Ph iPr tBu Np Ph iPr 
conf. ligand S S R S S S R S S S S S 
conv. [%] >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 
ee [%] rac 8 16 6 7 8 4 11 31 10 11 rac 
conf. product nd R R S S R R S S S S nd 
a 1 mol% catalyst, in dichloromethane (0.5 mL); b 1 mol% catalyst, in dichloromethane (1 mL) 
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2.5.3 2-(4’-Methoxyphenyl)-3-methyl-2-butene 
To date, the best results for the hydrogenation of 2-(4’-methoxyphenyl)-3-methyl-2-butene 
with chelating P,N-ligands was 81% ee with neopentyl-substituted standard-PHOX and a 
pyridylsubstituted ligand (Figure 2.1). In comparison, the new phosphinomethyloxazoline-
ligands performed especially well in terms of both activity and enantioselectivity. The 
tetrasubstituted alkene was hydrogenated with full conversion with most catalysts. In some 
cases, full conversion was even obtained at 50 bar hydrogen after 3 hours with 1mol% of 
catalyst.  
N
O
PPh
Ph
O
Pt-Bu
t-Bu
N
t-Bu
 
Figure 2.5: P,N-ligands for enantioselective hydrogenation of 2-(4’-methoxyphenyl)-3-methyl-2-butene 
Five different catalyst outperformed the above mentioned ligands with selectivities from 84 to 
93% ee. The best results were achieved with (R)-2-[(dicyclohexyl-phosphanyl)-methyl]-4-
phenyl)-4,5-dihydrooxazo-line ligand 74, closely followed by the corresponding neopentyl-
substitud ligand 73. 
*
MeO MeO
CH2Cl2, 50-100 bar H2
3h, rt
P N
O
R2
Ir
BArF-
R1
R1
 
Table 2.5: Hydrogenation of 2-(4’-methoxyphenyl)-3-methyl-2-butene 
catalyst 80b 81a 82b 83b 84b 85a 86b 87a 88b 89a 90a 91a 
R1 = tBu tBu tBu tBu Cy Cy Cy Cy Ph Ph Ph Ph 
R2 = tBu Np Ph iPr tBu Np Ph iPr tBu Np Ph iPr 
conf. ligand S S R S S S R S S S S S 
conv. [%] 93c 
(93)c 
98 >99c 
(>99) 
>99 >99 >99 >99 >99 66 
28d 
>99 >99 >99 
ee [%] 27 
(40) 
85 84d 
(87) 
74 
 
80 92 93d 84 30 
18d 
62 74 40 
conf. product - - + - - - + - - - - - 
a 2 mol% catalyst, in dichloromethane (0.5 mL); b 2 mol% catalyst, in dichloromethane (1 mL); 
c 4h, d 1 mol%; 50 bar (100 bar) 
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Better results with these substrates have only be obtained with Buchwald’s ansa-zirconocenes 
however these catalysts suffer from low activity, requiring in high catalyst loadings, rather 
drastic reaction conditions and long reaction times (compare 2.2).[53] 
2.5.4 6-Methoxy-1-methyl-3,4-dihydronaphtaline 
The internal alkene, 6-methoxy-1-methyl-3,4-dihydronaphtaline, was hydrogenated with full 
conversion by all twelve catalysts (Table 2.6). The selectivities were generally very low with 
only up to 55% ee for catalyst 88 (R1 = phenyl, R2 = tert-butyl). In contrast to the other 
unfunctionalized alkenes described above (2.5.1 to 2.5.3), diphenylphosphineoxazolines 
perform best with this substrate. Very high (~95%) enantioselectivities were previously 
obtained with di-o-tolylphosphinite-oxazoline ligand SimplePHOX.[57b] 
*
MeO MeO
CH2Cl2, 50 bar H2, 3h, rt
P N
O
R2
Ir
BArF-
R1
R1
 
Table 2.6: Hydrogenation of 6-methoxy-1-methyl-3,4-dihydronaphtaline 
catalyst 80b 81a 82b 83b 84b 85a 86b 87a 88b 89a 90a 91a 
R1 = tBu tBu tBu tBu Cy Cy Cy Cy Ph Ph Ph Ph 
R2 = tBu Np Ph iPr tBu Np Ph iPr tBu Np Ph iPr 
conf. ligand S S R S S S R S S S S S 
conv. [%] >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 
ee [%] 5 18 rac rac 15 rac 6 4 55 26 12 10 
conf. product S R nd nd S nd S S S S S S 
a 1 mol% catalyst, in dichloromethane (0.5 mL); b 1 mol% catalyst, in dichloromethane (1 mL) 
New PHOX Ligands for Enantioselective Hydrogenation 
 41
2.6 Enantioselective Hydrogenation of Functionalized Alkenes 
Crabtree showed that cationic iridium-catalysts are not only very efficient in the 
hydrogenation of three-and tetra-substituted alkenes, but that they also show functional group 
tolerance.[76] The chiral versions of Crabtree’s catalyst generally give good selectivities with 
alkenes bearing an additional chelating functional group such as alcohols, esters or carbonyls. 
2.6.1 (E)-Ethyl-3-phenyl-but-2-enoate 
α-Acylaminoacrylicacids and α,β-unsaturated acids were hydrogenated with high-
enantioselectivities when rhodium or ruthenium-catalysts were used. The conversion of 
unsaturated esters however, has only given comparatively poor results, with the exception of 
itaconic acid ester.[77] Over the last few years different research groups have shown, that 
cationic iridum-catalysts with chelating, chiral P,N-ligands can hydrogenate unsaturated 
esters with high enantioselectivities. 
(E)-Ethyl-3-phenyl-but-2-enoate was tested in the enantioselective iridium-catalyzed 
hydrogenation with the new phosphinomethyloxazolines. All catalysts hydrogenated the 
unsaturated ester with full conversion. The highest enantioselectivity (96%) was obtained 
with catalyst 82. The results obtained are similar to those of Zhang’s phospholane-oxazolines 
(compare 2.3). Here, the best result was 98% ee, also using a phenyl-substituted oxazoline. 
Results for di-tert-butylphosphinomethyloxazolines were better than for the cyclohexyl and 
phenyl-analogs (Table 2.7). Much better results (greater than 99% ee) have already been 
obtained with other P,N-ligands.[78] 
COOEt COOEt
*
CH2Cl2, 50 bar H2, 3h, rt
P N
O
R2
Ir
BArF-
R1
R1
 
Table 2.7: Hydrogenation of (E)-ethyl-3-phenyl-but-2-enoate 
catalyst 80b 81a 82b 83a 84b 85a 86b 87a 88b 89a 90a 91a 
R1 = tBu tBu tBu tBu Cy Cy Cy Cy Ph Ph Ph Ph 
R2 = tBu Np Ph iPr tBu Np Ph iPr tBu Np Ph iPr 
conf. ligand S S R S S S R S S S S S 
conv. [%] >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 
ee [%] 94 91 96 94 86 78 92 93 65 53 74 72 
conf. product R R S R R R S R R R R R 
a 1 mol% catalyst, in dichloromethane (0.5 mL); b 1 mol% catalyst, in dichloromethane (1 mL) 
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2.6.2 (E)-2-Methyl-3-phenyl-prop-2-enol 
Allylic alcohols can coordinate not only with the η2 of the olefin, but also via the OH-group 
to the iridium. Some cationic rhodium- and iridium-phosphine complexes are known to 
catalyze diastereoselective hydrogenation of chiral allylic and homoallylic alcohols, where the 
preexisting chirality of the sp3-hybridized carbons induces new asymmetry on the 
neighbouring olefinic diastereofaces through coordination of the hydroxyl group to the 
transition metals.[79] 
OH
Ru-(R)-BINAP
90-100 bar H2 OH
96-99% ee  
Scheme 2.16: Enantio- and regioselective reduction of geraniol. 
The enantioselective hydrogenation of prochiral substrates was first reported by Takaya et 
al..[50c] For the enantio- and regioselective hydrogenation of geraniol they were using a 
BINAP-based ruthenium (II) dicarboxylate complex (Scheme 2.16). 
In the present case, full conversion was obtained with 1 mol% catalyst in all cases. Lower 
catalyst loadings have not yet been investigated. The enantioselectivity was relatively good 
for those catalysts bearing a tert-butyl substituent at the oxazoline ring, giving 90 to 93% ee 
(Table 2.8, catalysts 80, 84 and 88). In this case, the substituent at the oxazoline seems to 
have a bigger effect than those at the phosphorus atom. 
*
CH2Cl2, 50 bar H2, 3h, rt
OH OH
P N
O
R2
Ir
BArF-
R1
R1
 
Table 2.8: Hydrogenation of (E)-2-methyl-3-phenyl-prop-2-enol 
catalyst 80b 81a 82b 83b 84b 85a 86a 87a 88b 89a 90a 91a 
R1 = tBu tBu tBu tBu Cy Cy Cy Cy Ph Ph Ph Ph 
R2 = tBu Np Ph iPr tBu Np Ph iPr tBu Np Ph iPr 
conf. ligand S S R S S S R S S S S S 
conv. [%] >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 
ee [%] 90 85 46 89 92 64 38 85 93 86 61 75 
conf. product - - + - - - + - - - - - 
a 1 mol% catalyst, in dichloromethane (0.5 mL); b 1 mol% catalyst, in dichloromethane (1 mL) 
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2.6.3 N-(1-Phenylethylidene)-aniline 
Imines are very challenging substrates with respect to enantioselective hydrogenation 
meaning that there is still great demand for catalysts which can give high enantioselectivities. 
The nature of imines render the catalytic hydrogenation more complex. Not only can syn/anti 
isomers lead to low selectivity, but the strong donor character of the NH group of an amine, 
with its ability to compete for coordination at the catalytic site, may be one factor contributing 
to the more difficult hydrogenation of imines.[80]  
N
O
HN
O
H
N
O
H
Cl
O
Ir-xylphos
AcOH, TBAI
FePh2P
PXyl2
CH3
Xylphos
(S)-metolachlor(S)-MEA amineMEA imine
80 bar H2
50 °C
S/C 1,000,000
79% ee  
Scheme 2.17: Industrial synthesis of (S)-metolachlor 
The key-step in the synthesis of (S)-metolachlor (N-(1’-methyl-2’-methoxyethyl)-N-
chloroacetyl-2-erhyl-6-methylanilin)[81], is the selective hydrogenation of an imine to a 
secondary amine.[82] (S)-Metolachlor is the active ingredient of Dual Magnum, which is one 
of the most important grass-herbicide applied in the cultivation of maize, which was first 
described in 1973. The development of a diphosphino-iridium-complex is one of the 
industrial success stories of the last years. iridium-xylphos catalyst enables the 
enantioselective hydrogenation of MEA imine in 79% ee. The process is presently operated 
on a > 10,000 tons/year scale. 
Apart from the industrially successful iridium-diphosphine catalysts, other ligand systems 
have been investigated. Iridium-phosphinooxazolines have been applied with success,[83] and 
more recently, secondary phosphine oxides have shown good results.[84] Apart from iridium 
catalysts, titanocene-complexes have been successfully applied by Buchwald et al.[85]  
In the present work, N-(1-phenylethylidiene)-aniline has been hydrogenated as a model 
system. All catalysts performed equally modest with enantioselectivities up to 63% ee for 86 
and 91. However, no distinct trends were observed. 
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N NH
*CH2Cl2, 50 bar H2, 3h, rt
P N
O
R2
Ir
BArF-
R1
R1
 
Table 2.9: Hydrogenation of N-(1-phenylethylidene)-aniline 
catalyst 80b 81a 82b 83b 84b 85a 86b 87a 88b 89a 90a 91a 
R1 = tBu tBu tBu tBu Cy Cy Cy Cy Ph Ph Ph Ph 
R2 = tBu Np Ph iPr tBu Np Ph iPr tBu Np Ph iPr 
conf. ligand S S R S S S R S S S S S 
conv. [%] >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 >99 
ee [%] rac 48 53 35 41 60 63 60 42 53 55 63 
conf. product nd R S R R R S R R R R R 
a 1 mol% catalyst, in dichloromethane (0.5 mL); b 1 mol% catalyst, in dichloromethane (1 mL) 
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2.7 X-Ray Crystallographic Studies 
Single-crystals of four complexes 80, 82, 83, 88, could be obtained from 
dichloromethane/hexane at low temperatures. The recorded and refined crystal-stuctures were 
compared regarding bond lengths and angles with those of standard iridium-PHOX-
complexes. The appendent crystallographic data are attached at the end of this work (page 
217). All structures are depicted without the BArF anion. Hydrogen atoms were also omitted 
for clarity. The POV-Ray datasets[86] for the preparation of the pictures were generated with 
ORTEP.[87] The absolute configuration could be determined by refinement of the flack 
parameter.[88] 
 
Figure 2.6: Envelope conformation of 80. The oxazoline-rings and the phosphorus substituents are omitted for 
clarity. 
All complexes have square planar geometry with the cyclooctadiene double-bonds 
perpendicular to the coordination-plane. The five-membered ring which is composed of the 
iridium atom and the chelating ligand exhibts in all cases an envelope-conformation. In the 
envelope the phosphorus-substituents are occupying pseudo-axial and pseudo-equatorial 
positions. As can be seen in Figure 2.6 the iridium atom is pointing out of the slightly tilted 
plane, which is composed of the ligand P-C-C-N-atoms.  
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 80 82 
Ir-P [Å] 2.3376 (12) / 2.3365 (14) 2.3410 (19) 
Ir-N [Å] 2.095 (4) / 2.085 (4) 2.101 (6) 
P-Ir-N [deg] 81.71 (12) / 82.72 (12) 81.54 (17) 
Figure 2.7: Selected bond lengths and angles of complexes 80 and 82 
The asymmetric units of 80 and 83 each contain two complexes, in 82 and 88 they are only 
occupied by one complex. Structure 88 also includes one molecule of dichloromethane. The 
P-Ir-N angles of complexes 80 to 83 are all around 82° - although the two angles of 80 differ 
by 1°. The P-Ir-N angle of 88 is considerably smaller (78.65°). This might be due to the 
smaller size of the phenyl groups compared to the bulky tert-butyl substituents. 
 
 83 88 
Ir-P [Å] 2.337(2) / 2.340(2) 2.262(2) 
Ir-N [Å] 2.097(5) / 2.068(4) 2.117(4)  
P-Ir-N [deg] 81.31(14) / 82.01(14) 78.65(14) 
Figure 2.8: Selected bond lengths and angles of complexes 83 and 88 
In comparison with Crabtree’s catalyst 17, standard iridium-PHOX complex 9 and the new 
phosphinomethyl-oxazolines have considerably smaller P-Ir-N angles. Apparently, this is due 
to the ring that is formed by the chelating ligand and the metal-center. The ring-size 
influences the width of this angle. For the six-membered ring chelating PHOX ligand the 
angle is around 3 to 6° wider than for the five-membered ring chelating phosphinomethyl-
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oxazolines. The P-Pd-N angle in palladium-complex 92 which also contains a five-membered 
ring compares well with these structural data.[78] The corresponding P-Ir-N angle of complex 
87 (compare chapter 3.4.1, page 66) is 80.45°, and thus also is in line with the angles of 80, 
82, 83, and 88. Bond lengths are all in the same range with ~2.1Å for the iridium-nitrogen 
bond and ~2.3Å for the iridium-phosphorus bond. 
Table 2.10: Comparison of x-ray structural data 
 complex R1 R2 Ir-P [Å] Ir-N [Å] Ir-C trans 
to P [Å] 
Ir-C trans 
to N [Å] 
P-Ir-N 
[deg] 
Cy3P N
Ir
PF6-
 
17 - - 2.37 2.09 2.18 2.15 92.2 
N
O
Ph2P
Ir
 
9 - - 2.274(2) 
2.258(3) 
2.119(7) 2.10 
2.11 
2.01 
2.03 
84.95 
N
Pd
Ph2P
NPh2P
2+
2Cl- 
92 - - - - - - 81.32(6) 
Ir
P N
O
BArF- 
87   2.295 (9) 2.084 (3) 2.180 (3) 
2.151 (3) 
2.167 (3) 
2.134 (3) 
80.45 (8) 
80 tBu tBu 2.338(2) 
2.337(2) 
2.095(4) 
2.085(4) 
2.202(5) 
2.172(5) 
2.144(5) 
2.128(5) 
81.71(12) 
82.72(12) 
82 tBu Ph 2.341(2) 2.101(6) 2.221(8) 
2.182(9) 
2.151(7) 
2.139(5) 
81.54(17) 
83 tBu iPr 2.337(2) 
2.340(2) 
2.097(5) 
2.068(4) 
2.165(6) 
2.192(6) 
2.130(7) 
2.134(7) 
81.31(14) 
82.01(14) 
 
 
Ir
P N
O
R2
BArF-
R1
R1
 
88 Ph tBu 2.262(2) 2.117(4) 2.212(5) 
2.214(5) 
2.112(6) 
2.113(5) 
78.65(14) 
 
Chapter 2 
48 
2.8 Conclusion 
Twelve new phosphinomethyl-oxazoline-borane adducts were prepared by two different 
syntheses. The corresponding ligands could be obtained after deprotection with diethylamine. 
In contrast to the method reported by Sprinz et al.[63] for diphenylphosphinomethyl-
oxazolines, these routes also allowed the preparation of phenylsubstituted ligands 70, 74 and 
78. 
After deprotection to the free ligands, the corresponding iridium-complexes 80-91 were 
synthesized as their BArF salts. Single crystals were obtained for four complexes 80, 82, 83, 
and 88. The crystal structures were compared with previously crystallized complexes. As 
expected, the P-Ir-N angle of these 5-membered-ring chelating iridium-complexes is 
somewhat smaller than those of the standard PHOX ligands.  
The new iridium complexes 80-91 were successfully tested in the enantioselective 
hydrogenation of unfunctionalized and functionalized olefins. Generally, the results are in the 
same range as those of existing P,N-ligands. The tetrasubstituted olefin, 2-(4’-
methoxyphenyl)-3-methyl-2-butene, was reduced with higher enantioselectivity than reported 
for other iridium catalysts. Better results were only observed for ansa-zirconocenes however 
these catalysts showed comparatively low activity. 
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3 Phosphinines as Ligands in Catalysis 
3.1 Phosphinines - Phosphabenzenes - Phosphorines 
For a considerable time the "double bond rule" has been established in chemistry textbooks. It 
states that elements outside the first row of the periodic table do not form multiple bonds 
either with themselves or with other elements. However, this rule was disproved by the 
spectroscopic detection of a compound having a multiple P-C bond in 1961.[89] Another 
fundamental breakthrough in maingroup-metal chemistry was achieved by Märkl.[90] In 1966 
he succeeded in preparing 2,4,6-triphenyl- λ3-phosphabenzene 93 (2,4,6-triphenyl- λ3-
phosphininei).[91]  
O P
BF4
P(CH2OH)3
pyridine
9493  
Scheme 3.1: Original Synthesis of 2,4,6-triphenyl- λ3-phosphabenzene[90] 
The synthesis was achieved by the formal exchange of O+ against P from the respective 
substituted pyrylium salt 93 using P(CH2OH)3 as a phosphine equivalent (Scheme 3.1). Other 
sources of PH3 (e.g., P(TMS)3, PH4I)[92] can also be employed. However, the synthesis 
starting from pyrylium salts is restricted to 2,4,6-trisubstituted derivatives. The unsubstituted 
“parent” phosphinine 97 was obtained by an entirely different route. It was obtained from 
reaction of 1,4-dihydro-1,1-dibutylstannabenzene 95 with PBr3 and liberation of the 
phosphinine from 1,4-dihydrophosphinine 96 by HBr elimination with DBN (Scheme 3.2).[93]  
Sn
Bu Bu
P
Br
P
DBNPBr3
979695  
Scheme 3.2: Synthesis of “parent”-phosphinine 65 by Ashe[93] 
                                                 
i According to IUPAC-nomenclature the phosphabenzene ring system was named λ3-phosphorin until 1982, now 
it is termed λ3-phosphinine. The  λ convention was introduced in 1979 to describe compounds containing 
skeletal atoms that can occur in two or more valence states. λ is written with a superscript number that gives the 
valence state of the heteroatom. In addition, the symbol δc was introduced. c gives the number of double bonds 
in the skeletal structure terminating at the heteroatom. Earlier the symbol σm, where m is the number of bonds 
terminating at the heteroatom was suggested in conjunction with the λn symbol. However, this symbolism was 
not included in the revision of the Section D rules for the 1979 edition of the IUPAC Organic Rules. 
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Later, Märkl, Dimroth, and Bickelhaupt prepared a variety of highly substituted λ3-
phosphinines and began to illuminate their chemistry.[94] A number of related λ5-phosphinines 
have also been investigated.[95] 
There are several other methods to obtain λ3-phosphinines. For example, λ5-phosphinines can 
serve as precursors for the respective λ3-phosphinines that are generated by thermal 
elimination.[96] Another general approach implies the ring-construction of the λ3-phosphinine 
by [4+2]-cycloaddition reaction. An already established phosphacycle, e.g. 1,3-
azaphosphinines can react with an alkyne.[97,98] The reverse scheme involves cycloaddition of 
a conjugated diene with phosphaalkyne or a suitable phosphaalkene.[99,100]  
O POR1
R2
R3
R4
R1
R2
R3
R4
t-Bu
P t-Bu O
P
R3
R2
R4
O
R1
110-140°C
 
Scheme 3.3: [4+2]-cycloaddition from α-pyron[99a] 
3.1.1 Aromaticity of λ3-Phosphinines 
Aromaticity cannot be described with a sole definition. In fact, it is associated with a set of 
properties, comprising planarity, lack of bond alternation, and multiple bond character of all 
ring bonds. More important are probably the magnetic criteria that characterize aromatic 
species. Aromaticity is indicated by large downfield NMR shifts (due to the presence of a 
diamagnetic ring current) and negtive NICS values (nucleus-independent chemical shift).[101] 
Already early articles about λ3-phosphinines mentioned typical features of aromaticity, such 
as planarity, no carbon-carbon bond lenghts alteration and short carbon-phosphorus bonds.[102] 
Aromatic character was also assigned because the peripheral protons of the planar molecule 
showed a considerable downfield shift.[103] The calculated Hückel-aromaticity of parent λ3-
phosphinine was calculated to be as high as 88% compared with benzene.[104] More advanced, 
recent studies even assigned an aromaticity of 97% compared with benzene.[105] NICS values, 
i.e. the ring-current contributions to the chemical shift of a central atom, were calculated to be 
-9.5 (vs -8.9 in benzene) for NICS(0) (atom at the center of the ring) and -11.4 (vs -10.6 in 
benzene) for NICS(1) (atom 1Å above the center of the ring).[101,106] 
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3.1.2 Chemical Reactivity 
The chemical consequences of aromaticity are far different from 
those observed in pyridines. In contrast to the nitrogen atom in 
pyridine, the phosphorus atom in λ3-phosphinine is less 
electronegative than the adjacent carbon atoms. Since the lone pair 
of pyridine occupies the HOMO, pyridine has good σ-donating 
ability. Photoelectron spectroscopy[107] and ab initio 
calculations[108] have shown that the lone pair of λ3-phosphinine is 
located at a lower energy level. The HOMO and LUMO of λ3-
phosphinine are the π and π* orbitals, respectively. Consequently, 
λ3-phosphinine posseses at least qualitatively an ideal frontier 
molecular-orbital situation for an efficient overlap with filled 
metal d-orbitals and the ability to function as π-acceptor ligand 
(compare orbital diagram). The phosphorus atom in λ3-phosphinine exhibits a strong s-orbital 
character (63.8% versus 29.1% found for the nitrogen atom in pyridine),[109] and is due to the 
low basicity comparatively inert towards electrophilic attack.[110] 
For the above reasons electrophilic attack at the phosphorus does not occur. Neither stable 
PH+ nor PR+ phosphininium salts are known. Reaction of λ3-phosphinines with nucleophiles 
leads to phosphininylanions by addition of the nucleophile to the phosphorus.[111] Subsequent 
reaction with soft electrophiles give λ5-phosphinines. Hard electrophiles lead to ortho- or 
para-substituted 1,2- or 1,4-dihydrophosphinines.[112] Functionalization is generally difficult.  
P
Ph
PhPh P
Ph
PhPh
PhLi
Ph
P
Ph
PhPh
Ph
P
Ph
PhPh
Ph
P
Ph
PhPh P
Ph
PhPh
Ph Ph
C(O)R
H
RC(O)Cl H2OMeI
P
Ph
PhPh
Ph
95
98 99 100  
Scheme 3.4: Nucleophilic attack at the phosphorus followed by reaction with an electrophile. 
X
X
X
X
N P
E
lone pair
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Oxidation leads to λ5-derivatives, reaction of 2,4,6-trisubstituted-phosphinines with bromine 
or chlorine give 1,1-dihalo-λ5-phosphinines.[113] In the 1990s, Mathey and co-workers 
developed a methodology for the synthesis of functionalized phosphinines using transition 
metal mediated reactions including palladium- and nickel-catalyzed coupling reactions.[114,115] 
Remarkably, phosphinines also function as dienes in [4+2]-cycloadditions when reacted with 
activated alkynes (Scheme 3.5).[116] 
P RR
Ph
P
R R
Ph
THF
reflux
95 101  
Scheme 3.5: Reaction of phosphinine with benzyne 
3.1.3 Coordination Chemistry 
The coordinative abilities of λ3-phosphinines are not limited to monodentate binding via the 
lone-pair at the phosphorus atom. Some phosphinine-complexes also involve π-coordination. 
While phosphinines usually undergo κ1-coordination with late transition metals in low 
oxidation states,[117] they are also able to bind η6, typically with early transition metals in high 
oxidation states.[118] For some metals both coordination modes were observed. 
Ir
2 SbF6
N
P
Ir
N
P
Ir
R
R
TMSO
OTMS
P
X
R
R
P
Ar
IrAr
Ar
H
CO
CO
CO
102 103 104  
Figure 3.1: Different coordination modes of iridium-phosphinine complexes η1 102, η6 104 (R = η4-1,5-
cyclooctadiene), µ2-bridging 103. 
Iridium can undergo both coordination modes, although the κ1-coordination is more typical 
(Figure 3.1).[119,120] According to Mathey and co-workers two very bulky groups are needed in 
ortho-position to favor η6- versus κ1-coordination. Interestingly, phosphinines can also serve 
as bridging ligands, as was shown in the case of NIPHOS ligand by Schmid et al.[121] 
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3.1.4 Application in Catalysis 
As electron withdrawing (π-acceptor) ligands phosphinines are able to stabilize metals in low 
oxidation states and electron-rich transition metal complexes.[122] Recently, Breit and co-
workers have systematically investigated the use of λ3-phosphinine ligands in rhodium-
catalyzed hydroformylation. The activity of a 2,6-dimethyl-4-phenyl-λ3-phosphinine 
complexe was found to be twice as high as that of the conventional triphenylphosphine 
catalyst. Furthermore, exellent branched to linear ratios were observed.[123] A η6-phosphinine 
iron complex was found to catalyze the cyclotrimerizaton of dimethyl acetylenecarboxylate. 
The co-cyclotrimerization of butyronitrile and alkynes afforded pyridine derivatives.[118a] 1,3-
Butadiene dimerization lead to cycloocatdienes.[118b] 
In the context of his research of the application of phosphinines in rhodium-catalyzed 
hydroformylation reactions, Breit investigated the use of chiral ligands in this reaction. In 
1999, he published the synthesis of phosphininoxazoline 105 and another 
phosphininoxazoline 106 which is enabled to form a larger chelating ring.[124] The ligands 
were tested in the hydroformylation of styrene. While ligand 105 lead to a disappointingly 
low yield (5%), ligand 106 performed to full conversion and showed a respectable 
regioselectivity (branched-to-linear ratio 25:1). The enantioselectivity of the reaction was not 
discussed. The poor result obtained with ligand 105 might have been caused by an impurity of 
20% starting material (i.e. the respective α-pyrone) in the ligand. It is reported that the 
catalyst was prepared in situ. Therefore, the pyrone-impurity might have inhibited the 
reaction. Probably in consideration of the poor results, no further applications of 
phospininoxazoline 105 were published.  
P
N
O P
O
O
N O105 106
 
Figure 3.2: Chiral phosphininoxazoline ligands 105 and 106 for rhodium-catalyzed hydroformylation[124] 
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3.2 Objectives of this Chapter 
Having already investigated a broad scope of related P,N-ligands in iridium-catalyzed 
hydrogenation,[125] we were interested in the performance of strong π-accepting ligands such 
as 105. Apart from the electronic characteristics, the phosphinine system exhibits an 
interesting planar geometry rather than a three-dimensional sterically more demanding 
phosphorus moiety. Unfortunately, the system is relatively complicated to synthesize and not 
as versatile as other phosphinoxazolines. Still, changing the substituent at the oxazoline-ring 
is feasible. Ligand 105 is capable of forming a five-membered ring chelate. For better 
comparability with other phosphinoxazoline ligands (most of the tested ligands in iridium-
catalyzed hydrogenation are forming six-membered chelate rings) the synthesis of a related 
phosphininoxazoline capable of forming a six-membered chelate ring was envisioned as well. 
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3.3 Improved Synthesis of Phosphininoxazolines 
For the synthesis of ligand 105 Breit has used the [4+2]-cycloaddition procedure described 
above to obtain the λ3-phosphinine moiety in the last step of the reaction sequence (Scheme 
3.6).[124] As the diene moiety he chose an α-pyrone that can react with tert-
butylphosphaalkyne in a hetero-Diels-Alder type reaction liberating carbon dioxide. 
P
N
O OO
N
O OO
H
N
OH
O
OO COOH
105
 
Scheme 3.6: Retrosynthesis of phosphininoxazoline 105 according to Breit[124] 
As mentioned, syntheses starting from e.g. a pyrylium salts are only possible for 2,4,6-
trisubstituted precursors. Preparation by [4+2]-cycloaddition bears the advantage that other 
substitution patterns can be achieved. The conditions, apart from the rather high temperature, 
are relatively mild, so that functional groups are tolerated. The drawbacks are the low yields 
of this procedure and the fact, that due to the limited number of phosphaalkynes, only 
variation of the second ortho-position is possible.  
3.3.1 Synthesis of Diene-Moiety 
The first three steps towards ligand 105 were performed according to literature procedures. 
O
Cl
O CCl3Cl
NEt3, CH2Cl2
0°C    rt, 30 h OO CCl3 OO COOH
H2SO4
80°C, 4h
ice
109 110107 108
+
 
Scheme 3.7: Preparation of 6-substituted α-pyrones 109 and 110 according to Rey et al.[126] 
2-Pyron-6-carboxylic acid 110 was prepared according to Rey et al..[126] First, 
trichloromethylpyrone 109 was obtained in 61% yield by condensation of crotonyl chloride 
107 and trichloroacetyl chloride 108 with triethylamine in dichloromethane. Then 109 was 
heated to reflux for four hours with concentrated sulfuric acid. Hydrolysis of the reaction 
mixture in an ice-bath afforded 110 in 83% yield. 
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Scheme 3.8: Synthesis of pyrone-oxazoline 112 
As described by Breit,[124] 111 was prepared by amide coupling with thionyl chloride and 
subsequent addition of the amino alcohol and triethyl amine. Amide 111 was obtained in up to 
70% yield. Instead of using Mitsunobu-conditions,[127] the following ring-closure was 
performed with (methoxycarbonyl-sulfamoyl) triethylammonium hydroxide, inner salt 
(Burgess’ reagent) to afford the oxazoline 112 in 77% yield.[128] 
3.3.2 Synthesis of Phosphaalkyne 
tert-Butylphosphaalkyne was prepared according to the reaction sequence depicted in Scheme 
3.9. Tris(trimethylsilyl)phosphine is prepared from sodium-potassium alloy, red phosphorus 
and trimethylsilyl chloride in DME.[129] The intermediately formed sodium-potassium 
phosphide reacts with trimethylsilyl chloride to yield 113 (58%). P(TMS)3 reacts with 
pivaloyl chloride in pentane to a bright yellow solution of phosphaalkene 114 (88%).[130] 
PP
TMSO TMS
O
Cl
P
TMS
TMS
TMS
hexane
rt, 7 days
NaOH
160-180°C
~10-3 mbar
TMSCl
rt, 1h
DME
reflux, 24hProt + Na/K alloy
113 114 115  
Scheme 3.9:Three-step synthesis of tert-butylphosphaalkyne 115 
According to Rösch et al. β-elimination of hexamethyldisiloxane from phosphaalkyne 73 was 
obtained under NaOH catalysis.[131] The reaction takes place in a vacuum apparatus under 
approximated 10-3 to10-4 mbar. An aggravating fact is the high volatility of both substrate and 
product, which have to be trapped seperately in individual cooling traps at -78°C and -196°C, 
respectively. First trials gave unsatisfactory yields, because the contact time between substrate 
and catalyst was too short and the trapping proved inefficient. Eventually, preparation of 
phosphaalkyne 115 was achieved with the kind help of Evelyn Fuchs and Bernhard Breit 
(University of Freiburg im Breisgau) who provided the suitable reaction apparatus and expert 
knowledge. Copound 115 was obtained in 61% yield as a 3.79 M solution in (TMS)2O. 
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3.3.3 [4+2]-Cycloaddition of α-Pyrone and tert-Butylphosphaalkyne 
The cycloaddition step was performed according to the published synthesis of 105 by mixing 
pyronoxazoline 112 and tert-butylphosphaalkyne 113 in toluene (Scheme 3.10). After heating 
to 140 °C for 3 to 5 days a dark brown oil was obtained. According to the publication, 
Kugelrohr distillation resulted in a lighter colored compound, but still separation from the 
starting material was not achieved. As described in the literature procedure compound 105 
was obtained with residual starting material as proven by 1H NMR. 31P NMR showed a single 
peak at 205 ppm, which is in the typical range for λ3-phosphinines. 
P
N
O
105
toluene
reflux, 72h
OO
N
O
112
P
 
Scheme 3.10: Synthesis of phosphininoxazoline 105 
When storing the product mixture at ambient atmosphere (the purification method applied did 
not suggest any particular sensitivity towards oxygen or water) ’decomposition’ of the 
product occurred. Although only a slight visible change took place (i.e. intesification of the 
color) the new 31P NMR spectrum displayed two new signals around 0 ppm, while the signal 
at 205 ppm had disappeared. (Figure 3.3). 
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Figure 3.3: 31P{1H} NMR of 105 (bottom) and its ’decomposition’ products (top). The spectra are not corrected 
to the internal standard, and therefore differ from the values given in Experimental. 
The 1H NMR spectrum revealed two new species which showed the same sets of signals as 
66, but were somewhat downfield shifted. One set of signals exhibiting a huge coupling (~485 
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Hz), appeared far downfield at 8.7 ppm. This suggested the addition of a proton, which is 
directly attached to the phosphorus atom (1JPH = 110 Hz to 1200 Hz).[132] A broad signal at 
9.85 ppm and 9.4 ppm, respectively, suggested an acidic proton. The addition of water from 
atmospheric moisture seemed to have occured. 
The addition of water to phosphinine-complexes was previously observed by Schmid et al.[133] 
and Nief et al..[134] In case of a palladium-complex 116 with P,N-chelating NIPHOS-ligand, 
addition of water afforded a palladium-coordinated λ3-1,2-dihydrophosphinine 117 (Scheme 
3.11, top). Addition of water to a (η6-phosphinine)-(η5-cyclopentadienyl)iron(II) complex 118 
resulted in the formation of (η5-phosphacyclohexadienyl)-(η5-cyclopentadienyl)iron(II) 119 
(Scheme 3.11, bottom). 
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Fe
Ph
Ph
Ph Fe
PhPh
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H2O
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N
Pd
Cl
L P
N
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Cl
L
HO
H
H2O
CHCl3
AlCl4
HAlCl4
116 117 118 119  
Scheme 3.11: Reaction of phosphinine-complexes with water 
The NIPHOS-adduct ring-moiety (Scheme 3.11, left) can be regarded as phosphinous acid 
tautomer of a secondary phosphine oxide. Secondary phosphine oxides are known to 
coordinate either via the ‘hard’ oxygen or in the phosphinous acid tautomeric form via the 
‘soft’ phosphorus donor.[135] In the second example (Scheme 3.11, right), formation of a 
secondary phosphine oxide is observed. Here, one proton is consumed by the aluminate anion 
and neither the lone-pair at the phosphorus atom nor the electron-pairs at the oxygen atom 
participate in the coordination at the iron center. 
Pt-Bu
N
OP
N
O
H
O Ht-Bu H OH
a b
 
Figure 3.4: Possible water-adducts of phosphineneoxazoline 
B. Breit suggested the water-adduct structure a (Figure 3.4), which he claimed to have 
observed after column chromatography. While a direct P-H bond seemed likely, due to the 
large coupling observed in the 1H NMR spectrum and the non-decoupled 31P NMR, the proton 
in α-position however was not in accordance with the signal observed at 9.4 or 9.85 
respectively. This suggested a somewhat more acidic proton as displayed in b. However, 
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structure b suggests that the phosphacycle still had aromatic character.[136] The very high-field 
shift in the 31P NMR instead suggests that aromaticity is lost. 
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Figure 3.5: 1H NMR Spectrum of 120cis (spectrum in CD2Cl2, contains ethyl acetate peaks) 
Reproduction of the synthesis and work-up by column chromatography afforded two isomers 
of the water-adduct, of which one could be crystallized from ethyl acetate. The structure was 
solved by x-ray crystallography (compare 3.3.4), and accounted very well for the 
characteristics observed in NMR spectrometry. The crystal structure matched cis-alkene 
120cis, which shows a direct P-H bond and an N-H bond which accounts for the broad signal 
at 9.85. The X-ray crystal structure is discussed in Chapter 3.3.4 and the corresponding 1H 
NMR spectrum is depicted in Figure 3.5. The conformation of the other isomer trans-alkene 
120trans was determined by difference NOESY which displayed the proximity of the 
phosphorus-bound and the nitrogen-bound proton.  
Schmid et al. proposed three different mechanisms for the formation of the palladium-
NIPHOS water-adduct (vide supra). They suggested two different stepwise mechanisms (I 
and II) starting either with a nucleophilic attack, or an electrophilic attack. As a third 
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possibility they envisioned a concerted mechanism (III). Without naming the reasons 
pathway I was stated to be the one most likely to occur. 
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Figure 3.6: Proposed mechanism by Schmid et al. for the formation of water adduct 
In our case the exact mechanism of water-addition is also unknown. From what is known of 
the chemistry of λ3-phosphinines, the attack of a proton can be excluded. Either the 
mechanism is concerted or occurs by nucleophilic attack of OH- or water to the phosphorus. 
Subsequent addition of a proton, leads to a 1,2-dihydrophosphinine or 1,4-
dihydrophosphinine (compare 3.1.2) which can possibly tautomerize to the observed water-
adducts. 
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Scheme 3.12: Possible interconversion of the water-adducts 
In solution the two isomers 120cis and 120trans slowly interconvert. Thus, one can expect that 
the water-addition is reversible. Scheme 3.12 depicts a possible equilibrium. In tautomer 121, 
the position of the proton, attached to the nitrogen could also be in ortho- or para-position to 
the phosphorus atom. Thus, the oxazoline-ring would remain intact. However, in all these 
isomers the conjugation of double bonds would be interrupted. 
The crystal structure showed that only one diastereomer of 120cis was obtained (compare 3.6). 
This allows the assumption that nucleophilic attack at the phosphorus is substrate-controlled. 
This is somewhat surprising, since the stereocenter at the oxazoline ring is relatively remote. 
Nemoto et al. have performed a stereoselective synthesis of a secondary phosphine oxide 
through substrate control, as depicted in Scheme 3.13.[137]  
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Scheme 3.13: Substrate-controlled synthesis of a secondary phosphine oxide 
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3.3.4 (S)-2-(6-tert-Butylphosphinin-2-yl)-4,5-dihydro-4-isopropyloxazole 
The observation of an equilibrium between 120cis and 120trans led to the assumption, that 
shifting the equilibrium back to 105 should be possible. Azeotropic removal of water was 
achieved by refluxing the water adducts in toluene and use of a Dean-Stark trap. Indeed, 
ligand 105 could be obtained after 24 hours as a yellow oil. Thus, purification of the [4+2]-
cycloaddition crude mixture can be performed by column chromatography and subsequent 
azeotropic removal of water. 
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reflux, 24h
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Scheme 3.14: Preparation of 105 from water-adducts 
The 1H NMR spectrum of 105 is depicted in Figure 3.7. The ligand was stored in a glove-box 
at ambient temperature. While the color darkened with time to light brown, the spectrum 
remained unchanged. 
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Figure 3.7: 1H NMR Spectrum of 105 (spectrum in CD2Cl2) 
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3.3.5 Analogous Phosphininoxazolines 
In analogy to 105 two related ligands were prepared. These are bearing different groups in 4-
position of the oxazoline ring, namely tert-butyl or a phenyl-group. The synthesis followed 
basically the same route as the preparation of 105. However, the amide coupling was 
performed using ethyl-N,N’-dimethylamino-propyl-carbodiimide hydrochloride (EDC) and 1-
hydroxybenzotriazole (HOBt). This was a faster and also more efficient method for the 
preparation of the amides 122 (40%) and 123 (52%) than the one employed for 111.[138] The 
oxazolines 124 and 125 were obtained in good yields (89% and 55%) using Burgess’ reagent. 
OO COOH OO
H
N
OH
O R1
OO
N
O
R1
EDC, HOBt
amino alcohol Burgess' reagent
THF, 70°C, 4 h
110 R1 = tert-butyl  
R1 = phenyl
122
123
CH2Cl2, rt, 1h
124
125
R1 = tert-butyl  
R1 = phenyl  
Scheme 3.15: Synthesis of pyronoxazolines 124 and 125 
Both pyrones were reacted with phosphaalkyne 115 to give the water-adducts 128 and 129 
after purification by column chromatography. The phosphinines 126 (31%) and 127 (28%) 
were obtained by azeotropic removal of water in toluene with a Dean-Stark trap. The 31P 
NMR chemical shifts of 126 and 127 are in complete accordance with those observed for 
other phosphinines, with 208.5 ppm and 210.8 ppm, respectively.[132] 
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Scheme 3.16: Preparation of phosphininoxazolines 126 and 127 
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3.3.6 A Related Chiral Chelating Phosphininimidazoline 
The imidazoline 130 was obtained via a procedure, previously described by Casey and co-
workers.[139] Herein, an amide is reacted with thionyl chloride to form an intermediate imidoyl 
chloride. This then reacts with a primary amine in the presence of triethylamine to the 
corresponding imidazoline. 130 was obtained in 65% yield. 
OO
N
N
OMe
OO
H
N
OH
O
111
SO2Cl, DMF
reflux, 4h
NEt3
4-methoxyaniline
toluene 130
 
Scheme 3.17: Reaction of 111 to N-(4-methoxy-aninline)-imidazoline 130 
When 130 was reacted under [4+2]-cycloaddition conditions for three weeks, about 8% of a 
water-adduct could be isolated. It is noteworthy, that while with analogous oxazolines cis- and 
trans-somers were obtained, only trans isomer 132 was isolated from the reaction of 130. 
With these trace amounts of product, formation of the corresponding phosphinine was 
attempted under the same conditions as for the oxazolines 112, 124 and 125. A 31P NMR 
spectrum revealed formation of, phosphinine-imidazoline 131 showing a chemical shift of 
212.4 ppm. 
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Scheme 3.18: Reaction of 130 giving trace amounts of water-adduct 132 and the corresponding phosphinine 131 
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3.4 Synthesis of Phosphinine-Iridium Complexes 
3.4.1 Iridium-Complexes with Chelating Phosphinines 
With ligand 105 in hands, the respective cationic iridium complex was prepared using 
standard procedures. [Ir(cod)Cl]2 was reacted with 105 and stirred for two hours at 48°C. 
After cooling to room temperature and anion exchange with NaBArF complex 133 was 
obtained. 
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BArF
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P N
O
R1
[Ir(cod)Cl]2
CH2Cl2, 48°C, 2h
NaBArF
R1 = iso-propyl
R1 = tert-butyl  
R1 = phenyl
105
126
127
R1 = iso-propyl
R1 = tert-butyl  
R1 = phenyl
133
134
135  
Scheme 3.19: Preparation of iridium-complex 133, 134 and 135 
In contrast to other PHOX-iridium complexes the addition of NaBArF resulted in a drastic 
color-change from dark-red to almost black. Black needles were obtained when a 
concentrated solution of 133 in dichloromethane was treated with hexane.  
However, when a concentrated solution of 133 in dichloromethane was treated with diethyl 
ether, an orange solid precipitated. Based on 1H- 13C- and 31P NMR data, structure 136 
(Figure 3.8) was suggested. 
Ir
P N
O
136
OH
H
BArF
 
Figure 3.8: Proposed structure of 136 
This structure denotes that a water-adduct was formed, implying that the diethyl ether 
contained traces of water. As can be seen in Figure 3.9 the protons belonging to the 
phosphorus heterocycle are shifted the most, i.e. about 2.5 ppm upfield. The additional proton 
α to the phosphorus atom was assigned by COSY since coupling to the vicinal proton was 
observed. The signal was found at 4.25 ppm, and the corresponding 13C NMR signal at 44.2 
ppm with 1JCP = 29.3 Hz. This shift is in accordance with reference 121 (compare Scheme 
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3.11, left), where the proton α to the phosphorus atom has a 13C NMR shift of 36.9 ppm (1JCP 
= 57.1 Hz). 31P NMR signal is shifted upfield by about 90 ppm from 176.9 ppm to 87.5 ppm. 
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Figure 3.9: 1H NMR spectra of 133 (bottom) and 136 (top, with residual diethyl ether) 
Although 105 containes bulky substituents in 2- and 6-position, formation of a η6-
phosphininoxazoline-iridium complex is unlikely (compare 3.1.3).[120] 31P NMR spectra of η6-
phosphinin-iridium complexes were reported to display a more high-field shift (58 ppm). 
However, the exact structure of 136 remains unknown. 
Iridium-complexes 134 and 135 (31P{1H} NMR (202.5 MHz, CD2Cl2, 300K): δ = 179.3 ppm 
and 176.2 ppm) with ligands 126 and 127 were prepared, accordingly. Unfortunately they 
contained up to 30% of unidentified side-products with phosphorus signals at 91.3 ppm and 
80.8 ppm, and 102.5 ppm and 88.2 ppm, respectively. 
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3.4.2 Iridium-Complexes with Monodentate Phosphinines 
It seemed feasible to synthesize an achiral analogue of 133, using readily available 
monodentate phosphinines and pyridine as ligands. With this phosphinine-version of 
Crabtree’s catalyst, a better comparison of phosphine and phosphinine ligands (e.g. in terms 
of reactivity in hydrogenation reactions) was envisioned. 
2,4,6-Trisubstituted λ3-phosphinines can be obtained from the corresponding pyrylium salts 
by the formal exchange of O+ and P. As phosphorus atom source serves phosphine or a 
suitable “masked” phosphine, such as P(TMS)3 113 (see 3.3.2). Two different monodentate 
λ3-phosphinines, namely 2,6-dimethyl-4-phenyl-phosphinine 141 and 2,4,6-triphenyl-
phosphinine 142 were synthesized. 
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PhMgBr
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HBF4
KI
H2O, AcOH
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Scheme 3.20: Synthesis of 2,4,6-trisubstituted phosphinines 95 and 96 
The anion exchange from tetrafluoroborate to iodide was reported to improve the subsequent 
step, in terms of yield and equivalents of phosphine 113 needed.[122] The phosphinines 141 and 
97 were obtained in 52% and 50% yield, respectively (Scheme 3.20).  
N N
Ir
P N
Ir
Ph
BArF BArF
141
CH2Cl2 Ir
PP
PP
PhPh
Ph Ph
BArF
not observed
141
CH2Cl2
[Ir(cod)Cl]2
P Cl
Ir
Ph
pyridine, NaBArF
144
145
142 143
 
Scheme 3.21: Attempted synthesis of a phosphinine analogue of Crabtree’s catalyst 
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When [Ir(cod)py2]BArF was treated with ligand 141 in dichloromethane-d2 the 31P NMR 
signal shifted from 193.6 ppm for the free ligand to 144.9 ppm. When a TLC was run, two 
spots occured, one bright yellow spot with the same low Rf value as [Ir(cod)py2]BArF, and a 
red spot (Rf = 0.86 in CH2Cl2). The red product was isolated by column chromatography. 
Single crystals were obtained by slow evaporation of the solvent (dichloromethane). Analysis 
by NMR and X-ray revealed the main product to be the homoleptic tetrakis(2,6-dimethyl-4-
phenyl-phosphinine)iridium(I) BArF complex 144. 
 
Figure 3.10: X-ray structure of 144 
Starting the synthesis by reaction of [Ir(cod)Cl]2 with 141, subsequent reaction with pyridine 
and anion exchange with NaBArF, also gave the homoleptic complex 144 via the intermediate 
145. Since a Crabtree’s catalyst analogue was not obtained by neither of these routes, the 
synthesis was abandoned. 
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3.5 Application in Catalysis 
3.5.1 Hydrogenation 
Iridium-complex 133 was tested in the hydrogenation of several highly substituted 
unfunctionalized and functionalized alkenes, as well as N-(1-phenylethylidiene)-aniline. 
R1 R1
CH2Cl2, 50 bar H2
3h, r.t.
BArF
Ir
P N
O
R3
X
R3
X
R4 R4
*R2 R2
 
Table 3.1: Hydrogenation with complex 133 
entry R1 R2 R3 R4 X conv.[%]a ee [%]a 
1 H Ph H Me C 67 33 (R) 
2 OMe Me H Me C 86 21 (R) 
3 OMe H Me Me C 92 rac 
4 OMe Me Me Me C 3 23 (-) 
5 OMe H (CH2)2 Me C >98 rac 
6 H CO2Et H Me C 58 29 (R) 
7 H CH2OH Me H C >98 92 (-) 
8 H Ph H Me N >98 37 (R) 
adetermined by GC, bdetermined by HPLC 
Compared to other PHOX-ligands (see chapter 2.5, page 37) complex 133 gave relatively low 
conversions and enantioselectivities. Only an internal alkene (entry 5), the imine (entry 8) and 
allylic alcohol (entry 7) were hydrogenated to full conversion. The latter substrate was 
hydrogenated with high enantioselectivity (92%). Other enantioselectivities were in the range 
of 21 to 37 %. A Z-alkene (entry 3) could be reduced almost to full conversion, but the 
product was racemic. 
Transfer hydrogenation of acetophenone with potassium methoxide in iso-propanol gave 
better results. The reaction was complete within minutes, and showed an enantioselectivity of 
65% ee. 
O
*
0.1 Mol%
KOMe, i-PrOH
OH
conv.
ee
>98%
65%  
Scheme 3.22: Transfer Hydrogenation with 130 
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3.5.2 Allylic Alkylation 
Iridium 
Many examples of the iridium-catalyzed asymmetric allylic alkylation with electron-poor 
catalysts were reported by Helmchen et al.. Especially good results were obtained by using 
rather electron-poor ligands. Since phosphinines show good π-acceptor abilities, it was 
interesting to see, how they perform in comparison to electron-poor ligands, such as 
trifluoromethyl-substituted phosphinoxazolines,[140] and phosphoramidites.[141]  
Chelating ligand 66 as well as two monodentate phosphinines 141 and 97 were tested in the 
iridium-catalyzed allylic alkylation of monosubstituted allyl acetates, namely 1-phenylallyl-
acetate (br) and cinnamylacetate (lin). The results are compiled in Table 3.2 and Table 3.3. 
Ph
OAc
OAcPh Ph
Ph
* O
O
O
O
O
O
O Obr
lin
b l
[Ir]
+
 
Table 3.2: Iridium-catalyzed allylic alkylation 
entry substrate anion additive T [°C] conv.[%]a ee [%]b b/la 
1 br Cl- - 20 >98 rac >98:2 
2 lin Cl- - 20 11 nd 50:50 
3 br BArF- - 20 >98 rac >98:2 
4 lin BArF- - 20 10 nd 50:50 
5 lin Cl- - 65 >98 13 (R) 63:37 
6 lin Cl- ZnCl2 65 >98 21 (S) 87:13 
7 lin Cl- CuCl 65 16 rac 50:50 
8 lin Cl- LiCl 65 61 rac 74:16 
[Ir]: 4 mol% 130 or 4 mol% 105 and 2 mol% [Ir(cod)Cl]2, sodium O,O’-dimethyl malonate, THF, 24 h 
adetermined by GC, bdetermined by HPLC 
The results obtained in iridium-catalyzed allylic alkylation were comparatively disappointing, 
compared to reported systems.[142] While good branched-to-linear-ratios were obtained using 
the branched substrate (br), no enantioselectivity was observed. Only when the linear 
substrate (lin) was used, some selectivity was obtained, whereas at the same time the 
branched-to-linear-ratio suffered. In accordance with literature, full conversion for the linear 
substrate was often only reached at elevated temperature.[140] When ZnCl2 was used as 
additive, the enantioselectivity could be slightly improved. However, the opposite enantiomer 
was obtained. Variation of the anion did not show any effect (entries 1-4). 
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Table 3.3: Iridium-catalyzed allylic alkylation with monodentate phosphinines 
entry ligand substrate anion [M]/L time [h] conv.[%]a b/la 
1 141 br Cl- 1 24 93 94:6 
2 141 lin Cl- 1 24 4 1:1 
3 141 br Cl- 2 24 >99 87:13 
4 141 lin Cl- 2 24 13 64:32 
5 97 br Cl- 1 24 >99 97:3 
6 97 lin Cl- 1 24 63 83:17 
7 97 br Cl- 2 24 >99 >98:2 
8 97 lin Cl- 2 24 59 80:20 
9 PPh3 br Cl- 1 3 15 98:2 
10 PPh3 lin Cl- 1 24c 58 64:36 
11 P(OPh)3 br Cl- 1 3 99 98:2 
12 P(OPh)3 lin Cl- 1 3 98 98:2 
13 ohneb br - − 3 98 98:2 
14 ohneb lin - − 24c 89 32:68 
The reaction was run in THF. 2 mol% [Ir(cod)Cl]2 and 2 equivalents sodium malonate were used. 
a GC-MS, bHelmchen et al., c 65°C 
Table 3.3 displays that the branched substrate often reacts to full conversion in 24 hours, 
whereas the linear substrates only reach up to 89% conversion (entry 12). As above (Table 
3.2), the branched-to-linear-ratio is higher in those cases where the branched substrate is used. 
Phosphinine ligand 141 is superior to ligand 97 regarding conversion and branched-to-linear-
ratio. The catalyst-to-ligand-ratio shows little influence. Phosphinines 141 and 97 are 
compared to other monodentate phosphorus ligands, i.e. in terms of reactivity (the results are 
from Helmchen et al., entries 9-14)[142] Apparently the reactivity of the complexes IrCl(cod)L 
increases in the order L = PPh3 < 141 < 97 < P(OPh)3. 
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Palladium and Rhodium 
Palladium- and rhodiumprecursor were also tested in the allylic alkylation of monosubstituted 
allyl acetates with 105. For the palladium-catalyzed allylic alkylation of the monosubstituted 
allyl acetates, (η3-allyl)-chloro-palladium(II)-dimer and for the rhodium-catalyzed allylic 
alkylation O,O-acetylacetonato-bis(η2-ethylene)-rhodium(I)[143] was used. The latter catalyst 
precursor was prepared for the rhodium-catalyzed allylic alkylation according to Hayashi et 
al.[144] Therefore, a solution of [Rh(µ-Cl)(ethylene)2]2 and acetyl acetone were treated with a 
solution of potassium hydroxide at -78°C. 
Ph
OAc
OAcPh Ph
Ph
* O
O
O
O
O
O
O Obr
lin
b l
[M] + 105
+
 
Table 3.4: Allylic alkylation with palladium- and rhodium-catalysts 
substrate [M] anion additive T [°C] conv.[%]a ee [%]b b/la 
br Pd Cl- - 20 >98 33 (S) 33:67 
lin Pd Cl- - 20 >98 47 (S) 38:62 
br Rh acac - 20 >98 rac 85:15 
[Pd]: 4 mol% 105, 2 mol% [Pd(allyl)Cl]2, 3.1 eq dimethyl malonicester, 3.1 eq BSA, KOAc, CH2Cl2, 24h. 
[Rh]: 5 mol% 105 and [Rh(acac)(C2H4)2], 3eq sodium malonate, THF, 15h. 
adetermined by GC, bdetermined by HPLC 
In palladium-catalysis ligand 105 performed better than in iridium-catalysis. 
Enantioselectivities of 33% and 47% were observed for the branched and the linear substrate, 
respectively. Unfortunately, here the branched-to-linear-ratio was unfavorable. The rhodium-
catalyst gave a better branched-to-linear-ratio, but only racemic product was obtained. 
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3.6 Discussion of X-Ray Crystal Structures 
X-ray structure of 120cis (see 3.3.3) shows that aromaticity and planarity is lost in the water-
adduct. The phosphorus atom is approximately 14° below the plane. Furthermore, the 
structure displays significant discrimination in bond-length of the localized double bonds 
(1.353 and 1.359 Å) and the single bonds (1.433 and 1.428 Å) of the phosphorus heterocycle. 
P-C bond-lengths (1.775 and 1.755 Å) are also slightly longer than in the aromatic 
coordinated ligand (1.73 Å). 
P1
C1
C2C4
C5
O1
C3
120cis
 
C1
C2
C4
C5
C3
P1
N1
Ir1
C16
C20
C17
C21
133
 
Table 3.5: Selected bond lengths and angles of 120cis, 133 and 96[145] 
[Å]/[deg] 120cis 133 96[145] 
C1-C2 1.428 (2) 1.373 (5) 1.396/1.410 
C2-C3 1.359 (2) 1.379 (6) 1.372/1.404 
C3-C4 1.433 (3) 1.370 (6) - 
C4-C5 1.353 (3) 1.394 (6) - 
P1-C1 1.756 (2) 1.728 (3) 1.734/1.746 
P1-C5 1.774 (2) 1.730 (3) - 
P1-O1 1.502 (2) - - 
Ir1-P1 - 2.295 (9) - 
Ir1-N1 - 2.084 (3) - 
Ir1-C16 
Ir1-C17 
- 
- 
2.180 (3) 
2.151 (3) 
- 
- 
Ir1-C20 
Ir1-C21 
- 
- 
2.167 (3) 
2.134 (3) 
- 
- 
P-Ir-N - 80.45 (8) - 
C-P-C 103.60 (8) 103.87 (7) 102.9 
On the other hand, the X-ray structure of 133 (see 3.4.1) shows that aromaticity is conserved 
in the iridium complex. C-C bond lengths all lie in a narrower range (1.37 to 1.394 Å) and C-
P bonds are considerably shorter (1.728 and 1.730 versus 1.756 and 1.774 Å). Furthermore, 
the phosphorus heterocycle is planar. 
Column 3 gives X-ray structural data of 2,6-dimethyl-4-phenyl-λ3-phosphinine 96. C-C as 
well as C-P bond lengths account well for the aromatic structure and lie in the same range as 
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the structural values of 133. However, the C-P-C angles of both structures 120cis and 133 are 
in the same range as observed for monodentate ligand 96 with 103.6° and 103.87°, 
respectively. 
The P-Ir-N angle (80.45°) matches well to those of other five-ring-chelating ligands (78.65 to 
82.72°, compare chapter 2.7). The Ir-C bonds trans to the phosphorus are shorter than those of 
the other discussed complexes. The Ir-P bond is little shorter than those of complexes 80, 82 
and 83, but still longer than that of complex 88. 
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3.7 Towards 6-Ring-Chelating Phosphininoxazolines 
The synthesis of related phosphininoxazolines capable of forming six-ring-chelates was tried 
by preparation of pyronoxazolines containing an additional methylene group between the 
pyrone- and the oxazoline-ring. Introduction of the phosphorus moiety was intended to be 
achieved by a [4+2]-cycloaddition reaction, as presented above (see 3.3.3). 
For the preparation of a 6-pyrone acetic acid derivative commercially available 4-hydroxy-
methyl-pyrone 146 was chosen. After protection of the hydroxygroup with benzyl bromide, 
the methyl-group of compound 147 was lithiated. Reaction with gaseous carbon dioxide and 
acidic work-up afforded acid 148 in 85% yield.[146] 
OO
OH
0°C    rt, 1h
OO
O PhBnBr, K2CO3
DMF
OO
O Ph
OH
O
LiHMDSA, THF
 -78°C, 2h
CO2, H+/H2O
146 147 148  
Scheme 3.23: Preparation of acid 148 
Amide coupling was performed as described above (see 3.3.5) using ethyl-N,N’-
dimethylamino-propyl-carbodiimide hydrochloride (EDC) and 1-hydroxybenzotriazole 
(HOBt). Amides 149 and 150 were obtained in 75% and 67% yield, respectively. Ring-
closure was achieved with tosylchloride, triethylamine and catalytic amounts of 4-
dimethylaminopyridine (DMAP). The oxazolines 151 and 152 were obtained in 96% and 84% 
yield, respectively. 
OO
O Ph
N
H
O
OH
R1
HOBt, EDC
L-Valinol
CH2Cl2
DMF
1h, rt
OO
O Ph
OH
O
148 149
OO
O Ph
N
O
TsCl, NEt3
DMAP (cat.)
CH2Cl2
151
150 152
R1 = iPr
R1 = tBu
R1 = iPr
R1 = tBu  
Scheme 3.24: Preparation of pyronoxazolines 151 and 152 
When 151 was subjected to the [4+2]-cycloaddition conditions stated above, i.e. reaction with 
phosphaalkyne 115 in toluene, no traces of the desired product 153 could be observed. A 31P 
NMR was taken of the crude mixture. The spectrum showed no signals in the characteristic 
area for phosphinines (~ 190 to 210 ppm). However, one main product 154 was isolated from 
the reaction mixture. Also a small amount of a bright yellow side product, with the postulated 
structure of 155, was obtained. 
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HO OH
O Ph
N O
O
OPh
O
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O
P
OO
O Ph
N
O
151
toluene
reflux, 24h
P
P
O Ph
N
O
153 154 155
not observed main product possibleside product  
Scheme 3.25: Unwanted reaction of 151 under [4+2]-cycloaddition conditions 
It is assumed that 154 was formed via a rearrangement previously described by Huber.[147] He 
observed the formation of a 4,5-disubstituted resorcinol when the corresponding 4,5-
disubstituted 6-methyl-2-pyrone was heated with an alkali metal alkoxide. Hansen et al. used 
this method for the preparation of phloroglucinol methyl ether from glucose via a 6-methyl-2-
pyrone (Scheme 3.26).[148] 
O
OMe
O
OMe
HO OH
Na, MeOH
185°C
glucose
156 157  
Scheme 3.26: Synthesis of phloroglucinol methyl ether from glucose 
However, the formation of 154 under these relatively mild reaction conditions might be due to 
the stabilization of an intermediate carbanion by the electron-withdrawing oxazoline ring 
(compare Scheme 3.27). Only very drastic reaction conditions were reported so far. 
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OR
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Scheme 3.27: Mechanism of the formation of 154 
155 was postulated on the basis of 1H- 13C- and 31P NMR. Some substructures, such as the P-
neopentyl-group were strongly supported. The formation of this group can be achieved 
through two ene-reactions, which were previously reported for phosphaalkynes. For example, 
reaction of tert-butyl-phosphaalkyne with iso-butene gives phosphine 158 (Scheme 3.28).[149] 
Chapter 3 
 78 
It is further known that pentamethyl-cyclopentadiene preferentially undergoes ene-reaction 
rather than Diels-Alder reaction with phosphaalkyne 115.[150] 
P P P
tBu
158115  
Scheme 3.28: Double ene-reaction with iso-butene 
A possible mechanism for the formation of 155 is depicted in Scheme 3.29. After a first ene-
reaction to the phosphaalkyne, a 1,3 shift reinstalls the 2-pyrone ring. Then a second ene-
reaction provides 155. 
O
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O
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O ene-reaction
P
H
H
O
OR
O
N
O
P
H
1,3-H
O
OR
O
N
O
P
H
H
ene-reaction
 
Scheme 3.29: Possible mechanism for the formation of 155 
To prevent the rearrangement to substituted dihydroxy-benzene 154 (Scheme 3.29), 
substitution of the methylene bridge of 151 was envisioned. Therefore, 151 was deprotonated 
with LiHMDS and quenched with methyl iodide. However, when 159 was subjected to the 
[4+2]-cycloaddition reaction conditions, no reaction occured. 
OO
O Ph
N
O
151
LiHMDSA, THF
-78°C, 1.5h
MeI, rt, 15h
OO
O Ph
N
O
159
toluene
reflux, 72h
P
no reaction
 
Scheme 3.30: Envisioned [4+2]-cycloaddition reaction with 159 
Since a six-ring chelating phosphininoxazoline could not be obtained through [4+2]-
cycloaddition, one has to think of a different approach. However, no further attempts towards 
the desired structure were undertaken in the course of this work. 
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3.8 Conclusion 
In summary, three chiral phosphininoxazolines were prepared by dehydration of a water-
adduct wherein the phosphorus atom is present as a secondary phosphine oxide. The 
corresponding cationic iridium-complexes were synthesized. 
Ligand 105 showed good conversion and moderate selectivity in the iridium-catalyzed 
hydrogenation and transfer-hydrogenation. In palladium-catalyzed allylic alkylation it showed 
moderate enantioselectivities, but a highly unfavorable regioselectivity. 
Recently, it was shown by Jiang et al. that secondary phosphine oxides are promising ligands 
in the iridium-catalyzed hydrogenation of imines.[151] The intermediate water-adducts possess 
a secondary phosphine oxide moiety, and thus could be tested in the hydrogenation of imines.  
The synthesis of six-ring chelating phosphininoxazolines was attempted but could not be 
achieved by [4+2]-cycloaddition of a methyleneoxazoline-substituted 2-pyrone with 
phosphaalkyne. Instead a rearrangement, and presumably an ene-reaction, were observed. 
An alternative approach towards phosphininimidazolines and six-ring chelating 
phosphininoxazlines could be attempted via dihydrostannabenzenes[152] and 
dihydrozirconabenzenes.[153]
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4 Asymmetric Catalytic Intramolecular Pauson-Khand Reaction 
Metal-promoted cycloadditions do not only provide a means for the construction of complex 
cyclic stuctures from readily available starting materials, but are also among the most atom 
economical methodologies in organic synthesis.[154] One of the most prominent cycloadditions 
is the Pauson-Khand reaction. 
4.1 The Pauson-Khand Reaction 
The Pauson-Khand reaction is a formal [2+2+1] cycloaddition of an alkene, an alkyne and 
carbon monoxide leading to a cyclopentenone. The reaction was first reported in the early 
seventies,[155] after Khand et al. had observed in 1971 that an acetylene-Co2(CO)6 complex 
reacted with norbornadiene, acetylene and carbon monoxide to “hydrocarbon and ketonic 
products” (Scheme 4.1).[156] At that time the thermal reaction was performed with 
stoichiometric amounts of dicobaltoctacarbonyl. The early examples involved only strained 
reactive alkenes, such as norbornene, since the use of unstrained alkenes usually resulted in 
low efficiency of the reaction. And the participation of unsymmetrical alkenes led to a 
mixture of regioisomers. Furthermore, the reaction required relatively harsh reaction 
conditions, i.e. high temperature and long reaction times, which often led to decomposition of 
substrates or products. 
R2
R1
O
R3
R2
R1
O
R3
R1
R2
R3
Co2(CO)8+ +
 
Scheme 4.1: Regioisomeric products in the Pauson-Khand with a monosubstituted alkyne 
In 1981 Shore introduced the intramolecular version of the Pauson-Khand reaction by 
connecting the alkene and alkyne moiety.[157] In this reaction strained alkenes were no longer 
required and only one regioisomer was obtained as 5.5- and 5.6-fused bicycles, respectively.  
O
E
E
E
E
n =1,2n  
Scheme 4.2: Intramolecular Pauson-Khand reaction 
The now widely accepted mechanism was first suggested 1985 by Magnus et al.[158] Co2(CO)8 
reacts with an alkyne under the loss of two CO-ligands to form the stable and fully 
characterized alkyne-Co2(CO)6 I complex (Scheme 4.3).[159] This step is followed by the π-
coordination of an olefin accompanied by the loss of another CO-ligand to form II. 
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Subsequent insertion of the olefine gives cobaltacycle III and alkyl migration provides a six-
membered acyl complex IV. Reductive elimination leads to the η2-bound cyclopentenone-
Co2(CO)6 complex V, which then undergoes elimination to product VI. 
R R'
- 2CO - COCo(CO)3
(CO)3
Co
R'
R
Co2(CO)8
R''
Co(CO)2
(CO)3
Co
R'
R
R''
Co(CO)2
(CO)3
Co
R'
R
R''
Co(CO)n
(CO)3
Co
R'
R
R''
O
Co(CO)4
(CO)3
Co
R'
R
R''
O
O
R' R''
R
n-1 CO 4-n CO  CO
I II III
IV V VI  
Scheme 4.3: Mechanism of the dicobaltoctacarbonyl catalyzed Pauson-Khand reaction[158] 
4.2 Catalytic Pauson-Khand Reaction 
The first catalytic version of this reaction was reported by Pauson and Khand in 1973.[155a] 
Later, better catalysts than Co2(CO)8 were developed, such as (indenyl)Co(cod) or a system 
derived from Co(acac)2 and NaBH4. Especially the latter was shown to tolerate more 
functional groups, such as esters and halides. 
Kerr and co-workers showed that that the application of an (R)-glyphos-substituted 
(alkyne)pentacarbonyldicobalt-complex resulted in a series of efficient asymmetric 
intermolecular Pauson-Khand reactions without the use of chiral auxiliaries.[160] Hiroi et al. 
obtained very good enantioselectivities (up to 90%) using chiral chelating diphosphane (S)-
BINAP. Unfortunately, high catalyst loadings were required for this rather inactive system. 
4.3 Pauson-Khand Reaction with other Metals 
A number of reviews were published on the recent progress in Pauson-Khand reactions, with 
respect to catalytic and asymmetric versions, and the use of different transition metals.[155c,161] 
Catalytic carbonylative alkene-alkyne couplings have not only been reported with Co,[162] but 
also with Fe[163], Ni[164], Ti[165], Zr[166], Ru[167], Rh[168], and Ir[169]. Furthermore, some trials 
were made using more physiologically and user friendly procedures that avoid the use of toxic 
carbon monoxide.[170] 
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TiCl Cl
5-20 mol% catalyst
14 psi (1 bar) CO
12 hours, 90°C
83-94% yield
72-96% ee
XX O
*
160
 
Scheme 4.4: (S,S)-[(ebthi)Ti(CO)2] 160 catalyzed intramolecular Pauson-Khand reaction 
Buchwald and co-workers showed, that titanocene complexes could not only mediate[171] the 
cyclocarbonylation reaction, but were effective catalysts.[172] In 1996, Hicks, Buchwald et al. 
reported the first example of a titanium-catalyzed asymmetric catalytic Pauson-Khand 
reaction (ACPKR). They employed a chiral titanocene catalyst,[173] using a reduced form of a 
Brintzinger-type ansa-titanocene (S,S)-[(ebthi)Ti(CO)2].ii 
In 1997, Morimoto et al. reported that catalytic quantities of [Ru3(CO)12] were able to cyclize 
a range of enynes with an internal alkyne group under 10 atm of carbon monoxide.[167a] 
Independently, Kondo et al. reported the first intramolecular Pauson Khand reaction using the 
same catalytic system.[167b]  
It was shown that a Rh(I) catalyst catalyzed the reaction under 1 atm of CO with only 5 mol% 
catalyst under optimized conditions. This system was especially efficient for electron-
deficient substrates.[168a,174] Following their own work on rhodium(I) catalysts for the Pauson-
Khand reaction,[168b] Jeong et al. published an asymmetric rhodium(I)BINAP-catalyst, that led 
to 96% ee with moderate to very good yields under 0.5 to 3 atm of CO.[175] 
In 2000, Shibata et al. described the use of iridium in a Pauson-Khand Type reaction [169] 
They observed that addition of the triphenylphosphane as coligand improved the reaction 
yield compared to [Ir(cod)Cl]2. By substituting triphenylphosphane for tolBINAP catalyst 
they obtained excellent yields and enantiomeric excesses. More recently, they extended the 
reaction to a wider range of substrates and employed aldehydes as CO source.[176] 
O
Ph
O O
Ph
H
 [Ir(codCl]2 + 2L*
10 mol%
toluene, reflux
1 atm CO
83% yield
93 % ee (S)L* = (S)-tolBINAP  
Scheme 4.5: Iridium-catalyzed ACPKR[169] 
                                                 
ii ebthi = ethylene-1,2-bis(η5-4,5,6,7-tetrahydro-1-indenyl) 
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A mechanism for the iridium-catalyzed intramolecular ACPKR was proposed by Shibata et 
al.. The chiral iridium catalyst I is formed by reaction of the iridium-complex precursor with 
CO. According to their mechanism the the enantioselective step is the formation of 
metallacycle III from II. Carbon monoxide is inserted between iridium and the sp2-carbon to 
provide IV.  Reductive elimination of iridium gives cyclopentenone and regenerates the chiral 
iridium catalyst I. 
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Scheme 4.6: Catalytic cycle of the iridium-catalyzed ACPKR 
4.4 Objectives of this Chapter 
Zhong-Lin Lu in our laboratory obtained very promising results in the iridium catalyzed 
Pauson-Khand type reaction by using PHOX ligands.[177] In his work, he optimized the system 
regarding ligand, solvent, catalyst loading, temperature, pressure and time. Furthermore, he 
observed a distinct influence of the counteranion. 
To supplement his studies, the relationship between the catalyst counteranion and the 
asymmetric induction of the intermolecular catalytic Pauson-Khand reaction was investigated 
in more detail.  
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4.5 Catalytic Intramolecular Pauson-Khand Reaction with Iridium-PHOX Catalysts 
In his postdoctoral research report, Lu described the use of iridium-PHOX catalysts in the 
ACPKR. The catalytically active species [Ir(CO)2PHOX]PF6 162 is formed by treatment of 
[Ir(cod)PHOX]PF6 161 with carbon monoxide.  
Ir
Ph2P N
O
COOC
CO, toluene
N
O
Ph2P
Ir
X X
162161  
Scheme 4.7: Synthesis of carbonyl-complex 162 
An X-ray crystal structure of the hexafluorophosphate carbonyl complex is depicted in Figure 
4.1. As to be expected, the iridium(I) complex exhibits a square-planar structure. The shorter 
bond length of the C-O bond trans to the phosphorus indicates a stronger π-acceptor ability of 
the phosphorus. Usually carbonyl bands in infrared spectra are consulted for the determination 
of the “electron donor-acceptor property”[178] of trans-standing ligands.[179] In chelating 
ligands with different coordinating groups (and thus two CO-ligands in different trans-
positions) however, the assignment of the bands is not possible. Here, the C-O bond lengths in 
the solid state can give additional information, and help with the assignment of CO-bands in 
solution.  
Ir-P [Å] 2.3166 (7) 
Ir-N [Å] 2.086 (2) 
Ir-Ctrans to P [Å] 1.915 (3) 
Ir-Ctrans to N [Å] 1.850 (3) 
O-Ctrans to P [Å] 1.126 (4) 
 
O-Ctrans to N [Å] 1.140 (4) 
Figure 4.1: Selected bond lengths [Å] of [Ir(CO)2PHOX]PF6. Anion and hydrogen atoms are omitted for clarity. 
Lu also discovered that the best ligands bear phenyl substituents at the phosphorus, and a 
small substituent at the oxazoline ring. Phosphorus substituents however exerted the biggest 
influence. Larger steric bulk at the phosphorus (e.g. o-tolyl group) resulted in a dramatic drop 
in yield. Bigger substituents at the oxazoline, namely in the 4-position and to a lesser degree 
in the 5-position, affected both activity and enantioselectivity. Furthermore, he observed that 
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among the solvents, THF and DME were the best regarding yield and enantioselectivity. Lu 
tested a number of enynes (Scheme 4.9) and obtained good results for various substrates using 
9 mol% iso-propyl substituted diphenylphosphinoxazoline-derived iridium-catalyst at 120°C 
under 1.1 bar CO pressure with triflate as counteranion. 
4.5.1 Complex Synthesis 
To test the anion influence of the iridium-PHOX system one can prepare the respective 
catalysts in situ by mixing 1 equivalent of [Ir(cod)Cl]2 with 2 equivalents of ligand and the 
respective silver salt. The catalyst precursor can also be prepared and characterized prior to 
the reaction. The latter method was chosen, to obtain well-defined catalyst precursors and 
therefore reproducible results (Scheme 4.8).  
N
O
Ph2P
Ir
X
161
PPh2 N
O 1. 0.5 [Ir(cod)Cl]2, 
    CH2Cl2, 48°C, 2h
2. MX, rt, 15h
4  
complex X M 
161a BArF Na 
161b OTs Na 
161c OMs Na 
161d Al(OC(CF3)3)4 Li 
161e OTf Ag 
161f BF4 Ag 
161g PF6 Ag 
161h SbF6 Ag 
161i OAcF Ag 
Scheme 4.8: Synthesis of iridium-PHOX complexes 161a-i 
The trifluoromethane-sulfonate (OTf-) 161e, hexafluorophosphate (PF6-) 161g and 
tetrafluoroborate (BF4-) 161f were prepared according to standard procedures from 
[Ir(cod)Cl]2, 2-[2-(diphenylphosphanyl)-phenyl]-4,5-dihydro-4-isopropyl-oxazole and the 
respective silver or ammonium salts.[56,180] The other iridium salts, namely 
hexafluoroantimonate (SbF6-) 161h, methylsulfonate (OMs-) 161c, toluenesulfonate (OTs-) 
161b, trifluoroacetate (OAcF-) 161i, and tetrakis(perfluoro-tert-butoxy)aluminate 
(Al(OC(CF3)3)4-)[181] 161d were prepared accordingly (i.e. 1 equivalent of [Ir(cod)Cl]2 and 2 
equivalents of ligand were stirred in dichloromethane for two hours at 48°C. Anion exchange 
over night was followed by filtration over celite and evaporation of the volatiles). The 
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tetrakis[3,5-bis(trifluoromethyl)phenyl]borate complex 161a was previously prepared by 
Esther Hörmann. 
4.5.2 Substrate Synthesis 
Z
R1
Z O
R1
R2
[Ir(cod)(PHOX)]X
2-9 Mol%
solvent, 120°C
CO
S1-S5 P1-P5
R2
 
 Z R1 R2 
S1 O Ph H 
S2 NTs Ph H 
S3 C(COOMe)2 Ph H 
S4 O Me H 
S5 O Ph Me 
Scheme 4.9: Iridium-PHOX catalyzed AIPKR 
Enynes S1, S4 and S5 were prepared by Lu. Enynes S2 and S3 were prepared according to 
literature procedures starting from 3-phenyl-propargylic alcohol.[174,177] The alcohol was 
brominated with phosphorus tribromide and pyridine in diethyl ether to yield (3-bromo-prop-
1-ynyl)-benzene 164. 
BrOH
PBr3, py
diethyl ether
40h, 0°C to rt 164
43%
163  
Scheme 4.10: Synthesis of (3-bromo-prop-1-ynyl)-benzene 164 
Propargyl bromide 164 was reacted with a ten-fold excess of allylamine 165 at 0 °C. The 
secondary amine 166 was obtained in 53% yield. Tosylation of 166 in dichloromethane and 
triethylamine afforded enyne S2 (Scheme 4.11). 
NHH2N
166
5, diethyl ether 53%
0°C to rt, 1.5 h
165
NS
O
O
S2
TsCl, 
NEt3, CH2Cl2
0°C to rt
15 h
99%NH
166  
Scheme 4.11: Synthesis of N-allyl-N-(3-phenyl-prop-2-ynyl)-4-methylphenylsulfonamide S2[177] 
Substrate S3 was synthesized from dimethylmalonate 167. Deprotonation with sodium 
hydride was followed by addition of allyl bromide to afford 2-allyl-dimethylmalonate 168. 
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After another deprotonation with sodium hydride, 168 was reacted with (3-bromo-prop-1-
ynyl)-benzene 164 to give product S3 (Scheme 4.12). 
O O
O O O O
O O
168
NaH, THF
0°C, 15 min.
allyl bromide
rt, 2h
88%
167  
O O
O O O
O
O
O
168 S3
NaH, THF
0°C to rt, 2h
3, 1.5 h, rt
59%
 
Scheme 4.12: Synthesis of 2-acetoxy-2-(3-phenyl-prop-2-ynyl)-pent-4-enoic acid methyl ester S3 
4.5.3 ACPKR of Allyl-(3-phenyl-prop-2-ynyl) Ether 
The results of the standard procedure for ACPKR as evaluated by Lu, (i.e. with the iridium-
PHOX catalyst at 120°C under 1.1 bar CO pressure) could not be reproduced. In particular, 
yields were very low under the stated reaction conditions. Changing to higher temperature did 
not giva a distinct improvement of the reaction. Therefore, the pressure dependence of the 
ACPKR of S1 was tested. The reaction was performed at five different pressures between 1.4 
and 2.2 bar. A linear dependence of pressure and yield was observed until 2.0 bar (Scheme 
4.13). 
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Scheme 4.13: Correlation of pressure with yield and enantioselectivity on ACPKR of S1 
Even at 2.2 bar the reported yields were not reached (Table 4.1). In contrast to the conversion, 
the enantiomeric excess drops to some extent with increasing pressure from 97 % at 1.4 bar to 
91 % at 2.2 bar. To obtain a reasonable yield for the ACPKR in the experiments below, a 
carbon monoxide pressure of 2.2 bar was used. 
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Table 4.1: Influence of CO-pressure on ACPKR of S1 
entry X solvent pCO (bar)c yield (%)a ee (%)b 
1 TfO DME 1.4 51 97 (R) 
2 TfO DME 1.6 61 96 (R) 
3 TfO DME 1.8 71 94 (R) 
4 TfO DME 2.0 81 92 (R) 
5 TfO DME 2.2 85 91 (R) 
Reaction performed with 9 mol% catalyst, reaction time: 24 h. 
a Isolated yield by silica gel column chromatograpy (n-hexane: ethyl acetate, 3:1). b determined by HPLC: AD, 
n-heptane: iso-propanol 90:10, 20°C, 1.0 ml/min, 220nm/254nm: 11.1 min (R), 14.6min (S). c The CO pressure 
given in this column is the value at ambient temperature. 
The following counteranions were tested in the carbonylative alkene-alkyne coupling of allyl-
(3-phenyl-prop-2-ynyl) ether S1: BArF-, TfO-, TsO-, MsO-, F3CCO2-, [Al(OCCF3)]4-, BF4-, 
PF6-, and SbF6- (Table 4.2). The best results were obtained when catalysts with small, weakly-
coordinating counteranions like BF4- (161f), PF6- (161g), and SbF6- (161h) were used. This 
result is in contrast to Lu’s postdoctoral report. Herein, PF6- was quoted to be not suitable as a 
counteranion, since the respective catalyst showed low reactivity.[177]  
Larger non-coordinating anions [Al(OCCF3)]4- and BArF- gave somewhat lower yields and 
enantioselectivities (85%). Triflate 161e gave approximately the same results as 161f to 161h, 
while the tosylate, mesylate and trifluoracetate did not show any activity. 
Table 4.2: Influence of anion on ACPKR of S1 
entry X pCO (bar) yield (%)a ee (%)b 
1 BArF 2.0 63 85 (R) 
2 BArF 2.2 69 85 (R) 
3 Al(OC(CF3)3)4 2.0 55 85 (R) 
4 Al(OC(CF3)3)4 2.2 78 85 (R) 
5 TfO 2.0 81 92 (R) 
6 TfO 2.2 85 91 (R) 
7 BF4 2.2 89 91 (R) 
8 PF6 2.2 93 91 (R) 
9 SbF6 2.2 96 91 (R) 
10 MsO 2.2 traces nd 
11 TsO 2.2 traces nd 
12 CF3COO 2.2 traces nd 
Reaction performed with 9 mol% catalyst, reaction time: 24 h. 
a Isolated yield by silica gel column chromatograpy (n-hexane: ethyl acetate, 3:1). b determined by HPLC: AD, 
n-heptane: iso-propanol 90:10, 20°C, 1.0 ml/min, 220nm/254nm: 11.1 min (R), 14.6min (S). c The CO pressure 
given in this column is the value at ambient temperature. 
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The influence of the catalyst loading was tested with 161f and the results are shown in Table 
4.4. This study showed that when using substrate S1, the catalyst loading can be reduced to 2 
mol% catalyst without significant change of yield and selectivity.  
Table 4.3: Influence of catalyst loading on ACPKR of S1 
entry X mol% cat yield (%)a ee (%)b 
1 BF4 9 89 91 (R) 
2 BF4 5 84 91 (R) 
3 BF4 2 88 91 (R) 
4 BF4 1 59 91 (R) 
Reaction performed with 9 mol% catalyst, reaction time: 24 h. 
a Isolated yield by silica gel column chromatograpy (n-hexane: ethyl acetate, 3:1). b determined by HPLC: AD, 
n-heptane: iso-propanol 90:10, 20°C, 1.0 ml/min, 220nm/254nm: 11.1 min (R), 14.6min (S). c The CO pressure 
given in this column is the value at ambient temperature. 
4.5.4 ACPKR of N-Allyl-N-(3-phenyl-prop-2-ynyl)-4-methylphenylsulfonamide 
The results of ACPKR using substrate S2 are depicted in Table 4.4. Some reactions, 
particularly those obtained with catalysts 161f to 161h were repeated several times to ensure 
reproducible results. In this reaction, catalysts 161f (BF4-) and 161e (OTf-) gave the best 
results regarding selectivity, whereas the spherical, large and low-coordinating anions BArF- 
and [Al(OCCF3)]4- showed lower enantioselectivities. 
NS
O
O
Ph
N
Ph
OS
O
O
S2 P2
[Ir(cod)(PHOX)]X
DME, 120°C
CO *
 
Table 4.4: Influence of anion on ACPKR of S2 
entry X yield (%)a ee (%)b 
1 BArF 96 50 
2 Al(OC(CF3)3)4 96 56 
3 OTf 93 81 
4 BF4 98 80-81c 
5 PF6 95 77-80d 
6 SbF6 95 71-74d 
Reaction performed with 9 mol% catalyst in DME, reaction time: 24 h. 
a Isolated yield by silica gel column chromatography (n-hexane: ethyl acetate, 2:1). b determined by HPLC: AD, 
n-heptane: iso-propanol 80:20, 20°C, 0.9 ml/min, 220nm/254nm: 19.7 min (major), 23.4 min (minor). 
c average of three measurements. d average of four measurements. 
In contrast to substrate S1, catalysts 161f-161h did not show the same enantioselectivity, 
which decreased with the size of the anion BF4- > PF6- > SbF6-. The enantioselectivites were 
not reproducible in all cases but varied by about 3%. One possible explanation could be a 
stronger pressure dependance of the selectivity than in the case of S1. Since the pressure can 
not be adjusted precisely (±0.1 bar), this could lead to somewhat incoherent results. 
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4.5.5 ACPKR of 2-Allyl-2-(3-phenyl-prop-2-ynyl)-malonic Acid Dimethyl Ester 
Dimethylmalonate-derived substrate S3 was also tested in ACPKR. The solvent influence 
using catalyst 161a (BArF-) was investigated (Table 4.5). As can be seen in Table 4.5, the 
solvent has an influence on the enantioselectivity in the formation of product P3. Whereas, 
entries 1 to 3 all show moderate selectivity, an ee of up to 71% was obtained in THF. 
However, better yields were obtained with DME and DCE (entries 1 and 2) than with toluene 
(entry 3) and THF (entry 4). Lu observed yields up to 81% in toluene, but this reaction has 
been performed presumably under 1.1 bar CO for 40 hours. He observed the best selectivities 
with [Ir(cod)PHOX]OTf in THF (79 % ee).[177] 
S3 P3
Ph
O
O
O
O
O
Ph
O
O
O
O
[Ir(cod)(PHOX)]X
solvent, 120°C
CO
*
 
Table 4.5: Influence of solvent on ACPKR of S3 
entry solvent mol% cat yield (%)a ee (%)b 
1 DME 9 64 47 
2 DCE 9 71 47 
3 toluene 9 47 44 
4 THF 9 46 71 
Reaction performed with 9 mol% 161c, reaction time: 24 h. 
a Isolated yield by silica gel column chromatograpy (n-hexane: ethyl acetate, 2:1). b determined by HPLC: AS, n-
heptane: iso-propanol 90:10, 20°C, 1.0ml/min, 220nm/254nm: 15.1 min (minor), 24.1 min (major). 
Table 4.6 comprises the results of ACPKR of S3 in THF with different reaction times and 
catalyst loadings. The overall conclusions are similar to those for substrate S2. Small anions 
with medium coordination ability, namely tetrafluoroborate and triflate( and to a lesser degree 
hexafluorophosphate and hexafluoroantimonate) give better results regarding both yield and 
enantioselectivity, than large and weakly coordinating anions. The yield is improved with 
catalyst loading and reaction time. It was observed however that the enantioselectivity slightly 
drops with both, higher catalyst loading and time. Somewhat contradictory is entry 10, which 
shows a surprisingly good yield for only 2 mol% catalyst loading, and a strong drop in 
enantionselectivity: 86% compared to 94% with 5mol%.  
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Table 4.6: Influence of anion on ACPKR of S3 
entry mol% time (h) X yield (%)a ee (%)b 
1 9 48 BArF 37 72 
2 5 24 BArF 46 71 
3 5 48 Al(OC(CF3)3)4 62 72 
4 9 24 OTf 57 88 
5 9 48 OTf 75 85 
6 5 48 OTf 48 94 
7 9 24 BF4 53 93 
8 9 48 BF4 76 91 
9 5 48 BF4 57 94 
10 2 48 BF4 93 86 
11 9 24 PF6 57 92 
12 9 48 PF6 60 92 
13 5 48 PF6 71 91 
14 9 24 SbF6 82 85 
15 9 48 SbF6 80 82 
16 5 48 SbF6 76 86 
Reaction performed in THF. 
a Isolated yield by silica gel column chromatograpy (n-hexane: ethyl acetate, 2:1). b determined by HPLC: AS, n-
heptane: iso-propanol 90:10, 20°C, 1.0ml/min, 220nm/254nm: 15.1 min (minor), 24.1 min (major). 
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4.5.6 ACPKR of [3-(2-Methyl-allyloxy)-prop-1-ynyl]-benzene and Allyl-(3-methyl-
prop-2-ynyl) Ether 
Both substrates S4 and S5 show rather poor results in iridium-PHOX-catalyzed ACPKR. The 
additional methyl-group in substrate S4 led to a significant drop in yield, as well as 
enantioselectivity. Only yields up to 28% were achieved for this substrate. With the iridium-
tolBINAP system, up to 30% yield and 88% ee in toluene were previously reported.[169] 
O
Ph
O O
Ph
S4 P4
[Ir(cod)(PHOX)]X
THF, 120°C
CO
 
Table 4.7: Influence of anion on ACPKR of S4 
entry anion solvent pCO (bar) yield (%)a ee (%)b 
1 TfO- DME 2.2 9 58-59 (R) 
2 BArF- DME 2.2 traces nd 
3 TfO- THF 2.2 10 71-73 (R) 
4 BArF- THF 2.2 28 64-65 (R) 
5 [Al(OC(CF3)3]4- THF 2.2 15 61-63 (R) 
Reaction performed with 9 mol% catalyst, reaction time: 24 h. 
a Isolated yield by silica gel column chromatograpy (n-hexane: ethyl acetate, 2:1), Rf = 0.4. b determined by 
HPLC: AD, n-heptane: iso-propanol 90:10, 20°C, 1.0 ml/min, 220nm/254nm: 8.3 min (R), 17.7 min (S). 
Allyl-(3-methyl-prop-2-ynyl) ether S5 was tested in the ACPKR, but no product was detected. 
The only difference to S1 is that the internal alkyne is methyl- instead of phenyl-substituted. It 
is somewhat surprising that the reactivity should be so strongly influenced by the substituent 
at the alkyne, especially since Shibata et al. observed similarly high activity and 
enantioselectivity for both substrates using their tolBINAP-iridium catalyst. 
OO O
[Ir(cod)(PHOX)]X
DME, 120°C
CO
S5 P5
*
 
Scheme 4.14: Pauson-Khand reaction of S5 
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4.5.7 Conclusion 
The influence of the counteranion on the enantioselectivity of the iridium-PHOX-catalyzed 
ACPKR was examined. 3-Phenylsubstituted enynes undergo cycloaddition with good to very 
good yields and good enantioselectivities. The 3-methylsubstituted enyne S5 was not 
converted to the cycloaddition product. Steric hindrance at the alkene moiety leads to a strong 
drop in yield. Generally, the best counteranions are small weakly-coordinating, such as 
triflate, tetrafluoroborate, hexafluorophosphate and hexafluoroantimonate. Large, weakly 
coordinating counteranions, namely BArF- and [Al(OC(CF3)3]4-, showed lower reactivity and 
selectivity, whereas the better donors tosylate, mesylate and trifluoroacetate were not reactive. 
A series of pressure experiments shows a strong CO-pressure dependence on the yield, and to 
a lesser degree, on the enantioselectivity of the iridium-PHOX-catalyzed ACPKR of S1. 
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5 Rhodium-Silylene Complexes 
5.1 Stable Silylenes 
Silylenes are divalent highly reactive silicon species, which have been known as reaction 
intermediates for a long time.[182] During the 1980s several organosilylenes were isolated and 
studied in argon or hydrocarbon matrices, at temperatures of 77 K or below.[183] While the 
first stable carbene was discovered in 1991,[30] and stannylenes and germylenes had long been 
established,[184] silicon was the last of the group 14 elements of which no dicoordinate, stable 
compound was known. Apart from this only a few divalent, though not dicoordinate 
compounds, such as decamethylsilicocene 169 (Figure 5.1, a) (π-donor-stabilized)[185] or a σ-
donor-stabilized silicon(II) species 170 (Figure 5.1, b),[186] were published. 
Si2Cl6 + 4Li[C(PMe2)2SiMe3)]
Me2P
Si
PMe2
PMe2
TMS
Me2P
TMS
Mg/THFSia) b)
169 170  
Figure 5.1: Divalent silicon compounds a) decamethylsilicocene 169 b) phoshpinomethanide stabilized 
silicon(II) 170 [185,186] 
The first stable silylene 171, a silicon analogue of an N-heterocyclic carbene (NHC), was 
reported by Denk et al. in 1994.[187] The saturated analogue 172 [188] and some benzo- and 
pyrido-fused derivatives 173 to 175 were synthesized shortly after.[189,190] All these silylenes 
are nitrogen-donor stabilized. More recently, Kira et al. developed silylene 176 with no such 
stabilization.[191] Among the mentioned silylenes (Figure 5.2) the saturated and the non-donor 
stabilized compounds are relatively unstable. An open chain bis(trimethylsilylamide)-
stabilized silylene could only be kept in solution for 12h at -20°C.[192] 
N
Si
N
N
Si
N
NRN
Si
N
N
Si
N
Si
TMS TMS
TMS TMS
171 172 R = H  
R = Me
175 176173
174  
Figure 5.2: Known stable silylenes 
The increased stability of the unsaturated silylene, namely 1,3-di-tert-butyl-2,3-dihydro-1H-
1,3,2-diazasilol-2-ylidene, in comparison to the saturated analogue 1,3-di-tert-butyl-2,3-
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[1,3,2]-diazasilolidine-2-ylidene, has been subject to several investigations. Steric hindrance 
is insignificant as a stabilizing factor, except for the non-donor-stabilized silylene. 
Undoubtedly, p-electron donation from the nitrogen lone pair into the empty p-orbital on the 
silicon is a strong stabilizing factor. Since the nitrogen atoms in the saturated silylene are 
more basic, which is reflected by shorter silicon-nitrogen bonds in the solid structure, this 
effect should be somewhat stronger. In the unsaturated, as well as in the benzo- and- pyrido-
fused silylenes, on the other hand, additional stabilization can be gained due to aromatic 
delocalization (Figure 5.3). The extent of aromaticity has been discussed.[193,194,195] 
N
Si
N
N
Si
N
N
Si
N
6 π
N
Si
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Figure 5.3: Aromatic delocalisation of the silylene 6-π-electron ring 
Experimental indications for aromaticity were obtained by Raman and NMR-spectroscopy. 
The 1H NMR chemical shifts of the ring-protons lie about 0.75 ppm downfield from those in 
the dichloro-precursor or the dihydro-analogue.[187] This shift is consistent with a moderate 
ring current, resulting from aromatic delocalization. Nucleus independent chemical shift 
calculations have also supported aromaticity, though the values are significantly smaller than 
for benzene (the shielding influence on the ghost atom 2Å above the ring-center is -5.3 for 
benzene and -2.7 for silylene).[194] Raman data also support the aromatic nature of the 
unsaturated silylene with its six π-electrons and the pariticipation of the empty silicon pz-
orbital therein.[195] 
The thermodynamic instability of the saturated silylene in comparison to its saturated 
analogue is demonstrated by the slow oligomerization that takes place at room temperature. 
When a solution of the silylene is concentrated, a silicon nitrogen bond is inserted to form 
(aminosilyl)silylene which then dimerizes to the disilene. The reaction which is accompanied 
by a change of colour from light-yellow to red is reversible. In solution the monomer is 
almost exclusively present, whereas the solid state favors the tetramer.[196] 
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Figure 5.4: Oligomerisation of saturated silylene 
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Stable silylenes are an extremely reactive class of compounds: With chalcogenes silylenes 
form spirocyclic dimers,[197] with Lewis acids they form the respective Lewis acid-base 
adducts, usually with subsequent insertion to obtain a tetravalent structure.[198] Furthermore, 
insertion in metal nitrogen bonds[196], carbon-halogen bonds[199], oxygen-hydrogen-bonds[200] 
and others are reported.[201,202] The amphiphilic character of silylenes has been discussed by 
Bharatam et al..[203] 
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Scheme 5.1: Typical reactions of stable N-heterocyclic silylenes reported in literature 
5.2 Silylene-Complexes 
Various transition metal complexes of silylenes[204] have been prepared.[205,206] Ni(cod)2 was 
shown to form homoleptic tris(silylene) complexes [Ni(171)3] and [Ni(172)3],[207] whereas a 
tetravalent (silylene)-nickel complex 177 was obtained starting from a N,N'-di-neopentyl-
substituted silylene 173 (Figure 5.5).[208,209] The crystal structure of this complex showed a 
tetrahedral arrangement of the four silylene ligands. Tris- and tetrakis(silylene)-palladium 
complexes [Pd(171)3] and [Pd(172)4], as well as dinuclear silylene-bridged compounds, were 
formed using [Pd(PPh3)3] or [Pd(cod)(CH3)2] as precursors.[210,40] However, no crystal 
structures were reported for the homoleptic complexes. 
L
L
L
Ni L
L = silylene
N
Si
N
t-Bu
t-Bu 177  
Figure 5.5: Tetrahedral silylene-nickel complex 177 
N-Heterocyclic carbenes (NHC) have emerged as a versatile class of ligands for homogeneous 
catalysis.[211] Accordingly, a wide variety of NHC-metal complexes have been prepared and 
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investigated as catalysts. In contrast, analogous silylene metal complexes have received much 
less attention. The potential of stable silylenes as ligands in catalysis remains to be explored. 
Recently, Fürstner et al. successfully used a mixed dinuclear (silylene)(phosphine)Pd(0) 
complex, in which a heterocyclic silylene acts as a bridging ligand, to catalyze the Suzuki 
coupling of aryl boronic acids with bromoarenes.[40] However, the nature of the actual 
catalytically active species in this reaction is not known. Recently, McGuinness et al. have 
calculated the barrier for methyl migration to the silylene ligand in palladium-silylene 
complexes.[212] The calculation revealed a low barrier to coupling of an alkyl ligand with the 
silylene ligand. Consequently, if silylene ligands are applied in homogeneous catalysis, and 
the catalytic cycle involves a metal-hydrocarbon species, migration is likely to be a significant 
factor. 
5.3 Objectives of this Chapter 
The objective of the research described in this chapter was the synthesis of well-defined 
iridium-and rhodium silylene complexes, that are potential catalysts for hydrogenation. Our 
interests were the application and the properties of these strong σ-donor ligands, which have 
been scarcely investigated to date. 
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5.4 Ligand and Complex Synthesis 
For the investigation unsaturated silyene 171, first published by Denk et al. in 1994[187] and 
the less stable saturated silylene 172[188] were synthesized and reacted with different potential 
metal precursors. Since we were looking for an application in catalysis, we were interested in 
the presence of a relatively labile group, that can dissociate from the metal centre during the 
catalytic cycle. In hydrogenation this group is usually a η4-bound diolefin, such as 
cyclooctadiene or norbornadiene, which is reduced under hydrogenation conditions. Also 
phosphines, such as triphenylphosphine in Wilkinson’s catalyst,[213] are known to dissociate 
and provide a free coordination site. The initial goal was the synthesis of cationic iridium 
complexes, but in the course of the investigation the synthesis of rhodium catalysts proved to 
be more feasible. Due to the high reactivity of the free stable silylenes the choice of dry and 
degassed solvents was limited. Chlorinated solvents cannot be used due to the insertion of 
silylenes into the carbon-halogen bond,[199] and nitriles are at least known to add to the benzo-
fused silylene. Alcohols and water also react with silylenes (see Scheme 5.1) 
5.4.1 Synthesis of N-Heterocyclic Silylenes 
1,3-Di-tert-butyl-2,3-dihydro-1H-1,3,2-diazasilol-2-ylidene 171 was prepared as has been 
described previously by Haaf et al.[200] Glyoxal 178 in aqueous solution was reacted with tert-
butyl amine to give the diimine 179. This was lithiated with lithium wire in THF at -78°C. 
The dark red dianion was then treated with tetrachlorosilane to yield the dichloride 180. The 
reduction was performed via a slightly different procedure. Instead of sodium-potassium alloy 
for the reduction of the dichlorosilane, stoichiometric amounts of potassium-graphite were 
used, according to Fürstner et al.[40], to prevent the overreduction and thus decomposition of 
171. 
N
Si
NH O
H O
N
N N
Si
N Cl
Cl
C8K, THF
rt, 18 h
1. Li, THF
2. SiCl4
tert-BuNH2
H2O, 0°C 
45 min
179 180 171
-78°C, 24 h
-196°C, 15 h
178  
Scheme 5.2: Synthesis of 1,3-di-tert-butyl-2,3-dihydro-1H-1,3,2-diazasilol-2-ylidene 171 
1,3-Di-tert-butyl-2,3-[1,3,2]-diazasilolidine-2-ylidene 172 was prepared according to Haaf et 
al.[204b] Dibromoethane 181 reacted with tert-butylamine to the diamine 182. This was reacted 
with tetrachlorosilane in the presence of triethylamine in toluene to give the dichloride 183. 
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Reduction in THF and triethylamine (15:2) with sodium-potassium alloy gave saturated 
silylene 172. 
N
Si
NH Br
H Br
NH
NH N
Si
N Cl
Cl
NaK2
THF/NEt3
SiCl4, NEt3
toluene
tert-BuNH2
hexane, H2O
182 183 172
reflux, 3 d reflux, 15 h -78°C    rt, 3h
181  
Scheme 5.3: Synthesis of 1,3-di-tert-butyl-2,3-[1,3,2]-diazasilolidine-2-ylidene 172 
5.4.2 Rhodium Complex Synthesis  
Although rhodium plays an important role in homogeneous catalysis, no complexes of this 
metal with η1-bound N-heterocyclic silylenes are known. For initial experiments with 
silylenes we chose rhodium-complex precursors which are all bearing a cyclooctadiene (cod) 
group. Ligand exchange liberates cod which is inert towards reaction with free silylene ligand. 
One of the cod groups was meant to not be exchanged, to obtain a catalytically active 
complex, since cod is expected to be reduced under hydrogenation conditions, whereby a free 
coordination site at the metal-center is generated.  
[Rh(cod)2]BF4 was prepared according to literature procedure, by reaction of [Rh(cod)Cl]2 
and cyclooctadiene in dichloromethane, and anion-exchange with silver tetrafluoroborate. 
[Rh(cod)2]BArF (BArF = tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate) was readily 
prepared, using a modified procedure reported for the preparation of the analogous 
tetrafluoroborate (Scheme 5.4).[214] 
Rh Rh
Cl
Cl
XRh AgBF4 or NaBArF
CH2Cl2, rt, 30 min
cod
X = BF4-
X = BArF-
184
185
83%
80% 
Scheme 5.4: Synthesis of rhodium-complex precursors 184 and 185 
When a slurry of 184 and 171 was stirred in hexane or benzene, an orange suspension of the 
cationic tetrakis(silylene) complex 186 was formed. However, it remained unclear, how many 
ligands were attached to the metal-center. It was assumed that for steric reasons only three 
ligands were attached to the metal, as it is known from [Ni(171)3][207] and [Pd(171)3].[210]  
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RhSi
N
N
Si
NN
Si
N
N
Si
N N
rt, 14 h
XRh X
X = BF4-
X = BArF-
186
187
171, hexane
 
Scheme 5.5: Synthesis of cationic rhodium-silylene complexes 186 and 187 
Therefore, a related complex 187 with a proton containing anion was prepared from 171 via 
the essentially same route as described before. This enables us to identify the number of 
silylene ligands by integration of the anion moiety in the 1H NMR spectrum.  
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Figure 5.6: 1H NMR of complex 187 in CD2Cl2 (bottom) and d8-THF (top) – with benzene rest signal 
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Product 187 was obtained after stirring over night at room temperature as an extremely air-
sensitive orange solid in quantitative yield and was finally crystallized from dichloromethane-
hexane. 
The metal/silylene ratio, determined by integration of the silylene and the BArF protons, was 
1:3 in dichloromethane-d2 or acetonitrile-d3. However, x-ray crystal structures revealed, that 
actually 4 ligands were coordinated to the rhodium center. Solution structures of complex 
187, analyzed by 1H-, 13C-, and 29Si NMR spectroscopy in tetrahydrofuran-d8 and diethyl 
ether-d10, were recorded and were consistent with the crystal structure. The reason for this 
discrepancy remains unclear (Figure 5.6). A dynamic process involving reversible 
dissociation of one ligand can be excluded, because the free silylenes 171 or 172 are known to 
decompose in chlorinated solvents,[199] whereas complexes 187 and 188 are stable in 
dichloromethane (they were recrystallized from this solvent). 
RhSi
N
N
Si
NN
Si
N
N
Si
N N
rt, 14 h
XRh X
X = BArF-188
172, hexane
 
Scheme 5.6: Synthesis of cationic rhodium-silylene complex 188 
The analogous cationic rhodium-silylene complex with saturated silylene 172 was obtained in 
the same way as described for 187.[204b] Attempts to synthesize mixed bis(silylene)(cod)Rh 
complexes by replacement of just one 1,5-cyclooctadiene moiety were unsuccesssful. When 
185 was diluted in acetonitrile, [Rh(cod)(CH3CN)2]BArF was formed as a yellow intermediate 
and the reaction did not proceed as cleanly as in hexane.[215] In both cases exchange of all 
ligands was observed.  
The homoleptic tetrakis(silylene)complexes 187 and 188 were the only products observed, 
even when less than 4 equivalents of silylene were used. In this respect, the reactivity of the 
silylenes 171 and 172 differs from that of analogous N-heterocyclic carbenes. Only partial 
ligand exchange leading to Rh(cod)(NHC)X complexes could be achieved, when excess of 
carbene was reacted with Rh2(cod)2X2.[216] Thus, it seems more difficult to form 
tetrakis(NHC) complexes, probably due to steric strain resulting from the shorter Rh-C 
compared to Rh-Si bonds. 
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5.4.3 Characterization of Rhodium-Silylene Complexes 
The solution structures of complexes 187 and 188, analyzed by 1H-, 13C-, and 29Si NMR 
spectroscopy in tetrahydrofuran-d8 and diethyl ether-d10, were consistent with the crystal 
structures. The 1H NMR spectra of the new rhodium-silylene compexes 187 and 188 are 
easily discussed since only two peaks for each the silylene moities and for the anion are 
observed. Complexation is accompanied by a downfield shift of the silylene protons of about 
0.1 ppm for the tert-butyl groups and the ring protons. The metal/silylene ratio, determined by 
integration of the silylene and the BArF protons, was 1:4 (Figure 5.6).  
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Figure 5.7: 29Si NMR spectra of complexes 187 (top) and 188 (bottom) in d8-THF 
A doublet is observed in the 29Si NMR spectrum of 187 at δ = 95.6 ppm (1JRhSi = 82.5 Hz) and 
of 188 at δ = 134.4 ppm (1JRhSi = 76.6 Hz). In comparison to the free silylenes 171 (78.0 ppm) 
and 172 (118.9) this is a considerable downfield shift (Figure 5.7). 
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5.5 Probing of Catalytic Activity 
Preliminary hydrogenation experiments with α-trans-methylstilbene showed some 
hydrogenation product with up to 78% conversion. Partial conversion also took place when 
Hg was added to suppress a heterogeneous reaction pathway that could result from 
decomposition of the complex. Unfortunately,  the experiments were not reproducible. 
It remained to discover a species that could have led to the observed reactivity, e.g. a 
rhodium-hydride compound. Complexes 187 and 188 were dissolved in a number of different 
solvents and each purged with hydrogen at 1 bar in a young valve NMR tube, and at 50 bar in 
an autoclave. After 24 hours still no hydride peaks could be detected by NMR. At 1 bar in 
diethylether almost no decomposition took place, and the solution also remained unchanged 
after one week. At 50 bar the complex was destroyed completely, i.e. no olefinic ring protons 
were visible, but a number of different decomposition products with multiplets around 5.6 
ppm were detected, which can probably be assigned to tetravalent silylene-addition products. 
No proof of a dissociative mechanism could was observed. 
Reaction of complex 187 under 1 bar carbonmonoxide in tetrahydrofurane led to a brown 
solution. In the 1H NMR general loss of signal intensity of the ligand protons relative to the 
solvent residual peaks was observed. Furthermore all peaks derived from the cationic moiety 
disappeared. No free silylene was observed. No characteristic peaks for rhodium-carbonyl-
compounds were detected in the 13C NMR. 
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5.6 X-ray Crystallographic Studies 
Complexes 187 and 188 crystallized from dichloromethane/hexane as orange and yellow 
plates, respectively, which were subjected to X-ray crystallographic analysis. POV-Ray 
representations of the crystal structures are depicted in Figure 5.8 and Figure 5.9; 
crystallographic data are found in the appendix and selected structural parameters are given in 
Table 5.1.  
 
Figure 5.8: Representation of the cation moiety of complex 187 in top view (left) and side view (right). 
Both complexes are centrosymmetric and show a windmill-shaped, square-planar 
arrangement of the four silylene ligands. The three-coordinate silicon atoms adopt an almost 
perfectly planar geometry, with the sum of bond angles being 360.6° (187) and 360.0° (188). 
Rh-Si distances are between 2.29-2.32 Å for both complexes. As expected, the Rh-Si bonds 
are somewhat shorter than in silyl-Rh complexes (2.32-2.38 Å) or bridged µ-(R2Si)Rh2 
complexes (2.34-2.36 Å).[217,218] 
 
Figure 5.9. Representation of the cation moiety of complex 188 in top view (left) and side view (right). 
Si-N Bond distances and N-Si-N angles of the free silylenes change very little upon 
coordination to Rh (171: 1.75 Å, 89.0°; 187: 1.73-1.74 Å, 91.0-91.3°).[187] No other examples 
of square-planar tetrakis(silylene) complexes were found in the literature. The only somewhat 
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related silylene complexes, for which crystal structures were reported, are the above-
mentioned tetrahedral [Ni(silylene)4] (Figure 5.5, page 101) and square-planar mixed trans-
bis(chlorosilyl)-bis(silylene)-Pd(II) and Pt(II) complexes.[207,208] 
Table 5.1: Selected Bond Lengths (Å) and Angles (deg) for 187 and 188 
 187 188 
Rh1-Si1 
Rh1-Si2 
Rh1-Si3 
2.3104(8) 
2.2922(8) 
2.2988(8) 
2.289(2) 
2.316(2) 
Si1-N1 
Si1-N2 
Si2-N3 
Si2-N4 
1.735(2) 
1.736(2) 
1.734(2) 
1.735(2) 
1.714(3) 
1.712(3) 
1.711(3) 
Si1-Rh1-Si1’ 
Si1-Rh1-Si2 
Si1-Rh1-Si2’ 
Si1’-Rh1-Si2 
Si1’-Rh1-Si2’ 
Si2-Rh1-Si2’ 
Si1-Rh1-Si3 
Si1’-Rh1-Si3 
Si2-Rh1-Si3 
94.63(4) 
173.86(2) 
86.72(2) 
86.72(2) 
173.86 (2) 
92.57(4) 
178.83(6) 
90.59(3) 
 
90.59(3) 
 
 
89.41(3) 
89.41(3) 
179.995 
N1-Si1-N2 
N3-Si2-N4 
N3-Si2-N3’ 
N4-Si3-N4’ 
91.0(2) 
91.3(2) 
94.1(2) 
 
94.1(2) 
94.2(2) 
Rh1-Si1-N1 
Rh1-Si1-N2 
Rh1-Si2-N3 
Rh1-Si2-N4 
Rh1-Si3-N4 
131.60(9) 
137.05(8) 
138.32(8) 
129.85(8) 
132.2(1) 
133.7(2) 
132.9(2) 
 
132.9(1) 
Both compounds show C2-symmetry. While in 188 two of the silicon atoms lie on the C2-
axes, all silicon atoms are in general positions in compound 187. Therefore, the number of 
Rh-Si distances, as well as the number of Si-Rh-Si, N-Si-N and Rh-Si-N angles differs in both 
cases. The symmetry generated atoms are marked with prime’. 
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5.7 Conclusion 
Two cationic rhodium(I)-tetrasilylene 187 and 188 were prepared from [Rh(cod)2]BArF 185 
and 1,3-di-tert-butyl-2,3-dihydro-1H-1,3,2-diazasilol-2-ylidene 171 or its saturated analogue 
172, respectively (Figure 1). The two complexes were characterized by X-ray analysis and 
NMR spectroscopy. The crystal structures revealed a square-planar coordination geometry for 
both complexes. Only tetrakis(silylene) complexes were formed, even in the presence of less 
than 4 equiv. of silylene. 
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6 Synopsis 
We were interested to extend our library of P,N-ligands, and to investigate the influence of a 
five-memebered ring-chelate, since most of the previously tested ligands form six-membered 
ring-chelates. In consequence, twelve new phosphinomethyl-oxazolines and their 
corresponding iridium-complexes were prepared and tested in the enantioselective 
hydrogenation of unfunctionalized and functionalized olefins. The tetrasubstituted olefin 2-
(4’-methoxyphenyl)-3-methyl-2-butene was reduced with higher enantioselectivity than 
reported for other iridium catalysts.  
*
MeO MeO
CH2Cl2, 50-100 bar H2
3h, rt
P N
O
R2
Ir
BArF-
R1
R1
R1 =  tert-butyl, cyclohexyl, phenyl
R2 =  tert-butyl, neopentyl, phenyl, iso-propyl
up to 94% ee
 
Scheme 6.1: Hydrogenation of tetrasubstituted alkene with new iridium-catalysts 
Another objective was to examine the effect of a strong π-accepting and planar phosphorus-
moiety. Three chiral phosphininoxazolines were prepared by dehydration of a water-adduct, 
wherein the phosphorus atom is present as a secondary phosphine oxide. The corresponding 
cationic iridium-complexes were synthesized. One of these complexes was also tested in the 
iridium-catalyzed hydrogenation and transfer-hydrogenation showing good conversion, but 
low to moderate enantioselectivity. 
R1 R1
CH2Cl2, 50 bar H2
3h, r.t.
BArF
Ir
P N
O
R3
X
R3
X
R4 R4
*R2 R2
3% to full conversion
0 to 92% ee  
Scheme 6.2: Hydrogenation with phosphininoxazolin-iridium catalyst 
We were interested in the scope of iridium-PHOX complexes in other catalytic reactions. 
Initial studies towards the application of this system in asymmetric catalytic Pauson-Khand 
reaction were completed regarding pressure influence, reproducability and the influence of the 
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counteranion on the enantioselectivity of the reaction. 3-Phenylsubstituted enynes undergo 
cycloaddition with good to very good yields and good enantioselectivities. Steric hindrance at 
the alkene moiety leads to a strong drop in yield. Among the tested counteranions, small and 
weakly-coordinating anions, such as triflate, tetrafluoroborate, hexafluorophosphate and 
hexafluoroantimonate proved to give the highest enantioselectivities.  
Z
R1
Z O
R1
R2
[Ir(cod)(PHOX)]X
2-9 Mol%
solvent, 120°C
CO
S1-S5 P1-P5
R2
 
 Z R1 R2 
S1 O Ph H 
S2 NTs Ph H 
S3 C(COOMe)2 Ph H 
S4 O Me H 
S5 O Ph Me 
Scheme 6.3: Asymmetric catalytic intramolecular Pauson-Khand reaction with iridum-PHOX catalyst 
Inspired by the recent success of NHCs in the iridium catalyzed hydrogenation, we envisioned 
the synthesis of iridium- and rhodium-complexes containing N-heterocyclic silylenes. Two 
cationic rhodium(I)-silylene complexes 187 and 188 were prepared from [Rh(cod)2]BArF 185 
and 1,3-di-tert-butyl-2,3-dihydro-1H-1,3,2-diazasilol-2-ylidene 171 and its saturated analogue 
172, respectively (Figure 1). Only catalytically inactive complexes were formed. The 
corresponding iridium-complexes were not accessible by the same method. 
rt, 14 h
BArFRh
hexane
N
Si
N
 
Scheme 6.4: Synthesis of a homoleptic rhodium-silylene complex 
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7 Experimental 
7.1 Analytical Methods 
NMR-Spectrometry: NMR spectra were recorded on Bruker Advance 250 (250 MHz), 
Bruker Advance 400 (400 MHz) and Bruker Advance DRX 500 (500 MHz) NMR 
spectrometers, equipped with BBO broadband probeheads. The chemical shift δ is given in 
ppm. References were 7.26 ppm (1H NMR) and 77.16 ppm (13C NMR) for CHCl3, 5.32 ppm 
(1H NMR) and 53.8 ppm (13C NMR) for CH2Cl2, 7.16 ppm (1H NMR) and 128.06 ppm (13C 
NMR) for C6H6, and 3.58 (1.73) ppm (1H NMR) and 67.4 (25.3) ppm (13C NMR) for 
THF.[219] 85% phosporic acid (0 ppm) was taken as an internal standard in a capillary for 31P 
NMR (sr(CD2Cl2) = 94.2 Hz, sr(CDCl3) = 130.69 Hz, sr(C6D6) = 127.98 Hz) measured on the 
500 MHz NMR spectrometer. For spectra that were measured on the 400 MHz NMR 
spectrometer, the shifts were corrected (+3.6 ppm for CD2Cl2, +3.2 ppm for C6D6). The 
assignment of 1H- and 13C-signals was made by 2D-NMR, namely COSY, HMQC, HMBC 
and difference NOESY-spectrometry. 13C and 31P, until otherwise noted, were recorded 1H-
decoupled. Multiplets were assigned with s (singlet), d (doublet), t (triplet), pst (pseudo-
triplet), m (multiplet). The index br stands for broad (usually no resolution), the indices eq 
and ax for equatorial and axial, respectively. 
Mass Spectrometry (MS): Mass spectra were recorded by Dr. H. Nadig. Electron ionization 
(EI) was measured on VG70-250, fast atom bombardment (FAB) was measured on MAR 312, 
Electron spray ionization (ESI) was measured on Finnigan MAT LCQ by B. Bulic and A. 
Teichert. FAB was performed with 3-nitrobenzyl alcohol as matrix. The signals are given in 
mass-to-charge ratio (m/z). The fragment and intensities of the signals are given in brackets. 
Infrared Spectrometry (IR): Infrared spectra were measured on a Perkin Elmer 1600 series 
FTIR spectrometer. Solid samples were prepared as KBr wafers, liquid samples were 
prepared between NaCl plates. For air and moisture sensitive compounds KBr was thoroughly 
dried under high vacuum and samples were prepared in the glove box. Absorption bands are 
given in wave numbers ν~ [cm-1]. The peak intesity is assigned with s (strong), m (medium), 
and w (weak). The index sh stands for shoulder, br for broad. 
Melting Point (m.p.): The melting point was measured in a Büchi 535 melting point 
apparatus. The values are not corrected. 
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Optical Rotation ( [ ]20Dα ): α-values were measured in a Perkin Elmer Polarimeter 341 in a 
cuvette (l = 1 dm) at 20°C at 589 nm (sodium lamp).Concentration c is given in g/100 mL.  
Thin Layer Chromatography (TLC): TLC plates were obtained from Macherey-Nagel 
(Polygram SIL G/UV254, 0.2 mm silica with fluorescence indicator, 40×80 mm). 
Gas Chromatography (GC): The gas chromatographs in use were Carlo Erba HRGC Mega2 
Series 800 (HRGC Mega 2). Achiral separations were performed with Macherey-Nagel 
Optima 5-Amine (30 m × 0.25 mm × 0.50 µm) and Restek Rtx-1701 (30 m × 0.25 mm × 0.25 
µm). For chiral separations β- and γ-cyclodextrine columns (30 m × 0.25 mm × 0.25 µm) 
were used. 
High Performance Liquid Chromatography (HPLC): For HPLC analysis Shimadzu 
systems with SCL-10A System Controller, CTO-10AC column oven, LC10-AD pump 
system, DGU-14A degasser, and SPD-M10A Diode Array- or UV-vis detector were used. 
Chiral columns Chiracel OD-H, OB-H, OJ, AS and Chiralpak AD from Daicel Chemical 
Industries Ltd. were used. 
Elemental Analysis (EA): Elemental analyses were carreid out by Mr. W. Kirsch at the 
Department of Chemistry at the University of Basel, on Leco CHN-900 (C-, H-, N-detection) 
and Leco RO-478 (O-detection) analysers. The data are indicated in mass percent. 
7.2 Working Techniques 
Sensitive Compounds: Syntheses of air- and moisture-sensitive compounds were carried out 
under inert atmosphere in a glove-box (MBRAUN labmaser 130, N2) or using standard 
Schlenk techniques (Ar).  
Solvents: Dichloromethane, diethyl ether, pentane, tetrahydrofurane, and toluene were dried 
and degassed by reflux over an adequate drying agent under nitrogen.[220] Other solvents were 
purchased dry at Fluka or Aldrich in septum sealed bottles, kept under inert atmosphere and 
over molecular sieves. If necessary, solvents were degassed by three freeze-pump-thaw 
cycles. Deuterated solvents were degassed and stored over activated molecular sieves (4Å). 
Column Chromatography: Silica gel was obtained from CU Chemie Uetikon (C-560 D, 
0.040-0.063 mm) or Merck (silica gel 60, 0.040-0.063 mm). Generally, the flash column 
chromatography according to Still[221] was performed. 
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7.3 New PHOX Ligands for Enantioselective Hydrogenation 
Di-tert-butylchlorophosphine [13716-10-4], chlorodicyclohexylphosphine [16523-54-9], 
dicyclohexylphosphine [6476-37-5], diphenylphosphine [829-85-6] and phenylglycinol 
[56613-80-0] were purchased from Aldrich. [Ir(cod)Cl]2 [12112-67-3] was purchased from 
Strem, neopentylglycine [88319-43-1] was purchased from Bachem, and L-valinol [473-75-6] 
and L-tert-leucinol [3907-02-6] were bought from Degussa. 
Synthesis of Amides 34-44 
general procedure 1: Phosphinoacetic acid-borane adduct (1 eq) and HOBt (1.2 eq) were 
dissolved in dichloromethane. EDC (1.2 eq) and amino alcohol (1 eq) were added and the 
mixture was stirred for 15 hours at room temperature. The mixture was then diluted with 
dichloromethane (20 mL) and water (30 mL) and extracted with 0.5M HCl (20 mL), 2.5% 
NaHCO3 (20 mL), water (20 mL), and brine (20 mL). Drying over MgSO4 and evaporation of 
the volatiles gave the crude product. The product was usually used without further 
purification. 
Synthesis of Oxazoline-Borane Adducts 45-47 
general procedure 2: Phosphinoacetamide-borane adduct (1 eq) was dissolvd in THF. 
Burgess’ reagent ((methoxycarbonylsulfamoyl)triethylammonium hydroxide, inner salt) (1.2 
eq) was added and the mixture stirred for four hours at 70 °C. The reaction mixture was 
dissolved in water (20 mL) and dichloromethane (20 mL) and the layers were separeted. The 
water layer was extracted with dichloromethane (3×20 mL). The combined organic layers 
were then extracted with brine (20 mL) and dried over Na2SO4. After evaporation of the 
volatiles the crude product was purified by column chromatography. 
Synthesis of Chloroacetamides 50-53 
general procedure 3: Chloroacetylchloride (1 eq) was slowly added to a solution of amino 
alcohol (1.01 eq) and triethylamine (1.05 eq) in dichloromethane at -20 °C. The reaction 
mixture was stirred at room temperature for 20 hours after which time all volatiles were 
removed and the residue suspended in ethyl acetete. Filtration was followed by evaporation of 
the solvent and purification by flash column chromatography or Kugelrohr distillation. 
Synthesis of Chloromethyloxazolines 54-57 
general procedure 4: To a solution of chloroacetamide (1 eq) in THF was added 
(methoxycarbonylsulfamoyl)triethyl-ammonium hydroxide, inner salt (1.2 eq).The solution 
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was heated to reflux for 4 hours after which time all volatiles were removed and the residue 
diluted in dichloromethane (100 mL). The organic layer was washed with water (100 mL) 
then brine (50 mL) and dried over MgSO4. After evaporation of the solvent, the crude 
material was purified by column chromatography. 
Synthesis of Oxazoline-Borane Adducts 59-67 
general procedure 5: method A: A two-neck flask under argon was charged with NaH (1-2.6 
eq) and THF. At 0 °C a mixture of chloro-methyl-4,5-dihydro-oxazoline (0.8-1.3 eq) and a 
secondary phosphine-borane adduct (1 eq) in THF was added dropwise to the suspension. 
After the formation of hydrogen had stopped, the mixture was stirred at room temperature 
until TLC indicated the consumption of starting material. The reaction was then quenched 
with HCl 1N and diluted with water. After extraction with dichloromethane the combined 
organic layers were dried over MgSO4. The crude product was purified by flash column 
chromatography. method B: In a schlenk under argon a secondary phosphine-borane adduct 
(1 eq) in THF was cooled to -78 °C. n-BuLi (1.05 eq) was slowly added and the mixture was 
stirred for 15 minutes at -78 °C and for 2 hours at room temperature. After cooling to -78 °C 
chloro-methyl-4,5-dihydro-oxazoline (0.8-1.3 eq) in THF was added via cannula, and the 
cannula was rinsed with THF. The mixture was stirred at room temperature until TLC 
indicated the consumption of starting material. Then the mixture was poured in saturated 
NaHCO3 solution and extracted with diethyl ether (3×10 to 20 mL) The combined organic 
layers were dried over MgSO4 and the crude product was purified by flash column 
chromatograph on silica eluting with diethyl ether and pentane. 
Deprotection of Oxazoline-Borane Adducts to Oxazolines 68-79 
general procedure 6: Borane-protected phosphanyl-methyl-4,5-dihydro-oxazoline was 
dissolved in diethylamine (1-2 mL) and stirred for 1 to 7 days. The conversion was controlled 
by 1H NMR. After completion of the reaction all volatiles were removed under high-vacuum 
at 60 °C. 
Synthesis of Iridium Complexes 80-91 
general procedure 7: Under argon, the corresponding P,N-ligand (1 equiv) was dissolved in 
dry dichloromethane, and [Ir(cod)Cl]2 (0.5 equiv) was added as a solid. The orange solution 
was heated for 2 hours to 48 °C in a closed screw-cap schlenk. After cooling to room 
temperature, NaBArF (1.3 equiv) was added. After 15 hours some silica was added and the 
volatiles were evaporated. Column chromatography with diethyl ether and dichloromethane 
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(gradient mixtures) afforded the pure complexes of which some could be recrystallized in 
dichloromethane/hexane. 
Catalytic Hydrogention at Elevated Pressure 
general procedure 8: In a glove box, substrate, iridium complex and dichloromethane were 
added into little vials (1.5 mL) equipped with a magnetic stir bar. Four vials were added to a 
60 mL autoclave (premex AG, Lengnau, Switzerland). The autoclave was pressuriesed with 
H2 (Carbagas, Switzerland, 99.995%) according to the stated reaction conditions. After 
reaction, the pressure was released and the solvent was evaporated. The residue was dispersed 
in hexane/ethyl acetate (9:1) and filtered over a short plug of silica gel eluting with hexane 
and ethyl acetate (9:1 to 1:1). The filtrate was analyzed by GC, chiral GC, and chiral HPLC to 
determine the conversion and enantioselectivity. HPLC samples were prepared in heptane and 
iso-propanol. The analytical procedures were used as previously described in reference 57b. 
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7.3.1 Phosphinoacetic Acid-Borane Adducts 
Di-tert-butylmethylphosphine-borane adduct (23)[65] 
Di-tert-butylchlorophosphine (2 g, 11 mmol) was dissolved in pentane and cooled to -78 °C. 
Methyllithium (12.2 mmol, 1.6M in diethyl ether) was added dropwise, and the solution was 
slowly brought to room temperature and stirred for further 12 hours. The resulting suspension 
was filtered over celite and washed with pentane (2×10 mL). The solution was reduced and 
added to borane-THF adduct (15 mmol, 1M in THF) at 0 °C. The mixture was stirred at room 
temperature for 15 hours. Then all volatiles were evaporated and the crude mixture was 
purified over a short column on silica eluting with pentane and diethyl ether. The product was 
obtained as a white solid (1.61 g, 84%). 
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C9H24BP (174.07) 
1H NMR (500.1 MHz, CDCl3, 300K): δ = 0.5 (mbr, 3H, 4)1.18 (d, 2JHP = 9.4 Hz, 3H, 1), 1.26 
(d, 3JHP = 12.6 Hz, 18H, 3). 31P{1H} NMR (202.5 MHz, CDCl3, 300K): δ = 38.5 (m, 1JPB = 
62.8 Hz). TLC (n-pentane/diethyl ether, 10:1) Rf = 0.53 
Di-tert-butylphosphino acetic acid-borane adduct (24)[65] 
Di-tert-butylmethylphosphine-borane adduct (450 mg, 2.6 mmol) was dissolved in THF (8 
mL) and degassed with three freeze-pump-thaw cycles. At -78 °C 1.9 eq sec-butyllithium (1.3 
M in cyclohexane) was added, and the yellow solution was stirred for 2 hours at this 
temperature. The cooling-bath was removed and CO2 was bubbled through the solution for 45 
minutes. The white suspension was diluted with diethylether (8 mL) and extracted with 
aqueous saturated Na2CO3 (4×10 mL). The water-phase was acidified and extracted with 
diethyl ether (6×20 mL). Drying over Mg2SO4 and evaporation of the volatiles afforded di-
tert-butylphosphine acetic acid-borane adduct 24 as a white solid (463 mg, 82%). 
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C10H24BO2P (218.08) 
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1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.55 (m, 1JHB = 100 Hz, 3H, 6), 1.33 (d, 3JHP = 
13.4 Hz, 18H, 1), 2.79 (d, 2JHP = 11.1 Hz, 2H, 3). 31P{1H} NMR (162 MHz, CDCl3, 300K): δ 
= 47.0 (m, 1JPB = 69.4 Hz). MS (+FAB, 3-NBA) m/z: 217 (R12R2P(11B)H2+, 81.9), 216 
(R12R2P(10B)H2+, 20.2), 159 (M+-BH3,-C4H10, 15.1), 103 (159-C4H8+, 13.1), 57 (C4H9+, 100). 
IR (KBr): ν~ [cm-1] = 2990.5s, 2967.4s, 2904.3m, 2882.5m, 2671.9w, 2571.4w, 2443.0s, 
2586.3s, 2268.0w, 1710.8s, 1481.6m, 1470.9m, 1424.7m, 1394.0m, 1373.9m, 1302.5s, 
1224.6w, 1188.3w, 1143.3m, 1076.m6, 1925.3m, 936.0m, 839.9w, 812.0m, 764.1w, 744.9w, 
686.8m, 634.6m, 602.1m, 531.4w, 470.6m. m.p. 138-140°C. EA %found (calcd): C: 55.00 
(55.08), H:10.94 (11.09). 
Dicyclohexylmethylphosphine-borane adduct (27) 
In a flame-dried schlenk, chlorodicyclohexylphosphine (2.13 g, 9.15 mmol) was dissolved in 
pentane (25 mL). The cloudy solution was cooled to -78 °C and methyllithium (10.1 mmol, 
1.6M in diethyl ether) was slowly added. The solution was slowly brought to room 
temperature and stirred for further 15 hours. The resulting suspension was filtered over celite 
and washed with pentane (2×10 mL). The filtered solution was reduced and cooled to 0 °C. 
Borane-THF adduct (12 mmol, 1M in THF) was added and the solution stirred for 6 hours at 
room temperature. After evaporation of the volatiles the crude product was purified by 
column chromatography on silica eluting with pentane and diethyl ether. The product was 
obtained as a white solid (1.95 g, 94 %). 
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C13H28BP (226.15) 
1H NMR (500.1 MHz, CDCl3, 300K): δ = 0.3 (q, 1JBH = ~100Hz, 3H, 6), 1.10 (d, 3JHP = 9.5 
Hz, 1), 1.25 (m, 10H, Cyeq),1.61 (m, 2H, Cyax), 1.72 (m, 5H, Cyax), 1.83 (m, 3H, Cyax), 1.87 
(m, 2H, Cyax). 13C{1H} NMR (125.8 MHz, CDCl3 300K): δ = 3.7 (d, 1JCP = 24.8 Hz, 1), 26.1 
(Cy), 26.2 (Cy), 26.6 (5), 26.8 (Cy), 26.9 (Cy), 31.3 (d, 1JCP = 34 Hz, 2). 31P{1H} NMR 
(202.5 MHz, CDCl3, 300K): δ = 20.3 (m, 1JPB = 56 Hz). MS (+FAB, 3-NBA) m/z: 223.2 
(20.0), 212.2 (C13H25P+, 100), 157.1 (16.6), 130.1 (C7H15P+, 82.3). IR (KBr): ν~ [cm-1] = 
3447.7mbr, 2916.8s, 2853.9s, 2667.3w, 2371.4s, 2327.5s, 2247.6m, 1447.6s, 1421.3m, 
1346.4m, 1295.9m, 1275.3w, 1211.6w, 1180.2w, 1131.4m, 1067.3s, 1048.5m, 1007.6s, 
920.7s, 906.6s, 851.8s, 779.0s, 754.4m, 739.5m, 704.1m, 599.m5, 588.9s, 516.4m, 446.9m. 
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m.p. 78°C. TLC (n-pentane:diethyl ether; 10:1) Rf = 0.46. EA % found (calcd) C 68.96 
(69.04), H 12.30 (12.48). 
Dicyclohexylphosphino acetic acid-borane adduct (28) 
Dicyclohexylmethylphosphine-borane adduct (1.7 g, 7.5 mmol) was dissolved in THF (30 
mL) and degassed with three freeze-pump-thaw cycles. At -78 °C 1.8 eq sec-butyllithium (1.3 
M in cyclohexane) were added, and the yellow solution was stirred for 2 hours at this 
temperature. The cooling-bath was removed and CO2 was bubbled through the solution for 45 
minutes. The white suspension was diluted with diethylether (40 mL) and extracted with 
aqueous saturated Na2CO3 (4×50 mL). The water-phase was acidified and extracted with 
diethyl ether (6×100 mL). Drying over Mg2SO4 and evaporation of the volatiles afforded the 
product as a white solid (1.33 g, 66 %). 
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C14H28BO2P (270.16) 
1H NMR (500.1 MHz, CDCl3, 300K): δ = 0.35 (mbr, 3H, 3), 1.25 (mbr, 6H, Cyeq), 1.43 (mbr, 
4H, Cyeq), 1.74 (mbr, 2H, Cyax), 1.84 (mbr, 8H, Cyax), 1.97 (mbr, 2H, 4), 2.73 (d, 2JHH = 10.0 
Hz, 2H, 1). 13C{1H} NMR (125.8 MHz, CDCl3, 300K): δ = 26.0 (4JCP = 1.2 Hz, 7), 26.5 (6), 
26.6 (d, 1JCP = 21 Hz, 4), 26.7 (6), 26.8 (2JCP = 12 Hz, 5), 26.9 (2JCP = 10 Hz, 5), 31.5 (d, 1JCP 
= 30.5 Hz, 1), 172.4 (d, 2JCP = 6.3 Hz, 2). 31P{1H} NMR (162 MHz, CDCl3, 300K): δ = 29.1 
(m). MS (-ESI), m/z: 270.2 (M-, 31.0), 269.2 (M-, 100.0), 268.2 (M-, 15.3), 225.1 (M- -CO2, 
7.9). IR (KBr): ν~ [cm-1] = 2933.5sbr, 2855.3s, 2671.5w, 2568.3w, 2383.1s, 2339.3m, 
2270.3w, 1700.7s, 1450.0s, 1432.6s, 1391.7m, 1300.8m, 1218.0m, 1140.6m, 1064.0m, 
1047.2m, 1002.4m, 950.6mbr, 922.8mbr, 896.2m, 851.2m, 826.0w, 802.9w, 761.9w, 680.8m, 
608.6m, 559.6m, 514.5m, 465.7mbr. m.p. 149-152°C. TLC (n-pentane:diethyl ether; 10.1) Rf 
= 0.46. EA %found (calcd): C: 62.19 (62.24), H: 10.22 (10.45). 
Diphenylphosphine-borane adduct (30)[66] 
To a 1M solution of borane in THF (15 mL, 15 mmol) was added diphenylphosphine (1.9 
mL, 11 mmol) at 0 °C. The reaction mixture was stirred room temperature for 15 hours. All 
volatiles were evaporated and the residue was diluted in diethyl ether and filtered over a plug 
of silica. After evaporation the product was obtained as a white solid (2.18g, 99%). 
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C12H14BP (200.02) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 1.05 (q, 1JHB = ~ 80 Hz, 3H, 6), 6.30 (dq, 1JHP = 
178.7 Hz, 3JHP = 7.1 Hz, 1H, 1), 7.43-7.52 (m, 6H, Ph), 7.64-7.69 (m, 4H, Ph). 13C{1H} NMR 
(100.6 MHz, CDCl3, 300K): δ = 126.3 (d, 1JCP = 57 Hz, 2), 129.2 (d, 2JCP = 10.3 Hz, 3), 131.8 
(d, 4JCP = 2.3 Hz, 5), 133.1 (d, 3JCP = 9.2 Hz, 4). 31P{1H} NMR (162 MHz, CDCl3, 300K): δ = 
2 (q, 1JPB ~50 Hz). MS (FAB, 3-NBA) m/z: 352 (53.02), 199 (M-H-, 100), 187 (Ph2PH2+, 
52.58), 109 (PhP+, 52.95). IR (KCl): ν~ [cm-1] = 3418mbr, 3052w, 2383s, 1478m, 1431s, 
1307w, 1184w, 1134m, 1106m, 1058s, 897s, 742s, 694s, 579m. m.p. 49°C, EA % found 
(calcd): C: 71.84 (72.06), H: 7.01 (7.05). 
Diphenylphosphino ethyl acetate-borane adduct (32)[66] 
NaH (312 mg, 13 mmol) and diphenylphosphine-borane adduct (1 g, 5 mmol) were dissolved 
in THF (5 mL). At 0 °C chloroethylacetate (0.7 mL, 6.5 mmol) in THF (10 mL) was added 
via a cannula. After stirring at room temperature for 17 hours the suspension was quenched 
with 1N HCl (4 mL) and extracted with ethyl acetate (3×20 mL). Drying over MgSO4 and 
evaporation of the solvents afforded a light-yellow oil that was purified by column 
chromatography on silica eluting with hexane and ethyl acetate. The product was obtained as 
a colorless oil (1.225g, 86%). 
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C16H20BO2P (286.11) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 1.04 (t, 3H, 4JHH = 7Hz, 9), 1.05 (qbr, 3H, 7), 3.32 
(d, 2H, 2JHP = 10.9 Hz, 2), 3.97 (q, 2H, 3JHH = 7 Hz, 8), 7.44-7.54 (m, 6H, 5-6), 7.71-7.77 (m, 
4H, 4). 13C{1H} NMR (100.6 MHz, CDCl3, 300K): δ = 13.9 (9), 33.1 (d, 1JCP = 28.7 Hz, 2), 
61.7 (8), 128.2 (d, 1JCP = 56 Hz, 3), 128.9 (d, 3JCP = 10.3 Hz, 5), 131.7 (d, 4JCP = 2.3 Hz, 6), 
132.7 (d, 2JCP = 10.0 Hz, 4), 166.9 (1). 31P{1H} NMR (162 MHz, CD2Cl2, 300K): δ = 17.2 
(mbr, 1JPB = 60 Hz). MS (+FAB, 3-NBA) m/z: 285 (M-H-, 100), 273 (MH+-BH3, 16.6), 199 
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(Ph2PCH2+, 27.8), 185 (Ph2P+, 62.7). IR (NaCl): ν~ [cm-1] = 3058w, 2984m, 2934w, 2386s, 
1733s, 1480w, 1438m, 1400w, 1367w, 1269s, 1189w, 1116s, 1062m-s, 1029m, 884w, 807w, 
739m, 695s. TLC (n-hexane:ethyl acetate, 7:3) Rf = 0.51. EA % found (calcd): C: 67.22 
(67.17), H: 6.99 (7.05). 
Diphenylphosphino ethanoic acid-borane adduct (33)[66] 
Potassium hydroxide (216 mg, 3.80 mmol) dissolved in a mixture of water (250 µL) and 
ethanol (1 mL) were added dropwise at 0 °C to ester 32 (1.00 g, 3.50 mmol). The mixture was 
stirred for 2 hours at room temperture, and ethanol was evaporated under reduced pressure. 
The oil obtained was dissolved in water (3 mL), washed with diethyl ether (3×5 mL). The 
aqueous layer was acidified to pH 1, with 1M hydrochloric acid, saturated with sodium 
chloride, and extracted with dichloromethane (3×10 mL). The organic layer was dried 
(MgSO4) and evaporated under reduced pressure affording carboxylic acid as a white powder 
(808 mg, 89%). 
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C14H16BO2P (258.06) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 1.05 (qbr, 3H, 7), 3.3 (d, 2H, 2JHP = 11.1 Hz, 2), 
7.43-7.55 (m, 6H, 5-6), 7.69-7.74 (m, 4H, 4). 13C{1H} NMR (100.6 MHz, CDCl3, 300K): δ = 
33.9 (d, 1JCP = 28.4 Hz, 2), 127.7 (d, 1JCP = 56 Hz, 3), 129.1 (d, 3JCP = 10.7 Hz, 5), 132 (d, 
4JCP = 2.7 Hz, 6), 132.5 (d, 2JCP = 10.0 Hz, 4), 171.7 (1). 31P{1H} NMR (162 MHz, CD2Cl2, 
300K): δ = 17.1 (mbr, 1JPB = 55.5 Hz). MS (-ESI) m/z: 213 (M--CO2, 100), 257 (M-, 27.8), 
515 (M2H-, 93.3). IR (KCl): ν~ [cm-1] = 3441br, 3054w, 2957m, 2919m, 2662m, 2566m, 
2402s, 2360m, 1972w, 1905w, 1828w, 1702s, 148m, 1432s, 197m, 1301s, 1215w, 1188w, 
1137m, 1103m, 1060s, 999w, 952m, 917m, 872m, 815m, 739s, 692s. m.p. 135-136°C (lit: 
141°C). EA %found (calcd): C: 65.05 (65.16), H: 6.28 (6.25). 
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7.3.2 Phosphanyl-methyl-4,5-dihydro-oxazoline-Borane Adducts by Cyclization 
(S)-2-(Di-tert-butyl-phosphanyl)-N-(1-hydroxymethyl-2,2-dimethyl-propyl)-acetamide-
borane adduct (34) 
According to general procedure 1, 24 (229 mg, 1.05 mmol), HOBt (170 mg, 1.26 mmol), 
EDC (241 mg, 1.26 mmol) and L-tert-leucinol (123 mg, 1.05 mmol) were reacted in 
dichloromethane (10 mL). The crude product was obtained in 93 % yield and was used 
without further purification. 
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C16H37BNO2P (317.26) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.6 (mbr, 3H, 9), 0.99 (s, 9H, 8), 1.27-1.33 (2×d, 
3JHP = 13.1Hz, 18H, 8), 2.75 (m, 2H, 1), 3.60 (m, 1H, 5), 3.78-3.86 (m, 2H, 4/5), 6.86 (dbr, 
3JHH = 7.3 Hz, 1H, 3). 31P{1H} NMR (162 MHz, CDCl3, 300K): δ = 41.9 (m). 
(S)-2-(Di-tert-butyl-phosphanyl)-N-(1-hydroxymethyl-3,3-dimethyl-butyl)-acetamide 
borane adduct (35) 
According to general procedure 1, 24 (504 mg, 2.31 mmol), HOBt (338 mg, 2.5 mmol), EDC 
(483 mg, 2.5 mmol) and (S)-neopentylglycinol 58 (303.5 mg, 2.3 mmol) were reacted in 
dichloromethane (25 mL). After column chromatography on silica eluting with pentane and 
diethyl ether the pure product was obtained as a white solid (510 mg, 62%). 
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C16H37BNO2P (317.26) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.64 (mbr, 3H, 12), 0.94 (s, 9H, 9), 1.28 (d, 9H, 
3JHP = 12.4 Hz, 10), 1.31 (d, 9H, 3JHP = 12.4Hz, 10’), 1.38-1.49 (ddd, 2H, 2JHH = 14.7 Hz, 
3JHH = 4.0 Hz, 7.3 Hz, 7), 2.57 (dd, 1H, 2JHH = 14.7 Hz, 2JHP = 10.9 Hz, 1), 2.74 (dd, 1H, 2JHH 
= 14.7 Hz, 2JHP = 12.9 Hz, 1’), 3.51 (dd, 1H, 2JHH = 11.3 Hz, 3JHH = 6.3 Hz, 5), 3.64 (dd, 1H, 
2JHH = 11.3 Hz, 3JHH = 4.8 Hz, 5), 4.05 (m, 1H, 4), 6.70 (dbr, 1H, 3JHH = 7.8 Hz, 3). 13C{1H} 
NMR (125.8 MHz, CDCl3, 300K): δ = 27.4 (8), 27.6 (d, 1JCP =  21 Hz, 1), 27.7 (d, 2JCP = 15 
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Hz, 10’), 29.8 (9), 30.5 (8), 32.7 (d, 1JCP = 27 Hz, 11), 33.2 (d, 1JCP = 27 Hz, 11’), 45.0 (7), 
50.3 (4), 67.8 (5), 167.7 (2). 31P{1H} NMR (162 MHz, CDCl3, 300K): δ = 42.1 (m, 1JPB = 75 
Hz). MS (+FAB, 3-NBA) m/z: 330 (M-H-, 63.1), 216 (C10H24BNOP+ 13.2), 57 (C4H9+, 100). 
IR (KCl): ν~ [cm-1] = 3461s, 3347s, 2960s, 2873s, 2364s, 2301m, 1658s, 1532s, 1471m, 
1394m, 1366m, 1320m, 1193w, 1151w, 1083ssh, 962w, 938wsh, 835w, 817wsh, 756w, 650,m, 
589m. m.p. 94-95°C. [ ]20Dα : -12.5° (c = 0.5, CHCl3). TLC (pentane:diethyl ether; 1:4) Rf = 
0.17. EA % found (calcd): C: 61.85 (61.63), H: 11.80 (11.87), N: 4.29 (4.23). 
(R)-2-(Di-tert-butyl-phosphanyl)-N-(1-hydroxymethyl-2-methylpropyl)-acetamide-
borane adduct (36) 
According to general procedure 1, 24 (300 mg, 1.37 mmol), HOBt (223 mg, 1.65 mmol) 
EDC (315 mg, 1.65 mmol) and (R)-phenylglycinol (189 mg, 1.37 mmol) were reacted in 
dichloromethane (15 mL). The crude product which was used without further purification. 
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C18H33BNO2P (337.24) 
1H NMR (400.1 MHz, CDCl3 300K): δ = 0.7 (q, 3H, 11), 1.22-1.35 (dd, 2 × 3JHP = 13.2Hz, 
2×9H, 13/13’), 1.49 (m, 1H, 4), 2.73 (m, 2H, 1), 3.87 (m, 2H, 5), 5.08 (m, 1H, 3), 7.35-7.38 
(m, 5H, Ph). 31P{1H} NMR (162 MHz, CDCl3 300K): δ = 42.4 (m). TLC (diethyl 
ether:pentane; 4:1) Rf = 0.12. 
(S)-2-(Di-tert-butyl-phosphanyl)-N-(1-hydroxymethyl-2-methylpropyl)-acetamide 
borane adduct (37) 
According to general procedure 1, 24 (250 mg, 1.15 mmol), HOBt (187 mg, 1.38 mmol) 
EDC (264 mg, 1.38 mmol) and L-valinol (119 mg, 1.15 mmol) were reacted in 
dichloromethane (10 mL). The crude product in 93 % yield. This was used without further 
purification. 
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C15H35BNO2P (303.23) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.6 (m, 3H, 9), 0.98 (d, 3JHH = Hz, 6H, 8), 1.28-
1.33 (2×d, 3JHP = 13.1Hz, 18H, 11), 1.42 (m, 1H, 7), 1.93 (m, 1H, 5), 2.73 (m, 2H, 1), 3.63-
3.78 (m, 2H, 4/5), 6.8 (d, 1H, 3). 31P{1H} NMR (CDCl3, 162 MHz, 300K): δ = 42.2 (m, 1JPB 
= 61.4Hz). 
(S)-2-Dicyclohexylphosphanyl-N-(1-hydroxymethyl-2,2-dimethyl-propyl)-acetamide-
borane adduct (38) 
According to general procedure 1, 28 (158 mg, 0.58 mmol), HOBt (94.6 mg, 0.7 mmol), 
EDC (133.8 mg, 0.7 mmol) and L-valinol (68.7 mg, 0.58 mmol) were reacted in 
dichloromethane (10 mL). The crude product (yield: 60 %) was used without further 
purification. 
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C20H41BNO2P (369.33) 
1H NMR (500.1 MHz, CDCl3, 300K): δ = 0.5 (mbr, 3H, 9), 0.97, (s, 9H, 8), 1.23-1.41 (m, 
~10H, Cyeq), 1.73-1.94 (m, 12H, Cyax), 2.66 (2×dd, 2H, 1), 3.60 (m, 1H, 5), 3.82 (m, 2H, 4/5), 
6.30 (d, 3JHH = 9.3 Hz, 1H, 3). 31P{1H} NMR (162 MHz, CDCl3, 300K): δ = 24.8 (m). TLC 
(n-pentane:diethyl ether; 1:2) Rf = 0.15. 
(S)-2-Dicyclohexylphosphanyl-N-(1-hydroxymethyl-3,3-dimethyl-butyl)-acetamide 
borane adduct (39) 
According to general procedure 1, 28 (540 mg, 2.0 mmol), HOBt (295 mg, 2.2 mmol), EDC 
(425 mg, 2.3 mmol) and (S)-neopentylglycinol 58 (262 mg, 2.0 mmol) were reacted in 
dichloromethane (25 mL). The pure product was obtained after column chromatography on 
silica eluting with pentane and diethyl ether as a white solid (443 mg, 58%). 
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C21H43BNO2P (383.36) 
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1H NMR (500.1 MHz, CDCl3, 300K): δ = 0.94 (s, 9H, 9), 1.2-1.3 (mbr, 10H, Cyeq), 1.35-1.45 
(m, 2H, 7), 1.69-1.95 (mbr, 12H, Cyax), 2.52 (dd, 1H, 2JHP = 10.5 Hz, 2JHH = 14.0 Hz, 1), 2.62 
(dd, 1H, 2JHP 13.1 = Hz, 2JHH = 14.0 Hz, 1), 3.48 (dd, 1H, 3JHH = 5.8 Hz, 2JHH = 11.2 Hz, 5), 
3.66 (dd, 1H, 3JHH = 3.8 Hz, 2JHH = 11.2 Hz, 5), 4.06 (m, 1H, 4), 6.13 (d, 1H, 3JHH = 8.2 Hz, 
3). 13C{1H} NMR (125.8 MHz, CDCl3, 300K): δ = 25.9-27.0 (m, Cy11-13), 29.0 (d, 1JCP = 23.5 
Hz, 1), 29.8 (9), 30.6 (8), 32.0 (d, 1JCP = 30 Hz, 10), 32.0 (d, 1JCP = 30 Hz, 10’), 45.2 (7), 49.9 
(4), 67.4 (5), 166.9 (2). 31P{1H} NMR (162 MHz, CDCl3, 300K): δ = 25.1 (1JPB = 71 Hz). MS 
(+FAB, 3-NBA) m/z: 382 (M+-H-, 100), 370 (M+-BH3, 16.2), 268 (15.5), 129 (20.1), 83 
(36.1), 55 (C4H7+, 76.0). m.p. 49 °C. TLC (n-pentane:diethyl ether; 1:5) Rf = 0.35. [ ]20Dα : -
12.6° (c = 0.53, CHCl3). EA % found (calcd): C: 65.80 (65.79), H: 11.13 (11.31), N: 3.73 
(3.65). 
(R)-2-Dicyclohexylphosphanyl-N-(1-hydroxymethyl-phenyl)-acetamide-borane adduct 
(40) 
According to general procedure 1, 28 (400 mg, 1.48 mmol), HOBt (240 mg, 1.78 mmol), 
EDC (340 mg, 1.78 mmol) and (R)-phenylglycinol (203 mg, 1.48 mmol) were reacted in 
dichloromethane (15 mL). The crude product was obtained in quantitative yield. The product 
was used without further purification. 
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C22H37BNO2P (389.32) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 0.5 (qbr, 3H, 15), 1.15-1.5 (m, 10H, Cyeq), 1.65-
1.95 (m, 12H, Cyax), 2.65 (m, 2H, 1), 3.89 (d, 3JHH = 5.5 Hz, 2H, 5), 5.07 (m, 1H, 4), 6.81 (dbr, 
3JHH = 7.5 Hz, 1H, 3). 31P{1H} NMR (202.5 MHz, CD2Cl2, 300K): δ = 25.2 (mbr). TLC (n-
pentane: diethyl ether; 1: 4) Rf = 0.24. 
(S)-2-(Dicyclohexyl-phosphanyl)-N-(1-hydroxymethyl-2-methylpropyl)-acetamide-
borane adduct (41) 
According to general procedure 1, 28 (473 mg, 1.75 mmol), HOBt (284 mg, 2.1 mmol), EDC 
(401 mg, 2.1 mmol) and L-valinol (181 mg, 1.75 mmol) in dichloromethane (20 mL) gave 41. 
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The crude product was purified by column chromatography on silica eluting with pentane and 
diethyl ether. 41 was obtained as a white solid (407 mg, 65%). 
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C19H39BNO2P (355.30) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 0.48 (m, 3H, 9), 0.98 (2×d, 3JHH = 6.8 Hz, 6H, 8), 
1.23-1.4 (m, 10H), 1.73-1.9 (m, 12H), 1.91 (m, 1H, 7), 2.57-2.69 (m, 2H, 1), 3.62-3.74 (m, 
3H, 4/5), 6.26 (d, 3JHH = 8.1 Hz 1H, 3). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 18.9 
(8), 19.5 (8’), 25.9 (Cy), 26.5 (Cy), 26.7 (Cy), 4×26.8 (Cy), 3×26.9 (Cy), 29.07 (d, 1JCP = 22.5 
Hz, 1), 29.14 (7), 32.1 (d, 1JCP = 32Hz, 10), 32.2 (d, 1JCP = 32 Hz, 10’), 58.2 (4), 63.8 (5), 
167.7 (2). 31P{1H} NMR (162 MHz, CD2Cl2, 300K): δ = 25.0 (m, 1JPB = 67.4 Hz). TLC (n-
pentane: diethyl ether; 1: 4) Rf = 0.12. 
(S)-2-Diphenylphosphanyl-N-(1-hydroxymethyl-2,2 dimethyl-propyl)-acetamide-borane 
adduct (42) 
According to general procedure 1, 33 (500 mg, 1.94 mmol), HOBt (288 mg, 2.13 mmol), 
EDC (407 mg, 2.13 mmol) and L-tert-leucinol (227 mg, 1.94 mmol) in dichloromethane (25 
mL) gave 42. After column chromatography on silica eluting with pentane and diethyl ether 
the product was as a white solid (445mg, 64%). 
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C22H29BNO2P (357.23) 
1H NMR (CDCl3, 400.1 MHz, 300K): δ = 0.84 (s, 9H, 8), 3.29 (dd, 2JHH = 11.4, 2JHP = 14.4 
Hz, 1H, 1), 3.42 (dd, 2JHH = 12.9 Hz, 2JHP = 14.7 Hz, 1H, 1), 3.45 (dd, 3JHH = 11.4 Hz, 3JHH = 
14.4 Hz, 1H, 4), 3.69-3.75 (m, 2H, 5), 6.40 (d, 3JHH = 9.1 Hz, 3), 7.45-7.54 (m, 6H, 10/12), 
7.71.7.78 (m, 4H, 11). 13C{1H} NMR (CDCl3, 125.8 MHz, 300K): δ = 27.0 (8), 33.6 (7), 35.9 
(d, 1JCP = 28.7 Hz, 1), 60.8 (4), 63.0 (5), 127.6 (d, 1JCP = 23.4 Hz, 9), 128.1 (d, 1JCP = 23.7 Hz, 
9’), 129.2 (d, 2JCP = 10.3 Hz, 10/10’), 132.0 (2×d, 4JCP = 2.7 Hz, 12/12’), 132.3 (2×d, 3JCP = 
5.0 Hz, 11/11’), 166.0 (2). 31P{1H} NMR (CDCl3, 162 MHz, 300K): δ = 13.0 (dbr, 1JPB = 63.4 
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Hz). MS (+FAB, 3-NBA) m/z: 356 (M-H-, 100), 344 (M-BH2-, 22.85), 256 (C14H16BNOP+, 
12.2), 185 (Ph2P+, 82.2). IR (KBr): ν~ [cm-1] = 3504s, 3317s, 3061w, 2974m, 2877m, 2379s, 
2336m, 1673s, 1547s, 1468w, 1435m, 1367w, 1339m, 1293m, 1221m, 1193w, 1124m, 1054s, 
998m, 960w, 910w, 849m, 804w, 734m, 694s. m.p. 141-142°C. [ ]20Dα : -21° (c = 0.53, 
CHCl3). TLC (diethyl ether) Rf = 0.11. EA % found (calcd): C: 67.09 (67.24), H: 8.04 (8.18), 
N: 3.93 (3.92). 
(S)-2-Diphenylphosphanyl-N-(2-hydroxy-1-phenyl-ethyl)-acetamide-borane adduct (43) 
According to general procedure 1, 33 (400 mg, 1.55 mmol), HOBt (230 mg, 1.7 mmol), EDC 
(325 mg, 1.7 mmol) and (R)-phenylglycinol (213 mg, 1.55 mmol) in dichloromethane (20 
mL) gave 43. After column chromatography on silica eluting with pentane and diethyl ether 
the product was as a white solid (350 mg, 60%). 
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C22H25BNO2P (377.22) 
1H NMR (CDCl3, 400.1 MHz, 300K): δ = 1.2 (mbr, 3H, 15), 3.26 (dd, JHH = 11.3, 14.3 Hz, 
1H, 1), 3.38 (dd, 12.7, 14.3 Hz, 1H, 1), 3.73 (d, 3JHH = 5.1 Hz, 2H, 5), 4.94 (ddd, 3JHH = 5.1, 
12.5 Hz, 1H, 4), 6.82 (d, 3JHH = 7.4 Hz, 1H, 3), 7.15-7.18 (m, 2H, 8), 7.24-7.30 (3H, 9/10), 
7.41-7.45 (m, 4H, 12), 7.46-7.54 (m, 2H, 14), 7.67-7.71 (m, 2H, 13), 7.75-7.79 (m, 2H, 13’). 
13C{1H} NMR (CDCl3, 125.8 MHz, 300K): δ = 35.8 (d, 1JCP = 28.5 Hz, 1), 56.6 (4), 66.2 (5), 
126.9 (8), 127.8 (dd, 1JCP = 31.5, 57 Hz, 11/11’), 128.0 (10), 128.9 (9), 129.2 (d, 2JCP = 10.5 
Hz, 12/12’), 132.0 (d, 4JCP = 2.4 Hz, 14/14’), 132.2 (dd, 3JCP = 2.5 Hz, 10.1 Hz, 13), 132.5 (d, 
3JCP = 9.9 Hz, 13’), 138.4 (7), 165.3 (2). 31P{1H} NMR (CDCl3, 162 MHz, 300K): δ = 13.9 
(mbr) MS (+FAB, 3-NBA) m/z: 376 (M-H-, 100), 364 (M+-BH2, 21.3), 256 (C14H16BNOP+, 
28.0), 185 (Ph2P+, 71.8), 103 (25.6). IR (KBr): ν~ [cm-1] = 3464s, 3313s, 3055m, 2962m, 
2866m, 2374s, 2305m, 1974w, 1906w, 1822w, 1675s, 1538s, 1488w, 1458w, 1430m, 1402m, 
1345w, 1283m, 1822w, 1110s, 1064s, 1028s, 848m, 806m, 745m, 694s, 657m. m.p. 124-
126°C. [ ]20Dα  (c = 1.0, CHCl3) = + 42.3°. TLC (diethyl ether:pentane; 4:1) Rf = 0.16. EA % 
found (calcd): C: 69.63 (70.05), H: 6.58 (6.68), N: 3.70 (3.71). 
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(S)-2-Diphenylphosphanyl-N-(1-hydroxymethyl-2-methyl-propyl)-acetamide-borane 
adduct (44) 
According to general procedure 1, 33 (500 mg, 1.94 mmol), HOBt (288 mg, 2.13 mmol), 
EDC (407 mg, 2.13 mmol) and L-tert-leucinol (200 mg, 1.94 mmol) in dichloromethane (25 
mL) gave 44. After column chromatography on silica eluting with pentane and diethyl ether 
the product was as a white solid (421.6 mg, 63.4%). 
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C19H27BNO2P (343.21) 
1H NMR (CDCl3, 400.1 MHz, 300K): δ = 0.82 (d, 3H, 3JHH = 6.8 Hz, 8), 0.84 (d, 3H, 3JHH = 
6.8 Hz, 8’), 1.15 (mbr, 3H, 13), 1.80 (m, 3JHH = 6.8 Hz 1H, 7), 3.26 (dd, 2JHH = 11.4, 2JHP = 
14.4 Hz, 1H, 1), 3.36 (dd, 2JHH = 11.4, 2JHP = 14.4 Hz, 1H, 1), 3.53 (m, 2H, 5), 3.64 (m, 1H, 
4), 6.33 (d, 3JHH = 8.1 Hz, 3), 7.45-7.55 (m, 6H, 10/12), 7.70-7.77 (m, 4H, 11). 13C{1H} NMR 
(CDCl3, 125.8 MHz, 300K): δ = 18.7 (8), 19.5 (8’), 29.0 (7), 35.9 (d, 1JCP = 28.7 Hz, 1), 58.0 
(4), 63.6 (5), 127.6 (d, 1JCP = 20.7 Hz, 9), 128.2 (d, 1JCP = 20.7 Hz, 9’), 129.2 (2×d, 2JCP = 
10.3 Hz, 10/10’), 132.0 (2×d, 4JCP = 2 Hz, 12/12’), 132.3 (d, 3JCP = 7.7 Hz, 11), 132.4 (d, 3JCP 
= 7.7 Hz, 11’), 165.8 (2). 31P{1H} NMR (CDCl3, 162 MHz, 300K): δ = 13.5 (dbr, 1JPB = 63.4 
Hz). MS (+FAB, 3-NBA) m/z: 342 (M-H-, 100), 330 (M-BH2-, 23.9), 256 (C14H16BNOP+, 
12.1), 185 (Ph2P+, 75.5). IR (KBr): ν~ [cm-1] = 3494s, 3304s, 3057w, 2965m, 2875m, 2376s, 
1977w, 1910w, 1833w, 1670s, 1550s, 1463w, 1435m, 1312m, 1226w, 1194w, 1135m, 
1108m, 1054m, 1017m, 850m, 806w, 735m, 693s. m.p. 109-110°C. TLC (diethyl 
ether:pentane; 4:1) Rf = 0.09. EA % found (calcd): C: 66.26 (66.49), H: 7.72 (7.93), N: 4.09 
(4.08). 
(S)-2-[(Di-tert-butyl-phosphanyl)-methyl]-4-tert-butyl)-4,5-dihydrooxazoline-borane 
adduct (45) 
The product was obtained according to general procedure 2 from 34 (310.2 mg, 0.98 mmol) 
and Burgess’ reagent (280.84 mg, 1.18 mmol) in THF (10 mL). Purification by column 
chromatography on silica (n-pentane:diethyl ether; 1:1) afforded the product as a colorless oil 
(163 mg, 56%). 
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C16H35BNOP (299.24) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.38 (qbr, 1JHB = 100 Hz, 3H, BH3, 9), 0.88 (s, 9H, 
6), 1.30-1.34 (2×d, 3JHP = 13.1 Hz, 18H, 8/8’), 2.75 (m, 2H, CH2, 1), 3.80 (ddd, 3JHH = 10.1, 
9.3 Hz, 4JHP = 3.3 Hz, 1H, 4), 4.00 (pst, 2JHH = 8.8 Hz, 3JHH = 8.8 Hz, 1H, 3), 4.17 (dd, 2JHH = 
8.6 Hz, 3JHH = 10.1 Hz, 1H, 3). 13C{1H} NMR (125.8 MHz, CDCl3, 300K): δ = 20.1 (d, 1JCP 
= 24.3Hz, 1), 26.2 (6), 28.1 (d, 2JCP = 2.8 Hz, 8), 28.2 (d, 2JCP = 2.8 Hz, 8’), 33.0 (d, 1JCP = 
24.6 Hz, 7), 33.1 (d, 1JCP = 24.6 Hz, 7’), 33.7 (5), 69.1 (3), 76.5 (4), 162.4 (d, 2JCP = 4.5 Hz, 
2). 31P{1H} NMR (162 MHz, CDCl3, 300K): δ = 48.3 (q, 1JPB ≈ 50 Hz). MS (+FAB, 3-NBA) 
m/z: 298 (R12R2P(11B)H2+, 100), 297 (R12R2P(10B)H2+, 24.4), 286 (M+-BH3, 54.8), 228 (286-
C4H10, 13.1), 172 (228-C4H8, 12.4), 57 (C4H9+, 90.3). TLC (n-pentane:diethyl ether 1:1) Rf = 
0.6. 
(R)-2-[(Di-tert-butyl-phosphanyl)-methyl]-4-phenyl)-4,5-dihydrooxazoline-borane (46) 
The product was obtained according to general procedure 2 from 36 (~1.34 mmol) and 
Burgess’ reagent (476 mg, 2 mmol). After column chromatography on silica (n-
pentane:diethyl ether 1:4) the product was obtained as a colorless oil (182 mg, 43%) over two 
steps. The other enantiomer was obtained with general method 5 (vide supra) which yielded 
47% ( [ ]20Dα : -55° (c = 0.23, CHCl3). 
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C18H31BNOP (319.23) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 0.45 (q, 1JHB = ~100Hz, 3H, 11), 1.34 (d, 3JHP = 
13 Hz, 9H, 10), 1.35 (d, 3JHP = 13 Hz, 9H, 10’), 2.86 (m, 2JHH = 10.9Hz, 2JHP = 1Hz, 2H, 1), 
4.06 (pst, 2JHH = 8.6, 1H, 3), 4.65 (dd, 2JHH = 8.4Hz, 3JHH = 10.2 Hz, 3), 5.16 (dt, 3JHH = 9.6 
Hz, 1H, 4), 7.25-737 (m, 5H, 6-8). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 19.8 (d, 
1JCP = 23.8 Hz, 1), 28.1 (2×d, 2JCP = 3 Hz, 10), 33.1 (d, 1JCP = 24.6 Hz, 9), 33.2 (d, 1JCP = 24.5 
Hz, 9), 70.4 (4), 75.1 (3), 127.3 (6), 127.8 (8), 128.9 (7), 142.5 (5), 164.2 (2JCP = 3.8 Hz, 2). 
31P{1H} NMR (162 MHz, CD2Cl2, 300K): δ = 49.0 (m, 1JPB = 57.5 Hz). MS (+FAB, 3-NBA) 
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m/z: 320 (MH+, 41.6), 306 (M-BH2-, 27.3), 250 (C14H21NOP+, 9.6), 214 (C10H22BNOP+, 8.3), 
147 (C8H20P+, 10.9), 103 (C5H12P+, 10.2), 57 (100). IR (KBr): ν~ [cm-1] = 3357.3mbr, 2989.1s, 
2964.6s, 2901.0m, 2870.4m, 2373.8s, 2349.6s, 2263.0w, 2134.2w, 1959.7w, 1900.5w, 
1787.5w, 1735.6w, 1661.8s, 1602.3w, 1466.7m, 1395.4m, 1370.1m, 1353.2m, 1308.7w, 
1270.8m,1235.3w, 1208.1w, 1186.3w, 1143.2m, 1072.7m, 1024.2w, 995.6m, 964.4w, 
922.1m, 830.7w, 813.6w, 772.3w, 734.7m, 701.8m, 633.0w, 607.6w, 580.4w. m.p. 106-
107°C. [ ]20Dα : +54.0° (c = 0.45, CHCl3). TLC: (diethyl ether:pentane; 4:1) Rf = 0.53. EA 
%found (calcd) C: 67.73 (67.72), H: 9.81 (9.79), N: 4.35 (4.39). 
(R)-4-Phenyl-2-[(dicyclohexylphosphanyl)-methyl]-4,5-dihydro-oxazoline-borane adduct 
(47) 
The product was obtained according to general procedure 2 from 40 (604 mg, 1.48 mmol) 
and Burgess’ reagent (423 mg, 1.78 mmol). After purification by column chromatography on 
silica (n-pentane:diethyl ether; 1:4). The product was obtained as a colorless oil (519 mg, 
94%) over two steps. The other enantiomer was obtained with general procedure 5 (vide 
supra) which yielded 60% ( [ ]20Dα :-28° (c = 0.3, CHCl3). 
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C22H35BNOP (371.30) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 0.4 (qbr, 3H, 13), 1.25 (m, 6H, Cy), 1.43 (m, 4H, 
Cy), 1.71 (m, 2H, Cy), 1.81 (m, 4H, Cy), 1.89 (m, 4H, Cy), 2.0 (m, 2H, 8), 2.76 (dd, 2JHH = 
9.8 Hz, 1JHP = 1 Hz, 2H, 1), 4.07 (pst, 3JHH = 8.6 Hz, 1H, 3), 4.65 (dd, 2JHH = 8.5, 3JHH = 10.2 
Hz, 1H, 3), 5.19 (m, 1H, 4). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 20.5 (d, 1JCP = 
25.9 Hz, 1), 26.3-27.3 (m, Cy), 31.8 (2×d, 1JCP = 30.9 Hz, 9), 70.2 (3), 75.0 (4), 127.0 (6), 
127.8 (8), 129.0 (7), 142.5 (5), 163.2 (d, 2JCP = 7.2 Hz , 2). 31P{1H} NMR (202.5 MHz, 
CD2Cl2, 300K): δ = 28.9 (mbr). MS (+FAB, 3-NBA) m/z: 370 (M-H-, 98.5), 358 (M+-BH3, 
57.8), 266 (14.0), 199 (18.2), 83 (53.8), 55 (100). IR (KBr): ν~ [cm-1] = 3362.3mbr, 2932.3s, 
2854.3s, 2362.7s, 2249.5w, 1735.8m, 1659.4s, 1491.9w,1446.9s, 1400.0m, 1355.0m, 
1318.5m, 1271.7m, 1241.9m, 1174.6w, 1136.6m, 1063.1s, 986.3s, 914.8m, 854.2w, 828.3w, 
795.9w, 755.6m, 701.1m, 598.0m. [ ]20Dα : +29.4° (c = 0.5, CHCl3). TLC (n-pentane: diethyl 
ether; 1: 4) Rf = 0.57. EA %found (calcd) C: 70.95 (71.16), H: 9.40 (9.50), N: 3.91 (3.77). 
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7.3.3 Secondary Phosphine-Borane Adducts 
Di-tert-butylmethylphosphine-borane adduct (48) 
To di-tert-butylphosphine (1 g, 6.84 mmol) in THF (10 ml) at room temperature, was slowly 
added borane-THF adduct (8 ml, 1M in THF). The reaction mixture was stirred for 2 hours. 
Then the solvent and other volatiles were removed under reduced pressure. The residue was 
dissolved in n-pentane (8 mL). At 4 °C the white product crystallized from the solution and 
was removed by filtration (890 mg, 81%). 
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C8H22BP (160.05) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.49 (m, 1JHB = 100 Hz, 4), 1.32 (d, 2JHP = 13.6 Hz, 
2), 4.11 (dq, 4JHH = 6.6 Hz, 1JHP = 351 Hz, 1). 13C{1H} NMR (125.8 MHz, CDCl3, 300K): δ = 
29.1 (d, 2JCP = 1.5 Hz, 2), 30.6 (d, 1JCP = 17.5 Hz, 2). 31P{1H} NMR (162 MHz, CDCl3, 
300K): δ = 48.5 (m, 1JBP = 51.5 Hz). MS (+EI), m/z: 159.1 (M-H-, 5.2), 146.1 (M+-BH3, 
53.98), 57.1 (tBu+, 100). IR (KBr): ν~ [cm-1] = 2969s, 2902ssh, 2809s, 2383s, 2351ssh, 2272m, 
2129w, 1809w, 1758w, 1698w, 1467s, 1392w, 1366s, 1196m, 1139m, 2067s, 1023s, 940m, 
900s, 754w, 691m, 620m. m.p. 62-63°C. EA % found (calcd): C: 60.19 (60.04), H: 13.72 
(13.86). 
Dicyclohexylphosphine-borane adduct (49)[72] 
To a solution of dicyclohexylphosphine (1.94 g, 10 mmol) in dry THF (10 mL) at 0 °C under 
argon was added solid sodium borohydride (574 mg, 15.1 mmol) in one portion followed by a 
solution of glacial acetic acid (1 mL) in THF (4mL) dropwise over 30 min. Subsequent to the 
acid addition, the reaction mixture was stirred at room temperature for 18 hours. All volatiles 
were removed, and the crude product purified by flash column chromatography on silica 
eluting with hexane and ethyl acetate to afford a white crystalline product (1.78 g, 86%). 
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C12H26BP (212.12) 
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1H NMR (250.1 MHz, CDCl3, 300K): δ = 0.41 (qbr, 3H, 6), 1.2-1.5 (mbr, 12H, Cyeq), 1.73-
1.83 (mbr, 10 H, Cyax), 4.11 (dm, 1H, 1JHP = 350 Hz, 1). 13C{1H} NMR (125.8 MHz, CDCl3, 
300K): δ = 25.9, 26.5, 26.6, 26.7, 26.8, 27.8, 28.9, 29.1, 29.4, 29.5, 31.1. 31P{1H} NMR (162 
MHz, CDCl3, 300K): δ = 18.3 (mbr, 1JPB = 67 Hz). MS (+EI), m/z: 209 (C12H23BP+, 17.6), 
198 (Cy2PH+, 100), 117 (CyPH2+, 76.1), 83 (Cy+, 47.8). IR (KBr): ν~ [cm-1] = 2930s, 2850s, 
2659w, 2377s, 2258s, 2122w, 1644w, 1447s, 1332m, 1298m, 1270m, 1206m, 1176m, 1132m, 
1065s, 1003s, 919s, 881ssh, 846m, 755m, 664m, 584m. m.p. 78-80°C. TLC (hexane:ethyl 
acetate; 85:15) : Rf = 0.73. EA % found (calcd) C: 67.80 (67.95), H: 12.15 (12.35). 
7.3.4 Chloromethyloxazolines 
 (S)-2-Chloro-N-(1-hydroxymethyl-2-tert-butyl)-acetamide (50) 
According to general procedure 3 chloroacetylchloride (1.58 mL, 19.8 mmol), (S)-tert-
leucinol (2.34 g, 20 mmol) and triethylamine (2.9 mL, 20 mmol) were reacted in 
dichloromethane (50 ml). Kugelrohr distillation (170°C, 0.4 mbar) afforded a colorless oil, 
that was recrystallized from ethyl acetate (2.81 g, 73%). 
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C8H16ClNO2 (193.67) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.98 (s, 9H, 8), 3.60 (dd, 3JHH = 7.6 Hz, 2JHH = 
11.1 Hz, 1H, 5), 3.80-3.90 (m, 2H, 5/4), 4.10 (droof, 2JHH = 15.2 Hz, 2H, 1), 4.14 (droof, 2JHH = 
15.2 Hz, 2H, 1), 6.75 (sbr, 1H, 3). 13C{1H} NMR (100.6 MHz, CDCl3, 300K): δ = 27.0 (8), 
33.7 (7), 40.1 (5), 60.2 (4), 62.9 (1), 167.2 (2). MS (+FAB, 3-NBA) m/z: 194 (MH+, 100). IR 
(KBr): ν~ [cm-1] = 3411s, 3280s, 3097w, 2964s, 2892m, 1739w, 1666s, 1566m, 1532m, 
1461w, 1410w, 1368m, 1262m, 1169w, 1092w, 1049m, 1002w, 913w, 722m, 701w, 670w, 
577m. m.p. 62-63°C, [ ]20Dα  (c = 1.04, CHCl3) = -15.3°, TLC (ethyl acetate) Rf = 0.28, EA % 
found (calcd): C: 49.48 (49.61), H: 8.32 (8.33), N: 7.27 (7.23). 
(S)-2-Chloro-N-(1-hydroxymethyl-2-neopentyl)-acetamide (51) 
According to general procedure 3 chloroacetylchloride (0.68 mL, 8.61 mmol), (S)-
neopentylglycinol (1.13 g, 8.61 mmol) and triethylamine (1.3 mL, 9.33 mmol) were reacted in 
dichloromethane (20 ml). Kugelrohr distillation (150°C, 10-1 mbar) afforded a colorless oil 
(1.32 g, 74%). 
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C9H18ClNO2 (207.70) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.94 (s, 9H, 9), 1.39 (dd, 2JHH = 14.6 Hz, 3JHH = 
8.9 Hz, 1H, 7), 1.51 (dd, 2JHH = 14.6 Hz, 3JHH = 2.9 Hz, 1H, 7), 2.06 (sbr, 1H, 6), 3.54 (dd, 
2JHH = 11.0 Hz, 3JHH = 6.1 Hz, 1H, 5), 3.64 (dd, 2JHH = 11.0 Hz, 3JHH = 4.2 Hz, 1H, 5), 4.05 
(dd, 2×2JHH = 15.3 Hz, 2H, 1), 4.10 (m, 1H, 4), 6.57 (sbr, 1H, 3). 13C{1H} NMR (100.6 MHz, 
CDCl3, 300K): δ = 29.9 (9), 30.5 (8), 42.8 (7), 45.1 (5), 49.7 (4), 67.3 (1), 166.3 (2). MS 
(+FAB, 3-NBA) m/z: 210 (MH+, 11), 209 (MH+, 31.7), 208 (MH+, 100), 57 (C4H9+, 70.6). IR 
(KBr): ν~ [cm-1] = 3289sbr, 3089w, 2955s, 2872m, 2364w, 1658s, 1548m, 1471w, 1414w, 
1367w, 1248w, 1051m, 914w, 778w. [ ]20Dα  (c = 1.02, CHCl3) = -34.5°, TLC (ethyl acetate) Rf 
= 0.28, EA % found (calcd): C: 50.74 (52.05), H: 8.72 (8.74), N: 6.71 (6.74). 
(S)-2-Chloro-N-(1-hydroxymethyl-2-phenyl)-acetamide (52) 
According to general procedure 3 chloroacetylchloride (1.65 g, 14.58 mmol), (S)-
phenylglycinol (2 g, 14.58 mmol) and triethylamine (2.15 ml, 15.4 mmol) were reacted in 
dichloromethane (50 ml). at -20 °C. The crude product was purified by flash column 
chromatography on silica eluting with ethyl acetate. The product was obtained as a white solid 
(2.9 g, 92 %). 
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C10H12ClNO2 (213.66) 
1H NMR (500.1 MHz, CDCl3, 300K): δ = 2.18 (sbr, 1H, 6), 3.91 (m, 2H, 5), 4.07 (d, 2JHH = 
15.3 Hz, 1), 4.12 (d, 2JHH = 15.3 Hz, 1), 5.09 (dt, 1H, 3JHH = 8.6, 5.8 Hz, 4), 7.28 (sbr, 1H, 3), 
7.32 (m, 3H, 8 /10), 7.38 (m, 2H, 9). 13C{1H} NMR (125.8 MHz, CDCl3, 300K): δ = 42.8 (1), 
55.9 (4), 66.3 (5), 126.7 (8), 128.3 (10), 129.1 (9), 138.3 (7), 166.4 (2). MS (+FAB, 3-NBA) 
m/z: 216 (MH+, 32.2), 215 (MH+, 13.2), 214 (MH+, 100), 182, 121, 94. IR (KBr): ν~ [cm-1] = 
3313sbr, 3063w, 2960m, 2923m, 2873m, 2666s, 1539s, 1454m, 1410w, 1230w, 1269w, 
1237m, 1095w, 1049m, 908w, 845w, 779w, 701m, 662w, 534mbr. mp. 105 °C, [ ]20Dα (c = 0.9, 
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CHCl3) = + 33.1°, TLC (ethyl acetate) Rf = 0.39, EA % found (calcd): C: 56.14 (56.21), H: 
5.64 (5.66), N: 6.52 (6.56), O: 15.09 (14.98) 
(S)-2-Chloro-N-(1-hydroxymethyl-2-methyl-propyl)-acetamide (53) 
According to general procedure 3 chloroacetylchloride (3.45 g, 29.1 mmol), (S)-valinol (3 g, 
29.1 mmol) and triethylamine (4.25 ml, 30.5 mmol) were reacted in dichloromethane (50 ml). 
The crude product was purified by flash column chromatography eluting with ethyl acetate 
(4.98 g, 95%). 
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C7H14ClNO2 (179.64) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.95 (d, 3JHH = 6.8 Hz, 3H, 8), 0.98 (d, 3JHH = 6.8 
Hz, 3H, 8’), 1.95 (m, 1H, 7), 3.68-3.80 (m, 3H, 4/5), 4.10 (s, 2H, 1), 6.75 (sbr, 1H, 3). 13C{1H} 
NMR (100.6 MHz, CDCl3, 300K): δ = 18.8 (8), 19.6 (8’), 29.1 (7), 42.9 (5), 57.6 (4), 63.6 
(1), 166.8 (2). MS (+FAB, 3-NBA) m/z: 180 (MH+, 100). IR (NaCl): ν~ [cm-1] = 3297sbr, 
3086w, 2963s, 2879, m, 2363w, 1659s, 1546s, 1466w, 1414w, 1370w, 1241m, 1153w, 
1075m, 1025w, 979w, 930w, 776w. m.p. 43°C. [ ]20Dα (c = 1.0, CHCl3) = -39.5°. TLC (ethyl 
acetate) Rf = 0.45 , EA % found (calcd): C: 46.80 (46.80), H: 7.72 (7.86), N: 7.76 (7.80). 
(S)-2-Chloromethyl-4-tert-butyl-4,5-dihydro-oxazoline (54) 
According to general procedure 4 amide 50 (2.81 g, 14.5 mmol) and Burgess’ reagent (4.1 g, 
17.4 mmol) were reacted in THF (70mL). The crude product was purified by column 
chromatography on silica eluting with ethyl acetate. The product was obtained as a colorless 
oil (1.65 g, 65%). 
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C8H14ClNO (175.66) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.88 (s, 9H, 6), 3.89 (m, 1H, 4), 4.11 (s, 2H, 1), 
4.14 (pst, 2JHH = 8.6 Hz, 3JHH = 8.3 Hz, 1H, 3), 4.26 (dd, 2JHH = 8.6 Hz, 3JHH = 10.1 Hz, 1H, 
3). 13C{1H} NMR (100.6 MHz, CDCl3, 300K): δ = 25.8 (6), 33.9 (5), 37.0 (1), 70.0 (3), 76.4 
(4), 162.3 (2). MS (+FAB, 3-NBA) m/z: 176 (M+, 100). MS (+EI) m/z: 119 (M+-C4H9, 100), 
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83 (C4H5NO+, 56.2), 57 (C4H9+, 61.7). IR (NaCl): ν~ [cm-1] = 341mbr, 2957s, 3000m, 2890m, 
1670s, 1481m, 1442w, 1364m, 1309w, 1274m, 1207w, 1166m, 1032w, 983s, 939w, 896m, 
855w, 729m, 583m. TLC (ethyl acetate) Rf = 0.56. [ ]20Dα  (c = 1.0, CHCl3) = -112.7°. EA % 
found (calcd): C: 54.03 (54.70), H: 7.73 (8.03), N: 8.00 (7.97) 
(S)-2-Chloromethyl-4-neopentyl-4,5-dihydro-oxazoline (55) 
According to general procedure 4 amide 51 (1.32 g, 6.35 mmol) was reacted with Burgess’ 
reagent (1.97 g, 8.26 mmol) in THF (50 mL). Kugelrohr distillation (100 °C, 10-1 mbar) 
afforded the product as colorless oil (1.07 g, 89%). 
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C9H16ClNO (189.68) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.94 (s, 9H, 7), 1.35 (dd, 2JHH = 13.9 Hz, 3JHH = 
7.6 Hz, 1H, 7) 1.72 (dd, 2JHH = 13.9 Hz, 3JHH = 5.0 Hz, 1H, 7), 3.86 (pst, 2JHH = 8.3 Hz, 3JHH 
= 8.6 Hz, 1H, 3), 4.08 (s, 2H, 1), 4.16 (m, 1H, 3), 4.47 (dd, 2JHH = 8.3 Hz, 3JHH = 9.6 Hz, 1H, 
3). 
13C{1H} NMR (100.6 MHz, CDCl3, 300K): δ = 29.9 (7), 30.4 (6), 37.1 (1), 50.5 (5), 64.4 (4), 
75.6 (3), 161.8 (2). 
(S)-2-Chloromethyl-4-phenyl-4,5-dihydro-oxazoline (56) 
According to general procedure 4 amide 52 (2.12 g, 9.92 mmol) was reacted with Burgess’ 
reagent (2.6 g, 10.9 mmol) in THF (50 mL). Distillation (100°C, 10-1bar) afforded the product 
as a colorless oil (1.5g, 77 %). 
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C10H10ClNO (195.65) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 4.19 (t, 2JHH = 8.6 Hz, 1H, 3), 4.23 (s, 2H, 1), 4.72 
(dd, 2JHH = 8.6 Hz, 3JHH = 10.4 Hz, 1H, 3), 5.24 (pst, 3JHH = 9.4/9.1 Hz, 1H, 4), 7.25 (m, 2H, 
6), 7.30 (m, 1H, 8), 7.35 (m, 2H, 7). 13C{1H} NMR (100.6 MHz, CD2Cl2, 300K): δ = 36.8 (1), 
69.6 (3), 75.4 (5), 126.3 (6), 127.4 (8), 128.5 (7), 141.5 (5), 163.3 (2). MS (+EI), m/z: 195 
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(M+, 35.9), 160 (M-Cl-, 53.7), 130 (100), 103 (65.4). IR (NaCl): ν~ [cm-1] = 3030m, 2930m, 
2903m, 2368w, 233w, 1665s, 1494w, 1453w, 1429w, 1361m, 1307w, 1241m, 1155m, 
1112w, 1080w, 981s, 926w, 890w, 758s, 701s. TLC (pentane:diethyl ether; 1:1) Rf = 0.2. EA 
%found (calcd): C: 61.39 (60.20), H: 5.13 (5.15), N: 7.01 (7.16). 
(S)-2-Chloromethyl-4-isopropyl-4,5-dihydro-oxazoline (57) 
According to general procedure 4 amide 53 (4.75 g, 26.4 mmol) was reacted with Burgess’ 
reagent (7.69 g, 32.3 mmol) in THF (50 mL). Distillation (40°C, 10-1 mbar) afforded the 
product as a colorless oil (2.6g, 61%). 
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C7H12ClNO (161.63) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.89 (d, 3JHH = 6.8 Hz, 3H, 6), 0.97 (d, 3JHH = 6.8 
Hz, 3H, 6’), 1.78 (m, 1H, 5), 3.96 (m, 1H, 4), 4.07 (t, 3JHH = 8.3 Hz, 3), 4.11 (s, 2H, 1), 4.35 
(dd, 3JHH = 8.3 Hz, 2JHH = 9.6 Hz, 3). 13C{1H} NMR (100.6 MHz, CDCl3, 300K): δ = 18.2 
(6), 18.8 (6’), 32.6 (5), 36.6 (1), 71.3 (3), 72.6 (4), 162.5 (2). MS (+FAB, 3-NBA) m/z: 180 
(MH3O+,100). MS (+EI) m/z: 118 (M+-C3H7, 100), 90 (30.8), 83 (C4H5NO+, 16.3), 43 (C3H7+, 
17.6). IR (NaCl): ν~ [cm-1] = 3319mbr, 2962s, 2906m, 2364w, 1670s, 1526w, 1469m, 1431w, 
1361m, 1306w, 1245m, 1158m, 1113w, 981s, 890w, 751m, 722m. EA %found (calcd): C: 
51.72 (52.02), H: 7.45 (7.48), N: 8.59 (8.67). 
(S)-Neopentylglycinol (58)[73] 
To a suspension of LiAlH4 (0.531 g, 14 mmol) in THF (35 mL) was added (S)-2-amino-4,4-
dimethylpentanoic acid (1.02 g, 7 mmol) portionwise at 0 ºC. The mixture was stirred under 
reflux for 4 hours after which time the reaction was successively quenched with water (0.6 
mL), 15% NaOH (0.6 mL), and water (1.8 mL) at 0 ºC. Filtration and concentration was 
followed by Kugelrohr distillation (bp 150°C, 37 mbar) to afford a colorless oil, that gave 
colorless crystals after drying in the desiccator (745 mg, 82%). 
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C7H17NO (131.22) 
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1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.95 (s, 9H, 7), 1.10-1.16 (m, 1H, 2JHH = 14.4 Hz, 
3JHH = 6.8 Hz, 4), 1.29-1.33 (m, 3JHH = 3.5 Hz, 2JHH = 14.4 Hz, 4), 2.17 (sbr, 3H, 1/5), 2.89-
2.95 (m, 1H, 2), 3.15-3.20 (dd, 3JHH = 8.6 Hz, 2JHH = 10.3 Hz, 3), 3.48-3.51 (m, 3JHH = 4.3 Hz, 
2JHH = 10.4 Hz, 3). 13C{1H} NMR (100.6 MHz, CDCl3, 300K): δ = 30.2 (7), 30.6 (6), 49.2 
(4), 50.0 (3), 68.1 (2). MS (+FAB, 3-NBA) m/z: 132 (MH+,100), 100 (C6H14N+, 11.3), 57 
(C4H9+, 24.6). IR (KBr): ν~ [cm-1] = 3368m, 3306m, 3172m, 2954s, 2123w, 1612s, 1544s, 
1479s, 1370s, 1218m, 1286w, 1245w, 1205w, 1138w, 1056s, 974m, 907w, 818w, 886w, 
843w, 567w. m.p. 39°C. [ ]20Dα  (c = 1.0, CHCl3) = +5.2°. EA % found (calcd): C: 63.16 
(64.07), H: 12.24 (13.06), N: 10.47 (10.67). 
7.3.5 Phosphanyl-methyl-4,5-dihydro-oxazoline-Borane Adducts by Coupling 
(S)-2-[(Di-tert-butyl-phosphanyl)-methyl]-4-neopentyl)-4,5-dihydrooxazole-borane (59) 
The product was prepared according to general procedure 5 method A from 48 (161.2 mg, 
1.0 mmol), chloromethyloxazoline 55 (247.6 mg, 1.3 mmol), and NaH (72 mg, 3 mmol) in 
THF (15 mL). After column chromatography on silica eluting with pentane and diethyl ether 
the product was obtained as a colorless oil that solidified in the freezer (164 mg, 57%). 
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C17H37BNOP (313.27) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 0.37 (qbr, 3H, 10), 0.93 (s, 9H, 7), 1.31 (d, 3JHP = 
12.9 Hz, 9H, 9), 1.32 (d, 3JHP = 12.9 Hz, 9H, 9’), 1.33 (dd, 1H, 5), 1.69 (dd, 2JHH = 13.9 Hz, 
3JHH = 5.1 Hz, 1H, 5), 2.73 (m, 2H, 1), 3.76 (pst, 2JHH = 8.3 Hz, 3JHH = 8.6 Hz, 1H, 3), 4.0 
(mbr, 1H, 4), 4.37 (dd, 2JHH = 8.1 Hz, 3JHH = 9.4 Hz, 1H, 3). 13C{1H} NMR (125.8 MHz, 
CD2Cl2, 300K): δ = 20.1 (d, 1JCP = 23.8 Hz, 1), 28.2 (d, 2JCP = 1.5 Hz, 9’), 28.2 (d, 2JCP = 1.5 
Hz, 9’), 30.0 (7), 30.4 (6), 33.1 (d, 1JCP = 24.5 Hz, 8), 33.2 (d, 1JCP = 24.2 Hz, 8’), 50.44 (5), 
64.2 (3), 74.6 (4), 161.9 (d, 2JCP = 5.0 Hz, 2). 31P{1H} NMR (162 MHz, CD2Cl2, 300K): δ = 
48.3 (mbr). IR (KBr): ν~ [cm-1] = 3448mbr, 2955s, 2905s, 2383s, 2267w, 1664s, 1472m, 
1396w, 1365m, 1281w, 1252w, 1192w, 1147w, 1073m, 986m, 948w, 817w, 632w. [ ]20Dα : -
43° (c = 0.25, CHCl3).TLC (diethyl ether:pentane; 1:1) Rf = 0.54.  
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(S)-2-[(Di-tert-butyl-phosphanyl)-methyl]-4-isopropyl)-4,5-dihydrooxazoline-borane (60) 
Synthesis according according to general procedure 5 method B, using 48 (200 mg, 1.25 
mmol), n-BuLi (1.05 eq), chloromethyloxazoline 57 (152.2 mg, 0.94 mmol) in THF (10 ml). 
After column chromatography on silica eluting with pentane and diethyl ether the product was 
obtained as a colorless oil (231.3 mg, 86%). 
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C15H33BNOP (285.21) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 0.38 (qbr, 1JHB = 100 Hz, 3H, 9), 0.85 (d, 3JHH = 
6.8 Hz, 3H, 6), 0.96 (d, 3JHH = 6.8 Hz, 3H, 6’), 1.31 (dd, 3JHP = 13.1 Hz, 18H, 8/8’), 1.68 (m, 
1H, 5), 2.74 (d, 2JHP = 10.8 Hz, 2H, 1), 3.77 (m, 1H, 4), 3.93 (pst, 2JHH = 8.6 Hz, 3JHH = 8.3 
Hz, 1H, 3), 4.26 (dd, 2JHH = 8.6 Hz, 3JHH = 9.6 Hz, 1H, 3). 13C{1H} NMR (100.6 MHz, 
CD2Cl2, 300K): δ = 18.0 (6), 18.7 (6’), 19.4 (d, 1JCP = 24.1 Hz, 1), 27.4 (pst, 2JCP = 2 Hz, 
8/8’), 32.3 (d, 1JCP = 6.9 Hz, 7), 32.5 (d, 1JCP = 6.9 Hz, 7’), 32.6 (5), 70.3 (3), 72.4 (4), 161.7 
(d, 2JCP = 5 Hz, 2). 31P{1H} NMR (162 MHz, CD2Cl2, 300K): δ = 48.4 (q, 1JPB = 55.5 Hz). 
MS (+FAB, 3-NBA) m/z: 284 (R12R2P(11B)H2+, 71.2), 283 (R12R2P(10B)H2+, 17.4), 272 (M+-
BH3, 39.9), 214 (272-C4H10, 18.8), 158 (214-C4H8, 14.2), 57 (C4H9+, 100). IR (NaCl): ν~ [cm-
1] = 2960s, 2903ssh, 2379s, 2269w, 1663s, 1472m, 1395w, 1367m, 1302w, 1254w, 1188w, 
1146m, 1073m, 1023w, 987m, 938m, 817w, 771w. TLC (n-pentane:diethyl ether; 1:1) Rf = 
0.38.  
(S)-4-tert-Butyl-2-[(dicyclohexylphosphanyl)-methyl]-4,5-dihydro-oxazoline-borane 
adduct (61) 
Synthesis according to general procedure 5 method B, using 49 (198 mg, 0.93 mmol), n-BuLi 
(1 mmol), chloromethyloxazoline 54 (169.1 mg, 0.96 mmol) in THF (10 ml). After column 
chromatography on silica eluting with pentane and diethyl ether the product was obtained as a 
white solid (293 mg, 89%). 
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C20H39BNOP (351.31) 
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1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 0.26 (qbr, 3H, 7), 0.89 (s, 9H, 6), 1.25 (m, 6H, 
Cyeq), 1.41 (m, 4H, Cyeq), 1.71 (m, 2H, Cyax), 1.81 (m, 8H, Cyax), 1.86 (m, 2H, Cyax), 2.00 
(m, 2H, 8), 2.63 (d, 3JHH = 9.6 Hz, 2H, 1), 3.83 (m, 1H, 4), 3.98 (pst, 2JHH = 8.9 Hz, 3JHH = 8.9 
Hz, 1H, 3), 4.19 (dd, 2JHH = 8.6 Hz, 3JHH = 10.1 Hz, 1H, 3). 13C{1H} NMR (125.8 MHz, 
CD2Cl2, 300K): δ = 20.5 (d, 1JCP = 26.8 Hz, 1), 26.1 (6), 26.3-27.3 (m, Cy), 31.7 (2×d, 1JCP = 
31.2 Hz, 8), 33.7 (5), 69.0 (3), 76.6 (4), 161.4 (2). 31P{1H} NMR (202.5 MHz, CD2Cl2, 
300K): δ = 28.3 (m). MS (+FAB, 3-NBA) m/z: 350 (MH+, 100), 338 (MH+-BH3, 56.6), 83 
(Cy+, 36.2), 55 (63.0). IR (KBr): ν~ [cm-1] = 3448mbr, 2937s, 2852s, 2661w, 2372s, 2342m, 
2248w, 2115w, 1660s, 1474w, 1446m, 1408w, 1359m, 1333m, 1299w, 1258m, 1178w, 
1134m, 1064m, 1004sh, 980m, 933m, 891w, 855w, 829w, 793w, 756w, 705w, 606m. m.p. 53 
°C. [ ]20Dα  (c = 1.06, CHCl3): -41.1°. TLC (n-pentane:diethyl ether; 1:2) Rf = 0.76. EA %found 
(calcd) C: 68.37 (68.38), H: 10.93 (11.19), N: 4.09 (3.99). 
(S)-2-[(Dicyclohexylphosphanyl)methyl]-4-neopentyl-4,5-dihydro-oxazole-borane (35) 
The product was obtained according to general procedure 5 method B from 49 (214.8 mmol), 
chloromethyloxazoline 55 (211.6 mg, 1.11 mmol), and n-BuLi (0.7 mL of 1.6M solution in 
hexane, 1.1 mmol) in THF (15 mL). After column chromatography on silica (pentane and 
diethyl ether) the product was obtained as a white solid (306 mg, 83%). 
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C21H41BNOP (365.34) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 0.25 (qbr, 3H, 12), 0.96 (s, 9H, 7), 1.26 (mbr, H, 
Cy), 1.32 (dd, 2JHH = 13.9 Hz, 3JHH = 6.8 Hz, 5), 1.40 (mbr, H, Cy), 1.65 (dd, 2JHH = 13.9 Hz, 
3JHH = 6.1 Hz, 5), 1.71 (mbr, 2H, Cy), 1.83 (mbr, 8H, Cy), 1.97 (mbr, 2H, Cy), 2.61 (m, 2H, 1), 
3.74 (pst, 2JHH = 8.3 Hz, 3JHH = 8.3 Hz, 3), 4.09 (m, 1H, 4), 4.37 (dd, 2JHH = 8.3 Hz, 3JHH = 9.6 
Hz, 3). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 20.4 (d, 1JCP = 26.1 Hz, 1), 26.3 (Cy), 
26.8 (Cy), 27.0 (Cy), 27.1 (Cy), 27.2 (Cy), 30.0 (7), 30.5 (6), 31.5 (d, 1JCP = 31.1Hz, 8), 31.6 
(d, 1JCP = 31.1 Hz, 8’), 50.7 (5), 64.3 (4), 74.6 (3), 160.9 (d, 2JCP = 7.7 Hz, 2). 31P{1H} NMR 
(162 MHz, CD2Cl2, 300K): δ = 28.1 (d, 1JPB = 69.4 Hz). MS (+FAB, 3-NBA) m/z: 364 (M-H-
, 100), 352 (MH+-BH3, 60.1), 57 (C4H9+, 56.6), 55 (C4H7+, 62.2). IR (KBr): ν~ [cm-1] = 
3436mbr, 2932s, 2857s, 2374s, 2343m, 2247w, 1658s, 1448m, 1405w, 1357m, 1302w, 
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1277w, 1202w, 1138w, 1064m, 1006w, 980m, 951w, 911w, 891w, 855w, 796w, 756w, 607w. 
m.p. 65-67°C. [ ]20Dα : -47° (c = 0.37, CHCl3). TLC (n-pentane: diethyl ether; 1:1) Rf = 0.43. 
EA % found (calcd): C: 69.07 (69.04), H: 11.09 (11.31), N: 3.95 (3.83). 
(S)-2-[(Dicyclohexylphosphanyl)-methyl]-4-isopropyl-4,5-dihydro-oxazoline-borane 
adduct (63) 
Synthesis according to general procedure 5 method B, using 49 (299 mg, 1.4 mmol), n-BuLi 
(1 eq), chloromethyloxazoline 57 (217.5 mg, 1.35 mmol) in THF (20 ml). After column 
chromatography on silica eluting with pentane and diethyl ether the product was obtained as a 
white solid (370 mg, 82%). 
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C19H37BNOP (337.29) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 0.88 (d, 3JHH = 6.7 Hz, 6), 0.98 (d, 3JHH = 6.7 Hz, 
6’), 1.25 (m, 6H, 10eq, 11eq), 1.41 (m, 4H, 9eq), 1.65 (m, 1H, 5), 1.71 (m, 2H, 11ax), 1.79-1.87 
(m, 8H, 9ax, 10ax), 1.96 (m, 2H, 8), 2.58-2.68 (m, 2H, 1), 3.79 (m, 1H, 4), 3.91 (pst, 2JHH = 8.5 
Hz, 1H, 3), 4.25 (dd, 2 JHH = 8.5 Hz, 3JHH = 9.7 Hz, 1H, 3). 13C{1H} NMR (125.8 MHz, 
CD2Cl2, 300K): δ = 18.8 (6), 19.3 (6’), 20.5 (d, 1JCP = 26.3 Hz, 1), 26.3 (dd, 11), 26.8 (dd, 9), 
27.0-27.2 (m, 9/10), 31.6 (pst, 1JCP = 61.8 Hz, 8), 33.5 (5), 71.0 (3), 73.2 (4), 161.4 (d, 2JCP = 
7.8 Hz, 2). 31P{1H} NMR (162 MHz, CD2Cl2, 300K): δ = 28.1 (m, 1JPB = 69.4 Hz). MS 
(+FAB, 3-NBA) m/z: 336 (M-H-, 100), 324 (MH+-BH3, 52.9). IR (NaCl): ν~ [cm-1] = 2930s, 
2856s, 2664w, 2372s, 2255w, 1663s, 1450m, 1404w, 1351m, 1201w, 1274w, 1252w, 1214w, 
1176w, 1139m, 1065m, 983m, 936m, 891w, 855w, 758w. TLC (n-pentane:diethyl ether; 4:1) 
Rf = 0.53. EA % found (calcd): C: 67.43 (67.66), H: 10.81 (11.06), N: 4.23 (4.15). 
(S)-4-tert-Butyl-2-[(diphenylphosphanyl)-methyl]-4,5-dihydro-oxazoline-borane adduct 
(64) 
Synthesis according to general procedure 5 method A, using 30 (400 mg, 2 mmol), 
chloromethyloxazoline 54 (457 mg, 2.6 mmol) and NaH (125 mg, 5.2 mmol) in THF (15 ml). 
After column chromatography on silica eluting with pentane and diethyl ether the product was 
obtained as a white solid (452.6 mg, 67%). 
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C20H27BNOP (339.22) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.72 (mbr, 3H, 11), 3.28 (ddd, 2JHH = 14.4 Hz, 2JHP 
= 10.6 Hz, 1H, 1), 3.43 (dd, 2JHH = 14.4 Hz, 2JHP = 11.6 Hz, 1H, 1), 3.73 (dt, 3JHH = 9.7 Hz, 
4JHH = 3.0 Hz, 1H, 4), 3.85 (t, 2JHH = 8.6 Hz, 1H, 3), 4.04 (dd, 2JHH = 8.6, 3JHH = 10.1 Hz, Hz, 
1H, 3), 7.43-7.52 (m, 6H, 8/10), 7.72-7.80 (m, 4H, 9). 13C{1H} NMR (100.6 MHz, CDCl3, 
300K): δ = 25.9 (6), 27.4 (d, 1JCP = 32.2 Hz, 1), 33.4 (5), 69.2 (3), 76.1 (4), 128.2 (d, 1JCP = 
55.6 Hz, 7), 128.7 (d, 1JCP = 55.6 Hz, 7’), 128.8 (d, 2JCP = 10.3 Hz, 8), 128.9 (d, 2JCP = 10.0 
Hz, 8’), 131.6 (2×d, 4JCP = 2.7 Hz, 10/10’), 132.6 (d, 3JCP = 9.6 Hz, 9), 132.9 (d, 3JCP = 10.0, 
9’), 160.7 (2). 31P{1H} NMR (162 MHz, CDCl3, 300K): δ = 17.6 (d, 1JPB = 65.4 Hz). MS 
(+FAB, 3-NBA) m/z: 340 (MH+, 52.5), 339 (M+, 29.3), 338 (M-H-, 74.5), 326 (M+-BH3, 
100), 185 (PPh2+, 54.7). IR (KBr): ν~ [cm-1] = 2959s, 2888m, 2387s, 2349m, 1668s, 1477m, 
1437m, 1400w, 1357m, 1333w, 1295w, 1252m, 1207m, 1134m, 1105m, 1060m, 1022w, 
991m, 932m, 745m, 695s, 580m. mp. 71 °C. [ ]20Dα : -35.0° (c = 1.01, CHCl3). TLC (diethyl 
ether:pentane ethanol; 4:1): Rf = 0.43. EA % found (calcd): C: 70.94 (70.81), H: 7.96 (8.02), 
N: 4.10 (4.13). 
(S)-4-Neopentyl-2-[(diphenylphosphanyl)-methyl]-4,5-dihydro-oxazole borane (65) 
The product was obtained according to general procedure 5 method B from 30 (206.7 mg, 
1.03 mmol), chloromethyloxazoline 55 (146 mg, 0.77 mmol), and n-BuLi (0.7 mL of 1.6M 
solution in hexane, 1.1 mmol) in THF (15 mL). After column chromatography on silica 
eluting with pentane and diethyl ether the product was obtained as a white solid (95 mg, 35 
%). 
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C21H29BNOP (353.25) 
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1H NMR (CDCl3, 400.1 MHz, 300K): δ = 0.87 (s, 9H, 7), 1.11 (qbr, 3H, 11), 1.11 (dd, 3JHH = 
7.1 Hz, 2JHH 13.9 Hz, 1H, 5), 1.44 (dd, 3JHH = 5.6 Hz, 2JHH 13.9 Hz, 1H, 5), 3.25 (dd, 2JHH = 
14.4 Hz, 2JHP = 10.6 Hz, 1H, 1), 3.32 (dd, 2JHH = 14.4 Hz, 2JHP = 11.1 Hz, 1H, 1), 3.51 (pst, 
2JHH = 8.3 Hz, 3JHH = 8.3 Hz, 1H, 3), 3.96 (m, 1H, 4), 4.18 (dd, 2JHH = 8.3 Hz, 3JHH = 9.6 Hz, 
3), 7.45-7.53 (m, 6H, 9/11), 7.71-7.78 (m, 4H, 10). 13C{1H} NMR (CDCl3, 100.6 MHz, 
300K): δ = 27.3 (d, 1JCP = 32 Hz, 1), 29.9 (7), 30.4 (6), 50.5 (5), 64.1 (4), 74.7 (3),128.7 (d, 
1JCP = 55.6 Hz, 8), 128.9 (d, 1JCP = 55.6 Hz, 8’), 129.0 (d,  2JCP = 10.3 Hz, 9), 129.1 (d,  2JCP = 
10.0 Hz, 9’), 131.8 (d, 4JCP = 2.4 Hz, 11/11’), 132.9 (d, 3JCP = 9.7 Hz, 10), 133.0 (d, 3JCP = 9.7, 
10’), 159.9 (d, 2JCP = 6.3 Hz, 2). 31P{1H} NMR (CDCl3, 162 MHz, 300K): δ = 17.6 (m, 1JPB = 
69 Hz). TLC (diethyl ether:pentane ethanol, 4:1): Rf = 0.46. 
(S)-2-[(Diphenylphosphanyl)-methyl]-4-phenyl-4,5-dihydro-oxazole-borane adduct (66) 
The product was obtained according to general procedure 5 method A from 30 (278.7 mg, 
1.39 mmol), chloromethyloxazoline 56 (257.2 mg, 1.31 mmol), and NaH (33.3 mg, 1.39 
mmol) in THF (15 mL). After column chromatography on silica eluting with pentane and 
diethyl ether the product was obtained as a white solid (209 mg, 44%). 
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C22H23BNOP (359.21) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 3.38-3.5 (m, 2H, 1), 3.84 (t, 3JHH = 8.6 Hz, 3), 
4.46 (dd, 3JHH = 8.3 Hz, 2JHH = 9.4 Hz, 3), 5.05 (ddd, 1H, 4), 7.01 (m, 2H, 6), 7.25-7.29 (m, 
3H, 7/8), 7.46-7.50 (m, 4H, 10/10’), 7.53-7.54 (m, 2H, 12/12’), 7.75-7.81 (m, 4H, 11/11’). 
13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 27.4 (d, 1JCP = 32 Hz, 1), 70.2 (3), 75.3 (4), 
126.9 (6), 127.7 (8), 128.6 (d, 1JCP = 55.5 Hz, 9), 128.8 (7), 128.8 (d, 1JCP = 55.5 Hz, 9’), 
129.1 (d, 2JCP = 10.3 Hz, 10), 129.2 (d, 2JCP = 10.3 Hz, 10’), 131.9 (2×d, 4JCP = 2.8 Hz, 
12/12’), 132.9 (d, 3JCP = 9.7 Hz, 11), 133.1 (d, 3JCP = 9.7 Hz, 11’), 142.3 (5), 162.1 (d, 2JCP = 
5.5 Hz, 2). 31P{1H} NMR (162 MHz, CD2Cl2, 300K): δ = 17.8 (d, 1JPB = 61.5 Hz). MS 
(+FAB, 3-NBA) m/z: 360 (MH+, 15.3), 346 (MH+-BH3, 26.2), 185 (Ph2P+, 14.7). IR (NaCl): 
ν~ [cm-1] = 3059m, 2969m, 2901m, 2386s, 2259w, 1964w, 1895w, 1815w, 1660s, 1487m, 
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1437m, 1400m, 1355m, 1308m, 1274m, 1247m, 1139m-s, 1109m-s, 1062s, 985s, 920m, 
846w, 745s, 689s. TLC (diethyl ether:pentane ethanol, 4:1): Rf = 0.3. 
(S)-2-[Diphenylphosphanyl-methyl]-4-isopropyl-4,5-dihydro-oxazoline-borane adduct 
(67) 
Synthesis according to general procedure 5 method A, using diphenylphosphine-borane 
adduct (400 mg, 2 mmol), chloromethyloxazoline 57 (420 mg, 2.6 mmol) and NaH (125 mg, 
5.2 mmol) in THF (15 ml). After column chromatography on silica eluting with pentane and 
diethyl ether the product was obtained as a white solid (529 mg, 91%). 
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C19H25BNOP (325.19) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 0.74 (d, 3H, 3JHH = 6.8 Hz, 6), 0.81 (d, 3H, 3JHH = 
6.8 Hz, 6’), 1.47 (m, 1H, 5), 3.27 (dd, 2JHH = 14.5 Hz, 2JHP = 11.2 Hz, 1H, 1), 3.34 (dd, 2JHH = 
14.5 Hz, 2JHP = 11.2 Hz, 1H, 1), 3.69 (m, 1H, 4), 3.72 (m, 1H, 3), 4.06 (dd, 1H, 3), 7.44-7.553 
(m, 6H, 8/10), 7.72-7.76 (m, 4H, 9). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 18.2 
(6), 18.6 (6’), 27.0 (d, 1JCP = Hz, 1), 32.8 (5), 70.7 (3), 72.6 (4),128.6 (2×d, 1JCP = 2×55.5 Hz, 
7/7’), 128.6 (d, 2JCP = 10.3 Hz, 8), 128.7 (d, 2JCP = 10.3 Hz, 8’), 131.4 (dd, 4JCP = 2.5 Hz, 
10/10’), 132.5 (d, 3JCP = 9.6 Hz, 9), 132.6 (d, 3JCP = 9.6, 9’), 159.9 (d, 1JCP = 6.1 Hz, 2). 
31P{1H} NMR (162 MHz, CD2Cl2, 300K): δ = 17.8 (d, 1JPB = 65.4 Hz). MS (+FAB, 3-NBA) 
m/z: 324 (M-H-, 81.3), 312 (MH+-BH3, 100), 185 (Ph2P+, 55.2). IR (NaCl): ν~ [cm-1] = 
3057w, 2961s, 2900sh, 2382s, 2259w, 1664s, 1476w, 1437m, 1399w, 1354m, 1304w, 1250w, 
1139m, 1109m,1061m, 983m, 935m, 843w, 743m, 696s. TLC (diethyl ether:pentane ethanol; 
4:1): Rf = 0.34. 
7.3.6 Deprotection and Complex Synthesis 
(S)-2-[(Di-tert-butyl-phosphanyl)-methyl]-4-tert-butyl)-4,5-dihydrooxazoline (68) 
The product was obtained according to general procedure 6 from protected ligand 45 (71 mg, 
237 µmol) in diethylamine (1 mL) in 3 days. To separate the diethylamine-borane adduct the 
brown oil was purified over a short argon column. The product was obtained as a colorless oil 
(45 mg, 66%). 
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C16H32BNOP (285.41) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 0.85 (s, 9H, 6), 1.4-1.18 (2×d, 3JHP = 11.1 Hz, 
18H, 8/8’), 2.39 (sbr, 2H, 1), 3.76 (pst, 3JHH = 9.6 Hz, 1H, 4), 3.97 (pst, 2JHH = 8.6 Hz, 3JHH = 
8.6 Hz, 1H, 3), 4.13 (dd, 2JHH = 8.6 Hz, 3JHH = 9.8 Hz, 1H, 3). 13C{1H} NMR (125.8 MHz, 
CD2Cl2, 300K): δ = 21.5 (d, 1JCP = 28 Hz, 1), 26.1 (6), 29.4 (d, 2JCP = 14 Hz, 8), 29.5 (d, 2JCP 
= 14 Hz, 8), 33.9 (5), 68.9 (3), 76.4 (4) quarternary carbons missing. 31P{1H} NMR (162 
MHz, CD2Cl2, 300K): δ = 27.3. TLC: (n-pentane:diethylether; 1:2) Rf = 0.46. 
(S)-2-[(Di-tert-butyl-phosphanyl)-methyl]-4-neopentyl)-4,5-dihydrooxazole (69) 
The product was obtained according to general procedure 6 from protected ligand 59 (139 
mg, 440 µmol) in diethylamine (2 mL) in 7 days. Evaporation of the volatiles afforded the 
product as a colorless oil. The ligand was used without further purification. 
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C17H34NOP (299.43) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 0.92 (s, 9H, 7), 1.13 (d, 3JHP = 11.1 Hz, 9H, 9), 
1.14 (d, 3JHP = 11.1 Hz, 9H, 9’), 1.28 (dd, 2JHH = 13.8 Hz, 3JHH = 7.9 Hz, 1H, 5), 1.66 (dd, 
2JHH = 13.8 Hz, 3JHH = 4.8 Hz, 1H, 5), 2.39 (ddq, 2JHP = 25.4 Hz, 2JHH = 14.3 Hz, 5JHH = 1.5 
Hz, 2H, 1), 3.73 (pst, 2JHH = 8.3 Hz, 3JHH = 8.3 Hz, 1H, 3), 4.03 (mbr, 1H, 4), 4.33 (dd, 2JHH = 
8.1 Hz, 3JHH = 9.4 Hz, 1H, 3). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 21.5 (d, 1JCP = 
28.4 Hz, 1), 29.4 (d, 2JCP = 8.4 Hz, 9), 29.5 (d, 2JCP = 8.4 Hz, 9’), 30.0 (7), 30.4 (6), 31.8 (d, 
1JCP = 23.1 Hz, 8), 31.8 (d, 1JCP = 23.3 Hz, 8), 50.8 (5), 64.1 (3), 74.6 (4), 166.5 (d, 2JCP = 
11.8 Hz, 2). 31P{1H} NMR (202.5 MHz, CD2Cl2, 300K): δ = 27.3. 
(R)-2-[(Di-tert-butyl-phosphanyl)-methyl]-4-phenyl)-4,5-dihydrooxazole (70) 
The product was obtained according to general procedure 6 from protected ligand 46 (110 
mg, 345 µmol) in diethylamine (2 mL) in 7 days. Evaporation of the volatiles afforded the 
product as a colorless oil. The ligand was used without further purification. 
Chapter 7 
 152
1 2
N
4
3O
5P
9
10
8
7
6
 
C18H28NOP (305.39) 
1H NMR (CD2Cl2, 500.1 MHz, 300K): δ = 1.17 (d, 3JHP = 11.1 Hz, 9H, 10), 1.18 (d, 3JHP = 
11.1 Hz, 9H, 10’), 2.52 (m, 2H, 1), 4.01 (pst, 2JHH = 8.5, 1H, 3), 4.59 (dd, 2JHH = 8.5 Hz, 3JHH 
= 10.1 Hz, 3), 5.12 (pst, 3JHH = 10 Hz, 1H, 4), 7.22-7.28 (m, 3H, 6/8), 7.31-7.35 (m, 2H, 7). 
13C{1H} NMR (CD2Cl2, 125.8 MHz, 300K): δ = 21.5 (d, 1JCP = 28.7 Hz, 1), 2×29.5 (dd, 
2×2JCP = 14 Hz, 10), 31.9 (d, 1JCP = 23.0 Hz, 9), 70.2 (4), 75.1 (3), 127.0 (6), 127.6 (8), 128.9 
(7), 143.3 5), 168.9 (2JCP = 12.6 Hz, 2). 31P{1H} NMR (CD2Cl2, 162.0 MHz, 300K): δ = 28.8. 
(S)-2-[(Di-tert-butyl-phosphanyl)-methyl]-4-tert-butyl)-4,5-dihydrooxazoline (71) 
The product was obtained according to general procedure 6 from protected ligand 60 (220 
mg, 677 µmol) in diethylamine (1.5 mL) in 1 day. Evaporation of the volatiles afforded the 
product as a colorless oil. The ligand was used without further purification. 
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C15H30NOP (271.38) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 0.84 (d, 3JHH = 6.8 Hz, 3H, 6), 0.93 (d, 3JHH = 6.8 
Hz, 3H, 6’), 1.30 (d, 3JHP = 11.1 Hz, 9H, 8), 1.14 (d, 3JHP = 11.1 Hz, 9H, 8’), 1.65 (m, 1H, 5), 
2.40 (2H, 1), 3.78 (m, 1H, 4), 3.89 (pst, 3JHH = 8.1 Hz, 2JHH = 8.1 Hz, 1H, 3), 4.19 (dd, 3JHH = 
11.6 Hz, 2JHH = 8.3 Hz, 1H, 3). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 18.5 (6), 
19.1 (6’), 21.5 (d, 1JCP = 28.3 Hz, 1), 29.5 (d, 2JCP = 14.2 Hz, 8), 29.6 (d, 2JCP = 1.24 Hz, 8), 
31.8 (d, 1JCP = 23 Hz, 7), 31.9 (d, 1JCP = 23 Hz, 7), 33.2 (5), 70.6 (3), 72.9 (4). 167.1 (2). 
31P{1H} NMR (202.5 MHz, CD2Cl2, 300K): δ = 27.2. 
(S)-4-tert-Butyl-2-[(dicyclohexylphosphanyl)-methyl]-4,5-dihydro-oxazole (72) 
The product was obtained according to general procedure 6 from protected ligand 61 (155.5 
mg, 443 µmol) in diethylamine (2 mL) in 5 days. Evaporation of the volatiles afforded the 
product as a colorless oil. The ligand was used without further purification. 
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C20H306NOP (337.48) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 0.86 (s, 9H, 6),1.24 (m, 8H, Cyeq), 1.56 (mbr, 1H, 
Cy), 1.59 (mbr, 2H, Cy), 1.68 (mbr, 2H, Cyax), 1.78 (mbr, 9H, Cyax), 2.34 (m, 2H, 1), 3.77 (ddd, 
1H, 4), 3.96 (t, 2JHH = 8.6 Hz, 1H, 3), 4.12 (dd, 2JHH = 8.6 Hz, 3JHH = 10.1 Hz, 1H, 3). 31P{1H} 
NMR (162 MHz, CD2Cl2, 300K): δ = -2.7. 
(S)-2-[(Dicyclohexylphosphanyl)methyl]-4-neopentyl-4,5-dihydro-oxazole (73) 
The product was obtained according to general procedure 6 from protected ligand 62 (181 
mg, 195 µmol) in diethylamine (2 mL) in 4 days. Evaporation of the volatiles afforded the 
product as a colorless oil. The ligand was used without further purification. 
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C21H38NOP (351.51) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 0.93 (s, 9H, 7), 1.23 (m, 10H, Cyeq), 1.28 (dd, 
2JHH = 13.9 Hz, 3JHH = 7.6 Hz, 1H, 5), 1.64 (m, 2H, Cyax), 1.66 (dd, 2JHH = 13.9 Hz, 3JHH = 
4.8 Hz, 1H, 5), 1.75 (mbr, 10H, Cyax), 2.34 (dd, 2JHP = 22.5 Hz, 2JHH = 13.9 Hz, 2H, 1), 3.71 
(pst, 2JHH = 3JHH = 8.3 Hz, 1H, 3), 4.03 (m, 1H, 4), 4.31 (2JHH = 8.3 Hz, 3JHH = 9.3 Hz, 1H, 3). 
31P{1H} NMR (162 MHz, CD2Cl2, 300K): δ = -3.1 
(R)-4-Phenyl-2-[(dicyclohexylphosphanyl)-methyl]-4,5-dihydro-oxazoline (74) 
The product was obtained according to general procedure 6 from protected ligand 47 (180 
mg, 485 µmol) in diethylamine (1.5 mL) in 7 days. The crude product was purified over a 
short argon column. The product was obtained as a colorless oil (181 mg, 87%). 
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C22H32NOP (357.47) 
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1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 1.25 (mbr, 6H, Cyeq), 1.43 (mbr, 4H, Cyeq), 1.71 
(mbr, 2H, Cyax), 1.81 (mbr, 4H, Cyax), 1.89 (mbr, 4H, Cyax), 2.0 (m, 2H, 8), 2.48 (s, 2 H, 1), 
4.03 (pst, 2JHH = 8.3 Hz, 3JHH = 8.3 Hz, 1H, 3), 4.58 (dd, 2JHH = 8.6, 3JHH = 9.9 Hz, 1H, 3), 
5.12 (m, 3JHH = 9.6 Hz, 1H, 4). 31P{1H} NMR (162 MHz, CD2Cl2, 300K): δ = -1.9 
(S)-2-[(Dicyclohexylphosphanyl)-methyl]-4-isopropyl-4,5-dihydro-oxazoline-borane 
adduct (75) 
The product was obtained according to general procedure 6 from protected ligand 63 (179 
mg, 530 µmol) in diethylamine (1.5 mL) in 1 day. Purification by column chromatography on 
silica with diethyl ether and pentane under argon afforded the product as a colorless oil (124 
mg, 72%). 
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C19H34NOP (323.45) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 0.85 (d, 3JHH = 6.8 Hz, 6), 0.94 (d, 3JHH = 6.8 Hz, 
6’), 1.1-13 (m, 6H, 9eq, 10eq, 11eq), 1.56-1.62 (m, 2H, 8ax), 1.66-1.68 (m, 3H, 5, 11ax), 1.75-
1.77 (m, 8H, 9ax, 10ax), 2.36 (m, 2JHH = 13.9 Hz, 2JHP = 7 Hz, 1), 3.77 (m, 1H, 4), 3.88 (pst, 
2JHH = 8.3 Hz, 1H, 3), 4.18 (pst, 2 JHH = 8.6 Hz, 3JHH = 9.1 Hz, 1H, 3). 13C{1H} NMR (125.8 
MHz, CD2Cl2, 300K): δ = 18.5 (6), 19.1 (6’), 21.6 (d, 1JCP = 25.4 Hz, 1), 26.8 (11),27.5 (m, 
10), 27.6 (m, 10’), 27.6 (m, 11’), 29.1 (dd, 9), 30.2 (pst, 9’), 32.3 (5), 33.9 (dd, 1JCP = 2×15 
Hz, 8), 72.9 (3), 73.2 (4), 166.2 (d, 2JCP = 7 Hz, 2). 31P{1H} NMR (162 MHz, CD2Cl2, 300K): 
δ = -2.9. TLC: (n-pentane:diethylether; 1:4) Rf = 0.53. 
(S)-4-tert-Butyl-2-[(diphenylphosphanyl)-methyl]-4,5-dihydro-oxazoline (76) 
The product was obtained according to general procedure 6 from protected ligand 64 (108 
mg, 0.32 mmol) in diethylamine (2 mL) in 1 day. Evaporation of the volatiles afforded the 
product as a colorless oil. 
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C20H24NOP (325.38) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 0.74 (s, 9H, 6), 2.00 (dd, 2JHH = 14.4 Hz,2JHP = 34 
Hz, 1H, 1), 3.09 (dd, 2JHH = 14.4 Hz, 2JHP = 1 Hz, 1H, 1), 3.74 (m, 1H, 4), 3.93 (t, 2JHH = 8.3 
Hz, 1H, 3), 4.08 (dd, 2JHH = 8.6, 3JHH = 10.0 Hz, 1H, 3), 7.33(m, 6H, 8/10), 7.47 (m, 4H, 9). 
13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 25.8 (6), 28.4 (d, 1JCP = 18.3 Hz, 1), 33.7 (5), 
69.1 (3), 76.4 (4), 128.8 (d, 2JCP = 6.7 Hz, 8/8’), 129.2 (d, 2JCP = 4.9 Hz, 10/10’), 133.0 (d, 
3JCP = 14.1 Hz, 9), 133.1 (d, 3JCP = 14.1 Hz, 9’), 138.4 (d, 1JCP = 34.4, 7), 138.5 (d, 1JCP = 34.4, 
7’), 163.9 (d, 2JCP = 8.3 Hz, 2). 31P{1H} NMR (162 MHz, CD2Cl2, 300K): δ = -17.3. 
(S)-4-Neopentyl-2-[(diphenylphosphanyl)-methyl]-4,5-dihydro-oxazole (77) 
The product was obtained according to general procedure 6 from protected ligand 65 (95 mg, 
269 µmol) in diethylamine (2 mL) in 2 days. Evaporation of the volatiles afforded the product 
as a colorless oil. The ligand was used without further purification. 
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C21H26NOP (339.41) 
1H NMR (500.1 MHz, CDCl3, 300K) δ = 0.88 (s, 9H, 7), 1.17 (dd, 2JHH = 13.9 Hz, 3JHH = 7.6 
Hz, 1H, 5), 1.52 (dd, 2JHH = 13.9 Hz, 3JHH = 5.1 Hz, 1H, 5), 3.01 (ddd, 2JHH = 14.2 Hz, 4JHH = 
1.3 Hz, 2JHP = 20.2 Hz, 2H, 1), 3.65 (pst, 2JHH = 8.2 Hz, 3JHH = 8.2 Hz, 1H, 3), 3.99 (m, 1H, 
4), 4.27 (dd, 2JHH = 8.3 Hz, 3JHH = 9.3 Hz, 1H, 3), 7.33-7.35 (m, 6H, 9/11), 7.42-7.46 (m, 4H, 
10). 13C{1H} NMR (125.8 MHz, CDCl3, 300K) δ = 28.2 (d, 1JCP = 18.7 Hz, 1), 30.0 (7), 30.4 
(6), 50.8 (5), 64.1 (4), 74.7 (3),128.7 (d, 4JCP = 6.8 Hz, 11), 128.9 (d, 2JCP = 54.8 Hz, 9), 129.0 
(d, 2JCP = 54.9 Hz, 9’), 132.9 (d,  3JCP = 19.5 Hz, 10), 133.1 (d, 1JCP = 19.5 Hz, 10’), 138.4 (d, 
1JCP = 14.3 Hz, 8/8’), 163.3. 31P{1H} NMR (202.5 MHz, CDCl3, 300K) δ = -17.0. 
(S)-2-[(Diphenylphosphanyl)-methyl]-4-phenyl-4,5-dihydro-oxazole (78) 
The product was obtained according to general procedure 6 from protected ligand 66 (180 
mg, 501 µmol) in diethylamine (1 mL) in 1 day. Evaporation of the volatiles afforded the 
product as a colorless oil. The ligand was used without further purification. 
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C22H20NOP (345.37) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 3.19 (2×dd, 2JHH = 14.4 Hz, 2JHP = 1.1 Hz, 2H, 1), 
3.91 (pst, 2JHH = 8.3 Hz, 3JHH = 8.3 Hz, 1H, 3), 4.53 (dd, 2JHH = 8.3 Hz, 3JHH = 10.2 Hz,1H, 
3), 5.08 (tbr, 1H, 4), 6.96 (m, 2H, 6), 7.23-7.25 (m, 3H, 7/8), 7.36-7.38 (m, 6H, 10/12), 7.47-
7.54 (m, 4H, 11). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 28.3 (d, 1JCP = 19 Hz, 1), 
70.2 (3), 75.4 (4), 126.9 (6), 127.6 (8), 128.8 (7), 128.8 (d, 2JCP = 3.1 Hz, 10), 128.9 (d, 2JCP = 
3.6 Hz, 10’), 129.3 (d, 4JCP = 24.1, 12/12’), 132.9 (d, 3JCP = 19.5 Hz, 11), 133.3 (d, 3JCP = 20.0 
Hz, 11’), 138.0 (d, 1JCP = 30 Hz, 9), 143.0 (5), 165.6 (d, 2JCP = 7.5 Hz, 2). 31P{1H} NMR (162 
MHz, CD2Cl2, 300K): δ = -17.1. 
(S)-2-[Diphenylphosphanyl-methyl]-4-isopropyl-4,5-dihydro-oxazole (79) 
The product was obtained according to general procedure 6 from protected ligand 67 (317 
mg, 975 µmol) in diethylamine (3 mL) in 1 day. Evaporation of the volatiles afforded the 
product as a colorless oil. The ligand was used without further purification. 
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C19H22NOP (311.36) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 0.75 (d, 3JHH = 6.8 Hz, 3H, 6), 0.81 (d, 3JHH = 6.8 
Hz, 3H, 6’), 1.54 (m, 3JHH = 6.8 Hz, 1H, 5), 3.03 (dd, 2JHH = 14.1 Hz, 2JHP = 22.5 Hz, 2H, 1), 
3.76 (m, 1H, 4), 3.83 (pst, 3JHH = 8.1 Hz, 2JHH = 8.8 Hz, 1H, 3), 4.13 (dd, 3JHH = 9.3 Hz, 2JHH 
= 8.1 Hz, 1H, 3), 7.33-7.34 (m, 6H, 8, 10), 7.42-7.48 (m , 4H, 9). 13C{1H} NMR (125.8 MHz, 
CD2Cl2, 300K): δ = 18.3 (6), 18.8 (6’), 18.4 (d, 1JCP = 18.5 Hz, 1), 33.0 (5), 70.6 (3), 72.8 (4), 
128.7 (d, 2JCP = 6.8 Hz, 8/8’), 129.1 (d, 4JCP = 7.7 Hz, 10/10’), 132.9 (d, 3JCP = 19.3 Hz, 9), 
133.2 (d, 3JCP = 19.4 Hz, 9’), 138.3 (d, 1JCP = 14.6 Hz, 7), 138.5 (d, 1JCP = 15.0 Hz, 7’), 163.9 
(d, 2JCP = 7.9 Hz, 2). 31P{1H} NMR (162 MHz, CD2Cl2, 300K): δ = -20.7. 
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(S)-2-[(Di-tert-butyl-phosphanyl)-methyl]-4-tert-butyl)-4,5-dihydrooxazoline-η4-(1,5-
cyclooctadiene) iridium(I) tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate (80) 
The reaction was performed according to general procedure 7 from ligand 68 (40 mg, 140 
µmol), [Ir(cod)Cl]2 (44 mg, 65 µmol) and NaBArF (149 mg, 168 µmol) in dichloromethane (3 
mL). Column chromatography with diethyl ether and dichloromethane (gradient mixture) 
afforded the product (188 mg, 80%). Single crystals could be obtained from dichloromethane 
/hexane. 
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C56H56BF24IrNOP (1449.01) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 1.00 (s, 9H, 1), 1.31 (d, 3JHP = 14.5 Hz, 9H, 8), 
1.43 (d, 3JHP = 14.3 Hz, 9H, 8’), 1.45 (m, 2×1H, cod, 15/12), 1.93 (m, 1H, cod, 15), 2.00 (m, 
1H, cod, 11), 2.11 (m, 1H, cod, 12), 2.22 (m, 1H, cod, 11), 2.41 (m, 2H, cod, 16), 2.58 (ddd, 
2JHH = 19.5 Hz, 2JHP = 5.5 Hz, 1.5 Hz, 1H, 6), 3.36 (dd, 2JHH = 19.5 Hz, 2JHP = 8.5 Hz, 1H, 6), 
3.67 (dt, 3JHH = 8.2 Hz, 1.8 Hz, 1H, 3), 3.97 (m, 1H, cod, 14), 4.30 (m, 1H, cod, 9), 4.47 (dd, 
2JHH = 9.8 Hz, 3JHH = 8.3 Hz, 1H, 4), 4.82 (dd, 2JHH = 9.8 Hz, 3JHH = 2.1 Hz, 1H, 4), 4.82 (m, 
1H, cod, 13), 4.99 (tbr, 1H, cod, 10), 7.56 (s, 4H, 20), 7.72 (t, 8H, 22). 13C{1H} NMR (125.8 
MHz, CD2Cl2, 300K): δ = 22.5 (d, 2JCP = 25.0 Hz, 6), 24.7 (15), 25.8 (1), 29.1 (12), 29.7 (d, 
2JCP = 3.5 Hz, 8), 30.1 (d, 2JCP = 5.0 Hz, 8), 33.8 (11), 35.4 (d, 1JCP = 21.2 Hz, 7), 35.6 (2), 
37.6 (16), 37.9 (d, 1JCP = 15.3 Hz, 7), 57.8 (14), 68.9 (13), 70.2 (3), 75.5 (4), 80.4 (d, 2JCP = 
16.6 Hz, 9), 91.6 (d, 2JCP = 6.1 Hz, 10), 117.8 (q, 3JCF = 4 Hz, 20), 125.0 (q, 1JCF = 270 Hz, 
21), 129.2 (q, 2JCF = 25.7 Hz 19), 135.1 (s, 18), 162.1 (q, 1JCB = 50 Hz, 17), 184.7 (d, 2JCP = 
16.4Hz, 5). 31P{1H} NMR (202.5 MHz, CD2Cl2, 300K): δ = 42.8. IR (KBr): ν~ [cm-1] = 
3446.3mbr, 2968.1m, 2889.5w, 1602.2m, 1474.5w, 1355.1s, 1277.4s, 1161.4s, 1124.7s, 
997.5w, 938.1w, 928.1w, 899.8w, 887.3m, 838.3w, 745.1w, 716.0m, 682.2m, 668.8m, 
581.0w, 453.4w. MS (+ESI) m/z: 587.3 (M+, 23.2), 586.3 (M+, 100), 584.3 (M+, 60.2). m.p. 
228-230°C. [ ]20Dα : +82° (c = 0.1, CHCl3). EA %found (calcd): C: 46.32 (46.42), H: 3.90 
(3.73), N: 0.97 (1.08), O: 1.10 (1.32). 
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(S)-2-[(Di-tert-butyl-phosphanyl)-methyl]-4-neo-pentyl)-4,5-dihydrooxazole-η4-(1,5-
cyclooctadiene) iridium(I) tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate (81) 
The reaction was performed according to general procedure 7 from ligand 69 (118 mg, 394 
µmol), [Ir(cod)Cl]2 (127 mg, 190 µmol) and NaBArF (452 mg, 510 µmol) in dichloromethane 
(5 mL). Column chromatography with diethyl ether and dichloromethane (gradient mixture) 
afforded the product (458 mg, 83%). 
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C57H58BF24IrNOP (1463.04) 
1H NMR (500.1 MHz, CD2Cl2, 300K) δ: 0.96 (s, 9H, 7), 1.31 (d, 3JHP = 14.5 Hz, 9H, 9), 1.35 
(d , 3JHP = 14.5 Hz, 9H, 9’), 1.49 (dd, 2JHH = 14.1 Hz, 3JHH = 11.3 Hz, 1H, 5), 1.52-1.59 (m, 
2H, 13/16), 1.59 (d, 2JHH = 14.1 Hz, 1H, 5), 2.00 (m, 1H, 16), 2.13 (m, 2H, 12/13), 2.71 (m, 
1H, 12), 2.42 (m, 2H, 17), 2.57 (ddd, 2JHH = 18.9 Hz, 2JHP = 5.3 Hz, 1.8 Hz, 1), 3.16 (dd, 2JHH 
= 18.9 Hz, 2JHP = 11.3 Hz, 1H, 1), 3.99 (m, 2H, 14/4), 4.59 (t, 2/3JHH = 9.2 Hz, 1H, 3), 4.59 
(m, 2H, 10/15), 4.65 (dd, 2JHH = 9.2 Hz, 3JHH = 8.3 Hz, 1H, 3), 4.86 (m, 1H, 11), 7.56 (s, 4H, 
20), 7.72 (t, 8H, 22). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K) δ: 22.6 (d, 1JCP = 24.8 Hz, 
1), 26.3 (d, 3JCP = 2. 0 Hz, 16), 29.3 (d, 2JCP = 3.7 Hz, 9’), 29.9 (d, 3JCP = 1.6 Hz, 13), 30.0 (7), 
30.1 (d, 2JCP = 3.2 Hz, 9), 30.9 (6), 32.2 (d, 3JCP = 1.4 Hz, 12), 35.2 (d, 1JCP = 20.3 Hz, 8’), 
36.0 (d, 3JCP = 3.9 Hz, 17), 39.6 (d, 1JCP = 16.3 Hz, 8), 49.1 (5), 60.8 (14), 62.5 (4), 65.4 (15), 
78.8 (3), 84.2 (d, 2JCP = 13.0 Hz, 10), 91.3 (d, 2JCP = 11.4 Hz, 11), 117.8 (q, 3JCF = 4 Hz, 21), 
125.0 (q, 1JCF = 270 Hz, 22), 129.2 (q, 2JCF = 25.7 Hz 20), 135.1 (s, 19), 162.1 (q, 1JCB = 50 
Hz, 18), 185.3 (d, 2JCP = 15.3 Hz, 2). 31P{1H} NMR (162 MHz, CD2Cl2, 300K) δ: 49.7. MS 
(+ESI) m/z : 601.4 (M+, 25.1), 600.4 (M+, 100), 599.5 (M+, 14.1), 598.5 (M+, 59.3). 
IR (KBr): ν~ [cm-1] = 3421mbr, 2968m, 1611m, 1476w, 1423w, 1357s, 1279s, 1129s, 1004w, 
950w, 889m, 839w, 745w, 714m, 675m. m.p. 128-129°C. [ ]20Dα : +45° (c = 0.13, CHCl3). EA 
%found (calcd) C: 46.89 (46.80), H: 3.99 (4.00), N: 1.20 (0.96). 
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(R)-2-[(Di-tert-butyl-phosphanyl)-methyl]-4-phenyl)-4,5-dihydrooxazoline -η4-(1,5-cyclo-
octadiene) iridium(I) tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate (82) 
The reaction was performed according to general procedure 7 from ligand 70 (68 mg, 222 
µmol), [Ir(cod)Cl]2 (74.3 mg, 110 µmol) and NaBArF (252 mg, 290 µmol) in dichloromethane 
(3 mL). Column chromatography with diethyl ether and dichloromethane (gradient mixture) 
afforded the product (256 mg, 79%). Single crystals could be obtained from dichloromethane 
/hexane. 
Ir
13 14
1512
18 17
1611
B
19
20
21
22
F3C CF3
CF3
CF3
CF3F3C
2
F3C
F3C
P
1 2
9
10
N
4
3
O
5
8
7
6
 
C58H52BF24IrNOP (1469.01) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 1.37 (d, 3JHP = 14.4 Hz, 9H, 10), 1.41 (d, 3JHP = 
14.3 Hz, 9H, 10’), 1.6 (m, 2×1H, cod), 1.67 (m, 1H, cod), 1.9 (m, 1H, cod), 2.02 (m, 1H, 
cod), 2.09 (m, 1H, 18), 2.14 (m, 1H, cod), 2.2 (m, 1H, cod), 2.82 (ddd, 2JHH = 19.0 Hz, 2JHP = 
7 Hz, 2 Hz, 1H, 1), 3.18 (dd, 2JHH = 18.9 Hz, 2JHP = 8.5 Hz, 1H, 1), 3.97 (m, 1H, 11), 4.21 (m, 
1H, 15), 4.30 (m, 1H, 16), 4.57 (dd, 2JHH = 9.3 Hz, 3JHH = 6.1 Hz, 1H, 3), 4.78 (m, 1H, 12), 
5.03 (pst, 2JHH = 9.4 Hz, 3JHH = 10.1 Hz, 1H, 3), 5.26 (ddd, 1H, 4), 7.15 (m, 2H, 6), 7.44 (m, 
3H, 7/8), 7.56 (s, 4H, 22), 7.72 (t, 8H, 20). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 
22.8 (d, 2JCP = 24.1 Hz, 1), 28.5 (17), 29.6 (14), 30.1 (d, 2JCP = 3.8 Hz, 10), 30.4 (d, 2JCP = 3.8 
Hz, 10), 31.4 (cod 13), 33.7 (18), 37.1 (d, 1JCP = 19.2 Hz, 9’), 38.4 (d, 1JCP = 18.4 Hz, 9), 62.9 
(15), 63.1 (16), 68.5 (4), 81.1 (3), 88.8 (d, 2JCP = 11 Hz, 11), 89.7 (d, 2JCP = 11 Hz, 12), 117.8 
(d, 4JCB = 3.8 Hz, 22), 125.0 (q, 1JCF = 273 Hz, 23), 126.6 (6), 129.2 (d, 2JCF = 32 Hz, 21) 
130.0 (8), 130.1 (7), 135.1 (20), 138.5 (5), 162.1 (q, 1JCB = 49.5 Hz, 19), 188.3 (2). 31P{1H} 
NMR (162 MHz, CD2Cl2, 300K): δ = 44.7. MS (+ESI) m/z: 607.35 (M+, 26.5), 606.18 (M+, 
100), 604.25 (M+, 59.8). IR (KBr): ν~ [cm-1] = 3426.6mbr, 2973.5m, 2361.1w, 1605.3m, 
1475.5w, 1421.7w, 1356.6s, 1278.0s, 1130.0s, 1004.1w, 941.6w, 888.8m, 836.7w, 765.4w, 
743.5w, 711.0m, 673.7m. m.p. 150°C. [ ]20Dα : -54° (c = 0.1, CHCl3). EA %found (calcd): C: 
47.28 (47.42), H: 3.38 (3.57), N: 1.05 (0.95). 
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(S)-2-[(Di-tert-butyl-phosphanyl)-methyl]-4-iso-propyl)-4,5-dihydrooxazole-η4-(1,5-
cyclooctadiene) iridium(I) tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate (83) 
The reaction was performed according to general procedure 7 from ligand 71 (181 mg, 608 
µmol), [Ir(cod)Cl]2 (201 mg, 300 µmol) and NaBArF (700 mg, 790 µmol) in dichloromethane 
(8 mL). Column chromatography with diethyl ether and dichloromethane (gradient mixture) 
afforded the product (827 mg, 96%). Single crystals could be obtained from dichloromethane 
/hexane. 
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C55H54BF24IrNOP (1434.99) 
1H NMR (400.1 MHz, CD2C2, 300K) δ = 0.78 (d, 3JHH = 6.6 Hz, 3H, 1), 0.96 (d, 3JHH = 7.1 
Hz, 3H, 1’), 1.33 (d, 3JHP = 14.4 Hz, 3H, 8), 1.37 (d, 3JHP = 14.4 Hz, 3H, 8’), 1.60 (m, 2H, 
16/11), 2.01 (m, 3H, 2/15/16), 2.1-2.3 (m, 3H, 15/11/12), 2.3-2.45 (m, 1H, 12), 2.64 (ddd, 
2JHH = 19.2 Hz, 2JHP = 1.8 Hz , 6.3 Hz, 6), 3.10 (dd, 2JHH = 19.2 Hz, 2JHP = 8.6 Hz, 6), 3.92 
(m, 1H, 3), 4.12 (m, 1H, 14), 4.49 (pst, 2JHH = 9.6 Hz, 3JHH = 9.3 Hz, 4), 4.50 (m, 1H, 9), 4.60 
(m, 1H, 13), 4.71 (dd, 2JHH = 9.6 Hz, 3JHH = 3.5 Hz, 4), 4.86 (m, 1H, 10), 7.56 (s, 4H, 20), 
7.72 (pst, 8H, 18). 13C{1H} NMR (125.8 MHz, CD2C2, 300K) δ = 14.6 (1), 19.4 (1’), 22.5 (d, 
1JCP = 24.7 Hz, 6), 26.9 (psd, 16/16’), 29.6 (d, 2JCP = 3.8 Hz, 8), 30.0 (d, 2JCP = 4.5 Hz, 8’), 
30.3 (psd, 11/11’), 31.9 (2), 32.2 (psd, 15/15’), 35.8 (psd, 12/12’), 36.4 (d, 1JCP = 19.9 Hz, 7), 
38.4 (d, 1JCP = 16.8 Hz, 7’), 61.5 (14), 66.2 (13), 68.3 (3), 73.5 (4), 82.1 (d, 2JCP = 13.5 Hz, 9), 
91.1 (d, 2JCP = 9.1 Hz, 10), 117.8 (q, 3JCF = 4 Hz, 20), 125.0 (q, 1JCF = 270 Hz, 21), 129.2 (q, 
2JCF = 25.7 Hz 19), 135.1 (s, 18), 162.1 (q, 1JCB = 50 Hz, 17), nd. 31P{1H} NMR (162 MHz, 
CD2C2, 300K) δ = 45.3. +ESI, m/e : 573.4 (M+, 21.8), 572.4 (M+, 100), 571.4 (M+, 14.7), 
570.4 (M+, 59.8). IR (KBr): ν~ [cm-1] = 3426mbr, 2969m, 1611m, 1476w, 1423w, 1358s, 
1281s, 1164s, 1128s, 1004w, 938w, 889m, 837w, 746w, 714w, 675m. m.p. 188-190°C. [ ]20Dα : 
+49° (c = 0.2 in CHCl3). EA %found (calcd): C: 45.91 (46.04), H: 3.74 (3.79), N: 1.16 (0.98) 
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(S)-2-[(Di-cyclohexyl-phosphanyl)-methyl]-4-tert-butyl)-4,5-dihydrooxazole-η4-(1,5-
cyclooctadiene) iridium(I) tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate (84) 
The reaction was performed according to general procedure 7 from ligand 72 (140 mg, 398 
µmol), [Ir(cod)Cl]2 (121 mg, 180 µmol) and NaBArF (445 mg, 500 µmol) in dichloromethane 
(5 mL). Column chromatography with diethyl ether and dichloromethane (gradient mixture) 
afforded the product (428 mg, 78%). 
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C60H60BF24IrNOP (1501.09) 
1H NMR (500.1 MHz, CD2Cl2, 300K) δ = 0.98 (s, 9H, 6), 1.25-1.39 (m, 10H, Cyeq), 1.50-
1.59 (m, 2H, coda,b), 1.64 (mbr, 1H, Cyeq), 1.77-1.95 (m, 9H, Cyax), 1.96-2.11 (m, 3H, coda,c,b), 
2.11-2.18 (m, 2H, 7), 2.19 (m, 1H, codc), 2.34 (mbr, 1H, Cyax), 2.40 (m, 2H, codd), 2.67 (ddd, 
2JHP = 6.0 Hz, 2JHH = 19.6 Hz, 4JHH = 1.4 Hz, 1H, 1), 3.12 (dd, 2JHP = 9.2 Hz, 2JHH = 19.5 Hz, 
1H, 1) 3.44 (m, 1H, 15), 3.64 (d, = 8.1 Hz, 1H, 4), 4.36 (m, 1H, 11), 4.46 (dd, 3JHH = 8.3, 2JHH 
= 9.8 Hz, 1H, 3), 4.61 (m, 1H, 16), 4.80, (dd, 3JHH = 2.1, 2JHH = 9.8 Hz, 1H, 3), 5.10 (mbr, 1H, 
12), 7.56 (s, 4H, 22), 7.72 (s, 8H, 20). 13C{1H} NMR (100.8 MHz, CD2Cl2, 300K) δ = 21.3 
(1JCP = 28.2 Hz, 1), 24.9 (d, coda), 25.6 (6), 25.9 (Cy), 26.2 (Cy), 26.5-26.7 (dd, 2×CH2), 26.9 
(Cy), 27.0 (d, Cy), 27.4 (d, Cy), 28.1 (Cy), 28.4 (Cy), 29.4 (codb), 30.8 (d, 1JCP = 29.4 Hz, 7), 
30.9 (Cy), 33.6 (codc), 35.2 (5), 35.6 (d 1JCP = 24.5 Hz, 7’), 37.6 (d, 3JCP = 4.2 Hz, codd), 58.0 
(15), 66.1 (16), 70.8 (4), 75.3 (3), 84.2 (d, 2JCP = 15.5 Hz, 11), 94.7 (d, 2JCP = 7.7 Hz, 12), 
117.8 (t, 3JCF = 4 Hz, 22), 124.9 (q, 1JCF = 270 Hz, 23), 129.2 (qq, 2JCF = 28.8 Hz, 3JBC = 3 
Hz, 21), 135.2 (20), 162.1 (q, 1JBC = 50 Hz, 19), 186.2 (d, 2JCP = 17.2 Hz, 2). 31P{1H} NMR 
(202.5 MHz, CD2Cl2, 300K) δ = 25.3. MS (+ESI) m/z: 639.4 (M+, 28.2), 638.4 (M+, 100), 
637.4 (M+, 22.5), 636.4 (M+, 51.1). IR (KBr): ν~ [cm-1] = 3426br, 2940m, 2863w, 1590m, 
1451w, 1356s, 1277s, 1130s, 997w, 930w, 889m, 837w, 745w, 713w, 675m. m.p. 94°C. 
[ ]20Dα : +54° (c = 0.18, CHCl3). 
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(S)-2-[(Di-cyclohexyl-phosphanyl)-methyl]-4-neopentyl)-4,5-dihydrooxazole-η4-(1,5-
cyclooctadiene) iridium(I) tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate (85) 
The reaction was performed according to general procedure 7 from ligand 73 (155 mg, 441 
µmol), [Ir(cod)Cl]2 (142 mg, 210 µmol) and NaBArF (501 mg, 570 µmol) in dichloromethane 
(5 mL). Column chromatography with diethyl ether and dichloromethane (gradient mixture) 
afforded the product (452 mg, 67%). 
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C61H62BF24IrNOP (1515.11) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 0.96 (s, 9H, 7), 1.29 (m, 1H, coda/9H, Cy), 1.52 
(m, 1H, coda/2H, 5), 1.65 (m, 2H, codb/Cy), 1.78 (m, 3H, Cy), 1.88 (m, 5H, Cy), 2.11-2.18 
(m, 2H, codb,c/1H, 8/2H, Cy), 2.19-2.3 (m, 2H, codc/8), 2.37 (m, 2H, codd), 2.69 (ddd, 2JHH = 
19.0 Hz, 2JHP = 16.6 Hz, 4JHH = 2.0 Hz, 1H, 1), 2.95 (dd, 2JHH = 19.0 Hz, 2JHP = 9.6 Hz, 1H, 
1), 3.65 (m, 1H, 16), 3.97 (m, 1H, 4), 4.31 (m, 1H, 17), 4.60 (pst, 2JHH = 9.1 Hz, 3JHH = 8.3 
Hz, 1H, 3), 4.62-4.68 (m, 2H, 3/12), 4.99 (m, 1H, 13), 7.57 (s, 4H, 23), 7.72 (pst, 3JHB = 2 Hz, 
8H, 21). 13C{1H} NMR (100.8 MHz, CD2Cl2, 300K): δ = 21.7 (d, 1JCP = 27.6 Hz, 1), 26.1 
(Cy), 26.2 (Cy), 26.7-27.0 (Cy), 27.7 (Cy), 28.5 (Cy), 29.1 (Cy), 29.7 (coda), 30.0 (7), 30.2 
(codb), 30.9 (Cy), 31.4 (d, 1JCP = 28.0 Hz, 8), 32.1 (codc), 36.0 (codd), 36.9 (d, 1JCP = 25.7 Hz, 
8’), 49.4 (5), 60.5 (16), 61.4 (4), 63.4 (17), 79.0 (3), 87.4 (d, 2JCP = 13.0 Hz, 12), 94.4 (d, 2JCP 
= 9.6 Hz, 13), 117.8 (t, 3JCF = 4 Hz, 23), 125.0 (q, 1JCF = 270 Hz, 24), 129.2 (qq, 2JCF = 28.8 
Hz, 3JBC = 3 Hz, 22), 135.2 (21), 162.1 (q, 1JBC = 50 Hz, 20), 185.5 (d, 2JCP = 16.9 Hz, 2). 
31P{1H} NMR (202.5 MHz, CD2Cl2, 300K): δ = 28.9. MS (+ESI) m/z: 653.5 (M+, 28.8), 
652.5 (M+, 100), 651.6 (M+, 15.2), 650.7 (M+, 58.2). IR (KBr): ν~ [cm-1] = 3426mbr, 2942m, 
2863w, 1604m, 1476w, 1451w, 1424w, 1357s, 1279s, 1126s, 1004w, 950w, 889m, 839w, 
744w, 713m, 676m. m.p. 72°C. [ ]20Dα : +50° (c = 0.13, CHCl3). EA % found (calcd): C: 48.31 
(48.36), H: 4.10 (4.12), N: 1.14 (0.92). 
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(R)-2-[(Di-cyclohexyl-phosphanyl)-methyl]-4-phenyl)-4,5-dihydrooxazoline-η4-(1,5-
cyclooctadiene) iridium(I) tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate (86) 
The reaction was performed according to general procedure 7 from ligand 74 (70 mg, 196 
µmol), [Ir(cod)Cl]2 (64 mg,95 µmol) and NaBArF (226 mg,255 µmol) in dichloromethane (4 
mL). Column chromatography with diethyl ether and dichloromethane (gradient mixture) 
afforded the product (232 mg, 80%). 
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C62H56BF24IrNOP (1521.08) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 1.14-1.48 (m, 11H, Cy/15), 1.56 (m, 1H, 15), 1.67 
(m, 1H, 16), 1.71-1.85 (m, 5H, Cy), 1.86-1.99 (m, 6H, Cy/20), 2.04-2.1 (m, 3H, 16/16’/19), 
2.16-2.25 (m, 4H, 9/9’/19’/20), 2.82 (dd, 2JHP = 7.6 Hz 2JHH = 19.7 Hz, 1H, 1), 3.06 (dd, 2JHP 
= 8.6 Hz, 2JHH = 19.2 Hz, 1H, 1), 3.83 (m, 1H, 18), 3.93 (m, 1H, 14), 4.0 (m, 1H, 17), 4.55 
(dd, 2JHH = 9.3 Hz, 3JHH = 7.1, 1H, 3), 4.88 (m, 1H, 13), 5.02, (pst, 2JHH = 9.4, 3JHH = 10.1 Hz, 
1H, 3), 5.23 (m, 1H, 4), 7.14 (s, 2H, Ph), 7.43 (m, 3H, Ph), 7.56 (s, 4H, 24), 7.72 (pst, 8H, 
22). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 21.6 (1JCP = 27.3 Hz, 1), 26.0-28.2 (Cy), 
28.4 (15), 29.1 (Cy), 30.7 (20), 31.2 (d, 3JCP = 2.4 Hz, 16), 33.1 (d, 1JCP = 27.7 Hz, 9), 34.5 (d, 
3JCP = 3.5 Hz, 19), 35.5 (d, 1JCP = 27 Hz, 9’), 60.8 (18), 61.4 (17), 68.2 (4), 81.1 (3), 92.2 (d, 
2JCP = 11.4 Hz, 14), 93.6 (d, 2JCP = 10.7 Hz, 13), 117.8 (d, 4JCB = 3.8 Hz, 24), 124.9 (q, 1JCF = 
273 Hz, 25), 126.3 (6), 129.1 (q, 2JCF = 32 Hz, 23) 130.0 (7/8), 135.2 (22), 138.7 (5), 162.1 (q, 
1JCB = 49.5 Hz, 21), 188.1 (d, 2JCP = 17.3 Hz, 2). 31P{1H} NMR (202.5 MHz, CD2Cl2, 300K): 
δ = 26.2. MS (+ESI) m/z: 659.3 (M+, 29.2), 658.3 (M+, 100), 657.3 (M+, 19.8), 656.3 (M+, 
62.4). m.p. 116-118°C. [ ]20Dα : -37° (c = 0.102, CHCl3).  
(S)-2-[(Di-cyclohexyl-phosphanyl)-methyl]-4-isopropyl)-4,5-dihydrooxazoline-η4-(1,5-
cyclooctadiene) iridium(I) tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate (87) 
The reaction was performed according to general procedure 7 from ligand 75 (116 mg, 359 
µmol), [Ir(cod)Cl]2 (117 mg, 175 µmol) and NaBArF (404 mg, 467 µmol) in dichloromethane 
(10 mL). Column chromatography with diethyl ether and dichloromethane (gradient mixture) 
afforded the product (410mg, 78%). 
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C59H58BF24IrNOP (1487.06) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 0.77 (d, 3JHH = 6.8 Hz, 3H, 6), 0.95 (d, 3JHH = 7.1 
Hz, 3H, 6), 1.2-1.41 (m, 1H, codb/11H, Cy), 1.59-1.69 (m, 1H, codb/ 2H, Cy), 1.72-1.82 (m, 
3H, Cy), 1.84-1.97 (m, 3H, Cy, 1H coda), 2.01 (m, 1H, 5), 1.97-2.12 (m, 1H, codc/2H, Cy), 
2.12 -2.3 (m, 3H, coda,c,d /1H, 7), 2.31-2.42 (m, 2H, codd/7’), 2.67 (ddd, 2JHH = 19.3 Hz, 2JHP 
= 17.5 Hz, 5JHH = 1.8 Hz, 1H, 1), 2.95 (dd, 2JHH = 19.3 Hz, 2JHP = 9.1 Hz, 1H, 1), 3.69 (m, 
1H, 15), 3.94 (m, 1H, 4), 4.33 (m, 1H, 16), 4.48 (pst, 2JHH = 9.4 Hz, 3JHH = 9.4 Hz, 1H, 3), 
4.60 (m, 1H, 11), 4.68 (dd, 2JHH = 9.6 Hz, 3JHH = 3.7 Hz, 1H, 3), 5.00 (m, 1H, 12), 7.56 (s, 
4H, 22), 7.72 (pst, 3JHB = 2 Hz, 8H, 20). 13C{1H} NMR (100.8 MHz, CD2Cl2, 300K): δ = 14.2 
(6), 19.0 (6), 21.3 (d, 1JCP = 27.9 Hz, 1), 26.1 (Cy), 26.5-27 (Cy), 27.8 (Cy), 28.5 (coda), 28.7 
(Cy), 29.6 (codb), 30.3 (d, Cy), 32.0 (5), 32.2 (codc), 32.3 (d, 1JCP = 28.3 Hz, 7), 36.1 (d, 1JCP 
= 26 Hz, 7’), 36.1 (d, 3JCP = 3.7 Hz, codd), 60.1 (15), 63.9 (16), 68.6 (4), 73.4 (3), 86.9 (d, 2JCP 
= 13.5 Hz, 11), 94.7 (d, 2JCP = 9.4 Hz, 12), 117.8 (t, 3JCF = 4 Hz, 22), 125 (q, 1JCF = 270 Hz, 
23), 129.2 (qq, 2JCF = 28.8 Hz, 3JBC = 3 Hz, 21), 135.2 (20), 162.1 (q, 1JBC = 50 Hz, 19), 186.2 
(d, 2JCP = 17.6 Hz, 2). 31P{1H} NMR (CD2Cl2, 162 MHz, 300K): δ = 26.5. MS (+ESI) m/z: 
625.3 (M+, 27.6), 624.3 (M+, 100), 623.3 (M+, 15.8), 622.3 (M+, 58.6). IR (KBr): ν~ [cm-1] = 
3448mbr, 2941m, 2862w, 1600m, 1452w, 1421w, 1356s, 1278s, 1129s, 1004w, 939w, 889m, 
838w, 743w, 713m, 674m. m.p. 128-129°C. [ ]20Dα : +45° (c = 0.1, CHCl3).  
(S)-2-[(Diphenyl-phosphanyl)-methyl]-4-tert-butyl)-4,5-dihydrooxazole-η4-(1,5-
cyclooctadiene) iridium(I) tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate (88) 
The reaction was performed according to general procedure 7 from ligand 76 (96 mg, 294 
µmol), [Ir(cod)Cl]2 (97 mg, 145 µmol) and NaBArF (335 mg, 382 µmol) in dichloromethane 
(5 mL). Column chromatography with diethyl ether and dichloromethane (gradient mixture) 
afforded the product (278 mg, 77%). Single crystals could be obtained from dichloro-
methane/hexane. 
Experimental 
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C60H48BF24IrNOP (1488.99) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 0.73 (s, 9H, 1), 1.53 (m, 1H, 17), 1.73 (m, 1H, 
13), 1.96 (m, 1H, 17), 2.11 (m, 1H, 13), 2.25 (m, 1H, 18), 2.35 (m, 1H, 18), 2.47 (m, 1H, 14), 
2.55 (m, 1H, 14), 2.92 (m, 1H, 16), 3.57 (ddd, 2JHH = 18.7 Hz, 2JHP = 1.7 Hz , 5.0 Hz, 1H, 6), 
3.73 (d, 3JHH = 7.6 Hz, 1H, 3), 3.96 (dd, 2JHH = 18.7 Hz, 2JHP = 11.6 Hz , 1H, 6), 4.21 (m, 1H, 
15), 4.51 (dd, 2JHH = 8.6 Hz, 3JHH = 9.8 Hz, 1H, 4), 4.76 (dd, 2JHH = 8.6 Hz, 3JHH = 1.5 Hz, 
1H, 4), 4.87 (m, 1H, 12), 5.23 (m, 1H, 11), 7.31-7.36 (m, 2H, 8a), 7.51-7.57 (m, 2H, 8b / 1H, 
10c), 7.56 (s, 4H, 22), 7.59-7.62 (m, 2H, 9d), 7.64-7.67 (m, 1H, 10e), 7.72 (pst, 8H, 20), 7.79-
7.84 (m, 2H, 9f). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 25.1 (1), 26.2 (d, 3JCP = 2.6 
Hz, 13), 29.3 (d, 4JCP = 2.0 Hz, 17), 31.5 (d, 1JCP = 34.2 Hz, 6), 33.1 (18), 34.9 (2), 36.6 (d, 
4JCP = 4.7 Hz, 14), 63.2 (15), 64.1 (16), 71.7 (3), 75.1 (4), 89.3 (d, 2JCP = 15.2 Hz, 12), 97.4 
(d, 2JCP =  9.3 Hz, 11), 117.8 (q, 3JCF = 4 Hz, 22), 125.0 (d, 1JCP = 56.4 Hz, 7), 125.0 (q, 1JCF = 
270 Hz, 23), 129.0 (d, 1JCP = 56.4 Hz, 7’), 129.2 (q, 2JCF = 25.7 Hz 21), 130.0 (d, 2JCP = 11.1 
Hz, 8b), 130.2 (d, 3JCP =11.2 Hz, 9d), 131.6 (d, 2JCP = 10.9 Hz, 8a), 132.6 (d, 4JCP = 2.6 Hz, 
10c), 133.8 (d, 4JCP = 2.3 Hz, 10e), 135.2 (s, 20), 135.8 (d, 3JCP = 24 Hz, 9f), 162.1 (q, 1JCB = 
50 Hz, 19), 180.3 (5). 31P{1H} NMR (162 MHz, CD2Cl2, 300K): δ = 28.5. MS (+ESI) m/z: 
626.3 (100.0), 624.5 (77.8), 627.3 (28.3), 625.4 (24.0), 628.4 (4.5). IR (KBr): ν~ [cm-1] = 
3427mbr, 2969w, 2891sh, 240w, 2366w, 1601m, 1481w, 1434w, 1357s, 1279s, 1132s, 997w, 
930w, 890m, 837m, 747w, 713m, 675m. m.p. 150-151°C. [ ]20Dα : +16° (c = 0.22, CHCl3). EA 
% found (calcd): C: 48.24 (48.40), H: 3.14 (3.25), N: 1.15 (0.94). 
(S)-2-[(Diphenyl-phosphanyl)-methyl]-4-neopentyl)-4,5-dihydrooxazole-η4-(1,5-
cyclooctadiene) iridium(I) tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate (89) 
The reaction was performed according to general procedure 7 from ligand 77 (80 mg, 240 
µmol), [Ir(cod)Cl]2 (75 mg, 111 µmol) and NaBArF (266 mg, 300 µmol) in dichloromethane 
(3 mL). Column chromatography with diethyl ether and dichloromethane (gradient mixture) 
afforded the product (216 mg, 65%). 
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C61H50BF24IrNOP (1503.02) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 0.96 (s, 9H, 1), 1.42 (dd, 2JHH = 14.2 Hz, 3JHH = 
11.3 Hz, 1H, 3), 1.57 (m, 1H, 15), 1.64 (d, 2JHH = 14.1 Hz, 1H, 3), 1.78 (m, 1H, 19), 1.96 (m, 
1H, 15), 2.20 (m, 1H, 19), 2.30 (m, 1H, 14), 2.35 (m, 1H, 14), 2.41 (m, 1H, 18), 2.49 (m, 1H, 
18), 3.00 (m, 1H, 16), 3.48 (ddd, 2JHP = 18.4 Hz, 2JHH = 7.0 Hz, 4JHH = 2.0 Hz, 1H, 7), 3.68 
(dd, 2JHP = 18.4 Hz, 2JHH = 11.3 Hz, 1H, 7), 3.93 (m, 1H, 17), 4.11 (m, 1H, 4), 4.56 (dd, 2JHH 
= 9.3 Hz, 3JHH = 4.1 Hz, 1H, 5), 4.69 (pst, 2JHH = 9.1 Hz, 3JHH = 9.0 Hz, 1H, 5), 5.12 (m, 1H, 
12), 5.19 (m, 1H, 13), 7.37-7.41 (m, 2H, 9a), 7.52-7.55 (m, 3H, 9b/10d), 7.56 (s, 4H, 23), 7.57 
(m, 2H, 11c), 7.65 (m, 1H, 11e), 7.72 (s, 8H, 21), 7.76-7.80 (m, 2H, 10f). 13C{1H} NMR 
(125.8 MHz, CD2Cl2, 300K): δ = 27.7 (d, 3JCP = 2.2 Hz, 19), 29.6 (15), 29.9 (1), 30.8 (2), 31.5 
(d, 1JCP = 32.8 Hz, 7), 32.3 (14), 35.5 (d, 3JCP = 4.4 Hz, 18), 50.1 (3), 61.8 (4), 62.5 (17), 64.6 
(16), 79.3 (5), 91.8 (d, 2JCP = 13.6 Hz, 12), 97.0 (d, 2JCP = 10.4 Hz, 13), 117.8 (q, 3JCF = 4 Hz, 
23), 125.0 (q, 1JCF = 270 Hz, 24), 125.1 (d, 1JCP = 51.6 Hz, 8), 129.1 (d, 1JCP = 51.6 Hz, 8’), 
129.2 (q, 2JCF = 25.7 Hz 22), 130.0 (d, 2JCP = 11.0 Hz, 9b), 130.2 (d, 3JCP =11.3 Hz, 10d), 
131.8 (d, 2JCP = 11.0 Hz, 9a), 132.6 (d, 4JCP = 2.5 Hz, 11c), 133.5 (d, 4JCP = 2.4 Hz, 11e), 135.2 
(s, 21), 135.3 (d, 3JCP = 13.3 Hz, 10f), 162.1 (q, 1JCB = 50 Hz, 20), 183.3 (d, 2JCP = 19.0 Hz, 
6). 31P{1H} NMR (202.5 MHz, CD2Cl2, 300K): δ = 24.1. MS (+ESI) m/z: 641.5 (M+, 29.5), 
640.5 (M+, 100), 639. 4 (M+, 18.1), 638.6 (M+, 60.0). IR (KBr): ν~ [cm-1] = 3426mbr, 2964m, 
1602m, 1477w, 1424w, 1357s, 1279s, 1127s, 1004w, 948w, 889m, 837w, 743w, 712m, 
677m, 529w, 487w, 449w. m.p. 70°C. [ ]20Dα : +8° (c = 0.11, CHCl3). EA % found (calcd): C 
48.56 (48.75), H 3.44 (3.35), N 1.14 (0.93). 
(S)-2-[(Diphenyl-phosphanyl)-methyl]-4-phenyl)-4,5-dihydrooxazole-η4-(1,5-
cyclooctadiene) iridium(I) tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate (90) 
The reaction was performed according to general procedure 7 from ligand 78 (120 mg, 346 
µmol), [Ir(cod)Cl]2 (113 mg, 168 µmol) and NaBArF (399 mg, 450 µmol) in dichloromethane 
(8 mL). Column chromatography with diethyl ether and dichloromethane (gradient mixture) 
afforded the product (148 mg, 29%). 
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C62H44BF24IrNOP (1508.98) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 1.59 (m, 2H, 19/15), 1.71 (m, 1H, 15), 1.99 (m, 
1H, 19), 2.15 (m, 3H, 16/20), 2.30 (m, 1H, 20), 3.12 (m, 1H, 18), 3.63 (m, 1H, 17), 3.63 (ddd, 
2JHH = 18.3 Hz, 2JHP = 8.0 Hz, 2.3 Hz, 1H, 1), 3.82 (dd, 2JHH = 18.3 Hz, 2JHP = 11.0 Hz, 1H, 
1), 4.28 (m, 1H, 13), 4.50 (dd, 3JHH = 6.7 Hz, 2JHH = 9.4 Hz, 1H, 3), 5.06 (dd, 3JHH = 10.3 Hz, 
2JHH = 9.4 Hz, 1H, 3), 5.12 (m, 1H, 14), 5.32 (m, 1H, 4), 7.05 (dd, 2H, 6), 7.38-7.41 (m, 3H, 
7/8), 7.44-7.48 (m, 2H, 10), 7.54-7.57 8 (m, 5H, 10-12), 7.56 (s, 4H, 24), 7.64 (m, 1H, 12), 
7.72 (pst, 8H, 22), 7.84 (m, 2H, 11). C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 28.6 (d, 
4JCP = 1.8 Hz, 15), 30.4 (d, 4JCP = 2.6 Hz, 19), 31.2 (d, 4JCP = 1.8 Hz, 20), 31.8 (d, 1JCP = 32.0 
Hz, 1), 34.2 (d, 4JCP = 4.1 Hz, 16), 61.7 (17), 64.6 (18), 68.3 (4), 81.1 (3), 95.6 (d, 2JCP = 12.2 
Hz, 13), 96.2 (d, 2JCP = 11.3 Hz, 14), 117.8 (q, 3JCF = 4 Hz, 24), 125.6 (d, 1JCP = Hz, ), 125.0 
(q, 1JCF = 270 Hz, 25), 126.5 (6), nd (9’), 129.2 (q, 2JCF = 25.7 Hz, 23), 130.0 (7), 130.0 (d, 
2JCP = 11.0 Hz, 10), 130.1 (8), 130.2 (d, 3JCP =11.3 Hz, 11), 130.4 (5), 132.1 (d, 2JCP = 11.2 
Hz, 10), 132.7 (d, 4JCP = 3.6 Hz, 12), 133.6 (d, 4JCP = 2.5 Hz, 12), 135.1 (s, 22), 135.3 (d, 3JCP 
=13.1 Hz, 11), 138.5 (), 162.1 (q, 1JCB = 50 Hz, 21), nd (2). 31P{1H} NMR (162 MHz, 
CD2Cl2, 300K): δ = 22.8. MS (+ESI) m/z: 647.4 (M+, 30.8), 646.4 (M+, 100), 645. 5 (M+, 
19.2), 644.5 (M+, 60.4). 
IR (KBr): ν~ [cm-1] = 3426mbr, 2890w, 1600m, 1478w, 1422w, 1357s, 1279s, 1126s, 968w, 
935w, 889m, 637w, 743w, 710m, 678m, 527w, 487w. m.p. 64°C. [ ]20Dα : +8° (c = 0.09, 
CHCl3). 
(S)-2-[(Diphenyl-phosphanyl)-methyl]-4-iso-propyl)-4,5-dihydrooxazole-η4-(1,5-
cyclooctadiene) iridium(I) tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate (91) 
The reaction was performed according to general procedure 7 from ligand 79 (111 mg, 356 
µmol), [Ir(cod)Cl]2 (117 mg, 175 µmol) and NaBArF (404 mg, 456 µmol) in dichloromethane 
(5 mL). Column chromatography with diethyl ether and dichloromethane (gradient mixture) 
afforded the product (336 mg, 65%). 
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C60H48BF24IrNOP (1474.97) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 0.40 (d, 3JHH = 6.8 Hz, 3H, 6), 0.90 (d, 3JHH = 6.9 
Hz, 3H, 6’), 1.59 (m, 1H, 17), 1.78 (m, 1H, 13), 1.96-2.01 (m, 1H, 17 & 1H, 5), 2.17-2.20 (m, 
1H, 13), 2.26-2.31 (m, 1H, 18), 2.34-2.40 (m, 1H, 18), 2.40-2.45 (m, 1H, 14), 2.51 (m, 1H, 
14), 3.02 (m, 1H, 16), 3.50 (ddd, 2JHH = 18.3 Hz, 2JHP = 6.8 Hz, 1.7 Hz, 1H, 6), 3.75 (dd, 2JHH 
= 18.5 Hz, 2JHP = 11.3 Hz, 1H, 6), 3.99 (m, 1H, 15), 4.06 (m, 1H, 4), 4.54 (pst, 3JHH = 9.5 Hz, 
2JHH = 9.6 Hz, 1H, 3), 4.64 (dd, 3JHH = 3.8 Hz, 2JHH = 9.9 Hz, 1H, 3), 5.01 (m, 1H, 12), 5.19 
(m, 1H, 11), 7.36-7.40 (m, 2H, 8), 7.51-7.60 (m, 5H, 8-10), 7.56 (s, 4H, 22), 7.64-7.66 (m, 
1H, 10), 7.72 (pst, 8H, 20), 7.80-7.84 (dd, 2H, 9). 13C{1H} NMR (125.8 MHz, CD2Cl2, 
300K): δ = 13.6 (6), 18.5 (6’), 27.6 (d, 3JCP = 2.2 Hz, 13), 29.6 (d, 4JCP = 2.2 Hz, 17), 31.4 (d, 
1JCP = 33 Hz, 1), 32.3 (18), 32.4 (5), 35.7 (d, 4JCP = 4.4 Hz, 14), 62.8 (15), 64.9 (16), 68.5 (4), 
73.5 (3), 91.2 (d, 2JCP = 13.7 Hz, 12), 97.3 (d, 2JCP = 10.3 Hz,11), 117.8 (q, 3JCF = 4 Hz, 22), 
125.2 (d, 1JCP = 53.6 Hz, 7), 125.0 (q, 1JCF = 270 Hz, 23), 129.1 (d, 1JCP = 51.6 Hz, 7’), 129.2 
(q, 2JCF = 25.7 Hz 21), 130.0 (d, 2JCP = 11.0 Hz, 8b), 130.2 (d, 3JCP =11.2 Hz, 9d), 131.7 (d, 
2JCP = 11.0 Hz, 8a), 132.6 (d, 4JCP = 2.6 Hz, 10c), 133.6 (d, 4JCP = 2.4 Hz, 10e), 135.2 (s, 20), 
135.5 (d, 3JCP = 13.4 Hz, 9f), 162.1 (q, 1JCB = 50 Hz, 19), 182.9 (d, 2JCP = 19.1 Hz, 2). 31P{1H} 
NMR (162 MHz, CD2Cl2, 300K): δ = 25.2. MS (+ESI) m/z: 612.4 (100.0), 610.4 (79.7), 
613.3 (37.7), 611.4 (30.3), 614.4 (5.1). IR (KBr): ν~ [cm-1] = 3426mbr, 2970w, 2842w, 1603m, 
1483w, 1431m, 1357s, 1278s, 1128s, 1005w, 938w, 889m, 637w, 742w, 712m, 675m. m.p. 
75-76°C. [ ]20Dα : +3 (c = 0.14, CH2Cl2). 
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7.4 Phosphinines as Ligands in Catalysis 
Crotonoyl chloride [10487-71-5], 2,4,6-triphenylpyrylium tetrafluoroborate 27 [448-61-3] 
were purchased from Fluka. 4-Hydroxy-methyl-pyrone 35 [675-10-5] and Dimethyl-gamma-
pyrone [1004-36-0] were purchased from Aldrich. 
Synthesis of 6-oxo-6H-pyran-2-carboxylic acid amides 111, 122, 123 
general procedure 9: 6-Oxo-6H-pyran-carboxylic acid (1 eq) and HOBt (1.2-1.6 eq) were 
dissolved in dichloromethane. EDC (1.2-1.6 eq) and amino alcohol (1 eq) were added and the 
mixture was stirred for 1 hour at room temperature. The mixture was then diluted with 
dichloromethane (20 mL) and water (30 mL) and extracted with 0.5M HCl (20 mL), 2.5% 
NaHCO3 (20 mL), water (20 mL), and brine (20 mL). Drying over Na2SO4 and evaporation of 
the volatiles gave the crude product. The products were purified by column chromatography. 
Synthesis of 6-oxo-6H-pyran-2-acid oxazolines 112, 124, 125 and [(4,5-dihydro-oxazol-2-
yl)methyl]-2H-pyran-2-ones 151, 152 
general procedure 10: To a 0.5 M solution of amide in THF was added of Burgess’ reagent 
(1.2 eq). The mixture was stirred for four hours at under reflux. After cooling to room 
temperature the solution was extracted with water (50 mL) and dichloromethane (50 mL). The 
layers were separated and the aqueous phase was washed with dichloromethane (3×50 mL). 
The combined organic layers were washed with brine (50 mL) and dried over MgSO4. The 
crude product was purified by column chromatography. 
Synthesis of 2E- and 2Z-2-(6-tert-butylphosphininoxide-2(1H)-ylidene)-oxazolinines 120, 
128, 129 
general procedure 11: 6-Oxo-6H-pyran-2-acid oxazoline (1 eq) and (2,2-dimethylpropy-
lidyne)phosphin (3 eq) were dissolved in toluene and heated to 140°C for 4 to 8 days. After 
cooling to room temperature a small amount of silica was added and all volatiles were 
removed. Column chromatography on silica afforded both isomers of the respective water-
adducts. 
Synthesis of 2-(6-tert-butylphosphinin-2-yl)-oxazolines 105, 126, 127 
general procedure 12: Wateradduct was dissolved in toluene (12-15 mL), and heated to reflux 
under argon. Water was removed by means of a Dean-Stark-trap. The product had to be 
handled under dry and inert atmosphere. 
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Synthesis of 6-Oxo-6H-pyran-2-carboxylic acetamides 149 and 150 
general procedure 13: Acid (1 eq) and HOBt (1.3 eq) were dissolved in dichloromethane and 
DMF. EDC (1.3 eq) and amino alcohol (1 eq) were added and the mixture was stirred 
overnight. Addition of 0.5 M HCl (20 mL) was followed by phase separation. The organic 
layer was then subsequently extracted with 2.5% NaHCO3 (20 mL), water (20 mL), and brine 
(20 mL) and dried over Na2SO4. Filtration and evaporation of the volatiles was followed by 
column chromatography on silica. 
Synthesis of Iridium-Complexes 133, 134 and 135 
general procedure 14: Phosphinineoxazoline (2eq) was dissolved in dichloromethane. Solid 
[Ir(cod)Cl]2 (1eq) added. The reaction mixture was heated to 48-50°C for two hours. In the 
glove-box water-free NaArF (2.6 eq) was added which resulted in a colorchange from deep-
red to almost black. The solution was stirred over night. The mixture was filtered over celite 
and dried under high-vacuum. Excess NaArF could only be removed by recrystallization. 
About 10 to 20% of side product were observed each time. 
Catalytic Hydrogenation at Elevated Pressure 
Hydrogenation with dihydrogen was performed according to general procedure 8.[57b] 
Transfer Hydrogenation 
The iridum catalyst (0.7 mg, 0.5 µmol) was dissolved in 2-propanol (10 mL) in a 25 mL 
Young- tube under argon. Then acetophenone (0.4 mmol) was added and the solution was 
degassed by three freeze-pump-thaw cycles before the flask was inserted into an oil-bath and 
stirred at 80°C. After 5 minutes the reaction was started by addition of a degassed solution of 
potassium methylate in dry 2-propanol (0.1 mL of 0.05 M). The reaction was finished after 15 
minutes. The analytical procedures were used as previously described.[61] 
Allylic Alkylation 
Allyic Alkylation with palladium[222], iridium[142] and rhodium[144] was performed as 
previously described. 
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7.4.1 Synthesis of Diene-Moiety 
6-(Trichlormethyl)-2H-pyran-2-one (109)[126] 
Crotonoyl chloride (1.18 g, 11.27 mmol) and trichloroacetic acid chloride (3.94 g, 21.7 mmol) 
were dissolved in dichloromethane (10 mL). At 0°C triethylamine (3.4 mL) in 
dichloromethane (10 mL) was slowly added. The darkbrown solution was left to stand for 20 
hours. Volatiles were removed under reduced pressure and the residue was diluted with 
diethyl ether (10 mL). After filtration and evaporation of the volatiles, the crude product was 
purified by Kugelrohr destillation (10-1 mbar, 200 °C) to yield a white solid (1.46 g, 61%). 
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C6H3Cl3O2 (213.45) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = (400 MHz, CDCl3): 6.43 (dd, 4JHH = 1 Hz, 3JHH = 
9.6 Hz, 1H, 2), 6.86 (dd, 4JHH = 1 Hz, 3JHH = 6.8 Hz, 1H, 4), 7.41 (dd, 3JHH = 6.8 Hz, 3JHH = 
9.6 Hz, 1H,3). 13C{1H} NMR (100.6 MHz, CDCl3, 300K): δ = 102.3 (2), 118.4 (4), 142.5(3), 
158.0 (1), 159.6 (5), 188.4 (8). MS (+FAB, 3-NBA), m/z: 211.9 (M+, 9.8), 177 (M+-Cl, 25.4), 
148.9 (M+-CO, 7.0), 95 (M+-CCl3, 100). IR (KBr): ν~ [cm-1] = 3118w, 1749s, 1632s, 1550s, 
1340m, 1331w, 1207m 1093s, 992s, 909s, 812s, 762s, 617s, 551m. m.p. 60°C (Lit 63-64°C). 
EA %found (calcd): C:33.76 (33.76), H: 1.39 (1.42), O: 15.12 (14.99). 
6-Oxo-6H-pyran-carboxylic acid (110)[126] 
6-(Trichlormethyl)-2H-pyran-2-one 109 (1g, 4.68 mmol) was dissolved in concentrated 
sulfuric acid (4 mL) and heated to 80°C for 4 hours. After cooling to room temperature the 
reaction mixture was carefully poured onto ice. The suspension was allowed to stand over 
night. The product was obtained by filtration. Extraction of the filtrate with ethyl acetate 
(3×40 mL) afforded the second crop. The product was obtained as an off-white solid (542 mg, 
83%). 
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C6H4O4 (140.09) 
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1H NMR (400.1 MHz, CDCl3, 300K): δ = (400 MHz, CDCl3): 6.59 (dd, 4JHH= 1 Hz, 3JHH = 
9.36 Hz, 1H, 2), 7.12 (dd, 4JHH= 1 Hz, 3JHH = 6.56 Hz, 1H, 4), 7.63 (dd, 3JHH = 6.56 Hz, 3JHH 
= 9.32 Hz, 1H, 3). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 110.8 (2), 120.8 (4), 
144.3 (3), 160.8 (1), 161.2 (5) quarternary carbon 6 missing. EA %found (calcd): C: 51.19 
(51.44), H: 3:00 (2.88). 
(S)-6-Oxo-6H-pyran-2-carboxylic-acid-(1-hydroxymethyl-2-methyl-propyl)-amide 
(111)[124] 
6-Oxo-6H-pyran-carboxylic acid 110 (240 mg, 1.71 mmol) was dissolved in benzene (4 mL) 
and DMF (2 drops). After the addition of thionyl chloride (0.5 mL, 6.86 mmol) the mixture 
was heated to reflux for 4 hours. All volatiles were removed, and the residue was dissolved in 
dichloromethane (4 mL). At 0°C a solution of L-valinol (176.6 mg, 1.71 mmol) in 
triethylamine (0.3 mL) and dichloromethane (5 mL) was added. After stirring at room 
temperature for 1 hour, the mixture was diluted with dichloromethane (40 mL) and washed 
with saturated NH4Cl solution (40 mL). After reextraction of the aqueous layer with 
dichloromethane (3×30 mL), the combined organic layers were washed with 1M HCl (40 mL) 
and saturated NaHCO3 (40 mL) solution and dried over Na2SO4. Evaporation of the volatiles 
afforded the crude product that was purified by column chromatography on silica eluting with 
ethyl acetate (2% ethanol). The product was obtained as a white solid (270 mg, 70%). 
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C11H15NO4 (225.24) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.98 (d, 3JHH = 6.84 Hz, 3H, 12), 1.01 (d, 3JHH = 
6.84 Hz, 3H, 12’), 1.98 (m, 1H, 11), 3.77 (m, 2H, 9), 3.89 (m, 1H, 8), 6.48 (dd, 4JHH = 1 Hz, 
3JHH = 9.32 Hz, 1H, 2), 7.00 (d, 3JHH = 8.08 Hz, 1H, 7), 7.13 (dd, 4JHH = 1 Hz, 3JHH = 6.8 Hz, 
1H, 4), 7.46 (dd, 3JHH = 6.56 Hz, 3JHH = 9.32 Hz, 1H, 3). 13C{1H} NMR (125.8 MHz, CDCl3, 
300K): δ = 19.1 (12), 19.6 (12’), 29.2 (11), 57.7 (9), 63.3 (8), 107.2 (4), 119.3 (2), 143.2 (3), 
152.5 (5), 158.9 (6), 160.0 (1). MS (+FAB, 3-NBA), m/z: 226 (MH+, 100), 140 (17.3), 95 
(C5H3O2+, 33.4), 39 (C3H3+, 11.1). IR (KBr): ν~ [cm-1] = 3439s, 3294s, 3084m, 2955s, 2872m, 
2368w, 1722s, 1654s, 1567s, 1541s, 1472m, 1412m, 1355m, 1340s, 1316m, 1295m, 1231m, 
1098s, 1067m, 1023m, 980w, 942w, 903w, 887m, 854m, 820s, 708m, 650m, 596m, 558m. 
TLC (ethyl acetate, 2% ethanol) Rf = 0.28. 
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6-[(S)-4,5-dihydro-4-Isopropyloxazol-2-yl]-2H-pyran2-one (112) 
6-Oxo-6H-pyran-2-carboxylic acid amide 111 (400 mg, 1.8 mmol) in THF (50 mL) was 
reacted with Burgess’ reagent (476 mg, 2 mmol) according to general procedure 10. The 
crude product was purified by column chromatography on silica eluting with diethyl ether and 
pentane (4:1) to yield of a light yellow solid (285 mg, 77%). 
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C11H13NO3 (207.23) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.92 (d, 3JHH = 6.82 Hz, 3H, 10), 1.02 (d, 3JHH = 
6.82 Hz, 3H, 10’), 1.85 (m, 1H, 9), 4.13 (m, 2H, 7), 4.43 (m, 1H, 8), 6.45 (dd, 4JHH = 0.76, 
3JHH = 9.6 Hz, 1H, 4), 6.89 (d, 3JHH = 6.56 Hz, 1H, 2), 7.36 (dd, 3JHH = 6.56 Hz, 3JHH = 9.6 
Hz, 1H, 3). 13C{1H} NMR (125.8 MHz, CDCl3, 300K): δ = 18.3 (10), 19.0 (10’), 32.8 (9), 
71.0 (7), 73.3 (8), 107.5 (4), 119.2 (2), 142.2 (3), 149.4 (5), 156.7 (6), 160.0 (1). [ ]20Dα : - 70.4° 
(c = 1.00, CHCl3). MS (+EI), m/z: 207.1 (M+, 9.7), 164 (M+-iPr, 65.3), 95 (C5H3O2+,100). IR 
(KBr): ν~ [cm-1] = 3115w, 3059w, 2966m, 2903w, 2871w, 1726s, 1633m, 1549m, 1471m, 
1411w, 1265m, 1316m, 1265m, 1123w, 1085m, 1029m, 980m, 949m, 911m, 828m, 725w, 
660w. m.p. 103-104 °C. TLC (TBME:hexane, 4:1) Rf = 0.25. EA %found (calcd): C: 63.47 
(63.76), H: 6.29 (6.32), N: 6.73 (6.76). 
7.4.2 Synthesis of Phosphaalkyne 
Tris(trimethylsilyl)phosphan (113)[129] 
In a flame-dried three-necked flask equipped with reflux-condenser, sodium (857 mg, 37.3 
mmol) and potassium (1.09 g, 27.7 mmol) were stirred in DME (50 mL) until the alloy 
formed. Then the suspension was heated to reflux for 2 hours. After cooling to room 
temperature, red phosphorus (670 mg, 21.6 mmol) was added, and the suspension was heated 
to reflux for 24 hours. After cooling to room temperature, freshly destilled TMSCl (9 ml, 70.9 
mmol) in DME (20 mL) was slowly added. When the addition was finished, the solvent was 
distilled from the suspension. Then the product was distilled under reduced pressure (0.1 
mbar, ~50°C), to yield a colorless air-sensitive liquid that solidifies at 4°C (2.5 g, 58%). 
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C9H27PSi3 (250.54) 
1H NMR (500.1 MHz, C6D6, 300K): δ = 0.31 (d, 3JHP = 4.4 Hz, 27H). 13C{1H} NMR (125.8 
MHz, C6D6, 300K) δ = 4.5 (2JCP = 11.2 Hz) 31P{1H} NMR (202.5.0 MHz, C6D6, 300K) δ =  
-252.2. 
[2,2-Dimethyl-1-(trimethylsiloxy)propyliden]-trimethylsilylphosphane (114)[223] 
To a solution of pivaloyl chloride (24 mL, 195 mmol) in pentane (250 mL) P(TMS)3 113 
(43.34 g, 173 mmol) is added via cannula. The solution is stirred for one week. Pentane is 
removed by distillation, and the yellow product is then distilled at reduced pressure using a 
vigreux column (40 g, 88%). 
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C11H27OPSi2 (262.48) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.32 (s, 9H, 4), 0.43 (d, 3JHH = 4 Hz, 9H, 5), 1.35 
(d, 4JHH = 1.5 Hz, 9H, 3). 31P{1H} NMR (162.0 MHz, CDCl3, 300K) δ = 131.9. 
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(2,2-Dimethylpropylidyne)phosphane (115)[131] 
 
Figure 7.1: Apparatus for the preparation of (2,2-dimethylpropylidyne)phosphane 
[2,2-Dimethyl-1-(trimethylsiloxy)propyliden]-trimethylsilyl-phosphane 114 (51 g, 193 mmol) 
was reacted with NaOH (22g, 550 mmol) under vacuum (~10-3 mbar) at 180°C. The side-
product TMS2O was trapped at -78°C, the product was trapped at -193°C. The product was 
obtained as a solution in TMS2O (25 g, 3.79 M in TMS2O, 61.4%) The colorless solution was 
stored at -20°C. It slowly turnes yellow upon standing, but without maJor changes of the 1H 
NMR spectrum. 
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C5H9P (100.1) 
1H NMR (400.1 MHz, C6D6, 300K): δ = 1.16 (d, 4JHP = 0.76 Hz). 13C{1H} NMR (100.6 
MHz, C6D6, 300K): δ = 31.4 (d, 3JCP = 6.13 Hz, 3), 36.5 (d, 2JCP = 18.4 Hz, 2), 185 (d, 1JCP = 
38.34 Hz, 1). 31P{1H} NMR (162.0 MHz, C6D6, 300K) δ = -68.4. 
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7.4.3 [4+2] Cycloaddition of α-Pyrone and tert-Butylphosphaalkyne 
(S,2E)-2-(6-tert-Butylphosphininoxide-2(1H)-ylidene)-4-isopropyloxazolidine (120trans) 
(S,2Z)-2-(6-tert-Butylphosphininoxide-2(1H)-ylidene)-4-isopropyloxazolidine (120cis) 
According to general procedure 11 6-oxo-6H-pyran-2-acid oxazoline 112 (947 mg, 4.57 
mmol), (2,2-dimethylpropylidyne)phosphin 115 (2.1 mL, 3.79 M in TMS2O, 8 mmol) were 
reacted in chlorobenzene (6 mL) and toluene (2 mL) for 4 days. The brown crude was purified 
by column chromatography eluting with ethyl acetate and methanol (both isomers:500 mg, 
39%). 
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C15H24NO2P (281.33) 
1H NMR (400.1 MHz, CD2Cl2, 260K): δ = 0.89 (d, 3JHH = 6.8 Hz, 3H, 13), 0.94 (d, 3JHH = 6.8 
Hz, 3H, 13’), 1.32 (s, 9H, 8), 1.89 (m, 1H, 12), 3.82 (m, 1H, 10), 4.25 (dd, 1H, 11), 4.49 (dd, 
1H, 11), 5.40 (ddd, 3JHH = 9.3Hz, 7.1, 4JHP = 2.8 Hz, 1H, 4), 6.74 (dd, 3JHH = 9.3 Hz, 1H, 3), 
6.87 (dd, 3JHH = 7.3, 1H, 5), 8.70 (d, 1JPH = 482 Hz, 1H, 1). 13C{1H} NMR (125.8 MHz, 
CD2Cl2, 260K): δ = 16.6 (13), 18.3 (13’), 31.0 (d, 2JCP = 5 Hz, 8), 31.2 (12), 35.6 (d, 2JCP = 
8.6 Hz, 7), 61.9 (11), 70.3 (10), 106.6 (d, 3JCP = 16.8 Hz, 4), 127.2 (5), 130.5 (d, 1JCP = 100 
Hz, 2), 134.2 (d, 2JCP = 5.2 Hz, 3), 168.5 (9), quarternary carbon 6 missing. 31P{1H} NMR 
(162.0 MHz, CD2Cl2, 300K): δ = -1.0 (d, 1JPH = 485 Hz). TLC (ethyl acetate:methanol 18:1) 
Rf = 0.16. 
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C15H24NO2P (281.33) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 0.89 (d, 3JHH = 6.8 Hz, 3H, 13), 0.93 (d, 3JHH = 6.8 
Hz, 3H, 13’), 1.33 (s, 9H, 8), 1.90 (m, 1H, 12), 3.85 (m, 1H, 10), 4.24 (m, 1H, 11), 4.47 (m, 
1H, 11), 5.43 (m, 1H, 4), 6.78 (m, 1H, 3), 6.80 (m, 1H, 5), 8.7 (d, 1JPH = 485 Hz, 1H, 1). 
13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 17.3 (13), 18.5 (13’), 30.9 (d, JCP = 5 Hz, 8), 
31.2 (12), 36.2 (7), 62.3 (11), 71.2 (10), 107.6 (d, 3JCP = 15.7 Hz, 4), 127.5 (d, 2JCP = 6Hz, 5), 
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134.7 (d, 2JCP = 6.1 Hz, 3), quarternary carbons 2, 6 and 9 are missing. 31P{1H} NMR (162.0 
MHz, CD2Cl2, 300K): δ = -3.2 (d, 1JPH = 485 Hz). TLC (ethyl acetate:methanol 18:1) Rf = 
0.11. 
(S)-2-(6-tert-Butylphosphinin-2-yl)-4,5-dihydro-4-isopropyloxazole (105) 
According to general general procedure 12 the product was obtained after evaporation of the 
toluene as an orange-yellow sticky solid, which becomes brown upon storage at room-
temperature. However, the NMR remains unchanged. 
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C15H22NOP (263.32) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 0.91 (d, 3JHH = 6.8 Hz, 3H, 12), 1.01 (d, 3JHH = 6.8 
Hz, 3H, 12’), 1.46 (d, 4JPH = 1.52 Hz, 9H, 7), 1.83 (m, 3JHH = 7.4 Hz, 1H, 11), 4.07 (m, 1H, 
10), 4.13 (m, 2JHH = 8.0 Hz, 3JHH = 8.2 Hz, 1H, 9), 4.42 (m, 2JHH = 8.1 Hz, 3JHH = 9.35 Hz, 
1H, 9), 7.51 (dpst, 3JHH = 8.3 Hz, 4JHP = 4.05 Hz, 1H, 3), 7.96 (dd, 3JHH = 8.6 Hz, 3JHP = 6.65 
Hz, 1H, 2), 8.28 (m, 3JHH = 8.1 Hz, 3JHP = 4.5 Hz, 1H, 4). 13C{1H} NMR (125.8 MHz, 
CD2Cl2, 300K): δ = 18.4 (12), 19.1 (12’), 32.9 (d, 3JCP = 1.5 Hz, 7), 33.4 (11), 39.1 (d, 2JCP = 
12.6 Hz, 6), 70.8 (9), 73.3 (10), 129.6 (d, 3JCP = 14.4 Hz, 3), 132.7 (d, 2JCP = 13.1 Hz, 4), 
133.0 (d, 2JCP = 11 Hz, 2), 153.4 (d, 1JCP = 50.6 Hz, 5), 165.1 (d, 2JCP = 25 Hz, 8), 185.3 (d, 
1JCP = 58.4 Hz, 1). 31P{1H} NMR (162.0 MHz, CD2Cl2, 300K): δ = 208.7. MS (+FAB, 3-
NBA), m/z: 264 (MH+, 100), 179 (11.2). 
7.4.4 Analogous Phosphininoxazolines 
(S)-6-Oxo-6H-pyran-2-carboxylic-acid-(1-hydroxymethyl-2,2-dimethyl-propyl)-amide 
(122) 
6-Oxo-6H-pyran-carboxylic acid (6 g, 42.8 mmol), HOBt (9.5 g, 70.6 mmol), EDC (13.5 g, 
70.6 mmol) and (S)-tert-leucinol (5.02 g, 42.8 mmol) were reacted in dichloromethane (300 
mL) and DMF (20 mL) according to general procedure 9. Column chromatography on silica 
eluting with ethyl acetate and ethanol yielded the product as an off-white solid (4.1 g, 40%). 
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C12H17NO4 (239.27) 
1H NMR (400.1 MHz, CDCl3 300K): δ = 0.97 (s, 9H, 12), 3.63 (m, 1H, 9), 3.91 (m, 1H, 9), 
3.98 (m, 1H, 8), 6.45 (m, 1H, 2) 7.08 (m, 2H, 7/4), 7.44 (m, 1H, pyron 3). 13C{1H} NMR 
(100.6 CDCl3 300K): δ = 27.0 (12), 34.1 (11), 60.1 (8), 62.2 (9), 107.2 (3), 119.2 (4), 143.2 
(2), 152.4 (5), 159.3 (6), 159.9 (1). MS (+FAB, 3-NBA) m/z: 240 (MH+, 100), 140 (21.1), 95 
(pyron, 28.5). IR (KBr): ν~ [cm-1] = 3464.2s, 3361.8s, 3093.8w, 2962.9m, 2870.8m, 2361.9w, 
1975.5w, 1723.6s, 1674.0s, 1557.9m, 1517.2s, 1474.1m, 1405.3, 1371.1m, 1331.0m, 1266.1s, 
1229.5m, 1098.1s, 1047.5s, 1001.4m, 942.1w, 880.8s, 817.0s, 645.0s, 589.7m, 558.0m, 
533.9m. m.p. 109°C. [ ]20Dα  = +9.5° (c = 1.02, CHCl3). TLC (ethyl acetate:ethanol; 98:2) Rf = 
0.38. EA %found (calcd): C: 60.21 (60.24), H: 7.10 (7.16) N: 5.82 (5.85) O: 26.99 (26.75). 
(S)-6-Oxo-6H-pyran-2-carboxylic acid (2-hydroxy-1-phenyl-ethyl)-amid (123) 
6-Oxo-6H-pyran-carboxylic acid (1.18 g, 8.42 mmol), HOBt (1.25 g, 9.26 mmol), EDC (1.77 
g, 9.26 mmol) and (S)-phenylglycinol (1.16 g, 8.42 mmol) were reacted in dichloromethane 
(70 mL) according to general procedure 9. Column chromatography on silica eluting with 
ethyl acetate (2% ethanol) yielded the product as a white solid (1.127 g, 52%). 
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C14H13NO4 (259.26) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 3.98 (m, 1H, 9), 5.20 (m, 1H, 8), 6.49 (d, 3JHH = 
9.3 Hz, 1H, 4) 7.11 (d, 3JHH = 6.8 Hz, 1H, 2) 7.26-7.40 (m, 5H, Ph), 7.46 (dd, d, 3JHH = 6.8 
Hz, 3JHH = 9.3 Hz, 1H, 3), 7.60 (d, 1H, 7). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 
56.2 (8), 65.9 (9), 107.3 (4), 119.6 (2), 127.0 (12), 128.4 (14), 129.1 (13), 138.1(11), 143.1 
(3), 152.3 (5), 158.5 (6), 159.8 (1). MS (+FAB, 3-NBA), m/z: 260 (MH+, 96.25%), 228 (MH+ 
- CH3OH, 21.16%), 140 (C6H6NO3+, 100), 121 (36.6), 95 (C5H3O2+, 88.0), 77 (Ph+, 19.9). IR 
(KBr): ν~ [cm-1] = 3460.8mbr (νNH), 3239.3s (νarom.), 3082.4m (νaliph.), 2940.8w(νaliph.), 1711.6s 
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(νCO-Lacton), 1654.9s (νCO-Amid), 1536.3m(νC=C), 1406.6w, 1354.4w, 1307.9w, 1230.6w, 
1096.2s, 1064.9w, 895.8w, 857.6w, 817.6m, 739.9m(νC-OH), 692.1m (δarom.), 629.0w(δarom.), 
585.2w, 551.6w, 483.5w. mp. 136°C. [ ]20Dα  = -39.2° (c = 1.0, CHCl3). TLC (ethyl 
acetate:ethanol;98:2) Rf = 0.37. EA %found (calcd): C: 64.73 (64.86), H: 5.10 (5.05), N: 5.30 
(5.40). 
6-[(S)-4-tert-Butyl-4,5-dihydrooxazol-2yl)-2H-pyran-2-one (124) 
6-Oxo-6H-pyran-2-carboxylic acid amide 122 (609 mg, 2.54 mmol) in THF (30 mL) was 
reacted with Burgess’ reagent (7.26 mg, 3.05 mmol) according to general procedure 10. The 
crude product was purified by column chromatography on silica eluting with ethyl acetate and 
ethanol to yield 124 (502 mg, 89%). 
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C12H15NO3 (221.25) 
1H NMR (500.1 MHz, CDCl3, 300K): δ = 0.93 (s, 9H, 10), 4.08 (m, 3JHH = 8.3, 10.1 Hz, 1H, 
8), 4.22 (pst, 2JHH = 8.6 Hz, 3JHH = 8.6 Hz, 1H, 7), 4.35 (m, 2JHH = 8.6 Hz, 3JHH = 10.1 Hz, 
1H, 7), 6.44 (dd, 3JHH = 6.6 Hz, 9.4 Hz, 1H, 4), 6.87 (dd, 4JHH = 0.7 Hz, 3JHH = 6.6Hz, 1H, 2), 
7.36 (dd, 4JHH = 1.0 Hz, 3JHH = 9.4 Hz, 1H, 3). 13C{1H} NMR (125.8 MHz, CDCl3, 300K): δ 
= 26.0 (10), 34.2 (9), 69.5 (8), 76.8 (7), 107.5 (4), 119.1 (2), 142.2 (3), 149.5 (5), 156.6 (6), 
160.1 (1). MS (+FAB, 3-NBA), m/z: 222 (MH+, 100), 95 (C5H3O2+, 6.1). IR (KBr) ν~ [cm-1] = 
3460.7sbr, 3110.4w, 3059.6w, 2962.8s, 2888.3m, 1739.0sbr, 1667.4m, 1612.7m, 1547.5m, 
1481.3m, 1384.0m, 1325.2m, 1298.7m, 1255.7m, 1211.9w, 1126.2m, 1093.0s, 1034.8m, 
976.6m, 952.0m, 903.6m, 812.0s, 741.5m, 661.4m, 568.3m. m.p. 90°C. [ ]20Dα : -94.5° (c = 
1.05, CHCl3). TLC (ethyl acetate:ethanol; 98:2) Rf = 0.72. EA %found (calcd): C: 65.05 
(65.14), H: 6.81 (6.83), N: 6.29 (6.33), O: 21 .79 (21.69). 
(R)-6-[4-Phenyl-4,5-dihydrooxazol-2yl)-2H-pyran-2-one (125 S) 
6-Oxo-6H-pyran-2-carboxylic acid amide 123 (1.08 mg, 4.16 mmol) in THF (60 mL) was 
reacted with Burgess’ reagent (1.19 mg, 5 mmol) according to general procedure 10. The 
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crude product was purified by column chromatography on silica eluting with diethyl ether and 
pentane to yield 125 (550 mg, 55%). 
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C14H11NO3 (241.24) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 4.29 (pst, 3JHH = 8.6 Hz, 3JHH = 8.6 Hz, 1H, 7), 
4.82 (dd, 2JHH = 8.6 Hz, 3JHH = 10.4 Hz, 1H, 7), 5.43 (pst, 3JHH = 8.8 Hz, 3JHH = 9.8 Hz, 1H, 
8), 6.45 (d, 3JHH = 9.6 Hz, 1H, 4), 6.95 (d, 3JHH = 6.6 Hz, 1H, 2), 7.40 (dd, 3JHH = 6.6 Hz, 3JHH 
= 9.4 Hz, 1H, 3). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 70.4 (8), 75.4 (7), 108.0 
(4), 119.5 (2), 126.8 (10), 128.0 (12), 128.9 (11), 141.0 (9), 142.1 (3), 149.1 (5), 157.9 (6), 
169.8 (1). IR (KBr): ν~ [cm-1] = 3448.2mbr, 2996.9w (νarom.), 2952.8m (νaliph.), 2895.2m 
(νaliph.), 1734.2s (νC=OLacton), 1661.0m (νC=N), 1608.9m (νC=C), 1549.3m (νC=C), 1491.2w, 
1450.1m, 1375.6m, 1300.1m, 1253.0m, 1195.6w, 1089.1s (νC-O), 1034.1m, 973.2m, 888.8m, 
805.4s, 757.2m (δarom.), 698.4m (δarom.). m.p. 119 °C. [ ]20Dα : -39.2° (c = 1.0, CHCl3). TLC (n-
pentane: diethyl ether; 1: 20) Rf = 0.21. EA %found (calcd): C: 69.35 (69.70), H: 4.67 (4.60), 
N: 5.86 (5.81), O: 20.14 (19.90). 
(R)-6-[4-Phenyl-4,5-dihydrooxazol-2yl)-2H-pyran-2-one (125R) 
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C14H11NO3 (241.24) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 4.29 (pst, 3JHH = 8.6 Hz, 3JHH = 8.6 Hz, 1H, 7), 
4.82 (dd, 2JHH = 8.6 Hz, 3JHH = 10.4 Hz, 1H, 7), 5.43 (pst, 3JHH = 8.8 Hz, 3JHH = 9.8 Hz, 1H, 
8), 6.45 (d, 3JHH = 9.6 Hz, 1H, 4), 6.95 (d, 3JHH = 6.6 Hz, 1H, 2), 7.40 (dd, 3JHH = 6.6 Hz, 3JHH 
= 9.4 Hz, 1H, 3). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 70.7 (8), 75.6 (7), 108.3 
(4), 119.5 (2), 127.0 (10), 128.2 (12), 129.1 (11), 141.7 (9), 142.6 (3), 149.3 (5), 158.1 (6), 
160.2 (1). MS (+FAB, 3-NBA), m/z: 483 (M2H+, 5.1), 242 (MH+, 100), 95 (C5H3O2+, 34.81). 
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IR (KBr): ν~ [cm-1] = 3447.7mbr, 2996.9w, 2952.8m, 2895.1m, 1733.9s, 1660.6m, 1608.8m, 
1549.0m, 1490.0w, 1450.3m, 1375.4m, 1299.9m, 1252.9m, 1195.3w, 1117.8w, 1089.0s, 
1033.9m, 972.7m, 888.9m, 805.1s, 757.0m, 698.3m. m.p. 122-123°C. [ ]20Dα : +41.5° (c = 1.0, 
CHCl3). TLC (n-pentane: diethyl ether; 1: 20) Rf = 0.22. EA %found (calcd): C: 69.53 
(69.70), H: 4.58 (4.60), N: 5.85 (5.81). 
(S,2E)-2-(6-tert-Butylphosphininoxide-2(1H)-ylidene)-4-tert.-butyloxazolidine (128trans) 
(S,2Z)-2-(6-tert-Butylphosphininoxide-2(1H)-ylidene)-4-tert.-butyloxazolidine (128cis) 
According to general procedure 11 6-oxo-6H-pyran-2-acid oxazoline 124 (400 mg, 1.81 
mmol), (2,2-dimethylpropylidyne)phosphine 115 (1.5 mL, 3.79 M in TMS2O, 5.69 mmol) 
were reacted in toluene (3 mL) for 5.5 days. The brown crude was purified by column 
chromatography eluting with ethyl acetate and methanol (E-isomer:118 mg, 22%; Z-isomer: 
30 mg, 5.6%; mixed 20 mg, 3.7%). 
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C15H24NO2P (295.36) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.91 (s, 9H, 13), 1.34 (s, 9H, 8), 3.79 (dd, 1H, 10), 
4.35 (dd, 1H, 11), 4.46 (pst, 1H, 11), 5.44 (ddd, 4JPH = 2.8 Hz, 3JHH = 7.1 Hz, 3JHH =  9.3 Hz, 
1H, 4), 6.73 (ddd, 3JPH = 21.8 Hz, 3JHH = 9.3 Hz, 1H, 5), 6.80 (ddd, 3JPH = 34.1 Hz, 3JHH = 7.1 
Hz, 1H, 3), 8.64 (d, 1JPH = 483.8 Hz, 1H, 1). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 
25.2 (13), 31.1 (d, 3JCP = 5.2 Hz, 8), 32.9 34.2 (12), 36.1 (d, 2JCP = 8.0 Hz, 7), 65.1 (11), 70.4 
(10), 76.5 (d, 1JCP = 110.4 Hz, 6), 108.1 (d, 3JCP = 17.0 Hz, 4), 127.2 (5), 131.9 (d, 1JCP = 97.9 
Hz, 2), 134.8 (d, 2JCP = 5.6 Hz, 3), 169.3 (d, 2JCP = 16.0 Hz, 9). 31P NMR (162.0 MHz, 
CDCl3, 300K): δ = -1.2 (d, 1JPH = 485 Hz). 31P{1H} NMR (162.0 MHz, CD2Cl2, 300K): δ = -
6.0. MS (+FAB, 3-NBA), m/z: 296 (MH+, 100), 278 (M+-H2O, 10.5), 220 (278-C4H10, 9.5), 
57 (C4H9+, 14.1). [ ]20Dα : +295.5° (c = 1.0, CHCl3). TLC (ethyl acetate:methanol 10:1) Rf = 
0.21. EA %found (calcd): C 64.84 (65.05), H 8.65 (8.87), N 4.59 (4.74), O 10.73 (10.83). 
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C15H24NO2P (295.36) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 0.95 (s, 9H, 13), 1.34 (s, 9H, 8), 3.75 (dd, 1H, 10), 
4.37 (dd, 1H, 11), 4.47 (pst, 1H, 11), 5.37 (ddd, 4JPH = 2.8 Hz, 3JHH = 7.1 Hz, 3JHH = 9.3 Hz, 
1H, 4), 6.70 (d, 3JPH = 21.8 Hz, 3JHH = 9.3 Hz, 1H, 5), 6.74 (d, 3JPH = 35.9 Hz, 3JHH = 7.1 Hz, 
1H, 3), 8.75 (d, 1JPH = 481.2 Hz, 1H, 1). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 25.2 
(13), 30.2 (d, 3JCP = 5.2 Hz, 8), 33.9 (12), 65.2 (11), 70.0 (10), 108.1 (d, 3JCP = 17.4 Hz, 4), 
127.1 (5), 135.1 (d, 2JCP = 6.5 Hz, 3), quarternary carbons 2, 6, 7, and 9 are missing.31P{1H} 
NMR (162.0 MHz, CD2Cl2, 300K): δ = 1.8 (d, 1JPH = 485 Hz). MS (+FAB, 3-NBA), m/z: 
296 (MH+, 100), 278 (M+-H2O, 10.5), 220 (278-C4H10, 9.5), 57 (C4H9+, 14.1). m.p. 171-172 
°C. [ ]20Dα : +73.4° (c = 1.0, CHCl3). TLC (ethyl acetate: methanol 10:1) Rf = 0.08. 
(S,2E)-2-(6-tert-Butylphosphininoxide-2(1H)-ylidene)-4-phenyloxazolidine (129trans) 
(S,2Z)-2-(6-tert-Butylphosphininoxide-2(1H)-ylidene)- 4-phenyloxazolidine (129cis) 
According to general procedure 11 6-oxo-6H-pyran-2-acid oxazoline 125 (480.5 mg, 1.99 
mmol), (2,2-dimethylpropylidyne)phosphin (1.6 mL, 3.79 M in TMS2O, 5.97 mmol) were 
reacted in toluene (5 mL) for 8 days. The brown crude was purified by column 
chromatography eluting with ethyl acetate and methanol (E-isomer:110 mg, 16%; Z-isomer: 
77 mg, 12.2%). 
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C18H22NO2P (315.35) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 1.07 (s, 9H, 13), 4.34 (dd, 3JHH = 4.5 Hz, 3JHH = 
8.3 Hz, 1H, 11), 4.81 (pst, 2JHH = 8.6 Hz, 3JHH = 8.6 Hz, 1H, 11), 5.16 (dd, 2JHH = 8.6 Hz, 3JHH 
= 4.5 Hz 1H, 10), 5.54 (ddd, 3JHH = 7.3 Hz, 3JHH = 9.3 Hz, 4JHP = 3 Hz, 1H, 4), 6.85 (dd, 3JHH 
= 7.1 Hz, 3JHP = 20 Hz, 1H, 3), 6.89 (dd, 3JHH =  9.3 Hz, 3JHP = 30 Hz, 1H, 5), 7.22-7.24 (m, 
2H, 13/13’), 7.26-7.34 (m, 3H, 14/14’/15), 8.59 (d, 1JHP = 483 Hz, 1), 11.2 (sbr, 1H, NH). 
13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 31.2 (d, 3JCP = 5.3 Hz, 8), 35.7 (d, 2JCP = 8.2 
Hz, 7), 59.6 (11), 76.4 (10), 77.6 (d, 1JCP = 112.2 Hz, 6), 108.0 (d, 3JCP = 16.8 Hz, 4), 126.4 
(13/13’), 127.3 (5), 128.6 (15), 129.3 (14/14’), 131.8 (d, 1JCP = 99.3 Hz, 2), 135.2 (d, 2JCP = 
5.7 Hz, 3), 140.8 (12), 169.3 (d, 2JCP = 16.8 Hz, 9). 31P{1H} NMR (162.0 MHz, CD2Cl2, 
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300K): δ = -6.5 (ddd, 1JPH = 483 Hz, 3JPH = 20 Hz, 3JPH = 30 Hz). TLC (ethyl 
acetate:methanol; 9:1) Rf = 0.37.  
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C18H22NO2P (315.35) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 1.33 (s, 9H, 13), 4.30 (t, 3JHH = 7.8 Hz, 1H, 10), 
4.84 (t, 2JHH = 8.6 Hz, 3JHH = 8.6 Hz 1H, 11), 5.13 (dd, 2JHH = 8.6 Hz,  3JHH = 7.6 Hz 1H, 11), 
5.47 (ddd, 3JHH = 7.3, 9.3 Hz, 4JHP = 3 Hz, 1H, 4), 6.79 (dd, 3JHH = 9.3 Hz, 3JHP = 20 Hz, 1H, 
3), 6.82 (dd, 3JHH =  7.3 Hz, 3JHP = 33.1 Hz, 1H, 5), 7.31 (m, 5H, 13/13’/14/14’/15), 8.74 (d, 
1JHP = 487 Hz, 1), 10.6 (sbr, 1H, NH). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 31.1 
(8), 36.1 (7), 60.1 (11), 75.4 (10), 108.3 (d, 3JCP = 16.8 Hz, 4), 126.7 (13/13’), 127.2 (5), 
128.7 (15), 129.1 (14/14’), 131.6 (d, 1JCP = 98 Hz, 2), 134.7 (d, 2JCP = 5.2 Hz, 3), 138.9 (12), 
168.9 (d, 2JCP = 16. Hz, 9), quarternary carbon 6 missing. 31P{1H} NMR (162.0 MHz, 
CD2Cl2, 300K): δ = -5.3 (d, 1JPH = 487 Hz). TLC (ethyl acetate:methanol; 9:1) Rf = 0.22. 
(S)-2-(6-tert-Butylphosphinin-2-yl)-4,5-dihydro-4-tert-butyloxazol (126) 
According to general procedure 12 the product was obtained after evaporation of the toluene 
as a yellow solid. 
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C16H24NOP (277.34) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 0.95 (s, 9H, 12), 1.48 (d, 4JPH = 1.55 Hz, 9H, 7), 
4.05 (dd, 3JHH = 8.1 Hz, 3JHH = 10.1 Hz, 1H, 10), 4.25 (pst, 3JHH = 8.1 Hz, 2JHH = 8.6 Hz, 1H, 
9), 4.37 (dd, 2JHH = 8.6 Hz, 3JHH = 10.1 Hz, 1H, 9), 7.53 (m, 3JHH = 8.4, 4JHP = 6.4 Hz, 1H, 3), 
7.97 (dd, 1JHH = 8.6 Hz, 3JHP = 4.7 Hz, 1H, 2), 8.30 (m, 1JHH = 8.1 Hz, 3JHP = 4.1 Hz, 1H, 4). 
13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 26.0 (12), 32.9 (d, 3JPC = 12.5 Hz, 7), 34.4 
(11), 39.2 (d, 2JCP = 21.8 Hz, 6), 69.3 (10), 76.7 (9), 129.6 (d, 3JCP = 14.3 Hz, 3), 132.8 (d, 
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2JCP = 13.1 Hz, 2), 133.0 (d, 2JCP = 10.9 Hz, 4), 153.7 (d, 1JCP = 58.6 Hz, 1), 177.2 (8), 185.5 
(d, 1JCP = 51 Hz, 5). 31P{1H} NMR (162.0 MHz, CD2Cl2, 300K): δ = 208.5. 
(S)-2-(6-tert-Butylphosphinin-2-yl)-4,5-dihydro-4-phenyloxazol (127) 
According to general procedure 12 the product was obtained after evaporation of the toluene 
as a yellow solid (104 mg, 89%). 
2
1 P
5
4
3
8
N 10
9
O
11
6
7
14
13
12
 
C18H20NOP (297.33) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 1.49 (d, 4JPH = 1.8 Hz, 9H, 7), 4.29 (pst, 2JHH = 
8.3 Hz, 3JHH = 8.3 Hz, 1H, 9), 4.83 (dd, 3JHH = 10.1 Hz, 2JHH = 8.3 Hz, 1H, 9), 5.40 (pst, 3JHH 
= 8.4 Hz, 3JHH = 9.9 Hz, 1H, 10), 7.29-7.38 (m, 5H, Ph), 7.57 (dt, 3JHH = 8.4 Hz, 4JHP = 4.3 
Hz, 1H, 3), 8.02 (dd, 3JHH = 8.6 Hz, 3JHP = 6.3 Hz, 1H, 2), 8.30 (dd, 3JHH = 8.1 Hz, 3JHP = 4.6 
Hz, 1H, 4). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 32.9 (d, 3JCP = 12.5 Hz, 7), 39.3 
(d, 2JCP = 21.9 Hz, 6), 70.5 (10), 75.3 (9), 127.1 (12), 127.8 (14), 129.0 (13), 129.8 (d, 3JCP = 
14.2 Hz, 3), 133.1 (d, 2JCP = 13.2 Hz, 4), 133.3 (d, 2JCP = 10.7 Hz, 2), 143.1 (11), 152.9 (1), 
~175 (8), 185.7 (d, 1JCP = 58.7 Hz, 5). 31P{1H} NMR (162.0 MHz, CD2Cl2, 300K): δ = 210.8.  
7.4.5 A Related Chiral Chelating Phosphininimidazoline 
6-[(S)-4-tert-Butyl-4,5-dihydro-1-(4-methoxyphenyl)-1H-imidazol-2yl]-2H-pyran-2-one 
(130)[139] 
Compound 122 (430 mg, 2.07 mmol) was dissolved in thionyl chloride (3 mL) and DMF (4 
drops) and stirred for 4 h at reflux. Excess thionyl chloride was removed by and the 
chloroimidoylchloride was dissolved in dry toluene (5 mL). Dry triethylamine (0.9 mL, 6.3 
mmol), and 4-methoxyaniline (565 mg, 5.28 mmol) were added and the reaction mixture was 
stirred for 15 h under reflux. The solution was washed with 10% NaOH (20 mL) and the 
aqueous layer was reextracted with dichloromethane (2 × 20 mL). The combined organic 
layers were washed with brine (20 mL) and dried over MgSO4. Column chromatography on 
silica eluting with ethyl acetate and hexane afforded light yellow crystals (440 mg, 65%). 
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C19H22N2O3 (326.39) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.96 (s, 9H, 10), 3.56 (pst, 1H, 7), 3.77 (s, 3H, 15), 
3.97 (m, 2H, 7/8), 6.26 (dd, 3JHH = 9.4 Hz, 4JHH = 1 Hz, 1H, 4), 6.62 (dd, 3JHH = 6.6 Hz, 4JHH 
= 1Hz, 1H, 2), 6.81 (d, 3JHH = 9.0 Hz, 1H, 18), 6.91 (d, 3JHH = 9.0 Hz, 1H, 19), 7.26 (dd, 3JHH 
= 9.1 Hz, 3JHH = 6.6 Hz, 1H, 3). 13C{1H} NMR (100.6 MHz, CDCl3, 300K): δ = 26.0 (10), 
34.4 (9), 55.6 (15), 56.2 (7), 75.0 (8), 107.1 (4), 114.7 (12), 117.5 (2), 124.9 (13), 135.7 (11), 
142.6 (3), 153.3 (5), 155.3 (6), 157.3 (14), 160.3 (1). TLC (hexane: ethyl acetyte; 1:10) Rf = 
0.14-0.32. EA %found (calcd): C: 67.61 (69.92), H: 6.77 (6.79), N: 8.30 (8.58). 
(S,2E)-2-(6-tert-Butylphosphininoxide-2(1H)-ylidene)-4-tert-butyl-4,5-dihydro-1-(4-
methoxyphenyl)-1H-imidazolidine (132) 
According to general procedure 11 6-oxo-6H-pyran-2-acid imidazoline 130 (365 mg, 1.1 
mmol), (2,2-dimethylpropylidyne)phosphine 115 (0.87 mL, 3.79 M in TMS2O, 3.3 mmol) 
were reacted in toluene (3 mL) for 3 weeks. Since the heater was out of order for some time, 
the actual reaction time is shorter. The brown crude was purified by column chromatography 
(ethyl acetate: ethanol, 9:1) to yield a yellow to brown oil (36.6 mg, 8.3%). 82% of the 6-oxo-
6H-pyran-2-acid imidazoline could be reisolated. 
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C23H33N2O2P (400.49) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.92 (s, 9H, 14), 1.35 (s, 9H, 8), 3.46 (dd, 3JHH = 
5.8, 2JHH = 10.1Hz, 1H, 12), 3.72 (m, 1H, 11), 3.79 (s, 3H, 19), 4.28 (pst, 2JHH = 10.1 Hz, 1H, 
12), 5.06 (ddd, 3JHH = 7.3 Hz, 3JHH = 9.3 Hz, 4JPH = 3.1 Hz 1H, 4), 6.01 (dd, 3JHH = 9.3 Hz, 
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3JPH = 23.2 Hz, 1H, 5), 6.78 (dd, 3JHH = 7.3 Hz, 3JPH = 34 Hz, 1H, 3), 6.86 (d, 3JHH = 8.8 Hz, 
2H, 17), 7.09 (d, 3JHH = 8.8 Hz, 2H, 18), 8.75 (d, 1JPH = 484.4 Hz, 1H, 1). 13C{1H} NMR 
(125.8 MHz, CDCl3, 300K): δ = 25.1 (14), 31.0 (d, 3JCP = 5.2 Hz, 8), 33.9 (13), 36.1 (d, 2JCP 
=7.7 Hz, 7), 55.6 (19), 56.1 (12), 62.3 (11), 105.3 (d, 3JCP = 17.8 Hz, 4), 115.0 (16), 115.3 (d, 
1JCP = 70.4 Hz, 1), 126.0 (17), 128.5 (d, 2JCP = 0 Hz, 5), 129.4 (d, 1JCP = 95.1 Hz, 6), 135.0 (d, 
2JCP = 23.0 Hz, 3), 135.0 (15), 157.8 (18), 162.6 (d, 2JCP = 10.7 Hz, 9). 31P{1H} NMR (162 
MHz, CDCl3, 300K): δ = 1.7. TLC (ethyl acetate:ethanol; 98:2): Rf = 0.18.  
(S)-2-(6-tert-Butylphosphinin-2-yl)-4-tert-butyl-4,5-dihydro-1-(4-methoxyphenyl)-1H-
imidazol (131) 
According to general procedure 12 the crude product was obtained after evaporation of 
toluene. 
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C23H31N2OP (382.48) 
31P{1H} NMR (162 MHz, CD2Cl2 , 300K): δ = 212.4. 
7.4.6 Synthesis of Phosphinine-Iridium Complexes 
(S)-2-(6-tert-Butylphosphinin-2-yl)-4,5-dihydro-4-isopropyloxazol-η4-(1,5-cycloocta-
diene)-iridium(I) tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate (133) 
According to general procedure 14 105 (40 mg, 152 µmol),[Ir(cod)Cl]2 (51 mg, 76 µmol) and 
NaBArF (175 mg, 197 µmol) were reacted in dichloromethane (3.5 mL). The product was 
obtained as a black foam that could be recrystallized from dichloromethane/hexane in black 
needles. 
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C55H46BF24IrNOP (1426.92) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 0.81 (d, 3JHH = 6.5 Hz, 3H, 12), 1.0 (d, 3JHH = 7.0 
Hz, 3H, 12’), 1.4 (s, 9H, 7), 1.76 (m, 1H, coda), 1.93 (m, 1H, codb), 2.07 (m, 1H, codc), 2.11 
(m, 1H, 11), 2.20-2.4 (m, 4H, coda-d), 2.56 (m, 1H, codd), 3.87 (m, 1H, 10), 4.42 (m, 1H, cod, 
18), 4.59 (t, 1H, 9), 4.67 (m, 1H, cod, 14), 4.77 (m, 1H, cod, 17), 4.91 (m, 1H, 9), 5.36 (m, 
1H, cod, 13), 7.56 (s, 4H, 24), 7.63 (m, 1H, 3), 7.72 (s, 8H, 22), 8.01 (ddd, 1H, 4), 8.25 (ddd, 
1H, 2). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 14.6 (12), 18.4 (12), 28.6 (coda), 30.1 
(codb), 30.5 (codc), 32.2 (d, 3JCP = 8.5 Hz, 7), 34.5 (codd), 39.1 (d, 1JCP 3.8 Hz, 6),39.2 (11), 
68.8 (18), 72.8 (9), 74.0 (17), 86.6 (d, 2JCP = 17.5 Hz, 14), 92.9 (d, 2JCP = 7.8 Hz, 13), 117.8 
(q, 3JCF = 3.8 Hz, 24), 125.0 (q, 1JCF = 272.5 Hz, 25), 129.2 (qq, 23), 130.3 (d, 3JCP = 26.4 Hz, 
3), 135.2 (s, 22), 136.4 (d, 2JCP = 13.9 Hz, 2), 140.8 (d, 2JCP = 12.8 Hz, 4), 162.1 (q, 1JBC = 50 
Hz, 21), 171.0 (8). 31P{1H} NMR (162.0 MHz, CD2Cl2, 300K) δ = 176.9. MS (+ESI) m/z: 
564.4 (M+(193Ir), 90.4), 562.4 (M+(191Ir), 90.4), 413.4 (C12H5IrNOP+, 39.0). 
(S)-2-(6-tert-Butylphosphinin-2-yl)-4,5-dihydro-4-isopropyloxazol-η4-(1,5-cycloocta-
diene)-iridium(I) Tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate (136) 
An attempt to recrystallize 133 in dichloromethane/diethyl ether (which probably contained 
traced of water) led to compound 136 an orange powder. 
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1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 0.54 (d, 3JHH = 6.8 Hz, 3H, 12), 0.87 (d, 3JHH 7.1 
Hz, 3H, 12’), 1.35 (s, 9H, 7), 1.80 (m, 1H, 11), 2.0 (m, 3H, cod), 2.28 (m, 4H, cod), 2.39 (m, 
1H, cod), 3.92 (m, 1H, 10), 4.21 (m, 1H, 13), 4.25 (m, 2H, 5/14), 4.44 (t, 1H, 9), 4.58 (ddd, 
1H, 9), 4.84 (m, 1H, 18), 5.04 (m, 1H, 17), 6.16 (dt, 1H, 4), 6.38 (m, 1H, 3), 6.65 (dd, 1H, 2), 
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7.56 (s, 4H, 24), 7.72 (s, 8H, 22). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 14.1 (12), 
18.4 (12’), 28.4 (d, 4JCP = 3.4 Hz, cod), 31.0 (d, 4JCP = 4.4 Hz, cod), 31.1 (d, 3JCP = 5.3 Hz, 7), 
31.7 (d, 4JCP = 2.9 Hz, cod), 33.9 (d, 4JCP = 4.8 Hz, cod), 36.7 (d, 2JCP = 14.4 Hz, 6), 44.2 (d, 
1JCP = 29.3 Hz, 5), 64.5 (14), 66.9 (13), 67.6 (10), 72.7 (9), 89.5 (d, 3JCP = 15.8 Hz, 18), 96.6 
(d, 3JCP = 12.5 Hz, 17), 117.8 (q, 3JCF = 3.8 Hz, 24), 120.4 (d, 2JCP = 8.6 Hz, 4), 125.0 (q, 1JCF 
= 272.5 Hz, 25), 128.3 (d, 2JCP = 14.4 Hz, 3), 129.2 (qq, 23), 129.4 (d, 3JCP = 5.8 Hz, 2) 130.3 
(d, 3JCP = 26.4 Hz, 3), 135.2 (s, 22), 144.3 (d, 1JCP = Hz, 1), 162.1 (q, 1JBC = 50 Hz, 21), 172.8 
(8). 31P{1H} NMR (162.0 MHz, CD2Cl2, 300K) δ = 87.5. 
(S)-2-(6-tert-Butylphosphinin-2-yl)-4,5-dihydro-4-tert-butyloxazol-η4-(1,5-
cyclooctadiene)-iridium(I) tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate (134) 
According to general procedure 14 126 (35 mg, 136 µmol),[Ir(cod)Cl]2 (38.6 mg, 57.4 µmol) 
and NABArF (145 mg, 164 µmol) were reacted in dichloromethane (3 mL). The product was 
obtained as a black foam. The product could not be recrystallized from either 
dichloromethane/hexane, dichloromethane/diethyl ether or diethyl ether/hexane. 
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C56H48BF24IrNOP (1440.95) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 1.03 (s, 9H, 12), 1.40 (s, 9H, 7), 1.65 (m, 1H, 
cod), 1.93 (m, 1H, cod), 2.05 (m, 1H, cod), 2.13-2.30 (m, 3H, cod), 2.43 (m, 1H, cod), 2.54 
(m, 1H, cod), 3.72 (d, 3JHH = 8.3 Hz, 1H, 10), 4.29 (m, 1H, 14), 4.57 (t, 1H, 9), 4.65 (m, 1H, 
18), 4.80 (mbr, 1H, 13), 5.04 (dd, 3JHH = 2.5, 10.0 Hz, 1H, 9), 5.40 (m br, 1H, 17), 7.56 (s, 4H, 
24), 7.62 (dd, 3JHH = 7.5, 3JPH = 16.5, 21.5 Hz, 1H, 3), 7.72 (s, 8H, 22), 8.02 (dd, 3JHH = 8.0, 
3JPH = 14.5 Hz, 1H, 4), 8.26 (dd, 3JHH = 8.5, 3JPH = 20.5 Hz, 1H, 2). 13C{1H} NMR (125.8 
MHz, CD2Cl2, 300K): δ = 25.9 (12), 27.3 (d, 2JCP = 4Hz, cod), 29.6 (11), 30.8 (d, 2JCP = 17.4 
Hz, cod), 31.9 (d, 3JCP = 8.9 Hz, 7) 35.6 (cod), 36.0 (d, 2JCP = 6.4 Hz, 6), 67.5 (14), 70.3 (10), 
74.1 (9), 74.4 (13), 87.1 (d, 2JCP = 19.8 Hz, 18), 92.8 (d, 2JCP = 19.8 Hz, 17), 117.8 (q, 3JCF = 
4Hz, 24), 125.0 (q, 1JCF = 270 Hz, 25), 129.3 (q, 2JCF = 25.7 Hz 23), 129.4 (d, 3JCP = 16.25 
Hz, 3), 135.2 (s, 22), 136.2 (d, 2JCP = 13.3 Hz, 4), 140.9 (d, 2JCP = 11.4 Hz, 2), 162.0 (q, 1JCB 
= 50 Hz, 21). 31P{1H} NMR (202.5 MHz, CD2Cl2, 300K): δ = 179.3. 
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(S)-2-(6-tert-Butylphosphinin-2-yl)-4,5-dihydro-4-phenyloxazol-η4-(1,5-cyclooctadiene)-
iridium(I) tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate (135) 
According to general procedure 14 127 (30 mg, 101 µmol),[Ir(cod)Cl]2 (33.7 mg, 50.2 µmol) 
and NABArF (115.2 mg, 130 µmol) were reacted in dichloromethane (5 mL). The product 
was obtained as an orange foam and contained about 20% impurities.  
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1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 1.41 (s, 9H, 7), 1.75 (m, 1H, cod), 1.86 (m, 2H, 
cod), 1.99 (m, 1H, cod), 2.10 (m, 1H, cod), 2.16-2.32 (m, 3H, cod), 4.51 (m, 1H, cod), 4.60 
(m, 2H, cod), 4.77 (dd, 2JHH = 9.1 Hz, 3JHH = 5.3 Hz, 1H, 9), 5.11 (dd, 2JHH = 9.1 Hz, 3JHH = 
9.8 Hz, 1H, 9), 5.22 (ddd, 1H, cod), 5.38 (m, 1H, 10), 7.25 (m, 2H, 12), 7.45 (m, 3H, 13/14), 
7.56 (s, 4H, 26), 7.69 (dd, 3JHH = 8.9 Hz, 1H, 3), 7.72 (s, 8H, 24), 8.12 (ddd, 3JHH = 8.1, 4JHH 
= 1.0 Hz, 3JPH = 15.2 Hz, 1H, 4), 8.30 (ddd, 3JHH = 9.1, 4JHH = 1.0 Hz, 3JPH = 21.7 Hz, 1H, 2). 
31P{1H} NMR (162.0 MHz, CD2Cl2, 300K): δ = 176.2. 
7.4.7 Iridium-Complexes with Monodentate Phosphinines 
2,6-Methyl-4-phenyl-pyrylium tetrafluoroborate (137)[119] 
2,6-Dimethyl-4-pyrone (5.0 g, 40 mmol) was dissolved in anisole (40 mL) with gentle 
heating. The solution was cooled to 5 °C and PhMgBr (1M in diethyl ether, 40 mmol) was 
added slowly via cannula. The purple solution was then warmed to room temperature and 
poured over HBF4 (54% in diethyl ether, 6.7 mL 48 mmol). The pale pink precipitate was 
isolated by filtration and washed with diehtyl ether. The pink-orange powder was 
recrystallized from hot water to give thin yellow-orange crystalls (26%-44%). 
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C13H13BF4O (272.05) 
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1H NMR (400.1 MHz, DMSO, 300K): δ = 2.04 (s, 6H, 1), 6.72 (dd, 3JHH = 7.3 Hz, 2H, 6), 
6.83 (pst, 3JHH = 7.3 Hz, 1H, 8), 7.22 (d, 3JHH = 7.3 Hz, 2H, 7), 7.47 (s, 2H, 3). 13C{1H} NMR 
(100.6 MHz, DMSO, 300K): δ = 21.1 (1), 118.0 (3), 129.3 (7), 129.8 (6), 131.1 (8), 135.3 (5), 
166.0 (4), 177.7 (2). MS (+FAB, 3-NBA), m/z: 185 (M+, 100). IR (KBr): ν~ [cm-1] = 3368mbr, 
3096m, 2929w, 1639s, 1590s, 1534m, 1453m, 1335m, 1288w, 1218m, 1065sbr, 941m, 881m, 
786m, 685m, 559w, 519m. m.p. 205°C. EA %found (calcd): C: 57.47 (57.40), H: 4.84 (4.82), 
O: 5.99 (5.88). 
2,6-Methyl-4-phenyl-pyrylium iodide (139)[122] 
To a warm slurry of 2,6-dimethyl-4-phenyltetrafluoroborate (2.85 g, 10.48 mmol) in water 
(50 mL) and acetic acid (2 drops) was added KI (1.64 g, 10.48 mmol). The solution was 
stirred at 50°C for 1.5 hours, until red, and cooled to room temperature. The iodide was 
collected by filtration, washed several times with diethyl ether and dried under high-vacuum. 
The product was obtained as a red crystalline solid (3.25 g, 100%). 
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C13H13IO (312.15) 
1H NMR (400.1 MHz, DMSO, 300K): δ = 2.00 (s, 6H, 1), 6.68 (pst, 3JHH = 8.1 Hz, 3JHH = 7.3 
Hz, 2H, 6), 6.80 (pst, 3JHH = 7.3 Hz, 1H, 8), 7.24 (d, 3JHH = 7.3 Hz, 2H, 7), 7.58 (s, 2H, 3). 
13C{1H} NMR (100.6 MHz, DMSO, 300K): δ = 21.4 (1), 118.2 (3), 129.5 (7), 129.8 (6), 
131.2 (8), 135.3 (5), 165.6 (4), 177.6 (2). MS (+FAB, 3-NBA), m/z: 185 (M+, 100). IR (KBr): 
ν~ [cm-1] = 3019m, 2929w, 2365w, 1636s, 1589m, 1533s, 1450m, 1331m, 1218m, 1190w, 
1155w, 1078m, 1032m, 941m, 896w, 868w, 787m, 683m. m.p. 213-214°C.  
2,4,6-Triphenyl-pyrylium iodide (140) 
To a warm slurry of 2,4,6-triphenylpyrylium tetrafluoroborate (1.505 g, 3.8 mmol) in water 
(20 mL) and acetic acid (2 drops) was added KI (0.59 g, 3.8 mmol). The solution was stirred 
for 1.5 hours, until red, and cooled to room temperature. The iodide was collected by 
filtration, washed several times with diethyl ether and dried under high-vacuum. The product 
was obtained as a red crystalline solid (1.65 g, 100%). 
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C23H17IO (436.28) 
1H NMR (400.1 MHz, MeOD, 300K): δ = 7.75-7.88 (m, 9H), 8.44 (d, 2H), 8.52 (m, 4H), 
9.00 (d, 2H). MS (+FAB, 3-NBA), m/z: 309 (MH+, 100), 77 (Ph+, 18.1). IR (KBr): ν~ [cm-1] = 
1621.1s, 1577.6s, 1528.6m, 1496.2222s, 1467.8s, 1419.4m, 1345.1w, 1273.4m, 1248.7s, 
1195.1w, 1158.7w, 1056.7w, 996.1s, 953.9m, 883.6w, 772.3s, 716.0m, 679.5s, 602.7s. m.p. 
246°C.  
2,6-Methyl-4-phenyl-λ3-phosphinin (141) 
To a solution of 2,6-dimethyl-4-phenylpyrylium iodide (717 mg, 2.3 mmol) in dry acetonitrile 
(13 mL) under argon is added tris(trimethylsilyl)phosphine (0.75 mL, 2.6 mmol). The mixture 
is heated to reflux and stirred at this temperature for 20 hours. Then silica is added and the 
volatiles are carefully evaporated through a frit. The mixture is purified by column 
chromatography on silica eluting with hexane (2% ethyl acetate). The product is obtained as a 
light-yellow solid (240 mg, 52%). Kugelrohrdistillation (10-1 mbar, 150°C) affords a white 
solid. 
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C13H13P (200.22) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 2.72 (d, 3JHP = 14.9 Hz, 6H, 1), 7.36 (pst, 3JHH = 
7.3 Hz, 1H, 8), 7.45 (m, 2H, 6), 7.58 (m, 2H, 7), 7.73 (d, 3JHP = 6.8, Hz, 2H, 3). 13C{1H} 
NMR (100.6 MHz, CDCl3, 300K): δ = 24.8 (d, 2JCP = 36.0 Hz, 1), 127.7 (8), 127.8 (d, 5JCP = 
1.5 Hz, 6), 129.0 (7), 132.3 (d, 2JCP = 13.4 Hz, 3), 142.5 (5), 143.5 (4), 168.6 (d, 1JCP = 50.2 
Hz, 2). 31P{1H} NMR (162 MHz, CDCl3, 300K): δ = 193.6. MS (+EI) m/z: 200.1 (M+, 100), 
185.1 (M+-CH3, 38.6). IR (KBr): ν~ [cm-1] = 3448br, 2994m, 2946m, 2904m, 2847m, 1953w, 
1891w, 1814w, 1766w, 1596w, 1565m, 1439s, 1377s, 1180w, 1102m, 1075m, 877s, 736s, 
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898s. m.p. 56-57°C. TLC (hexane:ethyl acetate; 98:2) Rf = 0.4. EA %found (calcd) C: 78.11 
(77.99), H: 6.60 (6.54). 
2,4,6-Triphenyl-λ3-phosphinine (97) 
2,4,6-Triphenylpyrylium iodide (1.1 g, 2.5 mmol) was dissolved in acetonitrile (15 mL). 
P(TMS)3 (0.7g, 2.8mmol) was added via syringe and the mixture was heated to reflux for 24 
hours. After evaporation of the volatiles the mixture was purified by column chromatography 
on silica (hexane:ethyl acetate, 10:1). The product is obtained as a light-yellow solid (405 mg, 
50%). 
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C23H17P (324.25)  
1H NMR (400.1 MHz, CDCl3, 300K): δ = 7.43 (m, 3H, 8/11), 7.50 (m, 6H, 5/9), 7.70 (d, 3JHH 
= 7.3 Hz, 2H, 7), 7.75 (d, 3JHH = 8.3 Hz, 4H, 9), 8.18-8.2 (d, 3JHP = 5.8 Hz, 2H, 2). 13C{1H} 
NMR (100.6 MHz, CDCl3, 300K): δ = 127.8 (7), 127.9 (5), 128.0 (d, 3JCP = 15.3 Hz, 9), 
128.1 (6), 129.1 (10), 129.2 (11), 131.9 (d, 2JCP = 12.3 Hz, 2), 142.3 (d, 4JCP = 3.0 Hz, 4), 
143.5 (d, 2JCP = 24.2 Hz, 8), 144.2 (d, 3JCP = 13.8 Hz, 3), 171.9 (d, 1JCP = 51.8 Hz, 1). 31P{1H} 
NMR (162 MHz, CDCl3, 300K): δ = 184.1. MS (+EI) m/z: 324 (M+, 100), 246 (15.08), 233 
(11.77), 191 (14.17). IR (KBr): ν~ [cm-1] = 3447br, 3018w, 1569m, 1489m, 1442m, 1379m, 
1348m, 1075m, 1026m, 887m, 754s, 693s, 587m, 484m. m.p. 167°C. TLC (hexane:ethyl 
acetate 10:1) Rf = 0.56. EA %found (calcd) C 84.83 (85.17), H 5.36 (5.28). 
η4-(1,5-Cyclooctadiene)bis(pyridine)iridium(I) Tetrakis-[3,5-bis(trifluoromethyl)phenyl] 
borate (142)[224] 
[Ir(cod)Cl]2 (420 mg, 620 µmol) was dissolved in dichloromethane (20 mL). Pyridine (0.7 
mL, 8.62 mmol) were added, which resulted in a colorchange from orange to yellow. After 
stirring for 15 minutes at room temperature, NaBArF (1.2 g, 1.35 mmol) was added and the 
solution was stirred for 7 hours at room temperature. Filtration and evaporation of the 
volatiles afforded 142 as a yellow powder that was recrystallized from 
dichloromethane/hexane (1.64 g, 95%).  
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C50H34BF24IrN2 (1321.81) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 1.86 (q, 4H, 5), 2.39 (m, 4H, 5), 3.81 (d, 4H, 4), 
7.27 (m, 4H, 1), 7.5 (s, 4H, 7), 7.63 (m, 2H, 3), 7.7 (s, 8H, 9), 8.6 (d, 4H, 2). 13C{1H} NMR 
(100.6 MHz, CD2Cl2, 300K): δ = 31.4 (5), 71.7 (4), 117.6 (9), 124.6 (q, 1JCF = 272 Hz, 10), 
127.1 (2), 129.1(q, 2JCF = 28.7 Hz, 8), 134.9 (7), 139.4 (3), 149.2 (1). MS (+ESI) m/z: 460.0 
(M+, 19.3), 458.9 (M+, 100), 457.0 (M+, 59.5). EA %found (calcd): C 45.35 (35.43); H 2.60 
(2.59); N 2.30 (2.12). 
Tetrakis(2,4-methyl-6-phenyl-phosphinine)-iridium(I) tetrakis-[3,5-bis(trifluoromethyl) 
phenyl]borate (144) 
To a solution of bis(pyridine)-η4-(1,5-cyclooctadiene)-iridium(I) tetrakis-[3,5-bis(trifluoro-
methyl)phenyl]borate (132.2 mg, 0.1 mmol) in dichloromethane (1 mL) was added 2,6-
dimethyl-4-phenylphosphinine (20 mg, 0.1 mmol). The yellow solution turned instantaniously 
red. Column chromatography of the mixture afforded a violet-red product and starting 
material. 
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C84H64BF24IrP4 (1856.29) 
1H NMR (500.1 MHz, CD2Cl2, 300K): δ = 2.62 (t, 24H, 1), 7.42 (m, 12H, 6/8), 7.54 (m, 12H, 
7/12), 7.7 (s, 8H, 10), 7.98 (m, 8H, 3). 13C{1H} NMR (125.8 MHz, CD2Cl2, 300K): δ = 23.7 
(m, 1), 117.8 (q, 3JCF = 3.8 Hz, 12), 125.0 (q, 1JCF = 272.5 Hz, 13), 128.7 (3), 129.2 (q, 2JCF = 
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31.1 Hz, 11), 129.5 (7), 135.2 (s, 10), 137.6 (6/8), 141.2 (5), 142.0 (4), 154.7 (m, 2), 162.1 (q, 
1JBC = 50 Hz, 9). 31P{1H} NMR (162 MHz, CD2Cl2, 300K): δ = 144.9. MS (+FAB, 3-NBA), 
m/z: 993 (M+, 100), 793 (M+-L, 53.6), 793 (M+-2L, 81.7). IR (KBr): ν~ [cm-1] = 2923.8, 
1609.7, 1457.0, 1355.5, 1277.9, 1124.3, 885.6, 836.9, 725.5, 674.9. TLC (dichloromethane) 
Rf = 0.86. 
Chloro-η4-(1,5-cyclooctadiene)-(2,4-methyl-6-phenyl-phosphinine)-iridium(I) (145) 
To a solution of bis-chloro-η4-(1,5-cyclooctadiene) iridium (I) dimer (50 mg, 74 µmol) in 
dichloromethane (1 mL), was added ,6-dimethyl-4-phenylphosphinine (30 mg, 150 µmol). 
The solution was stirred for 1 hour at room temperature. Then the solvent was evaporated and 
the crude was washed with pentane (3×1 mL). Drying under high-vacuum yielded an orange 
solid (78.5 mg, 99%). 
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C21H25ClIrP (536.07) 
1H NMR (500.1 MHz, CDCl3, 300K): δ = 1.91 (sbr, 4H, 10/11), 2.34 (sbr, 4H, 10/11), 2.80 (d, 
3JHP = 14.9 Hz, 6H, 1), 3.53 (sbr, 2H, 9), 5.36 (sbr, 2H, 12), 7.38 (m, 1H, 8), 7.44 (m, 2H, 7), 
7.50 (m, 2H, 6), 7.84 (d, 3JHP = 19.7 Hz, 2H, 3). 13C{1H} NMR (100.6 MHz, CDCl3, 300K): δ 
= 23.1 (d, 2JCP = 19.55 Hz, 1), 29.8 (10), 34.4 (11), 54.3 (9), 97.5 (d, 3JCP = 11.8 Hz, 12), 
127.5 (d, 4JCP = 3.2 Hz, 6), 127.9 (8), 129.1 (7), 136.5 (d, 2JCP = 12.1 Hz, 3), 140.5 (d, 3JCP = 
26.0 Hz, 4), 141.8 (d, 4JCP = 5.6 Hz, 5), 154.3 (d, 2JCP = 24.5 Hz, 2). 31P{1H} NMR (162 
MHz, CD2Cl2, 300K): δ = 178.1. 
7.4.8 Towards 6-Ring-Chelating Phosphininoxazolines 
4-(Benzyloxy)-6-methyl-2H-pyran-2-one (147)[146] 
4-Hydroxy-6-methyl-2-pyrone (3 g, 23.79 mmol) and K2CO3 (9.85 g, 71.34 mmol) were 
dissolved in DMF (100 mL). At 0°C benzyl bromide was added dropwise to the solution. 
After stirring at room temperature for 1 hour the solution was quenched with water (100 mL). 
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Extraction with ethyl acetate (3×100 mL) was followed by column chromatography 
(hexane:ethyl acetate, 7:3) to afford a white crystalline solid (1.42 g, 28 %). 
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C13H12O3 (216.23) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 2.20 (s, 3H, 6), 5.00 (s, 2H, 7), 5.49 (d, 4JHH = 2.0 
Hz, 1H, 2), 5.83 (dd, 4JHH = 1.0 Hz, 4JHH = 2.0 Hz, 1H, 4), 7.38 (m, 5H, 9-11). 13C{1H} NMR 
(125.8 MHz, CDCl3, 300K): δ = 20.0 (6), 70.8 (7), 88.6 (2), 100.7 (4), 127.9 (9), 128.9 (11), 
128.9 (10), 134.5 (8), 162.3 (5), 165.0 (3), 170.4 (1). MS (+EI) m/z: 216.1 (M+, 2.8), 132 
(9.9), 91, (Bn+, 100), 65 (7.7). IR (KBr): ν~ [cm-1] = 3076w, 3035w, 1736s, 1648s, 1569s, 
1497m, 1451s, 1380s, 1318m 1259s, 1181m, 1145s, 1014s, 949m, 909m, 859m, 819s, 737s, 
692s, 594m. m.p. 89-90°C. TLC (hexane:ethyl acetate; 7:3) Rf = 0.28. EA %found (calcd): 
C: 72.18 (72.21), H: 5.59 (5.59). 
2-(4-(Benzyloxy)-6-oxo-6H-pyran-2-yl)acetic acid (148) 
To a solution of 4-benzyloxy-6-methyl-2-pyron (108 mg, 0.5 mmol) in dry THF (10 mL) at -
78° LHMDS (1M in hexane, 0.8 mmol) are added over 10 minutes. The solution is stirred for 
1 hour at -78°C. Then the dry-ice bath is removed and CO2 is bubbled through the solution. 
The white dispersion is allowed to warm to room temperature. After extraction with diethyl 
ether (10 mL) and water (10 mL) the layers were separated. The organic layer was discarded. 
The aqueous layer was acidified to pH ≈1, and then extracted diethyl ether (3×10 mL). the 
combined organic phases were dried over Na2SO4. Filtration and evaporation of the volatiles 
gave a light-yellow oil which solidified upon standing to give an off-white solid (110 mg, 
85%). 
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C14H12O5 (260.24) 
1H NMR (400.1 MHz, DMSO, 300K): δ = 3.55 (s, 2H, 2), 5.15 (s, 2H, 8), 5.71 (d, 3JHH = 2.3 
Hz, 1H, 4), 6.24 (d, 3JHH = 2.28 Hz, 1H, 6), 7.39 (m, 5H, 10-12). 13C{1H} NMR (125.8 MHz, 
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DMSO, 300K): δ = 38.7 (2), 70.4 (8), 88.9 (4), 102.2 (6), 128.2 (11), 128.4 (12), 128.6 (10), 
135.0 (9), 158.7 (3), 163.3 (5), 169.4 (1), 169.6 (7). MS (+FAB, 3-NBA), m/z: 261 (MH+, 
48.1), 149 (32.9), 91 (PhCH2+, 100). IR (neat): ν~ [cm-1] = 2941wbr, 2517 wbr, 1749m, 1720m, 
1670s, 1636m, 1614s, 1549s, 1501m, 1456m, 1431m, 1367m ,1344s, 1313m, 1252s, 1236s, 
1202m, 1190m, 1138m, 1080w, 1013m, 1003msh, 962s, 903w, 885m, 835m, 821m. m.p. 112-
114°C. EA %found (calcd): C: 64.39 (64.61), H: 4.79 (4.65), O: 30.70 (30.74). 
(S)-2-[4-(Benzyloxy)-6-oxo-6H-pyran-2-yl]-N-[(S)-1-hydroxy-3-methylbutan-2-yl]-
acetamide (149) 
According to general procedure 13, (5'-benzyloxy-3'-pyron)-acetic acid 148 (130 mg, 0.5 
mmol), HOBt (91 mg, 0.67 mmol), EDC (128.4 mg, 0.67 mmol) and L-valinol (52 mg, 0.5 
mmol) were reacted in dichloromethane (5 mL) and DMF (1 mL) to yield 149 (130 mg, 75%). 
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C19H23NO5 (345.39) 
1H NMR (500.1 MHz, CDCl3, 300K): δ = 0.94 (d, 3JHH = 6.8 Hz, 3H, 12), 0.90 (d, 3JHH = 6.8 
Hz, 3H, 12’), 1.89 (m, 1H, 11), 3.43 (2×d, 2JHH = 15.0 Hz, 2H, 6), 3.71 (m, 3H, 9/10), 5.02 (s, 
2H, 13), 5.54 (d, 3JHH = 2.3 Hz, 1H, 4), 6.09 (d, 3JHH = 2.0 Hz, 1H, 2), 7.36 (m, 5H, Ph). 
13C{1H} NMR (125.8 MHz, CDCl3, 300K): δ = 18.9 (12), 19.5 (12), 28.9 (11), 41.8 (6), 57.6 
(10), 63.3 (9), 71.0 (13), 89.4 (4), 102.9 (2), 127.9 (Ph), 128.8 (Ph), 128.9 (Ph), 134.1 (14), 
158.5 (5), 164.4 (3), 166.9 (7), 170.2 (1). MS (+FAB, 3-NBA), m/z: 346 (MH+, 29.6), 91 
(Bn+, 100). IR (neat): ν~ [cm-1] = 3300w, 3072w, 2961w, 1726s, 11643s, 1545s, 1499w, 
1456w, 1435m, 1373w, 1331w,1244m, 1167w, 1140m, 1078w, 1018m, 1003msh, 943w, 
914w, 866w, 810m. m.p. 154°C. [ ]20Dα : -23.1° (c = 1.01, CHCl3). TLC (ethyl acetate:ethanol; 
98:2): Rf = 0.33. EA %found (calcd): C: 65.91 (66.07), H: 6.63 (6.71), N: 3.95 (4.06), O: 
23.22 (23.16). 
(S)-2-[4-(Benzyloxy)-6-oxo-6H-pyran-2-yl]-N-[(S)-1-hydroxy-3,3-dimethylbutan-2-
yl]acetamid (150) 
According to general procedure 13 148 (1g, 3.85 mmol), HOBt (1.04 g, 7.7 mmol), EDC 
(1.47 mg, 7.7 mmol), and L-tert-leucinol (450 mg, 3.85 mmol) were reacted in DMF (4 mL) 
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and dichloromethane (40 mL). After column chromatography on silica eluting with ethyl 
acetate and ethanol 150 was obtained as an off-white solid (935 mg, 67%). 
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C20H25NO5 (359.42)  
1H NMR (500.1 MHz, CDCl3, 300K): δ = 0.95 (s, 9H, 13), 3.01 (sbr, 1H, 11), 3.48 (m, 2H, 6), 
3.56 (m, 1H, 10), 3.81 (m, 2H, 9/10), 5.0 (s, 2H, 14), 5.52 (d, 1H, 2), 6.1 (d, 1H, 4), 6.75 (d, 
1H, 8), 7.36 (m, 5H, 16-18). 13C{1H} NMR (125.8 MHz, CDCl3, 300K): δ = 27.0 (13), 33.9 
(12), 41.7 (6), 60.1 (9), 62.4 (10), 71.1 (14), 89.4 (2), 103.0 (4), 127.9 (16/18), 129.0 (17), 
134.3 (15), 159.1 (5), 164.8 (1), 167.5 (7), 170.5 (3). TLC (ethyl acetate:ethanol; 98:2) Rf = 
0.2 
(S)-4-Benzyloxy-6-[(4,5-dihydro-4-isopropyloxazol-2-yl)methyl]-2H-pyran-2-one (151) 
Amide 149 (750 mg, 2.18 mmol) and DMAP (27 mg, 10 mol%) were dissolved in 
dichloromethane (5 mL). Triethylamine (0.73 mL, 5.5 mmol) and tosyl chloride (415 mg, 
2.18 mmol) in dichloromethane (6 mL) were added successively. The mixture was allowed to 
stir for 24 hours at room temperature. Extraction with saturated ammoniumchloride (15 mL), 
NaHCO3 solution (15 mL) and brine (15 mL) was followed by drying over Na2SO4. After 
filtration the volatiles were evaporated. After column chromatography on silica with eluting 
with diethyl ether and triethylamine, product 151 was obtained as a light yellow solid (681 
mg, 96 %).  
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C19H21NO4 (327.37) 
1H NMR (500.1 MHz, CDCl3, 300K): δ = 0.84 (d, 3JHH = 6.8 Hz, 3H, 11), 0.92 (d, 3JHH = 6.8 
Hz, 3H, 11’), 1.70 (m, 1H, 10), 3.42 (s, 2H, 6), 3.89 (m, 1H, 9), 3.95 (m, 1H, 8), 4.24 (m, 1H, 
8), 4.99 (s, 2H, 12), 5.48 (d, 3JHH = 2.28 Hz, 1H, 4), 6.02 (d, 3JHH = 2.28 Hz, 1H, 2), 7.37 (m, 
5H, 14-16). 13C{1H} NMR (125.8 MHz, CDCl3, 300K): δ = 17.9 (11), 18.5 (11’), 32.6 (10), 
Chapter 7 
 198 
32.9 (6), 70.6 (8), 70.8 (12), 72.5 (9), 89.1 (4), 101.6 (2), 127.9 (Ph), 128.7 (Ph), 134.6 (13), 
158.9 (5), 161.0 (7), 163.6 (3), 169.8 (1). MS (+FAB, 3-NBA), m/z: 328 (MH+, 85.4), 91 
(Bn+, 100). IR (neat): ν~ [cm-1] = . m.p. 90°C. [ ]20Dα  = - 41.8° (c = 1.00, CHCl3). TLC (dietyhl 
ether:triethylamine; 4:1): Rf = 0.47. EA %found (calcd): C: 69.69 (69.71), H: 6.5 (6.47), N: 
4.15 (4.28). 
(S)-4-Benzyloxy-6-[(4-tert-butyl-4,5-dihydrooxazol-2-yl)methyl]-2H-pyran-2-one (152) 
Amid 150 (900 mg, 2.5 mmol) and DMAP (30.5 mg, 10 mol%) were dissolved in 
dichloromethane (12 mL). Triethylamine (0.9 ml, 6.3 mmol) and tosyl chloride (477 mg, 2.5 
mmol) in dichloromethane (3 mL) were added successively. After evaporation of the volatiles 
the residue was directly subJected to column chromatography on silica eluting with diethyl 
ether and triethylamine to give 152 (717 mg, 84 %). 
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C20H23NO4 (341.4)  
1H NMR (400.1 MHz, CDCl3, 300K): δ = 0.9 (s, 9H, 11), 3.49 (s, 2H, 6), 3.89 (m, 1H, 9), 
4.09 (pst, 1H, 8), 4.21 (pst, 1H, 8), 5.0 (s, 2H, 12), 5.53 (d, 1H, 4JHH = 2 Hz, 2), 6.05 (d, 1H, 
4JHH = 2.2 Hz, 4), 7.39 (m, 5H, 14-16). 13C{1H} NMR (125.8 MHz, CDCl3, 300K): δ = 
(CDCl3, 500 MHz) 25.9 (11), 33.1 (6), 46.3 (10), 69.3 (9), 71.0 (8), 76.1 (12), 89.6 (2), 101.9 
(4), 128.0 (14), 129.0 (15/16), 134.4 (13), 159.0 (5), 161.3 (1), 164.2 (7), 170.0 (3). TLC 
(diethyl ether:triethylamine; 4:1) Rf = 0.6. 
(S)-5-Benzyloxy-2-[4,5-dihydro-4-isopropyloxazol-2-yl]benzene-1,3-diol (154) 
According to general procedure 11 151 (162 mg, 514 µmol) was reacted with phosphaalkyne 
115 (1 mmol) in toluene (1 mL) and chlorobenzene (1 mL) to yield after the crude reaction 
mixture was subJected to column chromatography on silica gel eluting with ethyl acetate and 
hexane (95 mg, 56%). 
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C19H21NO4 (327.37) 
1H NMR (500.1 MHz, CDCl3, 300K): δ = 0.95 (d, 3JHH = 6.8Hz, 3H, 6), 1.11 (d, 3JHH = 6.8 
Hz, 3H, 6’), 1.13 (m, 1H, 5), 4.07 (ddd, 3JHH = 9.4 Hz, 3JHH = 8.0 Hz, 3JHH = 6.8 Hz, 1H, 4), 
4.17 (pst, 2JHH = 8.0 Hz, 3JHH = 8.0 Hz, 1H, 3), 4.89 (dd, 2JHH = 8.1 Hz, 3JHH = 9.4 Hz, 1H, 3), 
5.04 (s, 2H, 10), 6.14 (s, 2H, 8), 7.38 (m, 5H, 12-14). 13C{1H} NMR (125.8 MHz, CDCl3, 
300K): δ = 18.5 (6), 18.6 (6’), 32.8 (5), 69.7 (4), 69.9 (10), 70.3 (3), 92.3 (1), 94.7 (8), 127.0 
(12), 127.5 (14), 128.6 (13), 136.3 (11), 163.5 (2), 163.7 (9). MS (+EI) m/z: 327.1 (M+, 62.9), 
284.1 (49.8), 242.1 (6.7), 208.1 (12.0), 110.1 (14.8), 91.1 (Bn+, 100). TLC (ethyl 
acetate:hexane; 1:2) Rf = 0.56. [ ]20Dα  = -23.7° (c = 1.00, CHCl3). EA %found (calcd) C: 69.25 
(69.71), H: 6.49 (6.47), N: 4.27 (4.28). 
(S)-5-Benzyloxy-4-(2,2-dimethyl-propyl)-3-isopropyl-2,3-dihydro-4H-1,8-dioxa-3a-aza-4-
phospha-cyclopenta[b]naphthalen-7-one (155) 
Was afforded as a side product of the reaction 154 when pyrone 151 (316mg, 0.97 mmol) and 
phosphaalyne (1.9 mmo) in chlorobenzene (0.5 mL) were used (75mg, 18%). 
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C24H30NO4P (427.47) 
1H NMR (500.1 MHz, CDCl3, 300K): δ = 0.80 (d, 3JHH = 6.8 Hz, 3H, 11), 0.88 (d, 3JHH = 6.8 
Hz, 3H, 11’), 0.93 (s, 9H, 14), 1.30 (dd, 2JHH = 14.5 Hz, 2JHP = 2.6 Hz, 1H, 12), 2.09 (m, 2H, 
10/12), 3.79 (m, 1H, 9), 4.27 (m, 2H, 8), 4.86 (s,1H, 6), 5.03 (s, 2H, 15), 5.22 (d, 4JHP = 4.9 
Hz, 1H, 2), 7.38 (m, 5H, 17-19). 13C{1H} NMR (125.8 MHz, CDCl3, 300K): δ = 15.6 (d, 4JCP 
= 1.5 Hz, 11), 17.8 (11’), 29.4 (d, 2JCP = 12.5 Hz, 13), 30.6 (d, 3JCP = 8.1 Hz, 14), 31.0 (d, 3JCP 
= 1 Hz, 10), 45.9 (d, 1JCP = 30 Hz, 12), 64.5 (d, 2JCP = 18.8 Hz, 9), 69.7 (d, 3JCP = 3 Hz, 8), 
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70.3 (15), 72.0 (6), 82.8 (d, 3JCP = 2.7 Hz, 2), 86.5 (d, 1JCP = 1 Hz, 4), 127.5 (17), 128.3 (19), 
128.5 (18), 135.3 (16), 164.1 (1), 165.1 (d, 2JCP = 12.9 Hz, 7), 165.8 (d, 2JCP = 4.1 Hz, 5), 
170.2 (d, 2JCP = 20.7 Hz, 3). 31P{1H} NMR (162.0 MHz, CDCl3, 300K): δ = 18.2. MS 
(+FAB, 3-NBA), m/z: 428 (MH+, 93.8), 356 (M+-Np, 100), 266 (M+-Np-OBn, 24.4), 91 (Bn+, 
93.2). TLC (ethyl acetate:hexane; 1:2) Rf = 0.28. 
(S)-4-Benzyloxy-6-[2-(4,5-dihydro-4-isopropyloxazol-2-yl)propan-2-yl]-2H-pyran-2-one 
(159) 
LiHMDSA (1M in hexane, 4.3 mmol) was dissolved in THF (15 mL). At -78°C a solution of 
pyrone 151 (469 mg, 1.43 mmol) in THF (10 mL) was added via cannula. The cannula was 
then rinsed with THF (5 mL). The orange to yellow solution was stirred at -78°C for 1.5 
hours. After quenching with methyl iodide (0.3 mL, 4.78 mmol) the solution was allowed to 
warm to room temperature over night. The orange-brown suspension was reduced and then 
diluted dichloromethane (20 mL). Extraction with 1M NH4Cl solution (20 mL) was followed 
by reextraction of the aqueous layer with dichloromethane (3×20 mL). The combined organic 
layers were washed with brine and dried over Na2SO4. Column chromatography on silica 
eluting with diethyl ether and hexan afforded 159 (206 mg, 40%). 
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C21H25NO4 (355.43) 
1H NMR (500.1 MHz, CDCl3, 300K): δ = 0.86 (d, 3JHH = 7 Hz, 3H, 13), 0.93 (d, 3JHH = 7 Hz, 
3H, 13’), 1.54 (2×s, 6H, 7-8,), 1.81 (m, 1H, 12), 3.97 (m, 2H, 10-11), 4.21 (m, 1H, 10), 4.99 
(s, 2H, 14), 5.52 (d, 1H, 4), 5.97 (d, 1H, 2), 7.38 (m, 5H, 16-18). 13C{1H} NMR (125.8 MHz, 
CDCl3, 300K): δ = 17.7 (13), 18.8 (13’), 24.6 (7/8), 32.4 (12), 41.8 (6), 70.3 (10), 71.0 (14), 
71.8 (11), 89.4 (2), 99.0 (4), 128.1 (16), 129.0 (17-18), 134.5 (15), 164.3 (5), 167.3 (9), 168.4 
(1), 170 (3). 
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7.5 Asymmetric Catalytic Intramolecular Pauson-Khand Reaction 
3-Phenylprop-2-yn-1-ol [1504-58-1] was purchased from Lancaster. Iridium complexes (S)-
[Ir(cod)PHOX]OTf 161e, (S)-[Ir(cod)PHOX]PF6 161g, (S)-[Ir(cod)PHOX]BF4 161f were 
prepared according to literature procedures.[180,56] (S)-[Ir(cod)PHOX]OAcF 161i, and (S)-
[Ir(cod)PHOX]SbF6 161h were prepared from the corresponding chloro-complexes by ion 
exchange with silver salts. (S)-[Ir(cod)PHOX]OTs 161b and (S)-[Ir(cod)PHOX]OMs 161c 
were prepared from the respective sodium salts. (S)-[Ir(cod)PHOX] BArF 161a was prepared 
by Esther Hörmann. (S)-[Ir(cod)PHOX][Al(OC(CF3)3)4] 161d was prepared with lithium 
tetrakis(perfluoro-tert-butoxy)aluminate (from Ingo Krossing[181]) according to the procedure 
of 161a. Allyl-(3-phenyl-prop-2-ynyl) ether S1, allyl-(3-methyl-prop-2-ynyl) ether S5 and [3-
(2-methyl-allyloxy)-prop-1-ynyl]-benzene S4 were prepared by Zhong-Lin Lu.  
Synthesis of Pauson-Khand Products P1 to P4 
general procedure 15: In the glove-box a flame-dried young-tube was charged with substrate 
S1 to S5 (0.22 mmol), catalyst (2.2 - 20 µmol) and solvent (5 mL). The mixture was degassed 
with three freeze-pump cycles, and charged with CO. After reaction at 140 °C (24 to 48 h) the 
reaction mixture was concentrated and purified by column chromatography on silica gel. 
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7.5.1 Substrate Synthesis 
3-Phenyl-prop-2-ynyl-bromide (164)[177] 
At 0°C PBr3 (7.4 g, 38 mmol) in diethyl ether (5 mL) was added to 3-phenylprop-2-yn-1-ol 
163 (5.0 g, 37.8 mmol) in diethyl ether (30 mL) and pyridine (5 mL). After stirring for 40 h, 
the mixture was poured into water (150 mL), and extracted with diethyl ether (3×100 mL). 
The combined organic layers were washed with brine (100 mL) and dried over MgSO4. After 
removal of solvent, the crude product was purified by column chromatography on silica 
eluting with hexane. The product was obtained as a colourless liquid that turns yellow upon 
standing (3.2 g, 43%). 
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C9H7Br (195.06) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 4.17 (s, 2H, 1), 7.29-7.35 (m, 3H, 5/7) 7.43-7.46 
(m, 2H, 6). 13C{1H} NMR (100.6 MHz, CDCl3, 300K): δ = 15.5 (1), 84.3 (2), 86.9 (3), 122.2 
(4), 128.5 (5), 129.0 (7), 132.0 (6). MS (+EI) m/z: 194 (M+, 5.3), 196 (M+, 5.1), 115.2 (M-Br-, 
100). IR (KBr): ν~ = 3057w, 2955w, 2926w, 2861w, 2364w, 2338w, 2219m, 2597w, 1490m, 
1442m, 1272m, 1203s, 1069w, 1029w, 985w, 756s, 689s.TLC (n-hexane) Rf = 0.36 
N-Allyl-N-(3-phenyl-prop-2-ynyl) amine (166)[174] 
In a dry flask under argon, a diethyl ether solution (5 mL) of allylamine 165 (2.4 mL, 31.4 
mmol) was added to a diethyl ether solution (5 mL) of 3-phenyl-prop-2-ynyl-bromide 164 
(613 mg, 3.14 mmol) at 0°C. The reaction mixture was stirred for 50 min at 0°C and then for 
45 min at ambient temperature. The reaction was quenched with water (15 mL) and extracted 
three times with ethyl acetate (3×15 mL). The combined organic layers were washed with 
brine (15 mL) and dried over magnesium sulfate. The solvent was removed in vacuo and 
purification by flash column chromatography (n-hexane: ethyl acetate 2:1 to 1:1) afforded N-
allyl-N-(3-phenyl-prop-2-ynyl)-amine (475 mg, 88 %). 
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C12H13N (171.24) 
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1H NMR (500.1 MHz, CDCl3, 300K): δ = 1.9 (br, 1H, 11), 3.43 (dt, 3JHH = 6.1 Hz, 4JHH = 1.1 
Hz, 2H, 1), 3.67 (s, 2H, 4), 5.16 (d, 1H, 3JHHcis = 10.2 Hz, 3), 5.27 (d, 1H, 3JHHtrans = 17.2 Hz, 
3), 5.94 (ddt, 1H, 2), 7.29-7.31 (m, 3H, 8/10), 7.41-7.44 (m, 2H, 9). 13C{1H} NMR (125.8 
MHz, CDCl3, 300K): δ = 38.3 (4), 51.1 (1), 84.0 (5), 87.1 (6), 117.2 (3), 123.2 (2), 128.3 (10), 
128.4 (8), 131.8 (9), 135.8 (7). MS (+EI) m/z: 170.2 (M+-H, 68.0), 142.1 (C10H8N, 41.8), 115 
(C9H7, 100). IR (NaCl): ν~ = 3324m, 3076m, 2979w, 2913m, 2825m, 2362s, 2338ssh, 1738w, 
1644m, 1598m, 1490m, 1446s, 1327m, 1249m, 1105s, 1030w, 995m, 920s, 756s, 691s. TLC 
(n-hexane: ethyl acetate, 2:1) Rf = 0.14 
N-Allyl-N-(3-phenyl-prop-2-ynyl)-4-methylphenylsulfonamide (S2)[177] 
To a mixture of N-allyl-N-(3-phenyl-2-propynyl) amine 166 (713 mg, 4.16 mmol), 
triethylamine (0.9 mL) and dichloromethane (5 mL) was added a solution of p-
toluenesulfonyl chloride (953 mg, 5 mmol) in dichloromethane (5 mL) at 0°C. The mixture 
was allowed to reach room temperature over night. The reaction was quenched after 14 hours 
with phosphate buffer (pH 7) and extracted with chloroform (3×10 mL). The combined 
extracts were washed with brine and dried over anhydrous MgSO4. Evaporation and flash 
column chromatography on silica (n-hexane: ethyl acetate, 1:1) were followed by 
recrystallization in ethyl acetate. The title compound was obtained as colorless crystals (1.2 g, 
89 %). 
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C19H19NO2S (325.42) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 2.33 (s, 3H, 15), 3.88 (d, 3JHH = 6.4 Hz, 2H, 1), 4.3 
(s, 2H, 4), 5.27 (dd, 1H, 3JHHcis = 10.1 Hz, 3), 5.33 (dd, 1H, 3JHHtrans = 19.9 Hz, 3), 5.75-5.85 
(ddt, 1H, 2), 7.04-7.07 (m, 2H, 12), 7.23-7.27 (m, 5H, 8-10), 7.76-7.79 (m, 2H, 13). 13C{1H} 
NMR (125.8 MHz, CDCl3, 300K): δ = 21.6 (15), 36.9 (4), 49.4 (1), 81.8 (5), 85.8 (6), 120.1 
(3), 122.4 (14), 128.0 (13), 128.3 (8), 128.5 (10), 129.7 (9), 131.6 (12), 132.2 (2), 136.1 (7), 
143.7 (11). MS (+FAB, 3-NBA) m/z: 326 (MH+, 58.7), 224 (C11H14NO2S+, 83.8), 170 (M+-
Ts, 25.9), 155 (Ts+, 25.7), 115 (C9H7+, 100), 91 (C7H7+, 48.8). IR (KBr): ν~ = 3424mbr, 
3085w, 3059w, 3012w, 2962w, 2909w, 2859w, 1922w, 1891w, 1648w, 1594w-m 1488w, 
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1442m, 1348s, 1322s, 1255w, 1160s, 1091m, 1060m, 996w, 942m, 902s, 814m, 762s, 694m, 
661s, 583s, 536s. TLC (n-hexane: ethyl acetate, 1:1) Rf = 0.47 
2-Allyl-malonic acid dimethyl ester (168)[177] 
To a suspension of NaH (1.01 g, 42 mmol) in THF (50 mL) was added dimethyl malonate 167 
(5.34 g, 40.4 mmol) at 0°C. After stirring for additional 15 min at 0°C, allyl bromide (9.7 g, 
80 mmol) was added dropwise at room temperature. After 2h, the reaction mixture was 
quenched with water (50 mL), extracted with diethyl ether (3×75 mL), and washed with brine 
(50 mL). The combined organic extracts were dried over MgSO4 and evaporated. The crude 
product was further purified by flash column chromatography on silica (n-hexane/ethyl 
acetate 15:1). The product was obtained as a colorless liquid (3.7 g, 53%). 
1
O 2 3 O
O O
4
5
6  
C8H12O4 (172.18) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 2.65 (tt, 2H, 4), 3.47 (t, 1H, 3), 3.74 (s, 6H, 1), 
5.06 (dd, 1H, 6), 5.12 (dd, 1H, 6), 5.76 (m, 1H, 5). 13C{1H} NMR (125.8 MHz, CDCl3, 
300K): δ = 33.0 (1), 51.5 (4), 52.7 (3), 117.8 (4), 134.0 (5), 169.4 (2). MS (+FAB, 3- NBA) 
m/z: 173 (MH+, 100), 141 (C7H9O3+, 25.5), 109 (34.8), 41 (C3H5+, 22.5). IR (NaCl): ν~ = 
3081w (νCH, C=C), 3004 (νCH, C=C), 2956w (νCH, CH3), 2365w, 1742s (νCO), 1644w, 1439m 
(δCH, CH3), 1343m (δCH, CH2), 1276m, 1240m, 1200m, 1159m, 1059w, 1026w, 924w (δCH, 
C=C), 853w, 462sbr. TLC (n-hexane/ethyl acetate 15:1) Rf = 0.13. 
2-Allyl-2-(3-phenyl-prop-2-ynyl)-malonic acid dimethyl ester (S3)  
To a suspension of NaH (288 mg, 12 mmol) in THF (10 mL) was added 2-allyl dimethyl 
malonate 168 (1.69 g, 9.81 mmol) in THF (15 mL) at 0°C. After stirring for additional 2 h at 
room temperature, 3-phenyl-prop-2-ynyl-bromide 164 (2.1 g, 10.8 mmol) in THF (15 mL) 
was added dropwise. After 1.5 h the reaction mixture was poured to saturated of NH4Cl (30 
mL) and extracted with diethyl ether (3×50 mL). The combined organic layers were dried 
over MgSO4. Flash column chromatography on silica (n-hexane: ethyl acetate, 4:1) followed 
by Kugelrohr destillation (200°C, 10-1 mbar) afforded  the product as a colourless oil (2.77g, 
99 %). 
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C17H18O4 (286.32) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 2.86 (d, 3JHH = 7.6 Hz, 2H, 1), 3.01 (s, 2H, 4), 3.76 
(s, 3H, 13), 5.13 (dd, 3JHH = 10.1 Hz, 2JHH = 2 Hz, 3), 5.20 (dd, 3JHH = 17 Hz, 2JHH = 2 Hz, 3), 
5.67 (ddt, 3JHH = 17, 10, 7.3 Hz, 2), 7.27-7.29 (m, 3H, 8&10), 7.35-7.38 (m, 2H, 9). 13C{1H} 
NMR (125.8 MHz, CDCl3, 300K): δ = 23.8 (4), 36.9 (1), 52.9 (13), 57.4 (11), 83.8 (6), 84.3 
(5), 120.0 (3), 123.3 (7), 128.2 (10), 128.4 (8), 131.8 (9), 132.0 (2), 170.5 (12). MS (+FAB, 3-
NBA) m/z: 287 (MH+, 100%), 227 (38.51%), 167 (24.35%), 147 (68.40%), 115 (30.43%). IR 
(NaCl): ν~ = 2954w, 2364w, 1740s, 1438m, 1327w, 1291m, 1217s, 1114w, 1067w, 926w, 
757m, 690w. TLC (n-hexane: ethyl acetate, 4:1) Rf = 0.31. 
7.5.2 Products of ACPKR 
2-Phenyl-7-oxabicyclo[3,3,0]oct-1-en-3-one (P1) 
The synthesis was performed according to general procedure 15. 
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C13H12O2 (200.23) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 2.35 (dd, 2JHH = 17.7 Hz, 3JHH = 3.8 Hz, 1H, 7), 
2.87 (dd, 2JHH = 17.7 Hz, 3JHH = 6.0 Hz, 1H, 7), 3.25 (dd, 3JHH = 11.1 Hz, 3JHH = 7.6 Hz, 1H, 
5), 3.33 (m, 1H, 6), 4.38 (pst, 3JHH = 7.6 Hz, 1H, 5), 4.60 (d, 3JHH = 16.4 Hz, 1H, 4), 4.95(d, 
3JHH = 16.2 Hz, 1H, 4), 7.34-7.37 (m, 1H, 11), 7.40-7.44 (m, 2H, 9), 7.51-7.54 (m, 2H, 10). 
13C{1H} NMR (125.8 MHz, CDCl3, 300K): δ = 40.5 (7), 43.5 (6), 66.5 (5), 71.5 (4), 128.2 
(9), 128.8 (10), 130.7 (11), 134.9 (8), 177.5 (2),207.0 (1). MS (+EI) m/z: 200.1 (M+, 85.1), 
170.0 (43.4), 158.1 (C11H10O+, 49.9), 141.1 (100), 128.1 (45.6), 115.1 (61.1), 105.0 (59.2), 77 
(Ph+, 32.5). IR (NaCl): ν~ = 3057m, 2977m, 2851m, 2236w, 1985w, 1890w, 1806w, 1707s, 
1658s, 1602w, 1496m, 1445m, 1411m, 1352m, 1352m, 1296m, 1241w, 1204w, 1165m, 
1119m, 1081w, 1026s, 968w, 906s,766s, 696s, 660m.TLC (n-hexane/ethyl acetate; 2:1) Rf = 
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0.3. HPLC Daicel Chiracel AD (25 cm×0.46 cm), n-heptane:i-propanol (90:10), 20 °C, 1.0 
mL/min, 220nm/254nm: 11.1 min (R), 14.6min (S). 
6-Phenyl-2-(toluene-4-sulfonyl)-2,3,3a,4-tetrahydro-1H-cyclopenta[c]pyrrol-5-one (P2) 
The synthesis was performed according to general procedure 15. 
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C20H19NO3S (353.43) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 2.25 (dd, 1H, 2JHH = 18.0 Hz, 3JHH = 3.5 Hz, 3), 
2.41 (s, 3H, 16), 2.61 (dd, 1H, 2JHH = 10.9 Hz, 3JHH = 9.3, 1), 2.80 (dd, 1H, 2JHH = 17.4 Hz, 
3JHH = 6.3 Hz, 3), 3.21 (mbr, 1H, 2), 4.08 (m, 2H, 1/7), 4.64 (dd, 1H, 2JHH = 17.0 Hz, 4JHH = 
1.8, 7) 7.31 (d, 2H, 3JHH = 8.1 Hz, 14), 7.36-7.46 (m, 5H, 9-11), 7.72 (d, 2H, 3JHH = 8.1 Hz, 
13). 13C{1H} NMR (100.6 MHz, CDCl3, 300K): δ = 21.7 (16), 40.9 (2), 42.0 (3), 48.5 (7), 
52.2 (1), 127.5 (13), 128.3 (9), 128.9 (10), 129.1 (11), 130.0 (5), 130.2 (14), 133.8 (8), 136.3 
(12), 144.2 (15), 172.0 (6), 205.6 (4). MS (+FAB, 3-NBA) m/z: 354 (MH+, 100), 198 
(C13H12NO+, 66.3), 115 (17.9), 91 (C7H7+, 69). IR (KBr): ν~ = 3427mbr, 1348m, 3845m, 
1702s, 1936m, 1596m, 1492m, 1442s, 1346s, 1282m, 1214m, 1159s, 1089m, 1044s, 918m, 
811s, 765s, 692s, 659s, 610m, 552s. m.p. 144-145 °C. TLC (n-hexane:ethyl acetate 2:1) Rf = 
0.15. HPLC Daicel Chiracel AD (25 cm×0.46 cm), n-heptane:i-propanol (80:20), 20 °C, 1.0 
mL/min, 220nm/254nm: 19.1 min (maJor), 22.7min (minor). EA % found (calcd): C: 67.74 
(67.97), H: 5.55 (5.42), N: 3.92 (3.96), O: 13.57 (13.58). 
5-Oxo-6-phenyl-3,3a,4,5-tetrahydro-1H-pentalene-2,2-dicarboxylic acid dimethyl ester 
(P3) 
The synthesis was performed according to general procedure 15. 
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C18H18O5 (314.33) 
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1H NMR (400.1 MHz, CDCl3, 300K): δ = 1.77 (pst, 3JHH = 12.6 Hz, 1H, 14), 2.31 (dd, 1H, 
12), 2.8-2.87 (m, 2H, 12/14), 3.14 (mbr, 1H, 13), 3.30 (d, 2JHH = 19.2 Hz, 1H, 4), 3.66 (d, 2JHH 
= 19.2 Hz, 1H, 4), 3.72 (s, 3H, 1), 3.83 (s, 3H, 1’), 7.33 (m, 1H, 10), 7.39-7.42 (m, 2H, 8), 
7.54-7.57 (m, 1H, 9). 13C{1H} NMR (125.8 MHz, CDCl3, 300K): δ = 36.1 (4), 39.0 (14), 42.8 
(12), 43.0 (13), 53.3 (1), 53.5 (1’), 61.3 (3), 128.4 (10), 128.6 (8), 128.6 (9), 131.0 (7), 135.7 
(6), 171.3 (2), 172.2 (2’), 178.8 (5), 207.2 (11). MS (+EI) m/z: 314 (M+, 38.7), 254.2 
(C16H14O3+, 100), 195.1 (C14H11O+, 75.4), 167.1 (C13H11+, 39.6). IR (NaCl): ν~ = 2956m, 
2364w, 1736s, 1706s, 1652m, 1601w, 1495w, 1439m, 1274s, 1197s, 1159s, 1121m, 1061m, 
1004w, 938w, 883w, 853w, 765m, 698m. TLC (n-hexane:ethyl acetate 2:1) Rf = 0.22. HPLC 
Daicel Chiracel AS (25 cm×0.46 cm), n-heptane:i-propanol (90:10), 20 °C, 1.0 mL/min, 
220nm/254nm: 15.0 min (minor), 24.3min (maJor). 
2-Phenyl-5-methyl-7-oxabicyclo[3,3,0]oct-1-en-3-one (P4) 
The synthesis was performed according to general procedure 15. 
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C14H14O2 (214.26) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 1.3 (s, 3H, 8), 2.58 (2×d, 2JHH = 17.2 Hz, 2H, 7), 
3.43 (d, 2JHH = 7.8 Hz, 1H, 5), 4.04 (d, 2JHH = 8.1 Hz, 1H, 5), 4.44 (d, 2JHH = 16.4 Hz, 1H, 4), 
4.95 (d, 2JHH = 16.1 Hz, lH, 4), 7.35-7.55 (m, 5H, 10-12). TLC (n-hexane/ethyl acetate; 2 : 1) 
Rf = 0.3. HPLC Daicel Chiracel AD (25 cm×0.46 cm), n-heptane:i-propanol (90:10), 20°C, 
1.0 mL/min, 220nm/254nm: 7.9-8.2 min (maJor R), 16.9-17.7 min (minor S).
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7.6 Rhodium-Silylene Complexes 
7.6.1 Synthesis of Silylenes 
NaBArF was prepared as previously described.[225] [Rh(cod)Cl]2 was purchased from Strem. 
1,5-Cyclooctadiene was purchased from Fluka and distilled prior to use. 
N,N’-Di-tert-butyl-ethylendiimin (179)[200] 
To a solution of tert-butylamine (73.1 mL, 696 mmol) in water (50 mL) was added dropwise 
at 0°C an aqueous 40% glyoxal solution (40 mL,348 mmol). After the resulting white 
suspension was stirred for an additional 45 min, the product was filtered and recrystallized 
from ethanol and water (1:1). Subsequent sublimation afforded the product as colorless 
crystals (53 g, 90%). 
3
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N21
 
C10H20N2 (168.28)  
1H NMR (400.1 MHz, CDCl3, 300K): δ = 1.25 (s, 18H, 1), 7.93 (s, 2H, 3). 13C{1H} NMR 
(100.6 MHz, CDCl3, 300K): δ = 29.5 (1), 58.4 (2), 158.1 (3). MS (+FAB, 3-NBA) m/z: 41 
(16.7), 57.1 (C4H9+, 100), 97.1 (23.54), 112.1 (MH+-C4H9, 20.6), 141.2 (9.5). IR (KBr): 
ν~ [cm-1] = 2968.1m, 1631.0m, 1475.5m, 1361.6m, 1304.0w, 1213.1s, 933.2m, 879.0m, 
746.2m, 594.5w, 482.0m. m.p. 51°C. EA %found (calcd): C: 71.20 (71.37), H: 11.71 (11.98), 
N: 16.40 (16.65). 
N,N’-Di-tert-butyl-ethylendiamine (182)[204b] 
Dibromoethane (6.5 mL, 75 mmol), tert-butylamine (39.4 mL, 375 mmol), hexane (10 mL), 
and water (10 mL) were heated to reflux for three days. During this time, a prcipitate formed 
and two layers became apparent. After refluxing, the mixture was colled in an ice bath and 
three portion s of NaOH (3×2.7 g) were sequentially added to the reaction mixture. The 
exothermic reaction made the solution reflux anew. After coooling, the hexane layer was 
stored over NaOH. This organic layer was then distilled to remove the hexane and any 
unreacted dibromoethane or tert-butylamine. The distillation was then continued under 
vacuum to yield the product as a colorless liquid (11.05 g, 85.5%). Noteworthy, in the 
presence of water the product crystallizes as a white solid (m.p. 46°C). 
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C10H24N2 (172.31)  
1H NMR (400.1 MHz, CDCl3, 300K): δ = 1.09 (s, 18H, 1), 2.64 (s, 2H, 3). 13C{1H} NMR 
(100.6 MHz, CDCl3, 300K): δ = 29.4 (1), 43.5 (2), 50.2 (3). 
N,N’-1,3-Di-tert-butyl-2,2-dichloro-2,3-dihydro-1H-[1,3,2]diazasilole (180)[206] 
N,N’-Di-tert-butyl-ethylendiimin 179 (10.05 g, 59.7 mmol) was dissolved in THF (100 mL) 
and cooled to -78°C. Small chunks of lithim wire (0.93 g, 133.7 mmol) were added, 
whereupon the mixture gradually darkened to a red solution. If reaction did not take place, it 
could be initialized by means of ultrason. The solution was allowed to warm to room 
temperature for 24 h. The reaction mixture was then frozen with a liquid nitrogen bath, and 
SiCl4 () was added. The resulting mixture was allowed to warm to room temperature over 
night. Then the mixture was filtered and all volatiles were evaporated. Subsequent distillation 
(95°C, 0.1 mbar) afforded a colorless, air-sensitive crystalline solid (11.47 g, 71%). 
3
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C10H20Cl2N2Si (267.27)  
1H NMR (400.1 MHz, C6D6, 300K): δ = 1.24 (s, 18H, 3), 5.75 (s, 2H, 1). 13C{1H} NMR 
(100.6 MHz, C6D6, 300K): δ = 30.9 (3), 53.2 (2), 113.3 (1). IR (KBr): ν~ [cm-1] = 3360.1sbr, 
2977.4 s, 1731.0w, 1624.6w, 1473.2w, 1379.2m, 1197.7m, 1099.9m, 937.5w, 685.3w, 
545.8w. m.p. 72-73°C. EA %found (calcd): C: 44.34 (44.94), H: 7.57 (7.54), N: 10.24 
(10.48). 
N,N’-1,3-Di-tert-butyl-2,2-dichloro-1H-[1,3,2]diazasilole (183)[210b] 
N,N’-Di-tert-butyl-ethylendiamine 182 (1 g, 5.8 mmol) was dissolved in hexane (12.5 mL). 
At 0°C, SiCl4 (1.5 mL, 6 mmol) was added via syringe. The solution was then allowed to 
warm to room temperature, at which time triethylamine (2 mL, 14.3 mmol) was added. The 
solution was heated to reflux and stirred overnight. After cooling to room temperature, the 
reacton mixture was filtered and washed with hexane (8 mL). The volatiles of the filtrate were 
evaporated. Distillation of the remaining solid afforded a white crystalline air-sensitive solid 
(1.05 g, 67 %).  
3
NN2
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Si
Cl Cl  
C10H22Cl2N2Si (269,29) 
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1H NMR (400.1 MHz, C6D6, 300K): δ = 1.28 (s, 4H, 3), 3.08 (s, 4H, 1). 13C{1H} NMR 
(100.6 MHz, C6D6, 300K): δ = 29.1 (3), 41.8 (1), 52.0 (2). IR (KBr): ν~ [cm-1] = 3406s, 
29.76s, 28.74m, 1781m, 2467w, 2361w, 1582w, 1474m, 1385m, 1217s, 1059s, 963m, 871w, 
807w, 672s, 536s, 466w. m.p. 64-65°C. EA %found (calcd): C: 42.16 (44.60), H: 8.09 (8.23), 
N: 9.65 (10.40). 
1,3-Di-tert-butyl-2,3-dihydro-1H-1,3,2-diazasilol-2-ylidene (171)[40] 
In the glovebox KC8 (2.5 g, 18.4 mmol) is added to a stirred solution of N,N’-1,3-di-tert-
butyl-2,2-dichloro-2,3-dihydro-1H-[1,3,2]diazasilole 180 (2 g, 7.4 mmol) in THF (20 mL). 
The resulting solution is stirred at room temperature for approximately 18 h. The conversion 
is monitored by 1H NMR. The solution is filtered over celite, and the volatiles are evaporated. 
The crude product is purified by sublimation (60-75°C, 0.1 mbar). The silylene is obtained as 
a colorless solid (730 mg, 3.72 mmol, 50%). 
3
NN2
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C10H20N2Si (196,36) 
1H NMR (400.1 MHz, C6D6, 300K): δ = 1.41 (s, 18H, 1), 6.76 (s, 2H, 3). 13C{1H} NMR 
(100.6 MHz, C6D6, 300K): δ = 33.1 (1), 54.1 (2), 120.1 (3). 29Si NMR (90 MHz, C6D6, 
300K): δ = 78.0. 
1,3-Di-tert-butyl-2,3-[1,3,2]-diazasilolidine-2-ylidene (172) 
To a solution of NaK2 from sodium (0.06 g, 2.6mmol) and potassium (0.2 g, 5.1 mmol) in 
THF (5 mL) and triethylamine (2 mL) was added a solution of N,N’-1,3-di-tert-butyl-2,2-
dichloro-1H-[1,3,2]diazasilole 183 (1 g, 3.71 mmol) in THF (10 mL) via cannula at -78°C. 
The conversion is monitored by 1H NMR and filtered when complete after approximately 3 h. 
The filtrate was concentrated. The product was obtained as yellow crystals which turned red 
upon standing (340 mg, 46%). 
3
NN2
1
Si  
C10H22N2Si (198,38) 
1H NMR (400.1 MHz, d8-THF, 300K): δ = 1.29 (s, 18H, 1), 3.31 (s, 4H, 3). 29Si NMR (90 
MHz, d8-THF, 300K): δ = 31.9 (1), 47.0 (3), 53.1 (2). 
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7.6.2 Synthesis of Complexprecursors 
Bis-η4-(1,5-cyclooctadiene) rhodium(I) tetrafluoroborate (184) 
To a solution of [Rh(cod)Cl]2 (735 mg, 1.49 mmol) in CH2Cl2 (10 mL) was added 
subsequently 1,5-cyclooctadiene (0.55 mL, 4.49 mmol) and a solution of AgBF4 (665 mg, 
3.42 mmol) in acetone (5 mL). The dark-red suspension was stirred for 30 min at room 
temperature and then filtered through a plug of celite. After evaporation of the volatiles the 
solid was suspended in THF (10 mL), and filtered. After washing with THF (10 mL) and 
diethyl ether (5 mL) the dark-red solid was air-dried to yield (1.01 g, 83%). 
1
2
Rh BF4-
 
C16H24BF4Rh (406.07) 
1H NMR (400.1 MHz, CDCl3, 300K): δ = 2.5 (mbr, 4H, 1), 2.63 (mbr, 4H, 1), 5.37 (s, 4H, 2). 
13C{1H} NMR (100.6 MHz, CD2Cl2, 300K): δ = 30.1 (1), 108.0 (2). MS (+ESI) m/z: 320 
(MH+, 51.5), 274 ([M(MeOH)2]+-cod, 100).  
Bis-η4-(1,5-cyclooctadiene) rhodium(I) tetrakis-[3,5-bis(trifluoromethyl)phenyl] borate 
(185) 
To a solution of [Rh(cod)Cl]2 (100 mg, 0.2 mmol) in CH2Cl2 (3 mL) was added solid NaBArF 
(363 mg, 0.41 mmol). Addition of 1,5-cyclooctadiene (75 µL, 0.6 mmol) to the orange 
reaction mixture resulted in immediate formation of a dark-red suspension, which was stirred 
for 30 min at room-temperature and then filtered through a plug of celite. Evaporation of the 
volatiles afforded the product (387 mg, 81 % yield). The dark-red solid was recrystallized 
from CH2Cl2/hexane to give dark-red needles (320 mg, 67% yield). 
1
2
Rh B
3
4
5
6
F3C CF3
CF3
CF3
CF3F3C
7
F3C
F3C
 
C48H36BF24Rh (1182.48) 
1H NMR (400.1 MHz, CD2Cl2, 300K): δ = 2.42 (s, 8H, 1); 5.11 (s, 4H, 2), 7.54 (s, 4H, 6), 
7.69 (s, 8H, 4). 13C{1H} NMR (100.6 MHz, CD2Cl2, 300K): δ = 29.9 (1), 108.0 (d, 1JC-Rh = 
7.7 Hz, 2), 117.9 (6), 125.0 (q, 1JF-C = 272 Hz, 7), 129.0 (3), 135.1 (4), ~162 (q, 1JB-C = 50 Hz, 
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3) not observed. MS (+FAB, 3-NBA) m/z: 319 (M+, 100), 211 (M+-cod, 42.2.). IR (KBr): 
ν~ [cm-1] = 2936.5m, 1896.7m, 2845.4w, 1612.4m, 1432.7w, 1358.7s, 1280.9s, 1121.1sbr, 
986.5w, 889.1m, 836.3m, 780.1w, 711.8m, 674.1m. m.p. 175 °C (decomposition). EA 
%found (calcd): C: 48.62 (48.76), H: 3.07 (3.07). 
7.6.3 Synthesis of Silylene Complexes 
Tetrakis-(1,3-di-tert-butyl-2,3-dihydro-1H-1,3,2-diazasilol-2-ylidene) rhodium(I) tetrakis 
tetrafluoroborate (186) 
Silylene 171 (10.4 mg, 52 µmol) was dissolved in benzene-d6 (0.6 mL). Addition of solid 
[Rh(cod)2]BF4 (5 mg, 12.5 µmol) gave an orange-red suspension. After standing for 20 hours 
at room temperature, the solvent was decanted from the orange solid. The residue was diluted 
in CD2Cl2 for NMR-analysis. 
RhSi
N
N
Si
N
3
N2
1
Si
N
N
Si
N N
BF4-
 
1H NMR (400 MHz, CD2Cl2, 300K): δ = 1.53 (s, 72H, 1), 6.86 (s, 8H, 3). 13C{1H} NMR 
(125 MHz, CD2Cl2, 300K): δ = 34.0 (1), 56.4 (2), 121.2 (3). 29Si NMR (99 MHz, CD2Cl2, 
300K): δ = 93.5 (1JSi-Rh = 82 Hz).  
Tetrakis-(1,3-di-tert-butyl-2,3-dihydro-1H-1,3,2-diazasilol-2-ylidene) rhodium(I) tetrakis 
-[3,5-bis(trifluoromethyl)phenyl]borate (187) 
[Rh(cod)2]BArF (98 mg, 0.075 mmol) was weighed into a Schlenk tube suspended in hexane 
(2 mL). Addition of solid silylene 171 (60 mg, 0.306 mmol) afforded an orange suspension 
after stirring for 14 hours. The resulting solid was separated by filtration and washed three 
times with small amounts of hexane. After drying under high-vacuum the product was 
obtained in quantitative yield (based on 1H NMR) as a light-orange powder, which showed 
essentially the same NMR spectrum as recrystallized material. The extreme air-sensitivity of 
the powderous compound results in fuming and immediate decomposition when in contact 
with air. The product was recrystallized from CH2Cl2/hexane to afford dark-orange crystals.  
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RhSi
N
N
Si
N
3
N2
1
Si
N
N
Si
N N
B
4
5
6
7
F3C CF3
CF3
CF3
CF3F3C
8
F3C
F3C
 
C72H92BF24N8RhSi4 (1751.57) 
1H NMR (500 MHz, THF-d8, 300K): δ = 1.5 (s, 72H, 1), 6.83 (s, 8H, 3), 7.6 (s, 4H, 7), 7.76 
(t, 4JH-F = 2.5 Hz, 8H, 5). 13C{1H} NMR (125 MHz, THF-d8, 300K): δ = 30.1 (1), 55.8 (2), 
117.2 (7), 120.8 (3), 124.5 (q, 1JF-C = 272 Hz, 8), 129.0 (6), 134.6 (5), 161.8 (q, 1JB-C = 50 Hz, 
4). 29Si NMR (99 MHz, THF-d8, 300K): δ = 95.6 (1JSi-Rh = 82.5 Hz). IR (KBr): ν~ [cm-1] = 
2977s, 1611w, 1466m, 1396w, 1356m, 1279s, 1207m, 1123sbr, 1000w, 885m, 839m, 809w, 
738m, 713m, 659s. m.p. 200°C (decomposition). EA %found (calcd): C: 49.31 (49.37), H: 
5.15 (5.29), N: 6.30 (6.40).  
Tetrakis-(1,3-di-tert-butyl-2,3-[1,3,2]-diazasilolidine-2-ylidene) rhodium (I) tetrakis-[3,5-
bis(trifluoromethyl)phenyl]borate (188) 
The complex was synthesized as described above, starting from 98 mg (0.075 mmol) of 
[Rh(cod)2]BArF and 60 mg (0.3 mmol) of 172. From the resulting bright-yellow suspension 
after complex 5 was obtained in quantitative yield (based on 1H NMR) as a yellow powder, 
which was recrystallized from CH2Cl2/hexane to give light orange crystals.  
C72H100BF24N8RhSi4 (1759,64) 
RhSi
N
N
Si
N
3
N2
1
Si
N
N
Si
N N
B
4
5
6
7
F3C CF3
CF3
CF3
CF3F3C
8
F3C
F3C
 
1H NMR (500 MHz, THF-d8, 300K): δ = 1.38 (s, 72H, 1), 3.28 (m, 16H, 3), 7.55 (s, 4H, 7), 
7.72 (m, 8H, 5). 13C{1H} NMR (125 MHz, THF-d8, 300K): δ = 32.0 (1), 46.6 (3), 54.1 (2), 
117.4 (7), 120.8 (3), 124.0 (q, 1JF-C = 272 Hz, 8), 128.8 (6), 134.7 (5), 161.8 (q, 1JB-C = 50 Hz, 
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4). 29Si NMR (99 MHz, THF-d8, 300K): δ = 134.5 (1JSi-Rh = 76.6 Hz). IR (KBr): ν~ [cm-1] = 
2976m, 1611w, 1474m, 1396w, 1355m, 1279s, 1126sbr, 1036w, 973m, 887m, 838m, 803w, 
744w, 713m, 682m. m.p. ~195 °C (decomposition). EA %found (calcd): C: 48.74 (49.14), H: 
5.57 (5.73), N: 6.13 (6.37).  
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8 Appendix 
8.1 X-Ray Crystal Structures 
Single crystals were usually obtained through crystallization by dissolving the product in a 
small quantitiy of dichloromethan and carefully adding a layer of a non-solvent, such as 
hexane. The crystals were mounted with paraffin on a glass fibre goniometer head. This was 
attached to the KappaCCD diffractometer. Measurement were recorded at 173K. The space 
group was determined the systematic extinction by means of the “Collect” data collection 
software (Nonius BV, 2002). Collect can use either the HKL software 
(denzo/scalepack/xdisp) for integration[226], or the dirax/view/EvalCCD programs from 
Utrecht University.[227] The structure was solved with either SIR92[228] or SIR97[229] and 
refined in Crystals.[230] The absolute configuration and enantiopurity could be determined by 
refinement of the flack parameter.[231] The refined structures were checked with checkcif.[232] 
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Table 8.1 
 80 82 
empirical formula C24H44IrNOP, C32H12BF24 C26H40IrNOP, C32H12BF24 
formula weight [g mol-1] 1449.02 1469.01 
shape plate plate 
color orange orange 
temperature [K] 173 173 
radiation type MoΚα MoΚα 
wavelength [Å] 0.710730  0.710730 
crystal size 0.13×0.20×0.20 mm  0.10×0.20×0.20 mm 
crystal system orthorhombic monoclinic 
space group P 21 21 21 P 1 21 1 
a [Å] a = 19.156(5)  12.7512(2) 
b [Å] b = 24.665(4)  18.2817(3) 
c [Å] c = 24.8124(16) 12.9646(2) 
α [°] 90 90 
β [°] 90 101.601(8)  
γ [°] 90 90 
unit cell volume [Å3] 11723.4(39) 2960.49(8) 
Z 8 2 
calcd density [g cm-3] 1.642 1.648 
absorption coeff. µ[mm-1] 2.421 2.399 
F(000) 5760 1456 
limiting indices (measured) h = ±25, k = ±32,  
lmin, lmax = -32, 28 
h = ±16, k = ±23, l = ±16 
reflections collected/unique 123531/28180 25750/13531 
θ range for data collection  3.151° to 28.003° 1.603° to 27.493° 
completeness to θmax 0.997 0.999 
data/parameters 21928 (I>3σ(I)), 1451 11099 (I>3σ(I)), 840 
goodness-of-fit on F 1.001 1.1352 
R 3.83 4.49 
Rw 4.29 5.02 
Flack parameter -0.007(4) 0.007(7) 
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Table 8.2 
 83 88 
empirical formula C23H22IrNOP, C32H12BF24 C29H38IrNOP, C32H12BF24 
formula weight [g mol-1] 1435.00 1573.94 
Shape block plate 
color orange orange 
temperature [K] 173 173 
radiation type MoΚα MoΚα 
wavelength [Å] 0.710730  0.710730 
crystal size 0.28×0.28×0.24 0.31×0.18×0.09 
crystal system orthorhombic orthorhombic 
space group P 21 21 21 P 21 21 21 
a [Å] 18.974 (10) 12747 (2) 
b [Å] 24.5613 (2) 18.7599 (2) 
c [Å] 25.2943 (10) 26.2140 (3) 
α [°] 90 90 
β [°] 90 90 
γ [°] 90 90 
unit cell volume [Å3] 11787.80 (12) 6266.85 (14) 
Z 8 4 
calcd density [g cm-3] 1.617 1.668 
absorption coeff. µ[mm-1] 2.407 2.355 
F(000) 5696 3112 
limiting indices (measured) h = ±24, k = ±31, l = ±32 h = ±16, k = ±24, l = ±34 
reflections collected/unique 85676/26991 54640/14867 
θ range for data collection  1.156 to 27.493° 1.335 to 28.848° 
completeness to θmax 0.999 0.998 
data/parameters 19985 (I>3σ(I)), 1676 9028 (I>3σ(I)), 875 
goodness-of-fit on F 1.0351 1.0288 
R 3.35 3.39 
Rw 4.38 3.78 
Flack parameter 0.002 0.020 (7) 
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Table 8.3 
 120cis 133 
empirical formula C15H24NO2P BC55 F24H46IrNOP 
formula weight [g mol-1] 281.33 1427.08 
Shape plate needle 
color yellow black 
temperature [K] 173K 173K 
radiation type MoΚα MoΚα 
wavelength [Å] 0.710730  0.710730  
crystal size 0.08×0.12×0.28 0.12×0.13×0.33 
crystal system monoclinic orthorhomic 
space group P 1 21 1 P 21 2 21 
a [Å] 8.4760(2) 15.7169(16) 
b [Å] 6.9815(2) 17.350(2) 
c [Å] 14.0521(3) 20.0286(17) 
α [°] 90 90 
β [°] 107.4342(13) 90 
γ [°] 90 90 
unit cell volume [Å3] 793.34(3) 5461.5(10) 
Z 2 4 
calcd density [g cm-3] 1.178 1.735 
absorption coeff. µ[mm-1] 0.172 2.598 
F(000) 304 2816.277 
limiting indices (measured) h = ±11, k = ±9, l = ±19 h = ±23, k = ±25, l = ±29 
reflections collected/unique 4558/4549 (Rint = 0.0) 194150/18927 (Rint = 0.08) 
θ range for data collection  3.039 to 29.983° 3.022 to 32.003° 
completeness to θmax 0.996 0.997 
data/parameters 3538 (I>3σ(I)), 172 13443 (I>3σ(I)), 842 
goodness-of-fit on F 1.0883 1.088 
R 3.69 2.79 
Rw 4.18 2.85 
Flack parameter -0.02 (8) -0.001(4) 
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Table 8.4 
 162 187 
empirical formula C26H24IrNO3 C40H80N8RhSi4, C32H12BF24 
formula weight [g mol-1] 766.64 1751.59 
Shape plate plate 
color yellow orange 
temperature [K] 173K 173K 
radiation type MoΚα MoΚα 
wavelength [Å] 0.71073 0.71073 
crystal size 0.09×0.15×0.20 0.23×0.32×0.4 mm 
crystal system monoclinic monoclinic 
space group P 1 21 1 C 2/c 
a [Å] 10.2868 (10) 21.827 (2) 
b [Å] 9.8003 (10) 19.811 (2) 
c [Å] 13.6871 (2) 19.503 (2) 
α [°] 90 90 
β [°] 90.1135 108.762 (8)° 
γ [°] 90 90 
unit cell volume [Å3] 1379.84 (3) 7985 (2) 
Z 2 4 
calcd density [g cm-3] 1.845 1.457 
absorption coeff. µ[mm-1] 5.024 0.376 
F(000) 744 3608 
limiting indices (measured) h = ±17, k = ±16, l = ±22 h = ±30, k = ±29, l = ±27 
reflections collected/unique 25556/13276 (Rint = 0.02) 91539/11663 (Rint = 0.06) 
θ range for data collection  2.977 to 36.341° 1.424 to 30.039° 
completeness to θmax 0.996 0.998 
data/parameters 10399 (I>3σ(I)), 417 6679 (I>3σ(I)), 553 
goodness-of-fit on F 0.992 1.1384 
R 2.66 3.92 
Rw 2.71 4.12 
Flack parameter 0.001 (4) - 
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Table 8.5 
 188 
empirical formula C40H88N8RhSi4, C32H12BF24 
formula weight [g mol-1] 1759.65 
shape plate 
color yellow 
temperature [K] 173K 
radiation type MoΚα 
wavelength [Å] 0.71073 
crystal size 0.3×0.4×0.5 mm 
crystal system monoclinic 
space group C 2/c 
a [Å] 20.9469 (6) 
b [Å] 20.6092 (6) 
c [Å] 19.3746 (4) 
α [°] 90 
β [°] 103.192 (2)° 
γ [°] 90 
unit cell volume [Å3] 8143.3 (4) 
Z 4 
calcd density [g cm-3] 1.435 
absorption coeff. µ[mm-1] 0.369 
F(000) 3640 
limiting indices (measured) h = ±29, k = ±28, l = ±27 
reflections collected/unique 88079/11880 (Rint = 0.08) 
θ range for data collection  1.405 to 30.024° 
completeness to θmax 0.997 
data/parameters 6019 (I>3σ(I)), 552 
goodness-of-fit on F 1.026 
R 5.04 
Rw 5.28 
Flack parameter - 
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